<SEC-DOCUMENT>0001534969-23-000051.txt : 20230510
<SEC-HEADER>0001534969-23-000051.hdr.sgml : 20230510
<ACCEPTANCE-DATETIME>20230510161138
ACCESSION NUMBER:		0001534969-23-000051
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		71
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230510
DATE AS OF CHANGE:		20230510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SERA PROGNOSTICS, INC.
		CENTRAL INDEX KEY:			0001534969
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				261911522
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40606
		FILM NUMBER:		23906480

	BUSINESS ADDRESS:	
		STREET 1:		2749 E. PARLEYS WAY
		STREET 2:		SUITE 200
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84109
		BUSINESS PHONE:		(801) 990-0520

	MAIL ADDRESS:	
		STREET 1:		2749 E. PARLEYS WAY
		STREET 2:		SUITE 200
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84109
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sera-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:b6fd7582-a32b-479d-9964-70f04b6c290c,g:3cb67c47-ddd7-494a-a3a9-536b1cbe927e,d:4308cf9785ac4015a6c4393be0d820f4--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:sera="http://www.seraprognostics.com/20230331" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sera-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8wLTEtMS0xLTUwNTMx_22f8f34b-4ba1-4a08-9b4c-9d4f2454f7d9">0001534969</ix:nonNumeric><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8xLTEtMS0xLTUwNTMx_f62a20cf-d708-4bbf-a22c-07413f056e5a">12-31</ix:nonNumeric><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8yLTEtMS0xLTUwNTMx_becbee07-ce6a-4715-b868-37587a42adf1">2023</ix:nonNumeric><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8zLTEtMS0xLTUwNTMx_991f3637-d2fc-451a-b735-c90380d8a9bc">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl80LTEtMS0xLTUwNTMx_e1e5a5fb-eef5-4a8c-b161-a707d343e621">false</ix:nonNumeric><ix:nonNumeric contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_6babe0e6-7d50-47d4-ae07-e3d8e9b39332">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_9f65a529-ecfc-438c-ac40-deeaa75b2ba3">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_25937204-c7d0-4da0-b8e8-5206df574dab">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_f6cc0dfd-5c42-43a4-b226-d068765cef24">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_0a2d43e5-22d4-456d-aeb7-ab2c07bd5c2e">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_54e9da06-5917-4d9b-92d1-259e176f90a9">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sera-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27cc1a39b2364e15ae9b07bafaed08b2_I20230505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="icad9b28978d3427cad4b33b66939a88c_I20230505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2f86cfb811b477c983db67e5f541347_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc43b85330464574a0488ebcc9d967d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i44fb940986b84760a203d1102bc5f10c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a6d82be7a45430fb85fd8fb397576f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d7acae39b0445e2914b0355b32a99e9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4d3bc1d35134987a7abd9a77560576f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60cd390e284b4c57b8f9e0990b0772c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3233753d7b7b4837a79035352c82a4f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdec2990e11742fcac46b167e2f60113_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd28250132e4da59b3527f68bcd2be8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d61589d78c40e5b1ddd61b6d506e58_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a6260114f4c4349925d48192e947ea9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib06c86d910fe465187240359ca033ca7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib63e3a10c281463dba0c42a75f266866_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e8c63944d94a20a9d6766b70a0c209_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe8a51550be47699966c38055bb1d4b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6871c65cc944ab196c8853108ee6522_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6969513749542aeafcd5cabd8aff333_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102890e5579345c7a2782bb6c17ab3d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759304c058dd41a1a56e8cbcac33058d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib631629e369e46c19c68e6078da4b53d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabcd47f9f5ed4cbeba9b2fdfbdc1b4e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb72449e36d49a0b292d86de7324cfe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4142468cfaf94c8d97f33b6fa3846d59_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf3445dbebdb41acb50360773c5fda39_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7322891383e14b2098410a7e202ed9fe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea46d61e8284efc8e56b1f492df7b7e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i867e414c4ecc491ab33db86a734bf4cb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f2b384898354117be5364c3873188d6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib14c1cf96c624315af3e9139180f2e92_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c4637a2a61f4b8590e6d478924a5417_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60661342614546588426a472b8ef53eb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4f2723f75e0456e8f0fa2a83157de06_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ae393d120f14bfba0f069e945f76104_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bda022044a541ba852cd6e4a507ce4e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4abd6f79e2649dea270a120dcbdc006_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1022d938781243e393cbc94f72b676c4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9217e3b057e04c0b8ad6ad0356390301_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87361057a25b44d5a2e75382401dcee3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fab6b70134645aeb45e87280e5fab28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe79aa1340684f9e9f19d3b7afc15826_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ffcd942edee4fe393481beeab7dd9d4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fd42b824770484b83699c48bd0c8cc7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe7f8c3896d4801a873549768ca0361_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb30e5979214b32b0ec957e0ac792be_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i456d438d68a64c3b8c0f616f14448bf9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedde383675c6474f9513b3d03ac58c92_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0075a7a5e5c84f4687883ce000262d46_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i875cb27901f440cf9dd94dd0c4f5f742_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2deca7aa011c40308abedfe147f96001_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i310f7526568741c38f0faf45c71f9fde_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd2491cc9c53478d8582d7bf64db387e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbc319516ea3419a9ab9f009e01ff404_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7861a57d258d4089bf6e3c4e064742cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf90f3640b8b40f28e3c77908d915dfc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0689a9a22417417aa602cdd82583f081_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a04512600a14358b38ac15e0b2e874e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8d9fcb90d124c48bf1d71f64aa3bd4e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6dda952857f4641ac1036d6bfa8fc81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6a5bd83d0814d7f87102db81904b40b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb3cdc18256f4159ae134effb7028788_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i813380ad283a4a6c88946834430e11fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie590573b76374ef5bb34894c50c9c607_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cf2635c182d4ec9aecdb319305ba09a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02380a24291e41fe8beb052dfb3634a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1e6b5e7a18d4714be7dc3cd442de182_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f666d3ee1114f89a06ced8d07c1cac1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i633da3607bf74e6399a271d9b5a872dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c7078405bba49d8b9ae3c7a24e77d59_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a4c9f1b7de04945b27590548f7a034a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f38e0fd91b4bc9a6edd8c6525262eb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4f0e071eb624dad8e0ef430093db2f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26ad96634a0944fc8ff1db153b046a32_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d1569554ae410b8a9034cde1714135_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5c62d74c5e4c13b5b1f9a2db0cb194_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied68b9ca26b446e59b4b4f792f403d2b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7460c4b611a4c1a8deecbf81c1f906d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id73796b542fb4928ade5f07ade35d66b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f78ab542cac4bd0a4cde222a8e7e773_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13be094f9c244c158024b56a7cb5ecff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e5fb142963d40bc9752b25c78058aa4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf70dfed4cf44986832bd01bae60b309_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55bf665ab22b48dd84b5f6508b6dc531_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i262be437741d4c54906e37b798c135cd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib13ca83ce3884e60b6458d148f1cdfe4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2277bfa471754111acad933a7e99966c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9901b75d0bf4b4595246dc12220f857_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14d03532a9124a129f1031a6ffcab6a8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3283049b13a48a5b0dbb4875b2c82fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a86a8c7fd3142b59e9f55ee76ca645f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib17e4dfe8114480a9bd0dd5e85c27414_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1fef988414b43c6b092ed0b459b393c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e6d0b3094cc43ca8063063fc0d62736_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife9e1cfb0901453096411529be5647f8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9909f01379d9443cbe56ab0eacbd84b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb26f6e075f649db844239697d35cf44_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d5bf6251b7b4c75840430bed4b53f15_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057f6cfcbe9647feaf5cdc6e8b694c95_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0936c84ad3f94183aeff5843d1470ea0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie061ca627cde49dea9441184eba4360a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia61bb82bb96640b6a960d4a434b01d37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec6934a5de584a6f907ec7efe8ab449b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc6c9adab7224ca2974718d2d132d7c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602355d9b023442ea2e229223e367f52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6e649c834f541b1a07b68af95f39792_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854e50c14d1a416c81e655b988108acc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida65d68be4234d39ae17f2b0901689e3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d852401dd8c45f8bac931d6391e0d8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4150a09b96f64456861db2de07189a11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e2b7a1779484a588d3e5dcc2f75c5c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe6c97e0a004df6add4d077081e8986_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25502e94a007481095a51420d5929626_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6233338a3de4492ac7fc3602d7b3429_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81e3ed0434cf4e1fb660521a3660854b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea4329433de54b779062bdcbf483862a_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f467c43c88a4619bd1e2b17c7062c3b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="common_stock_class"><xbrli:measure>sera:common_stock_class</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>sera:vote</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ie51451f721f248449b164911776d14cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e8d27e73cfa42b68409d0498a6072d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bac8f889d2845938fb80af53ea359b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64464d2a8cea488d9bf93bc83aac4914_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5056875ac3244f5dbc3045e076055486_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008a3034f9504be4bce1130bdf12035d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i721dc8e4c62a42abba54bc026dbfa057_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df48d3ee72046c1810e7e4afa6e12be_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id97654d11c5a4152b663b94b04260e41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08ddab687a264ed4a1e0870d43ec1462_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd0a6e59f784d5e8a2a70335dc43e4b_D20111101-20111130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2011-11-01</xbrli:startDate><xbrli:endDate>2011-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2b38bbfb8c44e16b1a98f32cc4e64da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f872c050a642a4bd7b0d7bf50b2c15_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589f0422795f40b0be50fa589249a5ab_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a70c0650fb42628493971aa4f0049c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib678e71d507240f7846a08db78ba061b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e85b9ebdb094f55a3f434b347ee787f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93bd5d88af7d410491f05716f1ed0e5f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52391e73e9df469c9e683c465b16f7c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91b41e5291034c509f187d546c338915_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd63d2c7f48d408eb0ef89901295964a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia80510f4b99d4483a37744999f4d0341_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97033eb4f8a64db2bc5f6fcfc26a6886_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c737e7bf4884940ada07d1250bbf18e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9359a27c7fc744aca0a2a0f6deb31bd8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e203d056cc4c4ca4772af00ea4d039_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i204da10f0e0c49cc8fb8c1a4ead9508e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id725e1f4b6344f8c9931c7da191af02c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30dc8f5c5dd54233a474c8e03313302d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ab44e1fd1540469f0224dbf57e43d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81d9531da7ae47c68f3176caa531bcf5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05a6fd71531c4266a8e69e0f3d9add84_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:OfficeAndLaboratorySpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="ie0f674f4a02e45538fdadde638cf5023_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5757bb4043fa4bfa81cdae4e0992837e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3457c2e17d7a435d9fb262c2803a96c4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b56fe25f1c4153929837bcc4db56ea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70567ef2894436ab885809a5090432e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa36120b8dea4505af0c3a1b3720cbf0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4308cf9785ac4015a6c4393be0d820f4_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:30pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY4_7edd7b2e-3892-4a9d-b96d-e4c8da8f1b19">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ODBkNTA3YjlmYjlkNDE1OThlYTllYmFkYTZmYWEyYzUvdGFibGVyYW5nZTo4MGQ1MDdiOWZiOWQ0MTU5OGVhOWViYWRhNmZhYTJjNV8wLTAtMS0xLTUwNTMx_e2bd8f0e-999b-4513-9af6-8e9c0ccda7cc">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8xODc_6e9018b6-95f8-44cd-a904-dc5e10de2a2b">March 31, 2023</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6Yjk2MjIxMTAwZmM1NDY2MTlhYWQ2NGI3M2JiNGUxZTUvdGFibGVyYW5nZTpiOTYyMjExMDBmYzU0NjYxOWFhZDY0YjczYmI0ZTFlNV8wLTAtMS0xLTUwNTMx_cb932ee4-3765-40b8-bc48-73b0717a5322">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY5_85cc7bb0-8bd2-4fb5-a895-b0eab58247c4">001-40606</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDYz_035633ec-4586-4361-8efa-bafbd5582f4a">SERA PROGNOSTICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18wLTAtMS0xLTUwNTMx_8fec0e5f-fc05-43ca-b9cc-c3882fa9ed1a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18wLTItMS0xLTUwNTMx_a807f338-49cb-45eb-836d-e6489b98227e">26-1911522</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfNQ_7ea810ac-6767-4746-b86f-2fde90c88dc4">2749 East Parleys Way</ix:nonNumeric>, <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfOQ_e9779dfa-1928-4be7-9b14-22754e4bf1dd">Suite 200</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfMTI_91809972-0989-4fb4-89c6-fa38c7bc2910">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfMTY_d07a7ce0-704c-40b5-bdf1-7d51e074f268">Utah</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTItMS0xLTUwNTMx_d26fb047-5597-40b2-be4b-e524c12b8bd8">84109</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY0_698035a7-ec8f-46d1-8f22-0075c3a59709">801</ix:nonNumeric>) <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY1_e3540ad7-8812-4cf6-b955-d9c6926ae4d4">990-0520</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6OTQyNWM0MWU1MjE3NGQ2NjhkMmFlMGVlOTJkODdiMWIvdGFibGVyYW5nZTo5NDI1YzQxZTUyMTc0ZDY2OGQyYWUwZWU5MmQ4N2IxYl8xLTAtMS0xLTUwNTMx_b1cd40f5-b440-434f-b222-3c18bc65647c">Class A Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6OTQyNWM0MWU1MjE3NGQ2NjhkMmFlMGVlOTJkODdiMWIvdGFibGVyYW5nZTo5NDI1YzQxZTUyMTc0ZDY2OGQyYWUwZWU5MmQ4N2IxYl8xLTItMS0xLTUwNTMx_abbf5408-9053-4dde-b2b4-621b499afeaa">SERA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">The <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6OTQyNWM0MWU1MjE3NGQ2NjhkMmFlMGVlOTJkODdiMWIvdGFibGVyYW5nZTo5NDI1YzQxZTUyMTc0ZDY2OGQyYWUwZWU5MmQ4N2IxYl8xLTQtMS0xLTUwNTMxL3RleHRyZWdpb246ZmU5MzM2MjI4MzdmNDgxZmIwMTFlMWI0MzY2ZTliMzZfOA_acc38ecf-3a38-4c3c-b877-19a3248188d4">Nasdaq</ix:nonNumeric> Stock Market LLC</span></div></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDcw_df0c372f-b4b1-47ee-b5bf-b51fe9c59d63">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDcx_3e10c087-940b-4d47-a55e-f64c1ee33fdb">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6M2M4YTMzZWE1NDFmNDQxNmIyOTE0OTdhMTA2NTRjZGIvdGFibGVyYW5nZTozYzhhMzNlYTU0MWY0NDE2YjI5MTQ5N2ExMDY1NGNkYl8xLTAtMS0xLTUwNTMx_7d51eb08-6e82-4e26-a2d5-516017373121">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6M2M4YTMzZWE1NDFmNDQxNmIyOTE0OTdhMTA2NTRjZGIvdGFibGVyYW5nZTozYzhhMzNlYTU0MWY0NDE2YjI5MTQ5N2ExMDY1NGNkYl8xLTMtMS0xLTUwNTMx_7623cd1c-e082-4aea-93f5-84827087aadd">x</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6M2M4YTMzZWE1NDFmNDQxNmIyOTE0OTdhMTA2NTRjZGIvdGFibGVyYW5nZTozYzhhMzNlYTU0MWY0NDE2YjI5MTQ5N2ExMDY1NGNkYl8yLTMtMS0xLTUwNTMx_293270ed-8a80-4013-99f3-9e54062b416c">x</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY3_b8661ae3-f64d-4f61-82d5-6a4de1280d00">o</ix:nonNumeric></span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDYy_e620940d-4dba-48c8-890e-59be38911b8a">x</ix:nonNumeric></span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of May&#160;5, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="i27cc1a39b2364e15ae9b07bafaed08b2_I20230505" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8xOTUy_d393ff17-e11b-49e6-9a93-f5514d83bf05">29,646,843</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="icad9b28978d3427cad4b33b66939a88c_I20230505" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8xOTU5_32c80571-34d9-4dde-9fba-ef933c030846">1,405,259</ix:nonFraction> shares of Class A and Class B common stock, $0.0001 par value per share, outstanding, respectively.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_10">Special Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_10">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_13">PART I &#8212; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_19">Condensed Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_22">Condensed Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_25">Condensed Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_28">Condensed Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_31">Notes to Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_79">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_79">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_115">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_115">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_115">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_118">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_118">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_118">27</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_121">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_121">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_124">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_124">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_124">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_127">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_127">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_127">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_130">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_130">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_130">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_133">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_133">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_133">69</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_136">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i4308cf9785ac4015a6c4393be0d820f4_136">70</a></span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Sera,&#8221; &#8220;PreTRM,&#8221; &#8220;The Pregnancy Company&#8221; and our logo are our trademarks. All other service marks, trademarks, and trade names appearing in this quarterly report on Form 10-Q are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies. Solely for convenience, trademarks and tradenames referred to in this quarterly report on Form 10-Q may appear without the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or &#8482; symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and tradenames. Unless the context otherwise requires, we use the terms &#8220;Sera,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this report to refer to Sera Prognostics, Inc.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In some cases, you can identify forward-looking statements by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these words or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimates of our addressable market, market growth, future revenue, key performance indicators, expenses, capital requirements, and our needs for additional financing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the rate and degree of market acceptance of our PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of our PreTRM test, including the results of any studies of the test, on the field of bioinformatics and proteomics and the size and growth of the addressable bioinformatics and proteomics market;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain funding for our operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage and grow our business and commercialize our PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and commercialize new products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to retain the continued service of our key professionals and to identify, hire, and retain additional qualified professionals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pricing and reimbursement of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model, strategic plans for our business, products and technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to our competitors and our industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the accuracy of our estimates regarding expenses, capital requirements, and needs for additional financing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of COVID-19 on our business; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conditions in general economic and financial markets; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial performance.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in the &#8220;Risk Factors&#8221; section and elsewhere in this report. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable as of the date of this report, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this report to conform these statements to new information, actual results or to changes in our expectations, except as required by law.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8212; FINANCIAL INFORMATION</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_16"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements (Unaudited)</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_19"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMy0xLTEtMS01MDUzMQ_fd611c45-90be-4300-89b6-34691ef4e54b">27,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMy0zLTEtMS01MDUzMQ_a8663b1d-c13d-4dc3-9684-477c507b2b66">29,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNC0xLTEtMS01MDUzMQ_e5cd3dd0-e7ee-4cbc-ab8f-12264a130dc6">43,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNC0zLTEtMS01MDUzMQ_b3c99fd3-dcf3-4ae6-8fa4-41e3da6b66d7">52,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNS0xLTEtMS01MDUzMQ_4436d1ae-5f02-4617-924f-abb2ad3bc9c4">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNS0zLTEtMS01MDUzMQ_bcac24ef-873a-49b8-b014-fc8a02b38c73">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNi0xLTEtMS01MDUzMQ_3e6b8b5b-6a01-421a-a0d9-db40d80bc53a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNi0zLTEtMS01MDUzMQ_6557fe7e-e347-460c-ac36-3387d5e4cd54">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNy0xLTEtMS01MDUzMQ_d34bc3d1-9993-408e-8c12-09a86dea72b4">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNy0zLTEtMS01MDUzMQ_f55ab9ff-e4e4-474b-9c28-e2080e91cd41">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOC0xLTEtMS01MDUzMQ_3780bb76-bce6-4ef0-a5c1-f468a5381ea3">72,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOC0zLTEtMS01MDUzMQ_02f02528-e953-4382-be59-26b929caf930">90,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOS0xLTEtMS01MDUzMQ_4e93333c-99f3-415d-859d-b5da63530e7b">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOS0zLTEtMS01MDUzMQ_afb7ff16-ab04-4a20-ac79-efc5d7648304">3,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTAtMS0xLTEtNTA1MzE_32ac1d93-680f-4e7a-b5fc-7cee80a40638">28,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTAtMy0xLTEtNTA1MzE_fb1a3d68-e81e-4f21-9256-b95839c7d684">21,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTEtMS0xLTEtNTA1MzE_bbaf9bf8-b540-42ac-9a12-02fe972b3d43">1,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTEtMy0xLTEtNTA1MzE_13aec41a-17f9-4652-b762-5b82f8387ad6">1,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTItMS0xLTEtNTA1MzE_2cc57e8d-6b69-4d7f-9060-cd1ce130f4c6">105,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTItMy0xLTEtNTA1MzE_72ffca1f-b9fd-408e-92c2-9a73ff8627e1">116,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTUtMS0xLTEtNTA1MzE_bc22f7a9-32f9-4672-9758-d5cc1f8df52f">1,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTUtMy0xLTEtNTA1MzE_f405e9f8-8668-4757-aff4-87b5d791564a">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTYtMS0xLTEtNTA1MzE_4f05a9bc-eab2-48ac-81eb-7a10e69bfb86">2,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTYtMy0xLTEtNTA1MzE_e9a66d75-1ade-4376-98ad-805dca0cf500">4,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance lease obligation, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTgtMS0xLTEtNTA1MzE_0362aa7e-81ca-4495-981a-f0d9c03eb621">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTgtMy0xLTEtNTA1MzE_72b68705-9537-41c5-9b54-4abfeaa71ce2">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTktMS0xLTEtNTA1MzE_65dd142f-f12d-4ab3-ba80-20edbb42f2a3">9,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTktMy0xLTEtNTA1MzE_e0433dac-acf2-4148-a03f-a34fd0a63918">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjAtMS0xLTEtNTA1MzE_15c62424-eb37-44e0-8f28-c7a776b9fdd6">13,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjAtMy0xLTEtNTA1MzE_4de95bf4-a45d-46aa-be6e-cf84dd45b63e">15,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance lease obligation, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMS0xLTEtNTA1MzE_7ed001a2-9f97-4e8e-851c-645ce403a15b">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMy0xLTEtNTA1MzE_22c16f78-e317-4eab-8fec-191f98172482">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating lease obligation, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMS0xLTEtNTEzNTU_2a763394-d9ad-4c40-a757-41785cff48fc">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMy0xLTEtNTEzNTU_5b1b830f-dc08-4be2-8a76-82a4ea39d85f">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjItMS0xLTEtNTA1MzE_d158c290-affc-4571-bb37-5062c5e6405f">15,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjItMy0xLTEtNTA1MzE_e54da24a-4463-48f2-a1dd-60a5e32a3f3f">17,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Commitments and contingencies (Note 12)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjMtMS0xLTEtNTA1MzE_34741ab3-0b29-456c-bed2-fc4f80a8888c"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjMtMy0xLTEtNTA1MzE_a0b2ce0f-7f84-4811-a796-294cd05c2432"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_074286c1-4027-4558-8584-fab7c6b717a0"><ix:nonFraction unitRef="usdPerShare" contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_5e6105c6-16e5-4b44-a61c-6c2597bcb09c"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_7fb32064-68dc-460d-95c5-f739c431677f"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_bfa72896-bfe8-4d3c-8827-85f1a73a6e97">0.0001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8zMg_57977e4b-17c0-40d0-ab66-f5dde3634b82"><ix:nonFraction unitRef="shares" contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8zMg_a169f7fa-0b64-4a93-ad8d-fce2fd5a14a2">150,000,000</ix:nonFraction></ix:nonFraction> Class A shares authorized; <ix:nonFraction unitRef="shares" contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV83OA_079bfd78-a8c1-492b-b705-a82edf313019"><ix:nonFraction unitRef="shares" contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV83OA_6b28fe5e-dc3e-4ed5-a383-33d493057dd9">29,616,781</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV84NQ_a941071c-6abf-4888-976a-c91d7178531d"><ix:nonFraction unitRef="shares" contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV84NQ_efa51b77-d4cf-4a9b-a8ce-edd189d9d0b5">29,612,687</ix:nonFraction></ix:nonFraction> Class A shares issued and outstanding as of March&#160;31, 2023 and December&#160;31, 2022, respectively; <ix:nonFraction unitRef="shares" contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xNTc_02afdc16-2cf4-42e5-8f82-b5a5b4df0041"><ix:nonFraction unitRef="shares" contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xNTc_4800c83d-fdaa-463c-94cb-73131ec1254e">1,500,000</ix:nonFraction></ix:nonFraction> Class B shares authorized; <ix:nonFraction unitRef="shares" contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_04d09fdd-36f0-47de-9828-d97c0e77393e"><ix:nonFraction unitRef="shares" contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_2d01cce8-e1b9-4972-8bc7-ee7f3cc3987f"><ix:nonFraction unitRef="shares" contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_5013eb0c-66d2-44fc-83f2-9c7b299c8f8f"><ix:nonFraction unitRef="shares" contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_54c3a112-3ace-41c0-a1c9-bb8d1d6b1182">1,405,259</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Class B shares issued and outstanding as of March&#160;31, 2023 and December&#160;31, 2022.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMS0xLTEtNTA1MzE_e9eaffb4-200a-405d-977d-83ec0f86e09c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMy0xLTEtNTA1MzE_e68a838e-6606-47cf-91da-1c0978aef40d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjYtMS0xLTEtNTA1MzE_4440f282-b022-4aeb-8eb0-004706efaea1">311,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjYtMy0xLTEtNTA1MzE_f2542505-a2da-4efb-90eb-3ca52a3c62c0">310,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjctMS0xLTEtNTA1MzE_db9d3a7c-5b28-4750-afc4-c6cd7858246f">457</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjctMy0xLTEtNTA1MzE_ecb8d4aa-9d23-4d09-bcb2-047cf5ee409b">981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjgtMS0xLTEtNTA1MzE_e866aaa8-8098-46fd-a7b4-429a45a2e49e">221,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjgtMy0xLTEtNTA1MzE_b82e948a-16a7-49b9-80a8-553a3d59b472">210,654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjktMS0xLTEtNTA1MzE_ea72505c-9b63-424a-94a4-a058065d8d8a">90,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjktMy0xLTEtNTA1MzE_57282779-34dd-41d7-9576-641b17113bcb">98,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMzAtMS0xLTEtNTA1MzE_485ba831-145a-4dfb-8275-3873278cb620">105,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMzAtMy0xLTEtNTA1MzE_76915d87-c62e-4746-a2ff-8bcf86256de0">116,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMi0xLTEtMS01MDUzMQ_5d4b3143-3733-4e26-81ab-cd323be44964">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMi0zLTEtMS01MDUzMQ_4c1b77f7-7dde-49ab-81ab-93745b62e72e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNC0xLTEtMS01MDUzMQ_fe173191-c55f-481c-a33a-ce7dd77a5b9d">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNC0zLTEtMS01MDUzMQ_7e4b1eb7-c6dc-44a9-aa45-c0549c9912e1">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNS0xLTEtMS01MDUzMQ_6cccb8db-fad5-4ab0-896a-379a35a35fe3">4,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNS0zLTEtMS01MDUzMQ_c46cd470-a993-4d06-b6ac-9207d0fec699">3,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNi0xLTEtMS01MDUzMQ_6fd50325-d923-45e0-8b13-69d0092f13cf">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNi0zLTEtMS01MDUzMQ_3689af41-4f5a-45bd-ac1b-963935e055d7">4,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNy0xLTEtMS01MDUzMQ_07c9f32e-a315-4f73-9346-5c8d6052dd0f">4,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNy0zLTEtMS01MDUzMQ_922bc64a-c29d-4418-8109-9245826427a1">4,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOC0xLTEtMS01MDUzMQ_4f542f12-5582-40f4-995f-a96d25349913">11,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOC0zLTEtMS01MDUzMQ_2f6d6a1e-7b57-40c8-ab9b-8f4cb25a7e73">12,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOS0xLTEtMS01MDUzMQ_1f0165aa-efe7-4c1a-b9a5-0f9c373ceaf9">11,329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOS0zLTEtMS01MDUzMQ_0ec407f0-f8ca-43c4-8638-234c898349ed">12,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTAtMS0xLTEtNTA1MzE_b3bc97c0-df3b-4c05-a79e-82786bb939f0">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTAtMy0xLTEtNTA1MzE_9521a544-c35c-4e05-a50c-54f3c34209c7">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTEtMS0xLTEtNTA1MzE_2b5fe9c0-c334-49fe-bf7b-cd19dc8e2cfb">780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTEtMy0xLTEtNTA1MzE_0f5ce87e-9707-471c-aedd-8cc5f75e71e5">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTItMS0xLTEtNTA1MzE_e765f4c1-e409-4f83-9387-cfe4a72feb03">10,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTItMy0xLTEtNTA1MzE_e82a2d35-ba53-4a2f-9caf-dfff1d034dda">12,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMS0xLTEtNTA1MzE_50792cf6-ec2e-4669-8ba3-661b98c7539e"><ix:nonFraction unitRef="usdPerShare" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMS0xLTEtNTA1MzE_761d01b5-f028-4a81-b433-d45751e7a06d">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMy0xLTEtNTA1MzE_b3f592ac-8d73-4b38-a006-70084f551f61"><ix:nonFraction unitRef="usdPerShare" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMy0xLTEtNTA1MzE_c205603d-0fa0-4f5e-9d63-914c3d7f9281">0.40</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMS0xLTEtNTA1MzE_5a487f19-4999-46e8-973e-a380f7d8df01"><ix:nonFraction unitRef="shares" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMS0xLTEtNTA1MzE_872c76a8-8106-4833-a7bf-f1a1e95fdbf7">31,019,311</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMy0xLTEtNTA1MzE_454b3d32-08bf-4e03-aed5-eb6a2d88d4bb"><ix:nonFraction unitRef="shares" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMy0xLTEtNTA1MzE_af998f3c-7731-4914-9d09-e645db052885">30,801,579</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on available-for-sale debt securities </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTYtMS0xLTEtNTA1MzE_894f8215-968d-452b-a0d1-5c59371a62c2">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTYtMy0xLTEtNTA1MzE_4490728b-3644-46e0-a888-92b96138ae5b">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTctMS0xLTEtNTA1MzE_c9ccfb34-4896-4743-8e74-cb4144e3db0f">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTctMy0xLTEtNTA1MzE_09cb37c2-d5e1-4e1b-bcec-45b1eaeff67a">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTgtMS0xLTEtNTA1MzE_bb7bd9f1-eaa7-4712-8f37-60d5b20689c8">10,041</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTgtMy0xLTEtNTA1MzE_1c2ddeeb-d0a4-428a-abcc-8daa0be0a9de">12,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share data)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.631%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock<br/>(Class A and B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="id4d3bc1d35134987a7abd9a77560576f_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xMC0xLTEtNTA1MzE_284294cd-d896-4fd2-b297-eab567f35eda">31,017,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id4d3bc1d35134987a7abd9a77560576f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xMi0xLTEtNTA1MzE_6a3306ca-e422-4d0d-be86-649a74933a78">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i60cd390e284b4c57b8f9e0990b0772c5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xNC0xLTEtNTA1MzE_6b18f2d3-db5a-4fe8-975f-e7985b09faec">310,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3233753d7b7b4837a79035352c82a4f5_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xNi0xLTEtNTA1MzE_912fd701-3a49-45cc-9d7c-9006b2e74118">981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibdec2990e11742fcac46b167e2f60113_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xOC0xLTEtNTA1MzE_e93fae71-fdd3-489f-bcd7-f99197f2254e">210,654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0yMC0xLTEtNTA1MzE_6cb53ce5-1a57-432f-8050-a5495f8770ac">98,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iebd28250132e4da59b3527f68bcd2be8_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMy0xMC0xLTEtNTA1MzE_e5ea616a-9934-40f8-abcc-f9dc1e186ee1">4,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i91d61589d78c40e5b1ddd61b6d506e58_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMy0xNC0xLTEtNTA1MzE_5cd37af6-db4f-45ca-970b-44b75ce1d041">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMy0yMC0xLTEtNTA1MzE_376dfda5-36fa-4bfb-8794-4f47b698e018">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i91d61589d78c40e5b1ddd61b6d506e58_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNC0xNC0xLTEtNTA1MzE_54712f7c-4a17-413d-9af6-e86c54dfc3e8">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNC0yMC0xLTEtNTA1MzE_3b2a7a40-d59d-46d0-9b65-d08b4b0bfaa9">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3a6260114f4c4349925d48192e947ea9_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNS0xNi0xLTEtNTA1MzE_3e9c192b-e9ac-4230-be05-8f8f280b491f">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNS0yMC0xLTEtNTA1MzE_71999a9c-af93-4361-ae7a-a181870fe86b">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib06c86d910fe465187240359ca033ca7_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNi0xOC0xLTEtNTA1MzE_a96e628d-3634-4df9-aed6-564df917afee">10,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNi0yMC0xLTEtNTA1MzE_369991ac-a93b-40a1-b2e7-25eaed685465">10,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.2pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ib63e3a10c281463dba0c42a75f266866_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xMC0xLTEtNTA1MzE_f32bd792-9abb-43f7-a7cd-e1ef744a5c78">31,022,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib63e3a10c281463dba0c42a75f266866_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xMi0xLTEtNTA1MzE_f6a5d6ea-3fb0-46c3-ae62-88b3d8c40f8d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i29e8c63944d94a20a9d6766b70a0c209_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xNC0xLTEtNTA1MzE_43d2c68c-29d9-48d1-ab80-7563c00b2e15">311,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9fe8a51550be47699966c38055bb1d4b_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xNi0xLTEtNTA1MzE_ca02bf3e-7d44-4bad-b164-2d4eed67d5b3">457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id6871c65cc944ab196c8853108ee6522_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xOC0xLTEtNTA1MzE_b4834f33-2a6b-4180-88d2-bda570b21c22">221,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0yMC0xLTEtNTA1MzE_6af6076c-6021-4339-b4f4-d8e74efa8fd2">90,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.631%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock<br/>(Class A and B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ie6969513749542aeafcd5cabd8aff333_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xMC0xLTEtNTA1MzE_88282d74-1161-4a4a-9c01-18d59713442b">30,774,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie6969513749542aeafcd5cabd8aff333_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xMi0xLTEtNTA1MzE_4abf4447-d265-4533-bffd-bbc282e907f9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i102890e5579345c7a2782bb6c17ab3d8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xNC0xLTEtNTA1MzE_d9654383-58ce-40e6-8a9c-cdb7b748c397">305,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i759304c058dd41a1a56e8cbcac33058d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xNi0xLTEtNTA1MzE_7878342a-a071-4445-b1a1-e3c334d3fa85">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib631629e369e46c19c68e6078da4b53d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xOC0xLTEtNTA1MzE_0034c27a-9df2-42df-87bf-69cf22b62e95">166,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iabcd47f9f5ed4cbeba9b2fdfbdc1b4e7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0yMC0xLTEtNTA1MzE_aac52567-0ed4-4b70-a7a9-16b986b47e12">138,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i3eb72449e36d49a0b292d86de7324cfe_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNC0xMC0xLTEtNTA1MzE_04f84187-036e-47be-9879-82e934e78517">123,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4142468cfaf94c8d97f33b6fa3846d59_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNC0xNC0xLTEtNTA1MzE_19babd2d-fb83-4eac-bdc8-6432ea23c076">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNC0yMC0xLTEtNTA1MzE_b73967b4-d476-4a5c-8ad5-1fe71eb13f9e">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4142468cfaf94c8d97f33b6fa3846d59_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNS0xNC0xLTEtNTA1MzE_17bcb2ca-0908-4afe-839f-4ff70c31a11e">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNS0yMC0xLTEtNTA1MzE_c72da1f0-db05-4801-ba72-7fefa8e30231">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="iaf3445dbebdb41acb50360773c5fda39_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNi0xNi0xLTEtNTA1MzE_94620d95-4f16-4ba2-a2c4-b1d0fd569125">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNi0yMC0xLTEtNTA1MzE_19c39774-09d3-4260-a5b9-ac860c53da88">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i7322891383e14b2098410a7e202ed9fe_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNy0xOC0xLTEtNTA1MzE_6c1d9b27-6f4b-41f1-b25e-e7d007556c9c">12,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNy0yMC0xLTEtNTA1MzE_c3a507c6-00a9-4434-83fa-10fb725dc4cc">12,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of March&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5ea46d61e8284efc8e56b1f492df7b7e_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xMC0xLTEtNTA1MzE_3bf8e9bd-46e1-4431-b485-60be0b602a4a">30,897,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5ea46d61e8284efc8e56b1f492df7b7e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xMi0xLTEtNTA1MzE_bdc1d6e5-8f7c-415a-ab1b-8242542f2817">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i867e414c4ecc491ab33db86a734bf4cb_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xNC0xLTEtNTA1MzE_35a114e1-8b0e-41b4-a565-5df9592676db">306,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5f2b384898354117be5364c3873188d6_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xNi0xLTEtNTA1MzE_325fac73-ea7a-440c-a703-4bee2934015c">656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib14c1cf96c624315af3e9139180f2e92_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xOC0xLTEtNTA1MzE_d7f1d984-ad9a-41d6-ac53-58f51991e5b9">178,676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0yMC0xLTEtNTA1MzE_0a32df1b-643d-41d5-964f-b929f43ca30f">127,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMy0xLTEtMS01MDUzMQ_c7e42871-eada-4c63-bb0c-6c34c724e35b">10,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMy0zLTEtMS01MDUzMQ_e30100f3-0642-4983-a9a4-9cfb78f14a8e">12,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNS0xLTEtMS01MDUzMQ_2b0ba7b8-e93c-428a-a378-b1d1c13072cb">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNS0zLTEtMS01MDUzMQ_ecf86797-ee57-4caa-abca-df06a1314aec">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNi0xLTEtMS01MDUzMQ_39d03e5a-3105-44d7-b5d2-9fd5e2d9d4c4">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNi0zLTEtMS01MDUzMQ_1f9bfb0c-53d2-4aef-9a70-c8ec15754874">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNy0xLTEtMS01MDUzMQ_327a1ab7-b423-4bfe-b188-1aab21a44393">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNy0zLTEtMS01MDUzMQ_cb1a05af-2923-47f5-ac59-6b82943b93d5">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:PaidInKindInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfOC0xLTEtMS01MDUzMQ_03c6704f-1ecc-4611-b8b7-c9f47d9a444c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:PaidInKindInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfOC0zLTEtMS01MDUzMQ_15207d21-cf4d-45f0-962f-af272c7fbeaf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTAtMS0xLTEtNTA1MzE_70410029-79f5-47b4-99d8-1672c3e2b9f5">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTAtMy0xLTEtNTA1MzE_3c3ed938-441d-43d4-96f2-6ee3df4357bd">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTItMS0xLTEtNTA1MzE_194d3399-47a0-4ace-8c85-2689d63460df">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTItMy0xLTEtNTA1MzE_fcb7093c-d38c-42f2-9463-e79aa7a36864">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTMtMS0xLTEtNTA1MzE_3c6974cf-da44-4242-a01c-afce4caddaec">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTMtMy0xLTEtNTA1MzE_b784be6e-5a47-4b66-9ad1-5ce2588b563e">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTQtMS0xLTEtNTA1MzE_678b6631-73b7-4f1d-b5d8-976df700f1bb">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTQtMy0xLTEtNTA1MzE_984895db-0920-4070-9f3e-bbf6cee96f07">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTUtMS0xLTEtNTA1MzE_8a54d8d3-b76e-41b2-b268-b87b169cbd5a">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTUtMy0xLTEtNTA1MzE_035b9c92-3e9c-4973-a598-e827962b6d88">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTYtMS0xLTEtNTA1MzE_660a8984-77d9-4682-a3a2-c48b6005aac8">1,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTYtMy0xLTEtNTA1MzE_dd169cc2-bcba-4301-9fdc-5ef49a65d11c">1,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTgtMS0xLTEtNTA1MzE_4bd696e3-0816-46d8-9fee-e238fc37a472">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTgtMy0xLTEtNTA1MzE_a3302257-7f28-4a5e-b094-5d1f0c264310">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTktMS0xLTEtNTA1MzE_8cedb829-526a-43d4-8e46-5a7a9ae38590">4,881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTktMy0xLTEtNTA1MzE_cd47979a-2ece-41d7-9e20-af491520a73b">9,557</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjEtMS0xLTEtNTA1MzE_0e487e86-7ee6-41ba-9341-9ef83eb76281">14,735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjEtMy0xLTEtNTA1MzE_5f54e306-2834-421f-9590-2607686c4b0c">6,614</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from maturities and sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjItMS0xLTEtNTA1MzE_a994f8b0-69a0-4415-bf74-64c4447c188c">17,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjItMy0xLTEtNTA1MzE_ee9da332-65ba-4e57-b925-b8a1a03b4155">21,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjMtMS0xLTEtNTA1MzE_66577e82-d01c-4e23-a756-f5f22b0d4a82">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjMtMy0xLTEtNTA1MzE_a0bf3273-71b1-42fa-a7b8-dd2f81562d2e">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjQtMS0xLTEtNTA1MzE_b4254903-168f-4239-8cc2-3c3eef257a61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjQtMy0xLTEtNTA1MzE_7e35ca34-13ac-41fc-a31a-56a0ec513708">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjUtMS0xLTEtNTA1MzE_d38f1abc-bada-4d78-a00e-e63423c3a694">2,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjUtMy0xLTEtNTA1MzE_51dc4802-99bc-48db-a20b-c63849e11505">14,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzAtMS0xLTEtNTA1MzE_b8375e1d-8a8c-4868-8ca7-6549504337eb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzAtMy0xLTEtNTA1MzE_a7bd7d0a-d0eb-4b96-8411-3aa43ecd79a4">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance lease principal payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzMtMS0xLTEtNTA1MzE_17f4c6f0-013c-4462-9174-1e45c3d97374">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzMtMy0xLTEtNTA1MzE_8e4fa3d3-9905-41a6-a4b1-26c562095a76">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzQtMS0xLTEtNTA1MzE_beae6397-50de-42d6-be1a-9d072404961d">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzQtMy0xLTEtNTA1MzE_efc51335-4548-4837-8caf-29a0ae43f4f4">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzUtMS0xLTEtNTA1MzE_255cd940-7bb1-4be4-8984-702d5cd26d5d">2,677</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzUtMy0xLTEtNTA1MzE_122555b2-f79b-4639-92fe-f4602f15a55a">5,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzYtMS0xLTEtNTA1MzE_14fc92e8-7a8e-4be7-9bba-1b7ed91558ed">29,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iabcd47f9f5ed4cbeba9b2fdfbdc1b4e7_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzYtMy0xLTEtNTA1MzE_8fa41bab-7344-4f8b-804b-2e7d1c985cf1">58,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzctMS0xLTEtNTA1MzE_70378a6c-e9fa-41fa-af69-74b2c79f7d0e">27,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzctMy0xLTEtNTA1MzE_ad8b23aa-5da0-4b19-80ad-f4022dc1165c">64,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzktMS0xLTEtNTA1MzE_4ef36726-3527-48c4-8798-c4caed8f2814">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzktMy0xLTEtNTA1MzE_edaccc4d-ef7e-4b11-aa5d-21281d0d2417">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Supplemental disclosure of non-cash investing and financing information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property and equipment in accounts payable and accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNDEtMS0xLTEtNTA1MzE_d84cde00-6055-4d69-8e64-5f88d2b2c63c">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNDEtMy0xLTEtNTA1MzE_c3dc67d1-dd51-4508-8749-1a3ffa435192">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNC9mcmFnOmMxNWViZGUyZGU1ZDRjZDJiM2E2YTJhNzIyYTljZWYyL3RleHRyZWdpb246YzE1ZWJkZTJkZTVkNGNkMmIzYTZhMmE3MjJhOWNlZjJfMzYzNw_545d2255-d634-4446-8931-524676dc7e38" continuedAt="ife2b120925bf447a99a516528428753f" escape="true">Description of Business and Financial Condition</ix:nonNumeric></span></div><ix:continuation id="ife2b120925bf447a99a516528428753f"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sera Prognostics, Inc. (the &#8220;Company&#8221;) is a women&#8217;s health company utilizing its proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests with an initial focus on improving pregnancy outcomes. The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;)-certified laboratory.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company&#8217;s activities have consisted of performing research and development, conducting clinical studies, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNC9mcmFnOmMxNWViZGUyZGU1ZDRjZDJiM2E2YTJhNzIyYTljZWYyL3RleHRyZWdpb246YzE1ZWJkZTJkZTVkNGNkMmIzYTZhMmE3MjJhOWNlZjJfMTExNQ_7a99765f-df62-4d0e-bb50-27a387a8b1c5">221.2</ix:nonFraction>&#160;million as of March&#160;31, 2023. The Company&#8217;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#8217;s commercialization activities for the PreTRM test, and to support additional clinical and preclinical trials and anticipated research and development activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its diagnostic products and could be required to delay, scale back, or abandon some or all of its development programs and other operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all. Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#8217;s future operations are highly dependent on a combination of factors, including (i) the successful commercial launch and market acceptance of the PreTRM test; (ii) the success of clinical trials and other research and development programs; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#8217;s ability to manage growth of the organization; (v) the Company&#8217;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal sources of the Company&#8217;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#8220;IPO&#8221;), which was completed in July 2021. As of March&#160;31, 2023, the Company had aggregate cash, cash equivalents, and available-for-sale securities of $<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-5" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNC9mcmFnOmMxNWViZGUyZGU1ZDRjZDJiM2E2YTJhNzIyYTljZWYyL3RleHRyZWdpb246YzE1ZWJkZTJkZTVkNGNkMmIzYTZhMmE3MjJhOWNlZjJfMzQxOQ_3ba771ac-10b2-48df-b3bc-b20025b91444">99.7</ix:nonFraction> million. See Note 3&#8212;Cash, Cash Equivalents and Marketable Securities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these unaudited condensed financial statements.</span></div></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNy9mcmFnOjFmYThjNDk4NjljOTQ3ODc5MzQzZWZhMzZjZTM4NGVlL3RleHRyZWdpb246MWZhOGM0OTg2OWM5NDc4NzkzNDNlZmEzNmNlMzg0ZWVfNjI3MQ_cac29c8e-92e2-430f-889f-92862b88cffe" continuedAt="i51a5951c20c1465ca7cd20e2c70f6743" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i51a5951c20c1465ca7cd20e2c70f6743" continuedAt="i4d29818437714336bb9d6777a1d6ae11"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNy9mcmFnOjFmYThjNDk4NjljOTQ3ODc5MzQzZWZhMzZjZTM4NGVlL3RleHRyZWdpb246MWZhOGM0OTg2OWM5NDc4NzkzNDNlZmEzNmNlMzg0ZWVfNjI3Mg_764ab0e5-cfda-48c9-aaf8-1df259fc8370" continuedAt="i94ab395af4d9410b8b551648479f4dc8" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. The unaudited interim condensed financial statements have been </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="i4d29818437714336bb9d6777a1d6ae11"><ix:continuation id="i94ab395af4d9410b8b551648479f4dc8" continuedAt="i389a0ea28e79492f9bac838ca27c0efd"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2022, and, in the opinion of the Company&#8217;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial results. The balance sheet as of December&#160;31, 2022 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2023, or any other period.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in the Company&#8217;s significant accounting policies during the three months ended March 31, 2023, as compared with those disclosed in its Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on March 22, 2023. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div></ix:continuation><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i389a0ea28e79492f9bac838ca27c0efd">Certain prior period amounts have been reclassified to conform with the current period&#8217;s presentation. The reclassifications did not have a significant impact on the condensed financial statements.</ix:continuation> </span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNy9mcmFnOjFmYThjNDk4NjljOTQ3ODc5MzQzZWZhMzZjZTM4NGVlL3RleHRyZWdpb246MWZhOGM0OTg2OWM5NDc4NzkzNDNlZmEzNmNlMzg0ZWVfNjI3NA_4173e7fd-2747-4ef8-a94d-5523a4c1232f" escape="true"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. </span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial statements as of and for the three months ended March&#160;31, 2023 reflect the Company&#8217;s estimates of the impact of the macroeconomic environment, including the impact of inflation, higher interest rates, and the COVID-19 pandemic. The extent to which these conditions will directly or indirectly impact the Company&#8217;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of this filing.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM4MA_712b7e3a-1da8-4186-8577-739487db7302" continuedAt="idcac88d9e53f449cbb6a65c7bb4aa5c8" escape="true">Cash, Cash Equivalents and Marketable Securities</ix:nonNumeric></span></div><ix:continuation id="idcac88d9e53f449cbb6a65c7bb4aa5c8" continuedAt="i171aa07c0fb24163a8496901891ace75"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its marketable securities as available-for-sale. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM4MQ_4fcc72ba-d07b-4c13-8e34-592d356c83ef" continuedAt="i48efa181db7e4809bf0e0f636fafd6f5" escape="true">The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of March&#160;31, 2023 and December&#160;31, 2022 were as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i48efa181db7e4809bf0e0f636fafd6f5"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60661342614546588426a472b8ef53eb_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy0xLTEtMS01MDUzMQ_9c7b7fdd-b992-4aaf-aff1-b0d0694bdf80">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60661342614546588426a472b8ef53eb_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy0zLTEtMS01MDUzMQ_6f903d0a-3ad9-408f-914d-64c78272eb97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60661342614546588426a472b8ef53eb_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy01LTEtMS01MDUzMQ_39e4b2fb-4076-4a1b-aea3-40301dfcc7b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60661342614546588426a472b8ef53eb_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy03LTEtMS01MDUzMQ_a84f02f2-7381-4a93-8234-f36e0682769a">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC0xLTEtMS01MDUzMQ_229c97fc-7f4c-45d9-9124-da24a1cda3d9">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC0zLTEtMS01MDUzMQ_01a3fda4-16ee-4761-b34b-eebbe766ac89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC01LTEtMS01MDUzMQ_bc218438-5989-4447-8146-9526869c6365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC03LTEtMS01MDUzMQ_f2c7b77c-d630-44e7-bbef-bb0c5bf2628e">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS0xLTEtMS01MDUzMQ_d60ae98e-a501-4938-8246-259e957e9e23">25,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS0zLTEtMS01MDUzMQ_f9a27a98-4076-41c1-bec1-dc5e0caea544">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS01LTEtMS01MDUzMQ_6fd3e11f-e5c1-4da4-854e-31f65d1ddfa7">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS03LTEtMS01MDUzMQ_090ce743-c661-4f66-8224-a38bc04fc462">25,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0xLTEtMS01MjAzNQ_2a777b69-6e5c-404b-b4c7-d8dcd624c768">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0zLTEtMS01MjAzNQ_b64cb23f-228d-486a-ae46-5d7f00917a01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi01LTEtMS01MjAzNQ_c4be651c-6901-4690-bb00-251fca9cc9a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi03LTEtMS01MjAzNQ_6a92d6a3-e995-4c18-9d99-5bab0b40c84a">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0xLTEtMS01MDUzMQ_a6c9f06f-86f9-455b-aa68-f3aff881c3d5">27,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0zLTEtMS01MDUzMQ_c6160d1b-29a4-493b-8154-fe8bb097e1ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi01LTEtMS01MDUzMQ_03ec136c-c751-4c71-8b8d-1520815284f4">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi03LTEtMS01MDUzMQ_8c8d717a-0b4f-4920-935d-04b71290653a">27,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC0xLTEtMS01MDUzMQ_d2a4bee5-539a-4424-8350-e32e0ca439e2">11,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC0zLTEtMS01MDUzMQ_974121f4-2b03-46cc-9c67-e39120aabbc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC01LTEtMS01MDUzMQ_284e6426-bf46-4da2-aea8-0dd7d3d51413">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC03LTEtMS01MDUzMQ_620463af-8840-46ac-8654-87be824ace31">11,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtMS0xLTEtNTA1MzE_73f42796-867c-41cc-90d3-49f1273b978f">26,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtMy0xLTEtNTA1MzE_e14807b4-19ad-441c-b20d-7104a081da46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtNS0xLTEtNTA1MzE_d6b471bd-1185-4071-a964-1b0842c79e59">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtNy0xLTEtNTA1MzE_8a4e048d-912c-4372-837c-db4426db3c5e">25,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtMS0xLTEtNTA1MzE_ee5e488c-2a84-4eed-8881-47929eea9d1c">6,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtMy0xLTEtNTA1MzE_76c7529f-6144-42ef-a3d7-6f8bcfc3cce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtNS0xLTEtNTA1MzE_70acefe1-2725-42e5-a58e-a1123bbb79df">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtNy0xLTEtNTA1MzE_87eae08a-e5c8-438e-a513-ddd9a18ede07">6,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1022d938781243e393cbc94f72b676c4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItMS0xLTEtNTA1MzE_63d8e088-f9a7-483d-b547-be006e041a0c">43,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1022d938781243e393cbc94f72b676c4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItMy0xLTEtNTA1MzE_64e6bc5a-c097-452a-bcc6-a2cbdcd829b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1022d938781243e393cbc94f72b676c4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItNS0xLTEtNTA1MzE_7ee3f88b-1259-4fab-aa52-5fac860ff3cd">318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1022d938781243e393cbc94f72b676c4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItNy0xLTEtNTA1MzE_ea3087ca-1c11-4381-9b05-53309f6fd599">43,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtMS0xLTEtNTA1MzE_4a216493-b5d2-4936-80e3-bb2c164b44b9">17,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtMy0xLTEtNTA1MzE_20fdf952-9418-4634-91d1-5cf89c9764c4">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtNS0xLTEtNTA1MzE_d5c841da-8ec0-4b74-b40d-ad1a2307171d">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtNy0xLTEtNTA1MzE_e89644b9-415a-4cab-bb38-ea6a99585676">17,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtMS0xLTEtNTA1MzE_577fc305-39cf-402f-a63d-bf5ac1f7602a">10,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtMy0xLTEtNTA1MzE_06e19d3f-6ae1-473c-bd4b-901c30a806a5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtNS0xLTEtNTA1MzE_3a02b0df-78c2-4cda-bdc7-5995816e3ea9">131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtNy0xLTEtNTA1MzE_1e7d860a-4ae1-4289-b27a-8c4db46b2167">10,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMS0xLTEtNTIwNDM_c6433e15-21ba-4a2a-97cb-76491fa6e8b3">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMy0xLTEtNTIwNDM_fa269825-1079-47a7-9698-4cdb3b618bbb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNS0xLTEtNTIwNDM_93dc47b7-52df-4863-9cb4-c400f99f78b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNy0xLTEtNTIwNDM_4bd65e46-7b12-4ffe-9b7c-84dea1980d55">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtMS0xLTEtNTA1MzE_b5addaff-f637-491b-bcf2-3920699b30f4">29,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtMy0xLTEtNTA1MzE_de797a8b-02d4-4780-bd4e-459eda6f0acc">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtNS0xLTEtNTA1MzE_e95fd83b-0fab-438d-9415-150b17426f9e">196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtNy0xLTEtNTA1MzE_767d5419-3631-478f-a323-23377306ea88">28,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMS0xLTEtNTA1MzE_d89f1a2f-a05e-4d57-ba95-5bf81acc6380">100,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMy0xLTEtNTA1MzE_2e9e99a0-e009-4d13-954e-91ef1849a038">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNS0xLTEtNTA1MzE_f84cd989-08b0-4e9e-af3f-54d59187e7c6">519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNy0xLTEtNTA1MzE_a29a7f8c-8e90-4a93-87ef-73aec6b9cac1">99,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy0xLTEtMS01MDUzMQ_1e8aa4e3-693f-44fc-bb59-38d3ac39f1c1">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy0zLTEtMS01MDUzMQ_774800d4-e59e-4d61-b86a-84fc6bfdcbfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy01LTEtMS01MDUzMQ_b1717252-0bac-443c-ad01-b9337f5d5d0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy03LTEtMS01MDUzMQ_59d90431-dcf9-4eca-84ba-b90c6212a333">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC0xLTEtMS01MDUzMQ_e50a1491-006a-4bea-9373-2874b75ffa60">2,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC0zLTEtMS01MDUzMQ_6e0226b3-9254-4225-a2b9-c54c17d7389c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC01LTEtMS01MDUzMQ_304e9a77-b596-4db2-b678-b62c9da538ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC03LTEtMS01MDUzMQ_7d589818-b752-42e2-b262-d42efb59eb69">2,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS0xLTEtMS01MDUzMQ_ae211fc7-0572-4dce-9867-1ffc8ecfae36">26,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS0zLTEtMS01MDUzMQ_838dc714-c8f5-4e51-bb3b-2ee5221da6cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS01LTEtMS01MDUzMQ_e73b713a-f25b-43da-9752-9d93a5a95c3a">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS03LTEtMS01MDUzMQ_10f03224-4333-4699-aa22-2d5bf46a43f6">26,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi0xLTEtMS01MDUzMQ_dbe6fbdc-d7e5-4f0a-bc9c-fcc5fbfd6e8f">29,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi0zLTEtMS01MDUzMQ_747024c7-ffc7-4338-b0a1-31cc26dfcae8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi01LTEtMS01MDUzMQ_97ed44b9-8492-42fb-8b51-64bb41b1a2d9">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi03LTEtMS01MDUzMQ_ea3a8dc3-08e1-4217-b11a-85ae88e60c12">29,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC0xLTEtMS01MDUzMQ_25e57eb0-308e-47c0-8a30-f782115d6538">15,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC0zLTEtMS01MDUzMQ_d20f9d77-7022-4b00-aa9d-c2b48019d024">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC01LTEtMS01MDUzMQ_c60f976e-e067-4d54-896d-18ba2f77bac4">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC03LTEtMS01MDUzMQ_454c77e7-0f95-4fcf-8453-95d1b6e8069b">15,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS0xLTEtMS01MDUzMQ_3da2219a-ac30-4ddb-8ee3-aa93fdaa1505">507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS0zLTEtMS01MDUzMQ_26abfddd-8ae1-4ced-bc59-404e75e88c7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS01LTEtMS01MDUzMQ_ac2bf089-44fd-4034-afb2-51e09adac518">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS03LTEtMS01MDUzMQ_5a3e8197-f2ec-4ee5-a32b-71b8dd1cbb15">502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMS0xLTEtNTIwNTM_22c6dd89-83a1-401d-b681-dfc48a3f5058">28,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMy0xLTEtNTIwNTM_71761ba7-69f0-42cf-bf21-9380dba3bcd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNS0xLTEtNTIwNTM_57092110-1e91-40fa-a596-87ba2c05e46b">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNy0xLTEtNTIwNTM_f46c3493-4d05-4f8c-a432-c6eb891481f5">28,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtMS0xLTEtNTIwNTM_7e9199b5-2e4a-453b-94de-570ac2d8ccd0">8,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtMy0xLTEtNTIwNTM_df4b8981-1979-4548-8715-b4b5f090e7fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtNS0xLTEtNTIwNTM_9874403a-fb06-4d31-9076-af5bc94dbf0f">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtNy0xLTEtNTIwNTM_42d09c51-8404-4acd-b8ef-32fbcac415e4">8,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMS0xLTEtNTA1MzE_c5cbab7a-f0e1-4770-80a9-d8dd6762fa63">53,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMy0xLTEtNTA1MzE_04db5fcd-d4aa-4702-bfb0-7c3083975502">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNS0xLTEtNTA1MzE_dd9cb00e-c5f2-42d5-8e39-e2e142856c56">568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNy0xLTEtNTA1MzE_d2e72b50-0688-449b-8b3c-4ff8a4321bb4">52,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItMS0xLTEtNTA1MzE_281d0325-d1f2-4566-9631-bf65adbe9142">9,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItMy0xLTEtNTA1MzE_7588758f-eec4-418c-8426-d671c9983fac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItNS0xLTEtNTA1MzE_f8027ef0-6c0e-49ff-869a-f69cd2a2bf13">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItNy0xLTEtNTA1MzE_c2e62bd8-12a5-4350-98dc-95ef64dc9daf">9,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtMS0xLTEtNTA1MzE_0ad6a015-31b8-43d8-9b12-04418082ba73">10,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtMy0xLTEtNTA1MzE_60354e57-5cff-42db-af5a-0b1a7c1703d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtNS0xLTEtNTA1MzE_875f0687-5010-4c0a-bf43-9e4ed9d5c0c0">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtNy0xLTEtNTA1MzE_c4d0fe3a-cd4f-4b2d-b7b6-f2c1902bb45f">10,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtMS0xLTEtNTA1MzE_bb267c34-666d-4cea-891e-b2376c1646eb">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtMy0xLTEtNTA1MzE_04379213-f6bb-4e5e-be86-22d7d6af1f79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtNS0xLTEtNTA1MzE_7b5d075b-e046-4d19-a4ef-8743bf696cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtNy0xLTEtNTA1MzE_1ca97c17-7f3e-410c-a3f1-392608866f17">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2deca7aa011c40308abedfe147f96001_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtMS0xLTEtNTA1MzE_a861769f-6c22-4c86-b2f1-56a76962b792">21,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2deca7aa011c40308abedfe147f96001_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtMy0xLTEtNTA1MzE_10c1f259-213c-46aa-b32f-a0b0ffa15358">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2deca7aa011c40308abedfe147f96001_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtNS0xLTEtNTA1MzE_9c8a2400-bab9-40c2-8eb1-70f8870bcddc">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2deca7aa011c40308abedfe147f96001_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtNy0xLTEtNTA1MzE_7b5b1feb-6f29-4928-8482-1f37226f55a1">21,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtMS0xLTEtNTA1MzE_9b785ea7-9972-435f-9629-e56781568099">105,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtMy0xLTEtNTA1MzE_0dd60049-24b8-4c0e-ad68-29e19c51f2e1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtNS0xLTEtNTA1MzE_ecd4eb08-0e54-40e4-bc40-f9abf849f99c">984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtNy0xLTEtNTA1MzE_ca451b5e-f01b-434c-bf19-f8d08e05e81c">104,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="i171aa07c0fb24163a8496901891ace75"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM4Mg_829e13a9-d731-48f8-a6d0-ccade567e05e" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of March&#160;31, 2023 and December&#160;31, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy0xLTEtMS01MDUzMQ_b0379328-89c2-40f8-af2d-1a6d9616cf35">32,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy0zLTEtMS01MDUzMQ_b40e3d5d-2c8d-499a-90d9-f9f25b1f36c5">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy01LTEtMS01MDUzMQ_95f4918d-277f-42ee-a023-9f8118d1d7a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy03LTEtMS01MDUzMQ_73fe8b3f-e569-41ce-8712-bd4d9cb0ef16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy05LTEtMS01MDUzMQ_47c16fb9-cc3a-4b18-8c93-f01274e7e860">32,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy0xMS0xLTEtNTA1MzE_7a1ddb1b-538c-477e-9a7b-6b2c08d72e99">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS0xLTEtMS01MDUzMQ_9373eca4-b8a8-4a39-b749-e5defd6952a1">11,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS0zLTEtMS01MDUzMQ_0d521569-4009-47f7-909b-f8a758e563f8">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS01LTEtMS01MDUzMQ_8fb818d3-ff6f-4ab0-a0f3-5a46391275d9">17,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS03LTEtMS01MDUzMQ_cf83938f-478b-43c1-a253-5a58f590ca92">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS05LTEtMS01MDUzMQ_6b58ebe1-d4c6-4ba5-b58e-35dc16134d03">29,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS0xMS0xLTEtNTA1MzE_78eaf7a0-899f-4497-b173-680781d6f827">275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi0xLTEtMS01MDUzMQ_87679ddb-9ef9-43b5-a7bd-67c00aa3acaf">10,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi0zLTEtMS01MDUzMQ_06274b0d-157a-4698-99f4-c324d4ac4ee2">156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi01LTEtMS01MDUzMQ_ffe369c2-fd90-402a-9c8a-aac525998f20">4,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi03LTEtMS01MDUzMQ_b25d90e0-772c-4b22-910c-ee44cf183270">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi05LTEtMS01MDUzMQ_fd505361-78b9-47d5-b730-72de1d6f3229">15,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi0xMS0xLTEtNTA1MzE_f21541d6-1194-44e9-a2e7-0d34d33d510e">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy0xLTEtMS01MDUzMQ_26360185-317d-46e4-81dd-b137b39c3eb3">54,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy0zLTEtMS01MDUzMQ_a31d28d5-4290-4f10-829d-160fc7f2f038">373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy01LTEtMS01MDUzMQ_917203ae-8398-4e7f-8a43-d07eadbc4fa2">22,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy03LTEtMS01MDUzMQ_4189840a-30f9-4583-b321-78bcf087f4cb">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy05LTEtMS01MDUzMQ_7f2a16b8-22db-47a5-a620-864b9aefd537">77,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy0xMS0xLTEtNTA1MzE_b848e24b-7795-4db3-8620-6f9c8fde3436">519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy0xLTEtMS01MjExNg_2d501252-b342-4be8-89a4-f5c18cfd4311">40,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy0zLTEtMS01MjExNg_0b9f7ef1-6e34-40a1-b8b3-8fb1908f022f">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy01LTEtMS01MjExNg_0f39cbd2-6234-4f14-9bad-3164ea634644">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy03LTEtMS01MjExNg_25bf5956-e798-4bf9-9981-e334294946b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy05LTEtMS01MjExNg_cd3fc48e-8bdd-4f8f-b4d3-3b8dd5b92074">40,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy0xMS0xLTEtNTIxMTY_40bdc140-438e-4327-bc1d-d86220c4124d">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC0xLTEtMS01MjExNg_a28ba361-c932-4c0d-acc0-c8437e42889e">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC0zLTEtMS01MjExNg_3ad518bb-33b8-4d0b-8df9-a97e28570df2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC01LTEtMS01MjExNg_f816ad48-52ba-4c45-9583-4010cba7296b">502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC03LTEtMS01MjExNg_236765fd-b6d8-48ac-a5c2-901c22a9aa34">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC05LTEtMS01MjExNg_9964785b-665c-4bd1-aec4-3172d1a96b1c">1,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC0xMS0xLTEtNTIxMTY_415609a0-8dbb-4145-930a-00873797fc93">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS0xLTEtMS01MjExNg_5669b943-dae7-4be2-bcfb-c978b285beb7">12,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS0zLTEtMS01MjExNg_07c6c940-b1c3-4bd8-9f5b-3861589c50a8">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS01LTEtMS01MjExNg_2e5c74d5-4a61-430e-ad26-1e0aa910d083">25,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS03LTEtMS01MjExNg_b458b0fe-d557-413b-ab28-1bedb1365d17">335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS05LTEtMS01MjExNg_d19e96e5-591a-45ba-974a-ac6c264352ef">38,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS0xMS0xLTEtNTIxMTY_8d6c0538-298c-4465-bf7d-63f02c0da11f">563</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi0xLTEtMS01MjExNg_c5be5e4f-9ab9-4476-a0f8-75521a36bcf0">10,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi0zLTEtMS01MjExNg_9e1a8f7f-efe5-4b83-976c-fe2850d82135">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi01LTEtMS01MjExNg_7cbf2b22-1663-4b10-84ed-ffd7c1dddc3c">8,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi03LTEtMS01MjExNg_34548215-79a8-4ec5-aacd-d69c1decb07f">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi05LTEtMS01MjExNg_aae839ca-f483-40b9-a077-c236e5f6f5b0">19,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi0xMS0xLTEtNTIxMTY_17c97747-0742-4a3c-9b1f-b816c42f93e8">341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy0xLTEtMS01MjExNg_a343113e-34a2-4a13-bf08-d3b8ade0c6a8">64,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy0zLTEtMS01MjExNg_812efba4-baa9-40dd-adce-b9ec2110dd28">511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy01LTEtMS01MjExNg_3728078a-0c65-4598-a972-35afb2c9fcc6">34,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy03LTEtMS01MjExNg_966f80aa-76b6-4ba5-abf7-d66479726766">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy05LTEtMS01MjExNg_5976efbd-0202-4363-95cb-aca74a031ec9">99,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy0xMS0xLTEtNTIxMTY_daa612d4-9737-4c1c-adbe-e70b0e6f0a56">984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, the Company had <ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfNTQ5NzU1ODE1NjY5_1f25f389-f554-4eb2-9052-f2cd32e93268"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfNTQ5NzU1ODE1NjY5_c4dd5978-f970-4766-b445-aa6d298b3462">no</ix:nonFraction></ix:nonFraction>t recorded any allowance for credit losses related to its available-for-sale securities. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM3OQ_ce062d03-9af2-4ea0-9696-f52a72b99972" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities classified by contractual maturities as of March&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMS0xLTEtMS01MDUzMQ_40a50f0e-24da-4795-a740-8403836bb484">43,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMS0zLTEtMS01MDUzMQ_401ab95c-215e-4b2e-99fc-a85ff35e3ad8">43,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMi0xLTEtMS01MDUzMQ_1c18fecf-a62c-4aa5-bb1e-37bbaddf5a98">29,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMi0zLTEtMS01MDUzMQ_e4d265d7-6436-4b01-87dd-6776a53ace2e">28,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMy0xLTEtMS01MDUzMQ_cd28667c-bd33-407f-a82e-5b67ee86b9d3">72,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMy0zLTEtMS01MDUzMQ_fee3f7fb-ff77-488f-b50d-89be75f839b3">72,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMzEw_efc2453b-9eec-4e47-9a35-862a435f3ecf" continuedAt="i7edd65bfb2f94e4ca69b761b0877148b" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="i7edd65bfb2f94e4ca69b761b0877148b" continuedAt="i135975b0d53743cd8a2544c1d9df0571"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMzEx_4ce25a8b-18bd-48ba-89be-9ddd13fbe1b7" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net, as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0689a9a22417417aa602cdd82583f081_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMS0xLTEtMS01MDUzMQ_f223abf9-6334-480a-b047-74a38bd167d6">5,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1a04512600a14358b38ac15e0b2e874e_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMS0zLTEtMS01MDUzMQ_7792ac43-c8dc-4749-bdb8-4ca9f8be5ce6">5,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if8d9fcb90d124c48bf1d71f64aa3bd4e_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMi0xLTEtMS01MDUzMQ_0845878c-14d3-4fbd-8f8b-ab94b7d2fe81">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id6dda952857f4641ac1036d6bfa8fc81_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMi0zLTEtMS01MDUzMQ_3bd9a6f5-5261-440e-8064-2ae69ab65090">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if6a5bd83d0814d7f87102db81904b40b_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMy0xLTEtMS01MDUzMQ_dbfff879-6471-4ffc-9928-f2cd127212a8">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibb3cdc18256f4159ae134effb7028788_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMy0zLTEtMS01MDUzMQ_6cd6f3ab-12b0-4797-930d-e188b95d51eb">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i813380ad283a4a6c88946834430e11fe_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNC0xLTEtMS01MDUzMQ_d4b69f66-3a93-4567-994e-e715c2782709">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie590573b76374ef5bb34894c50c9c607_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNC0zLTEtMS01MDUzMQ_4ea6c17a-926a-434c-8186-25e534c9e9c1">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0cf2635c182d4ec9aecdb319305ba09a_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNS0xLTEtMS01MDUzMQ_a2137157-ffed-4ab1-8258-797497d221ec">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02380a24291e41fe8beb052dfb3634a4_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNS0zLTEtMS01MDUzMQ_e1970175-698c-4b4d-b9cb-59a3a658ca35">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNi0xLTEtMS01MDUzMQ_849a7dfb-06ac-4c7b-aa13-41f277947480">9,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNi0zLTEtMS01MDUzMQ_33ebd57c-5290-402a-9ce2-8d55af82df04">9,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNy0xLTEtMS01MDUzMQ_fd354fe3-0bd5-4f90-8bc3-13c880bffbda">6,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNy0zLTEtMS01MDUzMQ_2f8ae2c0-9643-40dc-9674-dd25dc162a32">6,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfOC0xLTEtMS01MDUzMQ_9c6b6106-dc31-4ce7-baf7-46eb7cdbb4f2">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfOC0zLTEtMS01MDUzMQ_cee0a61d-8eac-4ee0-8e60-b5bd9c3630f7">3,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i135975b0d53743cd8a2544c1d9df0571">Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMTY0_775c557e-6633-499b-b755-4afd1a5e8ac5"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMTY0_cc51d413-0309-4226-914c-2e0d1015707c">0.2</ix:nonFraction></ix:nonFraction>&#160;million for each of the three months ended March&#160;31, 2023 and 2022.</ix:continuation> </span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RleHRyZWdpb246NDg3OWU1Mzc1Y2Y2NGNiOWJhNDYyZmM0MTEyOGIyM2VfMTI5_853998ed-fcdd-46b7-8dd0-f66bc775f0d0" continuedAt="ibb43f385e22842b49d11b67b4e8b4ee1" escape="true">Accrued and Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="ibb43f385e22842b49d11b67b4e8b4ee1"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RleHRyZWdpb246NDg3OWU1Mzc1Y2Y2NGNiOWJhNDYyZmM0MTEyOGIyM2VfMTMw_734b2355-4eb0-4dce-904e-8a36a87be1e5" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of accrued and other current liabilities as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMS0xLTEtMS01MDUzMQ_8ed20570-38ab-4464-ba59-0f2cb8fd581a">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMS0zLTEtMS01MDUzMQ_953fd365-b007-49a2-b456-5d5a6d87c102">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AccruedVacationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMi0xLTEtMS01MDUzMQ_4175bfae-4352-49b6-a41a-70891273a890">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AccruedVacationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMi0zLTEtMS01MDUzMQ_5e787f19-6710-4856-893b-a6b6ca31c15f">430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued 401(k) matching contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNC0xLTEtMS01MDUzMQ_f201a19f-b582-414e-8259-942433da7197">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNC0zLTEtMS01MDUzMQ_d2bd61b7-bddc-4b94-a312-7d25c87e9922">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNS0xLTEtMS01MDUzMQ_19e31a06-8b2d-400c-93ff-c5575471335d">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNS0zLTEtMS01MDUzMQ_034a969b-845f-42f3-8215-8e4cf40baa02">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNi0xLTEtMS01MDUzMQ_28170a51-87a3-4434-9981-f2e10d965602">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNi0zLTEtMS01MDUzMQ_d3938b37-3d35-4a19-9017-5390769be1f1">637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNy0xLTEtMS01MDUzMQ_20b3766a-79e7-464a-8c86-f0122537c5ed">2,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNy0zLTEtMS01MDUzMQ_03b43afc-d235-4dde-b9d4-a011b9fb8f8d">4,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RleHRyZWdpb246YTgwNjM4MDg0MDVkNGQ1MTkyNDVlY2UyOWY0NDU3ZDFfMTI4_552dd266-7672-4c3b-b30c-11ce84e96763" continuedAt="ia03ea3048dc54b318e9eb709c51c1fde" escape="true">Other Income, net</ix:nonNumeric></span></div><ix:continuation id="ia03ea3048dc54b318e9eb709c51c1fde"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RleHRyZWdpb246YTgwNjM4MDg0MDVkNGQ1MTkyNDVlY2UyOWY0NDU3ZDFfMTI5_c0206ef0-f6fc-42bd-8299-c8f2b64d184b" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of other income, net, for the three months ended March&#160;31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMi0xLTEtMS01MDUzMQ_d90f1134-75d2-4f74-b178-4b2e61212cba">257</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMi0zLTEtMS01MDUzMQ_43b1cb7f-a820-4deb-8bc5-65b52786e7fb">78</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investment income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMy0xLTEtMS01MDUzMQ_4b1e6048-75fe-422b-8d78-42ef6a7a5e32">523</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMy0zLTEtMS01MDUzMQ_ca7d7a6b-8311-4f5a-b731-a921c42c4510">18</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfNy0xLTEtMS01MDUzMQ_026a287f-7224-4d1f-a404-a1c166a28bab">780</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfNy0zLTEtMS01MDUzMQ_3170ad84-1435-434e-b04b-9e703add4ef8">96</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RleHRyZWdpb246N2JkZjc4ODcxN2IyNDU0OGEzN2FhYzhkYWYxMjM2NTFfMTg5MA_0cc0620d-59cc-4198-8c8c-cced77387290" continuedAt="i34de472f15f54387b585ce7dc4d3c639" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i34de472f15f54387b585ce7dc4d3c639" continuedAt="i9fbd492ae6cf40f0a2e09c9422b603a5">As of March&#160;31, 2023 and December&#160;31, 2022, the carrying amounts of the Company&#8217;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="i9fbd492ae6cf40f0a2e09c9422b603a5" continuedAt="i9aeda17bbd774e6b8a53232ee3695b6f"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds are highly liquid investments and are actively traded. The pricing information on money market funds is readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency bonds, U.S. government bonds, commercial paper, and corporate debt securities are measured at fair value using Level 2 inputs. The Company reviews trading activity and pricing for these investments as of each measurement date. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.</span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RleHRyZWdpb246N2JkZjc4ODcxN2IyNDU0OGEzN2FhYzhkYWYxMjM2NTFfMTg5MQ_23012ecb-0937-49ea-a762-7ff2f5486682" continuedAt="id6bfd9f1bc5a4135a291d92a4b7fcbab" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of March&#160;31, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib1e6b5e7a18d4714be7dc3cd442de182_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMy0xLTEtMS01MDUzMQ_037fd38e-9608-4f10-b9ae-6b1460368c10">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9f666d3ee1114f89a06ced8d07c1cac1_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMy0zLTEtMS01MDUzMQ_1aa72566-f3c1-4979-a672-345f3abe9412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i633da3607bf74e6399a271d9b5a872dc_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMy01LTEtMS01MDUzMQ_d5c3f738-0dd8-4704-a69e-985d3470cd49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2c7078405bba49d8b9ae3c7a24e77d59_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNC0xLTEtMS01MDUzMQ_a3bd0823-0f0a-451f-a5db-7686df55ea09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9a4c9f1b7de04945b27590548f7a034a_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNC0zLTEtMS01MDUzMQ_be887e76-33cd-48de-8a71-1f343f09ac54">25,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i42f38e0fd91b4bc9a6edd8c6525262eb_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNC01LTEtMS01MDUzMQ_65186d31-b1d2-4cab-9f75-b50c12a4a30e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib4f0e071eb624dad8e0ef430093db2f9_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNS0xLTEtMS01MjMzNw_6484f315-d7e6-4965-82a1-3a42502f21da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i26ad96634a0944fc8ff1db153b046a32_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNS0zLTEtMS01MjMzNw_2617aaf6-f9c8-4327-9edc-fe6568f51069">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id1d1569554ae410b8a9034cde1714135_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNS01LTEtMS01MjMzNw_126f9f9a-0651-4cef-9719-5a68bcb33c4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6b5c62d74c5e4c13b5b1f9a2db0cb194_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNi0xLTEtMS01MDUzMQ_c0d50c01-17c5-4949-a5a9-39dbd8426eae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ied68b9ca26b446e59b4b4f792f403d2b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNi0zLTEtMS01MDUzMQ_ccd050bc-6787-4eca-8d0b-53a5a9eae4fd">11,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if7460c4b611a4c1a8deecbf81c1f906d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNi01LTEtMS01MDUzMQ_c04240f9-8fef-4753-b7f8-3acda06ed74c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id73796b542fb4928ade5f07ade35d66b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNy0xLTEtMS01MDUzMQ_e562c04a-d266-4456-9dd9-74c394206d5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3f78ab542cac4bd0a4cde222a8e7e773_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNy0zLTEtMS01MDUzMQ_2a9c71aa-28cd-4060-ae82-359bd273a047">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i13be094f9c244c158024b56a7cb5ecff_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNy01LTEtMS01MDUzMQ_7576605b-664b-4fb6-935b-5e2b30de62cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3e5fb142963d40bc9752b25c78058aa4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOC0xLTEtMS01MDUzMQ_c76f3bae-4520-4d51-aab7-bc670e553002">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibf70dfed4cf44986832bd01bae60b309_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOC0zLTEtMS01MDUzMQ_8e2a61f5-02c6-4384-bdac-f11ac747ac34">43,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i55bf665ab22b48dd84b5f6508b6dc531_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOC01LTEtMS01MDUzMQ_8addc2af-31d5-4099-9748-9fad44b0ab75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i262be437741d4c54906e37b798c135cd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOS0xLTEtMS01MDUzMQ_d0d44ca6-cf45-4d91-83af-87d24f55802f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib13ca83ce3884e60b6458d148f1cdfe4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOS0zLTEtMS01MDUzMQ_dbc4ef1f-a334-4ff3-9ecc-48d61fabe521">17,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2277bfa471754111acad933a7e99966c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOS01LTEtMS01MDUzMQ_d2c28e42-2d78-4123-bf4e-70c15a3fc6d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie9901b75d0bf4b4595246dc12220f857_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMTAtMS0xLTEtNTA1MzE_e9977f8c-97df-4d8d-aa36-11d7ee4e2c11">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i14d03532a9124a129f1031a6ffcab6a8_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMTAtMy0xLTEtNTA1MzE_458d20a8-19d5-429d-826a-5bb3be472c73">99,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if3283049b13a48a5b0dbb4875b2c82fe_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMTAtNS0xLTEtNTA1MzE_95a06b3c-db35-4a78-922b-efcaa4184473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="i9aeda17bbd774e6b8a53232ee3695b6f"><ix:continuation id="id6bfd9f1bc5a4135a291d92a4b7fcbab"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6a86a8c7fd3142b59e9f55ee76ca645f_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMy0xLTEtMS01MDUzMQ_59cffab2-2033-48d8-9bcc-73cdc2702da2">2,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib17e4dfe8114480a9bd0dd5e85c27414_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMy0zLTEtMS01MDUzMQ_21556fa5-b024-4a8f-80c2-41500c8a7630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib1fef988414b43c6b092ed0b459b393c_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMy01LTEtMS01MDUzMQ_294a93d5-d0e5-4a5a-9c34-ac4c3dff38e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e6d0b3094cc43ca8063063fc0d62736_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNC0xLTEtMS01MDUzMQ_dc945b19-7e62-4575-a957-053e05d3eced">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ife9e1cfb0901453096411529be5647f8_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNC0zLTEtMS01MDUzMQ_4039232f-a8a2-488d-93d5-72471a8a07c2">26,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9909f01379d9443cbe56ab0eacbd84b4_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNC01LTEtMS01MDUzMQ_c9a0dbe1-83b3-40fe-b62e-cd8a41ecb4ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ieb26f6e075f649db844239697d35cf44_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNi0xLTEtMS01MDUzMQ_01ec5113-272e-4b2d-ad3e-5b2f910e054a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2d5bf6251b7b4c75840430bed4b53f15_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNi0zLTEtMS01MDUzMQ_d6debc41-5347-4cd4-8ba7-3dd655599422">15,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i057f6cfcbe9647feaf5cdc6e8b694c95_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNi01LTEtMS01MDUzMQ_3610f7fd-c47a-4c1a-89c3-70789c6fef5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0936c84ad3f94183aeff5843d1470ea0_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNy0xLTEtMS01MDUzMQ_c6e20e75-7e4e-49a2-a8f5-e1180e836051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie061ca627cde49dea9441184eba4360a_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNy0zLTEtMS01MDUzMQ_26cb421e-3133-4c8e-a254-88775ef53faa">1,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia61bb82bb96640b6a960d4a434b01d37_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNy01LTEtMS01MDUzMQ_9eb1bcf0-1fc0-4b55-845e-3659a3fb12c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iec6934a5de584a6f907ec7efe8ab449b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOC0xLTEtMS01MDUzMQ_0a6d1504-88e1-41b5-ba17-bbad0d74fb08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="icc6c9adab7224ca2974718d2d132d7c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOC0zLTEtMS01MDUzMQ_aeb5866c-22de-478a-98bb-cfa9d094c097">38,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i602355d9b023442ea2e229223e367f52_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOC01LTEtMS01MDUzMQ_b3b95ff6-f3d8-4270-92c7-1baf152c2595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic6e649c834f541b1a07b68af95f39792_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOS0xLTEtMS01MDUzMQ_415bdf22-cd2f-4b9c-bed0-907a3aae9309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i854e50c14d1a416c81e655b988108acc_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOS0zLTEtMS01MDUzMQ_32103c71-15d6-4451-9f56-a005afde1881">19,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ida65d68be4234d39ae17f2b0901689e3_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOS01LTEtMS01MDUzMQ_0fccd3da-59a2-4500-8eee-c540b21d60fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7d852401dd8c45f8bac931d6391e0d8a_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMTAtMS0xLTEtNTA1MzE_22d4499c-8c94-48cf-bc9f-5e2690763c2f">2,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4150a09b96f64456861db2de07189a11_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMTAtMy0xLTEtNTA1MzE_21f1c532-5921-4cf4-9bf5-46671f3be89b">100,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e2b7a1779484a588d3e5dcc2f75c5c3_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMTAtNS0xLTEtNTA1MzE_8b137ce2-0fac-478d-8b24-9efb8a99355e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfMzg5Nw_6f915529-43e0-4fef-b206-f925f6ccc023" continuedAt="i2ab9b13a1e6d41da99709708bf960c87" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="i2ab9b13a1e6d41da99709708bf960c87"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, the Company entered into a master services agreement with Carelon Research, a subsidiary of Elevance Health, Inc. (&#8220;Elevance Health&#8221;). This agreement covers a range of research projects, including Carelon Research&#8217;s role as a contract research organization for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rematurity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">isk Assessment Combined With Clinical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterventions for Improving Neonatal outco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s (&#8220;PRIME&#8221;) study. The Company paid fees related to this agreement of $<ix:nonFraction unitRef="usd" contextRef="iebe6c97e0a004df6add4d077081e8986_D20230101-20230331" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfNDk2_600521d4-211c-46d6-b2a0-391075466226">0.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i25502e94a007481095a51420d5929626_D20220101-20220331" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfNTAz_91b01162-32d1-419b-af30-a6b33fab70eb">0.7</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. The Company recognized revenues related to this agreement of $<ix:nonFraction unitRef="usd" contextRef="ic6233338a3de4492ac7fc3602d7b3429_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfODgz_1c41805c-49f3-46a0-aa47-5e41d4b75f25">21</ix:nonFraction>&#160;thousand and $<ix:nonFraction unitRef="usd" contextRef="i81e3ed0434cf4e1fb660521a3660854b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfNTQ5NzU1ODE3ODMy_ea81de63-3932-428f-8092-baa4f569dea9">19</ix:nonFraction> thousand for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#8220;Commercial Collaboration Agreement&#8221;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#8217;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first <ix:nonNumeric contextRef="iea4329433de54b779062bdcbf483862a_D20210201-20210228" name="sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfMTQ0Ng_df0b45f6-fee8-45f0-8ac9-41582806c228">three years</ix:nonNumeric> of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first three years of the term of the Commercial Collaboration Agreement. The Company received $<ix:nonFraction unitRef="usd" contextRef="i5f467c43c88a4619bd1e2b17c7062c3b_D20230101-20230331" decimals="-5" name="sera:RelatedPartyTransactionCashReceivedFromRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfMTY1OQ_ab04daa1-6cec-41b5-8e4d-84fe72528af5">6.0</ix:nonFraction>&#160;million during the three months ended March 31, 2023, which amount related to the minimum payments for the year ended December&#160;31, 2022. Such minimum payments were initially recorded as deferred revenue. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elevance Health has been participating in the Company&#8217;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#8217;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the three months ended March&#160;31, 2023 and 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfMTE0Mw_3b78ad98-274a-4004-9002-4d819751ca52" continuedAt="if89de2c72f094c47b9c95f5f5aa64da4" escape="true">Capital Structure</ix:nonNumeric></span></div><ix:continuation id="if89de2c72f094c47b9c95f5f5aa64da4"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="common_stock_class" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="sera:NumberOfCommonStockClassesAuthorized" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfNTIz_b73c8826-a655-4005-8e61-a2fe060e4796">two</ix:nonFraction> authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331" decimals="INF" name="sera:NumberOfVotesPerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfNzU2_18fb034d-63d7-4bff-a60a-6e1d33bba733">one</ix:nonFraction> vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to <ix:nonFraction unitRef="number" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="sera:CommonStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfODgy_0c92ec8f-9370-4aea-8221-e1173bb37b6c">one</ix:nonFraction> share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#8217;s amended and restated certificate of incorporation. </span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfMTE0NA_bd9eef8c-aa51-4141-9ddd-229f21914b7c" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares of Class A common stock were reserved for future issuance:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ie51451f721f248449b164911776d14cf_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMS0xLTEtMS01MDUzMQ_c20cb0b5-7007-4cf0-9f8c-21a8d19b3dc1">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i8e8d27e73cfa42b68409d0498a6072d5_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMS0zLTEtMS01MDUzMQ_2628eb09-dd1f-4a7d-9418-bf233ff312f8">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1bac8f889d2845938fb80af53ea359b9_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMi0xLTEtMS01MDUzMQ_a072ee66-1663-4f1d-8126-f8a8af5fbf56">8,875,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i64464d2a8cea488d9bf93bc83aac4914_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMi0zLTEtMS01MDUzMQ_e49de198-d18b-4199-840e-46b25ca8e066">8,428,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restricted stock units outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5056875ac3244f5dbc3045e076055486_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0xLTEtMS01MjQ1NA_f3f47fee-426b-41ba-be95-262a1355f8f4">347,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i008a3034f9504be4bce1130bdf12035d_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0zLTEtMS01MjQ1NA_1c525951-4523-435e-ab2a-c720eb9ec65f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i721dc8e4c62a42abba54bc026dbfa057_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0xLTEtMS01MDUzMQ_443547db-b87b-4f2d-99d5-958ba5704bd7">2,312,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i6df48d3ee72046c1810e7e4afa6e12be_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0zLTEtMS01MDUzMQ_4af0a1b6-12fc-44ec-b90a-8afaed242c54">1,926,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="id97654d11c5a4152b663b94b04260e41_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNC0xLTEtMS01MDUzMQ_aace4a43-d94d-4b23-aa86-10f113da8b37">894,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i08ddab687a264ed4a1e0870d43ec1462_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNC0zLTEtMS01MDUzMQ_8d0701e1-7d1a-4b51-a0c8-aa6cc02ad979">598,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNS0xLTEtMS01MDUzMQ_7af74880-30ae-4deb-84b2-d0a9f4c955d0">15,206,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNS0zLTEtMS01MDUzMQ_31a777b1-d09d-4ee4-bc3e-a220dd432df4">13,729,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4Ng_265143dd-b760-4482-be87-d473133fce53" continuedAt="i07201a8d4a614d75a3938a1b8ce4141f" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i07201a8d4a614d75a3938a1b8ce4141f" continuedAt="i22a18c205cad4064b0a4214cfbf53377"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2011 Plan&#8221;) and reserved shares of the Company&#8217;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a <ix:nonNumeric contextRef="iddd0a6e59f784d5e8a2a70335dc43e4b_D20111101-20111130" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4Nw_ef887e8d-262e-482b-9d83-fa03f23a1635">four-year</ix:nonNumeric> period and generally expire <ix:nonNumeric contextRef="iddd0a6e59f784d5e8a2a70335dc43e4b_D20111101-20111130" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMzM2_63699541-357a-4452-9bfd-17a20b02301c">ten years</ix:nonNumeric> from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors, and consultants of the Company. Options generally vest over a <ix:nonNumeric contextRef="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4OA_61451510-57e8-4e6f-8107-3f150fb6f955">four-year</ix:nonNumeric> period, are exercisable only to the extent vested, and generally expire <ix:nonNumeric contextRef="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfOTQ1_b3512352-d2a0-46d2-8ebd-e02b417d92eb">ten years</ix:nonNumeric> from the date of grant. Restricted stock units (&#8220;RSUs&#8221;) generally vest over a <ix:nonNumeric contextRef="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfNTQ5NzU1ODE3MzUw_57726f68-133b-4c88-acc0-c1b44e19de63">four-year</ix:nonNumeric> period. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of March&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="if2b38bbfb8c44e16b1a98f32cc4e64da_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMTM2OA_3c00fabf-f264-4ac4-83b7-d0438ff5fa8e">2,312,525</ix:nonFraction> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of March&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i10f872c050a642a4bd7b0d7bf50b2c15_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMTc5MA_5e0c25c1-4589-42d1-b109-a169264716f0">894,903</ix:nonFraction> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 ESPP. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="i22a18c205cad4064b0a4214cfbf53377" continuedAt="i1b7bc77fc634458db96fb69390c5bebe"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, references to &#8220;options&#8221; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4OQ_a805d2d8-2d0e-45f2-97df-98b433e506ed" continuedAt="id2fc91ffe2f449cb97075ee911cdd097" escape="true">The following table summarizes information about these options granted and outstanding:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="id2fc91ffe2f449cb97075ee911cdd097"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS0xLTEtMS01MDUzMQ_e9f87654-b125-42f9-8a0c-3620619feee0">8,428,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS0zLTEtMS01MDUzMQ_a0970530-94d1-483b-9b30-42062ade533e">3.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i589f0422795f40b0be50fa589249a5ab_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS01LTEtMS01MDUzMQ_c843e4ff-e3af-4025-b484-595fc6e60b00">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS03LTEtMS01MDUzMQ_44a1aa31-fffb-439f-adb8-6dc3aa719073">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMi0xLTEtMS01MDUzMQ_9c166a1a-11f6-48c4-99ce-bac2c381549b">612,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMi0zLTEtMS01MDUzMQ_c4ec1c20-b77c-4f31-8f6e-8371c90da8e8">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMy0xLTEtMS01MDUzMQ_c8690f68-97ca-4091-984f-0a33712dc321">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMy0zLTEtMS01MDUzMQ_8e191330-8f5c-4d0f-91c6-7390ee28d8d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNC0xLTEtMS01MDUzMQ_5f6bfe9b-a662-4762-976c-992e35ffda92">161,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNC0zLTEtMS01MDUzMQ_d81b66e0-5f22-4c43-95ac-25e78c284b01">6.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNS0xLTEtMS01MDUzMQ_3f320192-487e-4fec-8f2f-bb60f8d9e73e">4,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNS0zLTEtMS01MDUzMQ_04f0aa07-9ba2-47db-9eac-70c813d86deb">0.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi0xLTEtMS01MDUzMQ_30411d22-6d2a-4639-99ae-acabc103cc42">8,875,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi0zLTEtMS01MDUzMQ_6d62b34f-68c0-45d6-8f6f-ef7fece35ba2">3.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi01LTEtMS01MDUzMQ_c4e11fb4-a8f1-437c-bc4c-2791490819fe">7.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi03LTEtMS01MDUzMQ_939dbc60-5838-4a80-accf-fc322a05304f">9,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest at March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy0xLTEtMS01MDUzMQ_4bbef8c1-c410-455f-8a94-1c6480d6510a">8,497,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy0zLTEtMS01MDUzMQ_f6150245-f625-4b9e-876d-453c7f800dfb">3.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy01LTEtMS01MDUzMQ_2b99beba-8d11-4a35-bf66-80652cd64e14">7.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy03LTEtMS01MDUzMQ_36093c01-a308-4f2c-9a12-f9b5089ed292">9,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and exercisable at March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC0xLTEtMS01MDUzMQ_c0447ac5-5c5a-47d5-8c3e-e1a48bfe53bd">4,890,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC0zLTEtMS01MDUzMQ_66a51e75-46b4-4e0c-9853-b888bcde2dfd">3.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC01LTEtMS01MDUzMQ_2f33aab5-9e05-4f77-9763-c9ff3892f7b0">6.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC03LTEtMS01MDUzMQ_f2415f34-f8e2-456f-8457-9ce41f3aad4f">7,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfNTQ5NzU1ODE3MzUx_d5b7b12e-e3f1-4ae3-b4e2-dbc77e80a062" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding &#8212; December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMS0xLTEtMS01MjcyNA_4d641278-3468-4725-9962-56bbe6dc18e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMS0zLTEtMS01MjcyNA_d6bbe88f-e686-4a16-b787-9ddba3eb37ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMi0xLTEtMS01MjcyNA_16eb1f6e-6bdb-4282-ab32-eaeb5a35866f">347,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMi0zLTEtMS01MjcyNA_1b91e723-0f6e-457b-a2a2-d62508e5714a">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMy0xLTEtMS01MjcyNA_01e8a5f3-b1b7-4b3c-bb37-e6a519dafd4a">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMy0zLTEtMS01MjcyNA_07ac435a-4eb0-4519-a1e2-914eed443aba">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNC0xLTEtMS01MjcyNA_1fa894bb-0e2b-41f4-8b8e-82e7838d8885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNC0zLTEtMS01MjcyNA_f065fd72-8f3f-43b9-8e11-a276f9356066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding &#8212; March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i77a70c0650fb42628493971aa4f0049c_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNS0xLTEtMS01MjcyNA_1f402349-1017-4303-85dc-3b25ce3b4b9d">347,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77a70c0650fb42628493971aa4f0049c_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNS0zLTEtMS01MjcyNA_367cfe23-e61d-4630-a936-3a39e8c07b67">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU5MA_d5456b8c-9d1f-4d36-8861-cc344fa01165" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib678e71d507240f7846a08db78ba061b_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMi0xLTEtMS01MDUzMQ_75426a10-6e21-4bea-a890-fe764dc48d29">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0e85b9ebdb094f55a3f434b347ee787f_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMi0zLTEtMS01MDUzMQ_7fd2e7f4-6abb-4753-af4f-34bf35b6dc6e">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i93bd5d88af7d410491f05716f1ed0e5f_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMy0xLTEtMS01MDUzMQ_4c08f3be-3ec6-4924-940c-49707a26f6b5">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i52391e73e9df469c9e683c465b16f7c1_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMy0zLTEtMS01MDUzMQ_d19e2cb0-9c6e-4769-abe0-b1a4a880f408">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i91b41e5291034c509f187d546c338915_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNC0xLTEtMS01MDUzMQ_50258b4c-2a0d-4126-9ad8-04827e2304e0">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifd63d2c7f48d408eb0ef89901295964a_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNC0zLTEtMS01MDUzMQ_78833888-8b2e-43e7-97c1-33e2ca8154cd">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total employee stock-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNS0xLTEtMS01MDUzMQ_de421e19-1bea-45ef-9c6f-f17a649e0214">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNS0zLTEtMS01MDUzMQ_5ad26543-4b4f-461d-9e1e-f4e35443fae0">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="i1b7bc77fc634458db96fb69390c5bebe"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfNTQ5NzU1ODE3MzYx_f6acbf03-07f9-4c1d-9167-f30064efeea9" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of March&#160;31, 2023 was as follows (in thousands, except years):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Stock-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Period of Recognition (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMS0xLTEtMS01MzczOQ_2660e9a7-3df6-4405-89f7-d02bdc53050a">10,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMS0zLTEtMS01MzczOQ_fa2a9ac7-c170-4fd1-85b1-dbe155445f61">2.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i77a70c0650fb42628493971aa4f0049c_I20230331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMi0xLTEtMS01MzczOQ_84950b94-2e6a-4550-9f26-9c4519e8efbb">1,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMi0zLTEtMS01MzczOQ_55f662c4-7260-48d1-adf3-155863372ecd">3.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMy0xLTEtMS01MzczOQ_30078dc9-c8e0-497f-8ac6-8365ca62374c">11,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="sera:WarrantsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RleHRyZWdpb246ZDAzM2VlMzk2NmFlNDRiN2E3MmJjMzlkOWVhYTMyYzJfMzUy_2823bef6-4f51-4989-96bc-69a4360a2556" continuedAt="ib83bb0e0fc334496a94a32576795194b" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="ib83bb0e0fc334496a94a32576795194b"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RleHRyZWdpb246ZDAzM2VlMzk2NmFlNDRiN2E3MmJjMzlkOWVhYTMyYzJfMzUz_d20f505f-08bf-4b0b-a869-bb22f4e0d4e4" continuedAt="idb37f14246d84139887df95f175794fc" escape="true">The Company&#8217;s common stock warrants outstanding were as follows:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="idb37f14246d84139887df95f175794fc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:31.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of Warrants Outstanding as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia80510f4b99d4483a37744999f4d0341_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMi0wLTEtMS01MDUzMQ_a52109cb-d42b-429c-be45-990f211989a1">5.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia80510f4b99d4483a37744999f4d0341_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMi0yLTEtMS01MDUzMQ_3b0445bf-21cd-4a8b-9557-840709b35722">3,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i97033eb4f8a64db2bc5f6fcfc26a6886_I20221231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMi00LTEtMS01MDUzMQ_7571d45c-52e8-4492-baa7-ec9d897c83bf">3,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c737e7bf4884940ada07d1250bbf18e_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMy0wLTEtMS01MDUzMQ_0ba26662-1e12-4878-ab4d-24e402e48571">9.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i4c737e7bf4884940ada07d1250bbf18e_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMy0yLTEtMS01MDUzMQ_2b7dfcb7-cab3-403e-9781-1da9a0531a29">1,032,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9359a27c7fc744aca0a2a0f6deb31bd8_I20221231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMy00LTEtMS01MDUzMQ_81d557b0-3630-48aa-9478-1deabe1ca4b6">1,032,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i78e203d056cc4c4ca4772af00ea4d039_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNC0wLTEtMS01MDUzMQ_4bba6775-e026-46a2-ac67-f778c32b5a4b">10.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i78e203d056cc4c4ca4772af00ea4d039_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNC0yLTEtMS01MDUzMQ_96a33247-9625-46db-b0a5-99d2dd971b35">1,009,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i204da10f0e0c49cc8fb8c1a4ead9508e_I20221231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNC00LTEtMS01MDUzMQ_ddb42fda-5480-408a-a1c5-e15cba8110ee">1,009,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="id725e1f4b6344f8c9931c7da191af02c_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNS0wLTEtMS01MDUzMQ_b1bb6265-3ebf-4f34-9ab2-0317b830e344">12.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="id725e1f4b6344f8c9931c7da191af02c_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNS0yLTEtMS01MDUzMQ_23dd617f-8947-4737-ab64-cd5bdf7466cd">8,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i30dc8f5c5dd54233a474c8e03313302d_I20221231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNS00LTEtMS01MDUzMQ_61506a2b-8b74-4793-b49f-68122e1e4282">8,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41ab44e1fd1540469f0224dbf57e43d2_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNi0wLTEtMS01MDUzMQ_8231dd5c-fb18-40e4-940b-7a08de4b76db">20.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i41ab44e1fd1540469f0224dbf57e43d2_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNi0yLTEtMS01MDUzMQ_1f3c29c8-9402-4261-8959-fe539d0dec4a">722,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i81d9531da7ae47c68f3176caa531bcf5_I20221231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNi00LTEtMS01MDUzMQ_c359086f-f8e9-4fbe-acae-2a55a918d530">722,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNy0yLTEtMS01MDUzMQ_f485a8f9-08c8-4412-9cd5-3707f7bc0583">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNy00LTEtMS01MDUzMQ_607b8600-a39b-42e2-a508-d153816d6362">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwNQ_3608fb44-e72d-4272-bb69-a9f025f081c6" continuedAt="i67a3cb90a1234e99a4a5d18e057fc475" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i67a3cb90a1234e99a4a5d18e057fc475" continuedAt="ifb4528c864884181b58f027528ddad7c"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#8217;s leases, the Company&#8217;s incremental borrowing rate or the Company&#8217;s intent to exercise or not exercise options available in lease contracts. </span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwNg_1be961c2-2d8d-4536-8e95-1c53331f5219" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease-Related Assets and Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Statement Line Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_6babe0e6-7d50-47d4-ae07-e3d8e9b39332"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_9f65a529-ecfc-438c-ac40-deeaa75b2ba3">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi00LTEtMS01MDUzMQ_8709c395-9fc6-4a81-bff6-2124a62181fc">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi02LTEtMS01MzAzNA_12a11fdf-9f4e-465e-ba29-3741c116408e">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_25937204-c7d0-4da0-b8e8-5206df574dab"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_f6cc0dfd-5c42-43a4-b226-d068765cef24">Property and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy00LTEtMS01MDUzMQ_dd69536a-1f14-4c47-8f22-4fda916d618b">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy02LTEtMS01MzAzNA_401ecb0b-a162-482b-83ae-aee9283bcf74">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:RightOfUseAssetTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNC00LTEtMS01MDUzMQ_596858cb-d2f9-45af-80ee-3d6882f6ed8e">2,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="sera:RightOfUseAssetTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNC02LTEtMS01MzAzNA_554514af-caf7-454c-8aeb-ff6f2673e95c">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_0a2d43e5-22d4-456d-aeb7-ab2c07bd5c2e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_54e9da06-5917-4d9b-92d1-259e176f90a9">Accrued and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy00LTEtMS01MDUzMQ_b8da2025-7fcf-463f-a453-0643bb8e21b7">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy02LTEtMS01MzAzNA_19776d5e-e949-4fbd-a5b4-5f9c6d95525f">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOC00LTEtMS01MzA0Mg_80e7c401-d546-473f-b522-bc02fc552b83">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOC02LTEtMS01MzAzNA_87045ec2-3882-4edd-8d65-977fe150023b">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOC00LTEtMS01MDUzMQ_52807b4a-527c-4317-92a7-2f54f63b119a">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOS02LTEtMS01MzAzNA_2a011a30-d9fe-491d-a920-ca4602895ba9">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOS00LTEtMS01MDUzMQ_f9298451-65f1-4102-97b7-2f3c150f5798">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMTAtNi0xLTEtNTMwMzQ_9064ed75-9f77-4bf5-ba6d-de4cc1655374">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilitiesTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMTAtNC0xLTEtNTA1MzE_423491b5-2eb0-4869-860a-399c4a3a479b">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="-3" name="sera:LeaseLiabilitiesTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMTEtNi0xLTEtNTMwMzQ_629477f7-8ac5-4d7b-a085-7699bcaa265c">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="ifb4528c864884181b58f027528ddad7c" continuedAt="iebfdf60cd6284e47bf0305ad2b55c888"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwNw_c5805e6d-daeb-487e-bc6f-b266a6ce48aa" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNC0yLTEtMS01MDUzMQ_076d9934-7b73-4b8e-ac9e-9cf817b3df7f">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNC00LTEtMS01MDUzMQ_adc43a65-6fac-42f5-bfe0-461b265a2ca2">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNS0yLTEtMS01MDUzMQ_e848cb9a-108d-4648-949d-5f6aa10f9ae6">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNS00LTEtMS01MDUzMQ_17480ad8-b06f-4564-8cfc-97d0988cfc09">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNi0yLTEtMS01MDUzMQ_fd02b113-95e2-4b2b-b861-d55e01a574cc">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNi00LTEtMS01MDUzMQ_e8a10154-7f58-4ebc-8d89-2a2ecce5647d">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNy0yLTEtMS01MDUzMQ_371f6951-4f4b-4ae1-b8bc-3864a21bb70f">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNy00LTEtMS01MDUzMQ_2197745b-6ef3-4799-9255-165d095bf332">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTEtMi0xLTEtNTA1MzE_ee8b7e9d-910a-4588-817c-5a8078a2edba">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTEtNC0xLTEtNTA1MzE_78e6706d-83b4-4e60-839e-e2a3436bd9d1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTItMi0xLTEtNTA1MzE_7ef9a7c3-49fe-4821-9cb7-154face48fcc">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTItNC0xLTEtNTA1MzE_9eff9d0f-6bc5-4ec8-9ff6-477750ce694c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTMtMi0xLTEtNTA1MzE_f00de59b-6796-44dc-9359-21299b7b6327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTMtNC0xLTEtNTA1MzE_891476bd-7799-4f31-b4f6-9bf99e2aff57">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTQtMi0xLTEtNTA1MzE_a9ecccb0-569f-41da-9b2e-7d437aa3752c">2.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTQtNC0xLTEtNTA1MzE_421cabd3-3cc9-4259-b2e5-00eded1b6b42">2.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTUtMi0xLTEtNTA1MzEvdGV4dHJlZ2lvbjowZDliODY3MzE1MTk0MTlkYWIwMDQyMDM1NTAzN2NlN180_bf08ce52-3982-488c-9fdc-6cf898de3305">6.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTUtNC0xLTEtNTA1MzE_a07d00ee-78e0-46ff-b592-b20ecd27e80d">6.3</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTctMi0xLTEtNTA1MzE_9c26a88c-4ea4-40bc-bb73-7001d85b0e4e">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTctNC0xLTEtNTA1MzE_62c56140-5ccb-4050-a767-860a78420a46">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTgtMi0xLTEtNTA1MzE_51609c76-e934-4fea-9f81-8fc400ccca66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTgtNC0xLTEtNTA1MzE_3c3c1cf2-1e93-4976-be35-2e2114d0e6ae">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTktMi0xLTEtNTA1MzE_4b829e9a-6a7d-4c98-a33e-75d1bc76db2c">2.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTktNC0xLTEtNTA1MzE_8dd1960b-fbb3-4c72-b2dd-b1c50ab2eb99">0.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMjAtMi0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplMzkzODAxZDdhMDA0NzI4YjEyYzJjZjBmM2IwZjBmOV80_dd7e9ae1-d003-4fad-b996-d6f3289c44f2">7.5</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMjAtNC0xLTEtNTA1MzE_a73b7f2d-0147-496d-b8bd-8afe0c1aa85b">4.5</ix:nonFraction>%</span></div></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwOA_033ff345-f8cc-496a-96a4-1c1127b6c279" escape="true"><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwOA_ff5b00d7-63d8-441f-a7b8-fdc58396511b" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of March&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMS0yLTEtMS01MDUzMQ_ee1c80e9-3b38-4525-af6b-31841edf6cd2">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMS00LTEtMS01MDUzMQ_a374e871-6cfb-4c34-a7c9-f76187a68da3">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityToBePaidRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMS02LTEtMS01MDUzMQ_442f6144-a717-4a35-9358-4684634b8f4c">853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMi0yLTEtMS01MDUzMQ_56304b5e-fb95-4c32-8fa2-1f04ff3deb1b">646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMi00LTEtMS01MDUzMQ_36fa00f8-56f2-46c6-9488-e9bca009b054">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityToBePaidYearOne" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMi02LTEtMS01MDUzMQ_e4ad9151-740b-4787-841c-e9ae9d7f31dd">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMy0yLTEtMS01MDUzMQ_331fdb29-5dbe-45aa-bcce-11a3b2c648d1">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMy00LTEtMS01MDUzMQ_729d6174-2c0c-4c3e-9993-170d0b2ae5bb">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityToBePaidYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMy02LTEtMS01MDUzMQ_a92fad23-aa69-4f27-b8dc-c5abd9630c28">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNS0yLTEtMS01MDUzMQ_aa6d3800-a674-46be-9798-1889693c7e44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNS00LTEtMS01MDUzMQ_4b7848bb-049c-414f-95bb-20b898fb46c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityToBePaidYearThreeAndThereafter" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNS02LTEtMS01MDUzMQ_1beab543-16ea-4d63-b4cd-9ea211b92921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNi0yLTEtMS01MDUzMQ_4f3c7492-7c6b-44d0-b043-c1b371bed2b2">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNi00LTEtMS01MDUzMQ_807f8ccd-4fa0-4dbb-8d98-79accd258135">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityPaymentDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNi02LTEtMS01MDUzMQ_6bc5862e-cc02-4cf5-8646-632827a832f9">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNy0yLTEtMS01MDUzMQ_8f7b1b0a-82c1-4535-a14d-b97cd2b61002">169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNy00LTEtMS01MDUzMQ_6fc074d2-cb19-452b-b7c8-21b23236841c">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNy02LTEtMS01MDUzMQ_ee0a13b9-95d7-4dda-b2fc-15df2533ddba">234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOC0yLTEtMS01MDUzMQ_577d13f4-b462-4a40-a4de-84de8034a41f">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOC00LTEtMS01MDUzMQ_21f128d0-ad50-4ab9-8829-f02711577663">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilitiesTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOC02LTEtMS01MDUzMQ_4a88f725-e82e-41c0-8905-748d702804cf">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOS0yLTEtMS01MDUzMQ_98a1dab8-82ce-4fa0-90fc-bd02a9bd72e8">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOS00LTEtMS01MDUzMQ_a4024b2b-01bc-449e-a6d0-21a1c7c1853c">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOS02LTEtMS01MDUzMQ_4782c8c2-1f79-48de-9b29-1fa903238aa6">984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMTAtMi0xLTEtNTA1MzE_8abddaed-ccce-4af4-8782-bcae5db35a64">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMTAtNC0xLTEtNTA1MzE_5a929844-55f9-4241-8905-2140e05dd7bd">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="-3" name="sera:LeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMTAtNi0xLTEtNTA1MzE_de54c987-1cab-410f-84c2-20a0bca5f7a1">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a total of approximately <ix:nonFraction unitRef="sqft" contextRef="i05a6fd71531c4266a8e69e0f3d9add84_I20230331" decimals="0" name="sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfMTA1MQ_f3d18913-8b77-44bf-83da-8cd311bb3bc1">24,300</ix:nonFraction> square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2025 (as amended, the &#8220;Office Lease&#8221;). The Office Lease includes an early termination right which termination would occur under certain circumstances, as provided in the amended Office Lease, after July 1, 2024, if exercised. The Company is not currently reasonably certain it will exercise the termination right. The implicit rate provided in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#8217;s current finance leases include bargain purchase options that the Company is reasonably certain to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><ix:continuation id="iebfdf60cd6284e47bf0305ad2b55c888"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#8217;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#8217;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has <ix:nonFraction unitRef="usd" contextRef="if2f86cfb811b477c983db67e5f541347_I20230331" decimals="INF" name="sera:IndemnificationLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfMzA5Nw_45064c63-0cea-4e4c-bc4e-408f87457016"><ix:nonFraction unitRef="usd" contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231" decimals="INF" name="sera:IndemnificationLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfMzA5Nw_fd4b5488-5ec1-48ab-87c3-781af45637ca">no</ix:nonFraction></ix:nonFraction> liabilities recorded for these agreements as of March&#160;31, 2023 and December&#160;31, 2022. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#8217;s future results of operations, cash flows, or financial position.</span></div></ix:continuation><div id="i4308cf9785ac4015a6c4393be0d820f4_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RleHRyZWdpb246NWY4YjY3OGZhOTNmNDU5OTg1NzE1NTY3YjgyY2ZmOWNfMTUzMA_291a2447-829a-4a57-ba76-a740ab4e3081" continuedAt="i2ea4e9829f8e418b9de465ab96f373d9" escape="true">Net loss per share</ix:nonNumeric></span></div><ix:continuation id="i2ea4e9829f8e418b9de465ab96f373d9"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the three months ended March&#160;31, 2023 and 2022, the Company reported net losses and as such, basic and diluted net loss per share are the same. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the liquidation and dividend rights are identical for Class A and Class B common stock, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the three months ended March&#160;31, 2023 and 2022. </span></div><ix:nonNumeric contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RleHRyZWdpb246NWY4YjY3OGZhOTNmNDU5OTg1NzE1NTY3YjgyY2ZmOWNfMTUzMg_fdf1892d-7fff-4ccc-bb4f-2d3cf9d5b645" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ie0f674f4a02e45538fdadde638cf5023_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMi0xLTEtMS01MDUzMQ_062e6bf1-3695-438c-a820-70e04156a4cd">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5757bb4043fa4bfa81cdae4e0992837e_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMi0zLTEtMS01MDUzMQ_33e74547-6e3c-4918-b717-908086a2b3bb">2,788,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i3457c2e17d7a435d9fb262c2803a96c4_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMy0xLTEtMS01MDUzMQ_b1af2a01-a501-471f-9b3a-976ab5ddf1b3">8,875,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ic8b56fe25f1c4153929837bcc4db56ea_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMy0zLTEtMS01MDUzMQ_e8efedf7-e905-4d75-8013-ab7dae7ab81e">8,016,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restricted stock units outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if70567ef2894436ab885809a5090432e_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0xLTEtMS01MzI1Mg_d3d12045-b186-4d89-bca1-80411df961a8">347,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iaa36120b8dea4505af0c3a1b3720cbf0_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0zLTEtMS01MzI1Mg_ade20019-5fc6-4a90-9e70-08babce2ff3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0xLTEtMS01MDUzMQ_2ae51c2d-ff9e-4d3c-9177-b210317b9355">11,998,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0zLTEtMS01MDUzMQ_058dc365-5051-4725-bac3-ba18ceb15c78">10,805,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis or set forth elsewhere in this Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this Form 10-Q, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors and others should note that we routinely use the Investors section of our website to announce material information to investors and the marketplace. While not all of the information that we post on the Investors section of our website is of a material nature, some information could be deemed to be material. Accordingly, we encourage investors, the media, and others interested in us to review the information that we share on the Investors section of our website, investors.seraprognostics.com.</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a women&#8217;s health company utilizing our proprietary proteomics and bioinformatics platform to discover, develop, and commercialize clinically meaningful and economically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing and economic analysis enables us to provide physicians and patients with actionable data and information designed to result in better maternal and neonatal health at lower cost. Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly improve maternal and neonatal health and to dramatically reduce health care costs. We have built an advanced, proprietary, and scalable proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are highly accurate predictors of dynamic changes that occur during pregnancy. By incorporating our proprietary technology platform into our rigorous data-driven development process, we have created a differentiated approach for effectively addressing major conditions of pregnancy. We envision that our comprehensive approach will enable us to fully characterize one of the most important periods in the lives of women and children, and will help to improve their well-being. Our goal is to develop and commercialize tests that inform important decisions during all pregnancies. We also believe that the work we perform in pregnancy can ultimately be leveraged more broadly to address other areas in medicine and health care.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our first commercial product, the PreTRM test, is the only broadly validated, commercially available blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides an accurate prediction of the expectant mother&#8217;s risk of delivering spontaneously before 37 weeks&#8217; gestation. Our commercialization strategy includes conducting clinical trials to demonstrate the health and economic benefits of early and accurate detection of preterm birth risk coupled with well-recognized interventions in higher risk patients. Elevance Health, Inc., or Elevance Health, whose health plans cover more than 10% of U.S. pregnancies annually, agreed to make our PreTRM test available to eligible pregnant members as part of a multi-year contract. Elevance Health is one of the nation&#8217;s largest health insurers with greater than 47 million members nationwide. Through this collaboration, a significant number of physicians and patients in the U.S. gain access to early and accurate predictions of preterm birth to enable more informed decision-making during pregnancy. Sera believes that its commercial collaboration with Elevance Health further validates the clinical and economic value of its PreTRM test. We are actively discovering and developing several additional biomarker tests to predict other major conditions of pregnancy, such as preeclampsia, and gestational diabetes, among others, that have the potential to offer significant health benefits to women and their babies.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are approximately 140 million births globally each year. Of these, it is estimated that as many as 25% are affected by various complications, including: preterm birth, preeclampsia, fetal growth restriction, stillbirth, hypertension of pregnancy, gestational diabetes, and others. In the United States, there are approximately 3.7 million births annually, and 10.5% of those pregnancies result in preterm births with profound short- and long-term health consequences to the mother and baby. These health consequences are estimated to lead to associated costs of approximately $25 billion annually in the United States. Traditional methods to detect prematurity risk in time for proactive management have been limited and fail to identify the vast majority of women who will deliver prematurely. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our blood-based biomarkers were demonstrated to be predictive of very early preterm birth of any cause, length of neonatal hospital stay, and neonatal morbidity and mortality in the Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor (TREETOP) study, a large prospective U.S. study. Additional new data published in May 2022 showed improved PreTRM Test predictive performance for women whose due dates are more reliably determined by ultrasound. We believe our actionable blood-based biomarker test for prematurity risk can enable patients, physicians, and payers to more proactively manage and mitigate the complications and associated costs of prematurity. Given that pregnancy is the launch point for the future health of babies and a key determinant in the future health of mothers and babies, we believe this area is ripe for innovation and better tools to improve patient outcomes.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are located in Salt Lake City, Utah, including a CLIA-certified laboratory. Since our inception, we have devoted the majority of our efforts and resources to performing research and development, acquiring product rights, raising capital, establishing facilities, conducting clinical trials, and establishing commercial operations to market the PreTRM test. During this period, we have incurred annual net losses. We have largely funded our operations with proceeds from the sale and issuance of convertible preferred stock, debt financings, bank loans, and the sale and issuance of Class A common stock in our initial public offering, or IPO, which was completed in July 2021. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses since inception. Our net losses were $10.6&#160;million and $12.2&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively. We expect to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of our commercialization activities for the PreTRM test, and to support additional clinical studies, publications, and anticipated research and development activities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have signed an agreement with Elevance Health, pursuant to which Elevance Health agreed to purchase our PreTRM test, and we continue to negotiate contracts with private and governmental payers and health systems that could eventually result in revenues. If we are unable to secure payer contracts that result in significant revenues or access additional funds, we may be required to delay, scale back or abandon some, or all, of our development programs and other operations. Until such time as we can generate significant revenue from the sales of our products, if ever, we may need to continue to finance our cash needs through equity offerings, debt financings or other capital sources, potentially including collaborations or other similar arrangements. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends and may require the issuance of warrants. If we raise additional funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may have to significantly delay, reduce, or eliminate some or all of our product development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to access capital when needed is not assured and, if not achieved on a timely basis, will materially harm our business, financial condition, and results of operations.</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it appears its most severe effects have subsided, COVID-19 could re-emerge or new public health threats could appear. The future impact of the COVID-19 pandemic or a similar health disruption is highly uncertain and subject to change. We cannot predict the full extent of potential delays or impacts on our business, our clinical trials, health care systems or the global economy as a whole. To date, the primary impacts to our business have been the early cessation of enrollment in our Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls study, or the AVERT PRETERM TRIAL study, in March 2020, the delayed commencement of enrollment in our PRIME study until November 2020 and slower than expected enrollment thereafter, and limited access to ordering clinicians during our early commercialization of our PreTRM test. We have enrolled sufficient numbers of PRIME study patients to enable the interim analysis to occur in 2023, and expect to report the results of that analysis if and when we are able to do so. If COVID-19 re-emerges as a serious public health threat, or if another serious pathogen appears, then we may experience additional disruptions that could severely impact our business, preclinical studies, and clinical trials, including potential delays. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Components of Our Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to derive substantially all of our revenue in the near term from sales of the PreTRM test. We generally expect revenue to increase as sales volume continues to increase and as we continue to engage with payers and health systems to close payment contracts. These additional contracts may enable an upfront negotiated payment rate which could eventually result in additional revenues when health care providers order the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue reflects the aggregate costs incurred in delivering the proteomic testing results to clinicians and includes expenses for third-party specimen collection and shipping costs, as well as our lab personnel, materials and supplies, equipment, and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. We expect costs of revenue will generally move in line with the sales of the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist of costs incurred for our research activities and development of our product candidates. These expenses include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory processes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research and bioinformatic activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">biobanking and publication efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personnel-related expenses, including salaries, payroll taxes, employee benefits, and stock-based compensation charges for employees engaged in these research and development activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">direct clinical study expenses incurred under agreements with clinical study sites or contract research organizations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consultants engaged in our research and development efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory materials and supplies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facilities costs; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">depreciation, amortization, and other direct and allocated expenses, including rent, insurance, and other operating costs, incurred as a result of our research and development activities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense all research and development costs, both internal and external, in the period in which they are incurred. We expect that our research and development expenses will increase in 2023 compared to 2022. Research and development costs may increase in the medium to long-term as we support current and additional clinical studies, publications, and other product development activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and Marketing Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing expenses consist primarily of salaries, payroll taxes, employee benefits, and stock-based compensation charges for sales, marketing, and payer access personnel. Other significant costs include travel, consulting, public relations, and legal costs related to commercial efforts. We expect selling and marketing expenses to decrease in 2023 compared to 2022 as we have taken steps to streamline our sales team and focus our commercial strategy in response to market dynamics. We expect selling and marketing expenses to increase in the long-term as we expand our dedicated sales team to more completely cover U.S. sales channels over time as we enter into contracts with payers and health systems.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries, payroll taxes, employee benefits, and stock-based compensation charges for personnel in executive, finance, information technology, human resources, and other administrative functions. Other significant costs include facilities, corporate and intellectual property legal fees, accounting, insurance, consulting, and other professional fees.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect general and administrative expenses will remain relatively consistent in 2023 compared to 2022, which will maintain the appropriate level of support for our current level of operations. We expect general and administrative expenses to increase in the medium to long-term as needed to support future operations and anticipated revenue growth. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense represents interest incurred on our finance leases. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of interest income and other investment income earned on our cash, cash equivalents, and marketable securities, and other gains and losses. </span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations presented below should be reviewed in conjunction with the condensed financial statements and related notes included elsewhere in this report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended March 31, 2023 and 2022</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$ Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,640)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,429&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,338&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(909)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,329)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12,300)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">971&#160;</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">780&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">684&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,565)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12,208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our research and development expenses for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$ Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Clinical studies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,830&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and bioinformatics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,177&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total research and development expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.8&#160;million increase was due to a $0.6&#160;million increase in clinical study costs, a $0.1&#160;million increase in research and bioinformatics expenses, and a $0.1&#160;million increase in laboratory operations costs. The $0.6&#160;million increase in clinical study costs was primarily due to a $0.5&#160;million increase resulting from the increased enrollment and site setup activity in the PRIME study. The $0.1&#160;million increase in research and bioinformatics costs was primarily due to a $0.1 million increase in personnel costs driven by increased average headcount. The $0.1&#160;million increase in laboratory operations costs was primarily due to a $0.1 million increase in depreciation related to additional equipment and capitalized software. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and Marketing Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.6&#160;million decrease was due primarily to decreases of $1.1 million in personnel-related costs driven by decreased average headcount, $0.2 million in travel expenses, $0.2 million in consulting and other professional service fees, and $0.1 million in stock-based compensation expense. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.7&#160;million increase in other income, net was due to a $0.5 million increase related primarily to investment income on our marketable securities and a $0.2 million increase in interest income related primarily to our marketable securities. </span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have not generated a significant amount of commercial revenue from product sales or any other sources and have incurred significant operating losses and negative cash flows from operations. We anticipate that we will continue to incur net losses for the foreseeable future. We have financed our operations primarily through proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in our IPO, which was completed in July 2021. As of March&#160;31, 2023, we had aggregate cash, cash equivalents, and available-for-sale securities of $99.7 million, and an accumulated deficit of $221.2 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the periods indicated:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:63.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,881)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9,557)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(116)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (decrease) increase in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,677)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net cash used in operating activities during the three months ended March 31, 2023 was primarily due to a net loss of $10.6&#160;million partially offset by non-cash charges of $1.5 million and an increase in operating assets and liabilities of $4.2&#160;million. The net cash used in operating activities during the three months ended March 31, 2022 was primarily due to a net loss of $12.2&#160;million partially offset by non-cash charges of $1.5&#160;million and an increase in operating assets and liabilities of $1.1&#160;million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities for the three months ended March 31, 2023 was primarily due to $17.1&#160;million in proceeds from maturities and sales of marketable securities, partially offset by $14.7&#160;million in purchases of marketable securities. Net cash provided by investing activities for the three months ended March 31, 2022 was primarily due to $21.3&#160;million in proceeds from maturities and sales of marketable securities, partially offset by $6.6&#160;million in purchases of marketable securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities for the three months ended March 31, 2023 was due to $0.1 million of finance lease principal payments. Net cash provided by financing activities for the three months ended March 31, 2022 was primarily due to $0.1&#160;million in proceeds from options exercised. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Funding Requirements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to incur significant additional operating losses and negative cash flows for the foreseeable future. We expect our losses in the future to arise principally as a result of our commercialization activities for the PreTRM test, and to support additional clinical studies and anticipated research and development activities. There can be no assurance that we will eventually achieve significant revenues or profitability, or if achieved, can sustain either on a continuing basis. If we are unable to achieve significant revenues or raise additional funding, when needed, we may not be able to continue the development or commercialization of our diagnostic products and could be required to delay, scale back, or abandon some or all of our development programs and other operations. No assurance can be given that we will be successful in raising the required capital at reasonable cost and at the required times, or at all. Any additional equity financing may not be available on favorable terms, most likely will be dilutive to our current stockholders, and debt financing, if available, may involve restrictive covenants and dilutive financing instruments. Further, our operating plan may change, and we may need additional funds to meet operational needs and capital requirements for product development and commercialization sooner than planned. We currently have no credit facility or committed sources of capital. Our future funding requirements will depend on many factors, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, receipt, and amount of sales from the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing sales, marketing, and other commercialization capabilities in the United States and abroad;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and commercialize other products;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of any collaborative, licensing, and other arrangements that we may establish;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost, timing, and outcomes of regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, rate of progress, results, and cost of our clinical studies, and other related activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of preparing, filing, prosecuting, defending, and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in businesses, products or technologies, although we currently have no commitments or agreements relating to any of these types of transactions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">partnerships and other strategic options for our product and other product candidates; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors described in the &#8220;Risk Factors&#8221; section and elsewhere in this report.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months.</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contractual obligations and commitments for the year ended December&#160;31, 2022 are set forth in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on March 22, 2023. No material changes have occurred during the three months ended March 31, 2023. </span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies, Significant Judgments and Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our critical accounting policies, significant judgments, and use of estimates is included in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on March 22, 2023. There have been no significant changes in the application of our critical accounting policies, significant judgments and use of estimates during the three months ended March 31, 2023.</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. We elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (1) are no longer an EGC or (2) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies, reduce disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and are exempt from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. As an EGC, we are also not required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section 404 of the Sarbanes-Oxley Act. As a result, our financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates and we are not required to provide auditor attestation regarding requirements of Section 404(b) of Sarbanes-Oxley.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will remain an EGC until the earliest to occur of: (1) the last day of the fiscal year in which we have at least $1.235&#160;billion in annual revenue; (2) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) December 31, 2026.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies until the fiscal year following the determination that the market value of our voting and non-voting common stock held by non-affiliates is more than $250 million measured on the last business day of our second fiscal quarter, or our annual revenues are less than $100 million during the most recently completed fiscal year and the market value of our voting and non-voting common stock held by non-affiliates is more than $700 million measured on the last business day of our second fiscal quarter.</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no recent accounting pronouncements that we currently expect will have a material impact on our financial position, results of operations or cash flows. </span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_115"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to changes in interest rates relates primarily to interest earned and market value on our cash and cash equivalents and marketable securities. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents and marketable securities consist of cash held in banks, money market funds, commercial paper, U.S. government securities, U.S. federal agency securities and investment grade corporate securities. Our investment policy and strategy are focused on preservation of capital and supporting our liquidity requirements. Changes in U.S. interest rates affect the interest earned on our cash and cash equivalents and marketable securities, and the market value of those securities. A hypothetical 100 basis point increase in interest rates would have resulted in a decrease of $0.6 million in the market value of our available-for-sale debt securities as of March&#160;31, 2023. Any realized gains or losses resulting from such interest rate changes would only occur if we sold the investments prior to maturity. We do not believe we will be required to sell the investments before recovery, which may be maturity. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not regularly incur expenses with vendors outside the United States or that are denominated in currencies other than the U.S. dollar. We may incur such expenses in the future at which point exchange rate fluctuations might adversely affect our expenses, results of operations, financial position and cash flows. To date, exchange rate fluctuations have not had a material effect on our results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Inflation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe inflation has had a material effect on our results of operations during the periods presented. However, the current inflationary environment could affect us by increasing our costs of labor, laboratory supplies, and clinical trials and could adversely affect our business, results of operations, financial position and cash flows. In addition, increased inflation has had, and may continue to have, an effect on interest rates and may adversely affect our borrowing rate and our ability to obtain any potential additional funding. </span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (our principal executive officer) and Chief Financial Officer (our principal financial officer and principal accounting officer), evaluated the effectiveness of our disclosure controls and procedures as of March&#160;31, 2023. Based on the evaluation of our disclosure controls and procedures as of March&#160;31, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8212; OTHER INFORMATION</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material litigation or other material legal proceedings. We may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect our future results of operations, cash flows, or financial position.</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our Class A common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, the section of this Quarterly Report Form 10-Q entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and related notes, before investing in our Class A common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, operating results and prospects could be materially harmed. In that event, the price of our Class A common stock could decline, and you could lose part or all of your investment. </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties, including those highlighted in this section below, that represent challenges that we face in connection with the successful implementation of our strategy. The occurrence of one or more of the events or circumstances described in more detail in the risk factors below, alone or in combination with other events or circumstances, may have an adverse effect on our business, cash flows, financial condition, and results of operations. Such risks include, but are not limited to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred net losses since our inception and we anticipate that we will continue to incur losses for the foreseeable future, which could harm our future business prospects.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating our business requires a significant amount of cash, and our ability to generate sufficient cash depends on many factors, some of which are beyond our control and if we cannot raise additional capital when needed, we may have to curtail or cease operations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our quarterly and annual results may fluctuate from period to period, which could adversely impact the value of our Class A common stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have derived substantially all of our revenues to date from the PreTRM test, and if our efforts to further increase the use and adoption of the PreTRM test or to develop new products and services in the future do not succeed, our business will be harmed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the near future, we expect to rely on sales to a limited number of direct customers for a significant portion of our revenue and cash flows related to the sale of the PreTRM test, making us subject to customer concentration risk.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to establish and maintain sales and marketing capabilities, we may not be successful in commercializing the PreTRM test.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition in the life science industry, including companies engaged in molecular diagnostics and proteomics, is intense. If we are unable to compete successfully with respect to our current or future products or services, we may not be able to increase or sustain our revenues or achieve profitability.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our CLIA-certified laboratory facility becomes inoperable, we will be unable to perform our tests and our business will be harmed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interim, top-line and preliminary data from our clinical trials that we announce or publish from time to time may change as additional data become available and are subject to confirmation, audit, and verification procedures that could result in material changes in the final data.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business would be materially harmed if our proprietary biobank were to become contaminated, lost or destroyed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on third parties for specimen collection, including phlebotomy services, and commercial courier delivery services, and if these services are disrupted, our business will be harmed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on a limited number of suppliers or, in some cases, single suppliers, for some of our laboratory instruments and materials and may not be able to find replacements or immediately transition to alternative suppliers on a cost-effective basis, or at all.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A re-emergence of COVID-19, or the emergence of a new pathogen, could materially affect our operations, as well as the business or operations of third parties with whom we conduct business. Our business could be adversely affected by the effects of other future public health threats in regions where we, or third parties on which we rely, have significant business operations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we lose the services of our Chairman, President and Chief Executive Officer or other members of our senior management team, we may not be able to execute our business strategy.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our estimates of total addressable market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at a similar rate.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The inflationary environment could materially adversely impact our business and results of operations. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If third-party payers do not adequately reimburse for the PreTRM test or any new tests we may develop, such tests may not be purchased or used, which may adversely affect our revenue and profits.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New reimbursement methodologies applicable to the PreTRM test, and other future tests, including new CPT codes, may decrease reimbursement rates from third-party payers.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Billing disputes with third-party payers, including disagreement regarding the selection and use of CPT codes when submitting claims, may decrease realized revenue and may lead to requests for recoupment of past amounts paid.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">When third-party payers deny coverage, we are often unable to collect from the patient or any other source and risk disputes if we attempt to do so.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our revenues may be adversely impacted if third-party payers withdraw coverage or provide lower levels of reimbursement due to changing policies, billing complexities or other factors.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Status as an out-of-network provider with a large commercial insurer may cause health care providers to avoid recommending our tests.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the validity of an informed consent from a patient is challenged, we could be precluded from billing for such patient&#8217;s testing, be forced to stop performing certain tests, forced to exclude the patient&#8217;s data or specimens from clinical trial results or be subject to lawsuits or regulatory enforcement.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the way the FDA regulates laboratory developed tests or the reagents, other consumables, and testing equipment we use when developing, validating, and performing our tests could result in delay or additional expense in bringing our tests to market or performing such tests for our customers.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with federal and/or state laboratory licensing requirements, we could lose the ability to perform our tests or experience disruptions to our business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any failure to obtain, maintain, and enforce our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Issued patents covering our tests and technology could be found invalid or unenforceable, if challenged.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our intellectual property may be infringed by a third party.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to prevent disclosure of our trade secrets and other proprietary information, the value of our tests and technology could be significantly diminished.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of our Class A common stock may be volatile, and you could lose all or part of your investment.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales of a substantial number of shares of our Class A common stock by our existing stockholders in the public market could cause our stock price to fall.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Need for Additional Capital</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred net losses since our inception and we anticipate that we will continue to incur losses for the foreseeable future, which could harm our future business prospects.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses each year since our inception in 2008. To date, we have financed our operations primarily through private placements of our equity and debt securities, bank loans and the sale and issuance of Class A common stock in our initial public offering (&#8220;IPO&#8221;), which was completed in July 2021. Our net loss for the three months ended March 31, 2023 and 2022 was $10.6&#160;million and $12.2 million, respectively. As of March&#160;31, 2023, we had an accumulated deficit of $221.2 million. Our losses may continue to increase in the future as we continue to devote a substantial portion of our resources to efforts to increase the adoption of, and reimbursement for, the PreTRM test, make improvements to this product, and research, develop, and commercialize new products.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently receive and expect to continue to receive substantially all of our revenues from the sales of the PreTRM test for the foreseeable future. It is possible that we will not generate sufficient revenue from the sale of our products to cover our costs, including research and development expenses related to furthering our product pipeline, and achieve or sustain profitability. A significant element of our business strategy is to increase and maintain our in-network coverage with third-party payers. However, third-party payers, such as commercial insurers and government health care programs, may decide not to reimburse for the PreTRM test, may not reimburse for uses of the PreTRM test for the pregnant patient population, or may set the amounts of such reimbursements at prices that do not allow us to cover our expenses. Many third-party payers currently either have negative coverage determinations or otherwise do not reimburse for low-risk patient preterm birth screening tests. State Medicaid programs currently do not reimburse for our tests; third-party payers are increasingly requiring that prior authorization be obtained prior to conducting testing as a condition to reimbursing for it, which may reduce and/or delay the reimbursement amounts.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As there is a possibility that our company, any collaborators and/or licensees may not successfully develop additional products, obtain required regulatory authorizations for such products, manufacture such products at an acceptable cost or with sufficient quality or successfully market and sell such products with desired margins, our expenses may continue to exceed any revenues we may receive. Our operating expenses also will increase as, or if, among other factors:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our earlier-stage products move into later-stage development, which is generally more expensive than early-stage development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we select additional technologies or products for development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we increase the number of patents we are prosecuting or otherwise expend additional resources on patent prosecution or defense; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we acquire or in-license additional technologies, product candidates, products or businesses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating our business requires a significant amount of cash, and our ability to generate sufficient cash depends on many factors, some of which are beyond our control and if we cannot raise additional capital when needed, we may have to curtail or cease operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we expect to incur significant costs in connection with our operations, including, but not limited to, the development, marketing authorization, and commercialization of new tests, and other products. These development activities generally require a substantial investment before we can determine commercial viability. We expect to need to raise additional funds through public or private equity or debt financings, collaborations or licensing arrangements to continue to fund or expand our operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our actual liquidity and capital funding requirements will depend on numerous factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve broad commercial success with the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and duration of, and expenditures associated with, our discovery efforts and research and development programs, including for our proprietary proteomics and bioinformatics platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs to fund our commercialization strategies for any product candidates which we launch and to prepare for potential product marketing authorizations, as required;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of any acquisitions of complementary businesses or technologies that we may pursue;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential licensing or partnering transactions, if any;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our facility expenses, which will vary depending on the time and terms of any facility lease or sublease we may enter into, and other operating expenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and extent of the expansion of our sales and marketing efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the commercial success of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain more extensive coverage and reimbursement for the PreTRM test and other products, if any; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to collect our accounts receivable.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of additional capital, whether from private capital sources, such as banks, or the public capital markets, may fluctuate as our financial condition and market conditions in general change. There may be times when the private capital sources and the public capital markets lack sufficient liquidity or when our securities cannot be sold at attractive prices, or at all, in which case we would not be able to access capital from these sources. In addition, any weakening of our financial condition or deterioration in our credit ratings could adversely affect our ability to obtain necessary funds. Even if available, additional financing could be costly or have adverse consequences.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional capital, if needed, may not be available on satisfactory terms or at all. Furthermore, any additional capital raised through the sale of equity or equity-linked securities will dilute our stockholders&#8217; ownership interests and may have an adverse effect on the price of our Class A common stock. In addition, the terms of any financing may adversely affect stockholders&#8217; holdings or rights. Debt financing, if available, may include restrictive covenants. To the extent that we raise additional funds through collaborations and licensing arrangements, it may be necessary to relinquish some rights to our technologies or grant licenses on terms that may not be favorable to us.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to obtain adequate funding when needed, we may be required to delay development programs or sales and marketing initiatives. If we are unable to raise additional capital in sufficient amounts or on satisfactory terms, we may have to reduce our workforce and may be prevented from continuing our discovery, development and commercialization efforts and leveraging other corporate opportunities. In addition, it may be necessary to work with a partner on one or more of our tests or products under development, which could lower our economic value of those products. Each of the foregoing factors may harm our business, operating results, and financial condition and may impact our ability to continue as a going concern.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and our financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or the FDIC, as receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership. Although a statement by the Department of the Treasury, the Federal Reserve and the FDIC stated that all depositors of SVB would have access to all of their money after only one business day of closure, including funds held in uninsured deposit accounts, uncertainty remains over liquidity concerns in the broader financial services industry. Similar impacts have occurred in the past, such as during the 2008-2010 financial crisis. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation and rapid increases in interest rates have led to a decline in the trading value of previously issued government securities with interest rates below current market interest rates. Although the U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25 billion of loans to financial institutions secured by certain of such government securities held by financial institutions to mitigate the risk of potential losses on the sale of such instruments, widespread demands for customer withdrawals or other liquidity needs of financial institutions for immediate liquidity may exceed the capacity of such program. There is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions, or that they would do so in a timely fashion. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we assess our banking relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations could be significantly impaired by factors that affect us, the financial institutions with which we have arrangements directly, or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of events or concerns that involve one or more of these factors could include a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations. These could include, but may not be limited to, the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of access to revolving existing credit facilities or other working capital sources and/or the inability to refund, roll over or extend the maturity of, or enter into new credit facilities or other working capital resources; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential or actual breach of contractual obligations that require us to maintain letters or credit or other credit support arrangements; or </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Termination of cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our financial and/or contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our current and/or projected business operations and financial condition and results of operations. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any further deterioration in the macroeconomic landscape or financial services industry could lead to losses or defaults by parties with whom we conduct business, which in turn, could have a material adverse effect on our current and/or projected business operations and results of operations and financial condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly and annual results may fluctuate from period to period, which could adversely impact the value of our Class A common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly and annual results of operations, including our revenues, gross margin, net loss, and cash flows, may vary from period to period as a result of a variety of factors, many of which are outside of our control, including those listed elsewhere in this &#8220;Risk Factors&#8221; section, and as a result, period-to-period comparisons of our operating results may not be meaningful. Our quarterly and annual results should not be relied upon as an indication of future performance. In addition, to the extent that we continue to spend considerably on our internal sales and marketing and research and development efforts, we expect to incur costs in advance of achieving the anticipated benefits of such efforts. We also face competitive pricing and reimbursement pressures, and we may not be able to maintain our premium pricing in the future, which would adversely affect our operating results. Fluctuations in quarterly and annual results and key metrics may cause our results to fall below our financial guidance, if any, or other projections or goals, or the expectations of analysts or investors, which could adversely affect the price of our Class A common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have derived substantially all of our revenues to date from the PreTRM test, and if our efforts to further increase the use and adoption of the PreTRM test or to develop new products and services in the future do not succeed, our business will be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently receive and expect to continue to receive substantially all of our revenues from the sales of the PreTRM test for the foreseeable future. We intend to establish early reimbursement for the PreTRM test by collaborating with payers to perform rigorous analysis to demonstrate the health and economic benefits of our biomarker tests within their </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">own network using customized inputs based on the plan&#8217;s patient population. We plan to leverage early payer reimbursement decisions to obtain widespread commercial coverage of the PreTRM test from many regional and national plans and medical groups with doctors ordering the PreTRM test. If we are unable to execute on this commercial strategy and increase our revenues from the sale of the PreTRM test, our business may be materially adversely impacted. Our ability to increase sales of the PreTRM test and establish greater levels of adoption and reimbursement for the PreTRM test is uncertain for many reasons, including, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to demonstrate to clinics, clinicians, physicians, payers, and patients that the PreTRM test is superior to alternatives with respect to value, convenience, accuracy, scope of coverage, and other factors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party payers may set the amounts of reimbursement at prices that reduce our profit margins or do not allow us to cover our expenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to maintain and grow effective sales and marketing capabilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our sales and marketing efforts may fail to effectively reach customers or communicate the benefits of the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">superior alternatives to the PreTRM test may be developed and commercialized and we may not be able to compete against these alternatives;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may face competitive pressures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may experience supply constraints, including due to the failure of our key suppliers to provide required sequencing instruments and reagents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may encounter difficulties with transportation logistics and regulations associated with shipping blood specimens, including infrastructure conditions and transportation delays;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. or foreign regulatory or legislative bodies may adopt new regulations or policies or take other actions that impose significant restrictions on our ability to market our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to compete successfully with respect to our current or future products or services, as a result of which we may not be able to increase or sustain our revenues or achieve profitability; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to protect our intellectual property position.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our market share for the PreTRM test fails to grow or grows more slowly than expected, our business, operating results, and financial condition would be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on broad scientific and market acceptance of the PreTRM test, which we may fail to achieve.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to achieve and maintain scientific and commercial market acceptance of the PreTRM test will depend on a number of factors. We expect that the PreTRM test will be subject to the market forces and adoption curves common to other new technologies. The market for proteomics and bioinformatics technologies and products is in its early stages of development. If widespread adoption of the PreTRM test or any other products that we commercialize in the future takes longer than anticipated, we will continue to experience operating losses. The success of life sciences technologies and products is due, in large part, to acceptance by the scientific and medical communities and their adoption of certain products in the applicable field of research. The life sciences scientific community is often led by a small number of early adopters and key opinion leaders who significantly influence the rest of the community through publications in peer-reviewed journals. In such journal publications, the researchers will describe their discoveries, and also the methods, and typically the products used, to fuel such discoveries. Mentions in peer-reviewed journal publications may be a driver for the general acceptance of products for the life sciences industry, such as the PreTRM test. In addition, continuing collaborative relationships with opinion leaders will be vital to maintaining any market acceptance we achieve. If too few researchers describe the use of our products, too many researchers shift to a competing product and publish research outlining their use of that product, or too many researchers negatively describe the use of our products in publications, it may drive customers away from our products. Other factors in achieving commercial market acceptance include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to market and increase awareness of the capabilities of the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the PreTRM test to demonstrate comparable performance in intended use applications broadly in the hands of customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our customers&#8217; willingness to adopt new products and workflows;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the PreTRM test&#8217;s ease of use and whether it reliably provides advantages over other alternative technologies;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate of adoption of the PreTRM test by patients, physicians, payers and the medical community at large;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prices we charge for the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop new products and solutions for customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether competitors develop and commercialize products that perform similar functions as the PreTRM test; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of our investments in product innovation and commercial growth.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure that we will be successful in addressing each of these criteria or other criteria that might affect the market acceptance of any products we commercialize, particularly the PreTRM test. If we are unsuccessful in achieving and maintaining market acceptance of the PreTRM test, our business, financial condition, and results of operations would be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In the near future, we expect to rely on sales to a limited number of direct customers for a significant portion of our revenue and cash flows related to the sale of the PreTRM test, making us subject to customer concentration risk.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that a significant portion of our revenue and cash flows in the near future will be related to sales to a limited number of customers, including Elevance Health, the loss of any of which could adversely affect our business, financial condition, cash flows, and results of operations. Accordingly, we are subject to customer concentration risk. Furthermore, any termination of our relationship with Elevance Health would also adversely impact our strategy to rapidly accelerate commercialization of the PreTRM test and help incentivize broader market adoption.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish and maintain sales and marketing capabilities, we may not be successful in commercializing the PreTRM test.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience as a company in sales and marketing and our ability to achieve profitability depends on our being able to attract customers for the PreTRM test and our future products, once approved. Although members of our management team have considerable industry experience, successfully commercializing the PreTRM test will require adapting our sales, marketing, distribution, and customer service and support capabilities to current and ever-changing market conditions. To perform sales, marketing, distribution, and customer service and support successfully, we will face a number of risks, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, retain, and manage the sales, marketing, and customer service and operations workforce necessary to commercialize and gain market acceptance for our technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and cost of establishing a specialized sales, marketing, and customer service and operations workforce; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our sales, marketing, and customer service and support team may be unable to initiate and execute successful commercialization activities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek to enlist one or more third parties to assist with sales, distribution, and customer service and support. There is no guarantee, if we do seek to enter into such arrangements, that we will be successful in attracting desirable sales and distribution partners or that we will be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales and distribution partners, are not successful, the PreTRM test may not gain market acceptance, which could materially impact our business operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if the PreTRM test achieves broad scientific and market acceptance, if we fail to improve it or introduce compelling new products, our future revenues and prospects could be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to achieve broad scientific and market acceptance for the PreTRM test, our ability to grow our business will depend in large part on our ability both to enhance and improve the PreTRM test and to introduce compelling new products, including for major pregnancy related conditions beyond preterm birth. The success of any enhancement to the PreTRM test or introduction of new products depends on several factors, including completion of certain clinical development requirements, timely completion and delivery of the product, competitive pricing, adequate quality testing, integration with existing technologies, appropriately timed and staged product introductions, and overall market acceptance. Any new product or enhancement to the PreTRM test that we develop may not be introduced in a timely or cost-effective manner, may contain defects, errors or vulnerabilities or may not achieve the market acceptance necessary to generate significant revenue.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The typical development cycle of new life sciences products can be lengthy and complicated and may require new scientific discoveries or advancements, considerable resources, and complex technology and engineering. Such developments may involve external suppliers and service providers, making the management of development projects complex and subject to risks and uncertainties regarding timing, timely delivery of required components or services and satisfactory technical performance of such components or assembled products. If we do not achieve the required technical specifications or successfully manage new product development processes, or if development work is not performed according to schedule, then such new technologies or products may be adversely impacted. To date, we have only completed the development process for one product. We cannot assure you that we will ever succeed in completing that process for another product, including for major pregnancy related conditions beyond preterm birth, or that even if we do, it will be launched successfully in the market and find commercial acceptance. If we are unable to successfully develop new products, enhance the PreTRM test to meet customer requirements, compete with alternative products or otherwise gain and maintain market acceptance, our business, results of operations, and financial condition could be harmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition in the life science industry, including companies engaged in molecular diagnostics and proteomics, is intense. If we are unable to compete successfully with respect to our current or future products or services, we may not be able to increase or sustain our revenues or achieve profitability.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a women&#8217;s health diagnostic company utilizing our proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests, and our first commercial product, the PreTRM test, is designed to accurately predict the risk of premature delivery. The proteomics and bioinformatics industry is characterized by rapid technological changes, frequent new product introductions, reimbursement challenges, emerging competition, intellectual property disputes and litigation, price competition, aggressive marketing practices, evolving industry standards and changing customer preferences. We cannot guarantee that research, discoveries or other advancements by other companies will not render our existing or potential products and services uneconomical or result in products and services that are superior or otherwise preferable to our current or future products and services.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition with respect to the PreTRM test and expect to face competition with respect to any product candidates that we may seek to develop or commercialize in the future. Many of the companies against which we are competing or may compete against in the future have significantly greater financial resources and expertise in research and development, manufacturing, and commercialization. Mergers and acquisitions in our industry may result in even more resources being concentrated among a smaller number of our competitors. Smaller and early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel and conducting clinical trials, as well as in acquiring technologies complementary to, or necessary for, our products and services.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remain competitive over time, we will need to continually research and develop improvements to our products and services. However, we cannot assure you that we will be able to develop and commercialize any improvements to our products and services on a timely basis. Our competitors may develop and commercialize competing or alternative products and services and improvements faster than we are able to do so, which would negatively affect our ability to increase or sustain our revenue or achieve profitability.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our products do not perform as expected, our operating results, reputation, and business will suffer.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on the market&#8217;s confidence that we can provide reliable, high-quality testing results. There is no guarantee that the accuracy and reproducibility we have demonstrated to date will continue as our test volumes continue to increase and our product portfolio continues to expand. We believe that patients that rely on our tests are particularly sensitive to test limitations and errors, including inaccurate test results. As a result, if our tests do not perform as expected or favorably in comparison to competing tests, our operating results, reputation, and business will suffer. We may also become subject to legal claims arising from such limitations, errors or inaccuracies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PreTRM test uses, and our future tests will use, a number of complex and sophisticated proteomic and bioinformatics processes and advanced mass spectrometry techniques, which are highly sensitive to external factors. An operational, technological or other failure in one of these complex processes may result in sensitivity or specificity rates that are lower than we anticipate. In addition, we regularly evaluate and refine our testing processes, and any refinements we make may not improve our tests as we expect and may result in unanticipated issues that may adversely affect our test performance as described above. Such operational, technical, and other difficulties adversely affect test performance, may impact the commercial attractiveness of our products and may increase our costs or divert our resources, including management&#8217;s time and attention, from other projects and priorities. Furthermore, any changes to our testing process may require us to use new or different suppliers or materials with whom or which we are unfamiliar, and which may not perform as we anticipate, and could cause delays, downtime or other operational issues.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our CLIA-certified laboratory facility becomes inoperable, we will be unable to perform our tests and our business will be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate a CLIA-certified laboratory facility in Salt Lake City, Utah, which processes the PreTRM test that represents the source of substantially all of our revenues. Our facility could be harmed or rendered inoperable, or our supplies or other assets could be damaged or destroyed, by natural or man-made disasters, including earthquakes, severe weather, flooding, power outages, and contamination, including as a result of a public health threat, which may render it difficult or impossible for us to operate our business and/or perform our tests for some period of time. The inability to perform our tests or the backlog of tests that could develop if our facility is inoperable&#8201;&#8212;&#8201;for even a short period of time&#8201;&#8212;&#8201;may harm our reputation and result in a material adverse effect on our revenues.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The marketing, sale, and use of the PreTRM test and any other products that we develop in the future could result in substantial damages arising from product liability or professional liability claims, associated with product recalls or otherwise, that exceed our resources.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketing, sale, and use of the PreTRM test and any other products that we develop and commercialize in the future could lead to product liability claims against us if someone were to allege that the PreTRM test or any future product failed to perform as it was designed or as claimed in our promotional materials, was performed pursuant to incorrect or inadequate laboratory procedures, if we delivered incorrect or incomplete test results or if someone were to misinterpret test results. In addition, we may be subject to liability for errors in, a misunderstanding of, or inappropriate reliance upon, the information we provide, or for failure to provide such information, in connection with our marketing and promotional activities or as part of the results generated by the PreTRM test and other future tests. Even though the PreTRM test is highly accurate, no test is 100% accurate, and we may report false results. In such a scenario, the patient or her family may file a lawsuit against us claiming product or professional liability. In addition, any manufacturing or design defects in our products could lead to product recalls, either voluntary or as required by government authorities, which could result in the removal of a product from the market.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A product liability or professional liability claim could result in substantial damages and be costly and time-consuming for us to defend. Although we maintain product and professional liability insurance, our insurance may not fully protect us from the financial impact of defending against product liability or professional liability claims or any judgments, fines or settlement costs arising out of any such claims, or the financial and reputational consequences of a product recall. Any product liability or professional liability claim brought against us, with or without merit, could increase our insurance rates, cause our insurance coverage to be terminated or prevent us from securing insurance coverage in the future. As we attempt to bring new products to market, we may need to increase our product liability coverage, which would be a significant additional expense that we may not be able to afford. Additionally, any product liability or professional liability lawsuit could harm our reputation, result in a cessation of PreTRM testing or cause our partners to terminate our agreements with them, any of which could adversely impact our results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The results of our clinical trials and studies may not support the use of our tests and other product candidates, or may not be replicated in later studies.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have conducted and are currently conducting a variety of observational and interventional studies for the PreTRM test and our other tests in development that involve clinical investigators at multiple sites in the United States. We may need to conduct additional studies for the PreTRM test, as well as other tests we may offer in the future, to drive test adoption in the marketplace and reimbursement. Should we not be able to perform these studies, or should their results not provide clinically meaningful data and value for clinicians, or if our results are unfavorable, adoption of our tests could be impaired.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The administration of clinical and economic utility studies is expensive and demands significant attention from certain members of our management team. Data collected from these studies may not be positive or consistent with our existing data, or may not be statistically significant or compelling to the medical community or payers. If the results obtained from our ongoing or future studies are inconsistent with certain results obtained from our previous studies, adoption of our products would suffer and our business would be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peer-reviewed publications regarding our products and product candidates may be limited by many factors, including delays in the completion of, poor design of, or lack of compelling data from clinical studies, as well as delays in the review, acceptance, and publication process. If our products or product candidates or the technology underlying our current or future products or product candidates do not receive sufficient favorable exposure in peer-reviewed publications, or are not published, the rate of health care provider adoption of our tests and positive reimbursement coverage decisions for our tests and other products could be negatively affected. The publication of clinical data in peer-reviewed journals can be a crucial step in commercializing and obtaining reimbursement for tests, and our inability to control when, if ever, results are published may delay or limit our ability to derive sufficient revenues from any test that is the subject of a study. The performance achieved in published studies may not be repeated in later studies that may be required to obtain FDA marketing authorizations should we decide to do so for business reasons, or should we be required to submit applications to the FDA or other health authorities seeking such authorizations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, clinical trials must be conducted in accordance with applicable laws and subject to the oversight of Institutional Review Boards, or IRBs, at the medical institutions where the clinical trials are conducted. We rely on clinical trial sites to ensure the proper and timely conduct of our clinical trials and while we have agreements governing their committed activities, we have limited influence over their actual performance. We depend on our collaborators and on medical institutions to conduct our clinical trials in compliance with applicable human subject protection regulations and Good Clinical Practice, or GCP, requirements. To the extent our collaborators fail to enroll participants for our clinical trials, fail to conduct our trials in compliance with applicable law and GCP requirements, or are delayed for a significant time in the execution of trials, including achieving full enrollment, we may be affected by increased costs, program delays, or both.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interim, top-line and preliminary data from our clinical trials that we announce or publish from time to time may change as additional data become available and are subject to confirmation, audit, and verification procedures that could result in material changes in the final data.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may publicly disclose interim, top-line or preliminary data from our clinical trials, which is based on a preliminary analysis of then-available data, and these results and related findings and conclusions may be subject to change following a more comprehensive review of the data. We also make assumptions, estimations, calculations, and conclusions as part of our analyses of data, and we may not have received or have had the opportunity to fully and carefully evaluate all data. As a result, the interim, top-line or preliminary data that we report may differ from future results of the same trials, or different conclusions or considerations may qualify such results once additional data have been received and fully evaluated. Interim data from clinical trials are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary, interim or top-line data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary top-line data we previously published. As a result, preliminary, interim, and top-line data should be viewed with caution until the final data are available. Adverse differences between preliminary, interim, and top-line data and final data could significantly harm our business prospects and may cause the price of our Class A common stock to fluctuate or decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, payers, physicians, and others may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could adversely impact the potential of the particular product or program, the prospects for commercialization of any product, and the business prospects of our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is derived from information that is typically extensive, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the preliminary, interim or top-line data that we report differ from actual results, or if payers, physicians or others disagree with the conclusions reached, our ability to commercialize our product candidates may be significantly impaired, which could materially harm our business, operating results, prospects or financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business would be materially harmed if our proprietary biobank were to become contaminated, lost or destroyed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A fundamental component of our platform is our proprietary biobank, consisting of comprehensive, clinically and demographically annotated blood specimens collected from thousands of pregnant U.S. women, representing the broad demographic and geographic diversity inherent in the U.S. population. This biobank is maintained at our facility in Salt Lake City, Utah, in a secure environment. If the specimens and information contained in the biobank were to become compromised or destroyed, through contamination, theft, a cybersecurity breach, a natural disaster or otherwise, our ability to rely on the data represented in the biobank could be significantly impaired, which could materially harm our business, operating results, prospects or financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International expansion of our business will expose us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside the United States.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we decide to market our products and services outside the United States, our business will be subject to the risks associated with doing business outside the United States, including an increase in our expenses and diversion of our management&#8217;s attention from the development of future products and services. Accordingly, our business and financial results in the future could be adversely affected due to a variety of factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing laws and regulations such as privacy, security and data use regulations, tax laws, export and import restrictions, economic sanctions and embargoes, employment laws, anti-corruption laws, regulatory requirements, reimbursement or payer regimes and other governmental approvals, permits, and licenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure by us or our distributors to obtain any necessary regulatory clearance, authorization or approval for the use of our products and services in various countries;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional potentially relevant third-party patent rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complexities and difficulties in obtaining intellectual property protection and maintaining, defending, and enforcing our intellectual property outside the United States;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in staffing and managing foreign operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employment risks related to hiring employees outside the United States;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complexities associated with managing multiple payer reimbursement regimes, government payers or patient self-pay systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in negotiating favorable reimbursement negotiations with governmental authorities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">logistics and regulations associated with shipping specimens, including infrastructure conditions and transportation delays;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limits in our ability to penetrate international markets if we are not able to sell our products or conduct services locally;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local and regional financial crises on demand and payment for our products and services and exposure to foreign currency exchange rate fluctuations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters, political and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts, curtailment of trade, and other business restrictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory and compliance risks that relate to maintaining accurate information and control over sales and distributors&#8217; activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act, or FCPA, its books and records provisions, or its anti-bribery provisions, or laws similar to the FCPA in other jurisdictions in which we may operate, such as the United Kingdom Bribery Act of 2010, or the U.K. Bribery Act; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">onerous anti-bribery requirements of several member states in the European Union, the United Kingdom, Japan, and other countries that are constantly changing and require disclosure of information to which U.S. legal privilege may not extend.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors could significantly harm our future international expansion and operations and, consequently, our revenue and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain and maintain the third-party relationships that are necessary to develop and commercialize some or all of our tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to depend on collaborators, partners, licensees, and other third parties to support our test development and validation efforts, to deliver needed supplies, and to transport specimens for testing, among other things. Any problems we experience with any of these third parties could delay the development, validation, commercialization, and performance of our testing, which could harm our results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that we will be able to successfully negotiate agreements for, or maintain relationships with, collaborators, partners, licensees, and other third parties on favorable terms, if at all. If we are unable to obtain or maintain these agreements, we may not be able to develop, validate, obtain regulatory authorizations for, or commercialize any future tests, which will in turn adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to expend substantial management time and effort to enter into relationships with third parties and, if we successfully enter into such relationships, to manage these relationships. In addition, substantial amounts will be paid to third parties in these relationships. However, we cannot control the amount or timing of resources our future contract partners will devote to our business endeavors, and we cannot guarantee that these parties will fulfill their obligations to us under these arrangements in a timely fashion, if at all. In addition, while we manage the relationships with third parties, we cannot control all of the operations of and protection of intellectual property by such third parties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for specimen collection, including phlebotomy services, and commercial courier delivery services, and if these services are disrupted, our business will be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties to perform specimen collection, including phlebotomy services, and to transport specimens to our laboratory facility in a timely and cost-efficient manner. Disruptions in these services, whether due to any natural or other disasters, pandemics, acts of war or terrorism, shipping embargoes, labor unrest, political instability or similar events could adversely affect specimen integrity and our ability to process specimens in a timely manner and to service our customers, and ultimately our reputation and our business. In addition, if we are unable to continue to obtain expedited delivery services on commercially reasonable terms, our operating results may be adversely affected.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our relationships with these service providers could be scrutinized under federal and state health care laws such as the federal Anti-Kickback Statute and the Stark Law, and their implementing regulations, to the extent, for example, that these services provide a financial benefit to or relieve a financial burden for a potential referral source. If our operations are found to be in violation of any of these laws and regulations, we may be subject to administrative, civil and/or criminal penalties, damages, fines, individual imprisonment, refunding of payments received by us, exclusion from government health care programs, and/or curtailment or cessation of our operations, among other potential penalties, any of which could harm our reputation and adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on a limited number of suppliers or, in some cases, single suppliers, for some of our laboratory instruments and materials and may not be able to find replacements or immediately transition to alternative suppliers on a cost-effective basis, or at all.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We source components of our technology from third parties and certain components are sole sourced. Obtaining substitute components may be difficult or require us to re-design our products. We expect to continue to depend on third-party contract suppliers for the foreseeable future. Any natural or other disasters, such as re-emergence of COVID-19 pandemic, acts of war or terrorism, shipping embargoes, labor unrest or political instability or similar events at our third-party suppliers&#8217; facilities that cause a loss of manufacturing capacity or a reduction in the quality of the items manufactured would heighten the risks that we face. In addition, inflation and/or global supply chain disruptions may have a negative impact on our third-party contract suppliers&#8217; ability to acquire the materials necessary for our business and we could incur higher costs for certain goods or services due to inflation or increased freight costs. Changes to, failure to renew or termination of our existing agreements or our inability to enter into new agreements with other suppliers could result in the loss of access to important components of our tests and could impair, delay or suspend our commercialization efforts. Our failure to maintain a continued and cost-effective supply of high-quality components could materially and adversely harm our business, operating results, and financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully scale our operations, or attract and retain highly skilled employees, our business could suffer.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our test volumes grow and we develop future product offerings, we will need to continue to ramp up our testing capacity and implement increases in scale, such as increased headcount, additional or upgraded equipment, additional qualified laboratory personnel, increased office and laboratory space, expanded customer service capabilities, improved billing and systems processes, enhanced controls and procedures and expanded or internal quality assurance program and technology platform. The value of the PreTRM test and our other testing products that we may develop in the future depends on our ability to perform, and our reputation for performing, these tests on a timely basis and with an exceptionally high standard of quality. Failure to implement necessary procedures, transition to new facilities, purchase and maintain equipment, establish processes, or hire the necessary personnel in a timely and effective manner could result in higher processing costs or an inability to meet market demand or could otherwise affect our operating results.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To execute our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel is intense, especially for sales, scientific, medical, laboratory, research and development, and other technical personnel. The turnover rate of such personnel can be high. We may, from time to time, experience difficulty in hiring and retaining employees with appropriate qualifications. Many of the companies with which we compete for highly qualified personnel have greater resources than we have. If we hire employees from competitors or other companies, their former employers may attempt to assert that these employees or our company have breached their legal obligations to their former employers, which occurs from time to time. Furthermore, to the extent that we are unable to retain our employees and they leave our company to join one of our competitors, we cannot assure you that any invention, non-disclosure or non-compete agreements we have in place will provide meaningful protection against a departing employee&#8217;s unauthorized use or disclosure of our confidential information.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our growth may place a significant strain on our operating and financial systems and our management, sales, marketing, and administrative resources. As a result of our growth, our operating costs may escalate faster than we anticipate, we may face difficulties in obtaining additional office or laboratory space and some of our internal systems may need to be enhanced or replaced. If we cannot effectively manage our expanding operations and our costs, we may not be able to grow successfully or we may grow at a slower pace, and our business could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may engage in acquisitions, dispositions or other strategic transactions that could disrupt our business, cause dilution to our stockholders or reduce our financial resources.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may enter into transactions to acquire or dispose of businesses, products or technologies or to engage in other strategic transactions. Because we have not made any such acquisitions to date, our ability to do so successfully is unproven. Even if we identify suitable transactions, we may not be able to complete such transactions on favorable terms or at all. Any acquisitions or other strategic transactions we consummate may not strengthen our competitive position, and these transactions may be viewed negatively by customers or investors. We may decide to incur debt in connection with an acquisition or issue shares of our common stock or other equity securities to the stockholders of the acquired company, which would cause dilution to our existing stockholders. We could incur losses resulting from such strategic transactions, including undiscovered liabilities of an acquired business that are not covered by any indemnification we may obtain from the seller. In addition, we may not be able to successfully integrate any acquired personnel, technologies, and operations into our existing business in an effective, timely and non-disruptive manner. Any dispositions may also cause us to lose revenue and may not strengthen our financial position. Strategic transactions may also divert management attention from day-to-day responsibilities, increase our expenses, result in accounting charges, and reduce our cash available for operations and other uses. We cannot predict the number, timing or size of future strategic transactions or the effect that any such transactions might have on our operating results.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to raise additional funds through equity or debt financings, corporate collaborations or licensing arrangements to continue to fund or expand our operations. Additional capital, if needed, may not be available on satisfactory terms or at all. Furthermore, any additional capital raised through the sale of equity or equity-linked securities, or grant of equity or equity-linked securities in connection with any debt financing, will dilute stockholders&#8217; ownership interests in us and may have an adverse effect on the price of our Class A common stock. In addition, the terms of any financing may adversely affect stockholders&#8217; holdings or rights. To the extent that we raise capital through collaborations and licensing arrangements, it may be necessary to relinquish some rights to our technologies or grant licenses on terms that may not be favorable to us.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to obtain adequate funding when needed, we may have to delay development programs or sales and marketing initiatives. In addition, we may have to work with a partner on one or more of our tests or programs, which could lower the economic value of those programs to our company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A re-emergence of COVID-19, or the emergence of a new pathogen, could materially affect our operations, as well as the business or operations of third parties with whom we conduct business. Our business could be adversely affected by the effects of other future public health threats in regions where we, or third parties on which we rely, have significant business operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and operations, including, but not limited to, our laboratory operations, sales and marketing efforts, supply chain operations, research and development activities, and fundraising activities, could be adversely affected by public health disruptions in regions where we have business operations, and such health disruptions could cause significant disturbance in the operations of third parties upon whom we rely. As a recent example, in March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic, and the U.S. government imposed restrictions on travel between the United States, Europe, and certain other countries. In the years following the initial outbreak, numerous state and local jurisdictions, including the jurisdictions where our headquarters and laboratory are located, imposed quarantines, shelter-in-place orders, executive orders, and similar government orders for their residents to control the spread of COVID-19. A re-emergence of COVID-19, or the emergence of a new pathogen, as a serious public health threat could result in similar restrictions being imposed. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of new variants of the COVID-19 virus or any future severe public health threats, together with any executive orders or shelter-in-place orders, may negatively impact productivity, disrupt our business and delay our clinical programs and timelines, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business in the ordinary course. These and similar, and perhaps more severe, disruptions in our operations could negatively impact our business, operating results and financial condition. We have processes in place to respond to any future state and local quarantine, shelter-in-place orders, executive orders, and similar government orders. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarantines, shelter-in-place orders, executive orders, and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, could impact personnel at third-party manufacturing facilities, or the availability or cost of materials we use or require to conduct our business, which would disrupt our supply chain. In particular, some of our suppliers of certain materials used in our laboratory operations and research and development activities may be located in areas that are subject to executive orders and shelter-in-place orders. While many of these materials may be obtained from more than one supplier, port closures and other restrictions resulting from the COVID-19 pandemic or future pandemics may disrupt our supply chain or limit our ability to obtain sufficient materials to operate our business. Furthermore, the COVID-19 pandemic resulted in a sharp decrease in the number of patient visits to health care providers. As a result of the COVID-19 pandemic, we have experienced disruptions that impacted our business and may see further disruptions that could cause further impacts, including on our ability to successfully commercialize the PreTRM test in the United States.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our clinical trials were affected by the COVID-19 pandemic. The primary impacts to our business have been the early cessation of enrollment in our AVERT PRETERM TRIAL in March 2020, the delayed commencement of enrollment in our PRIME study until November 2020 and slower than expected enrollment thereafter, and limited access to ordering clinicians during our early commercialization of our PreTRM test. We have enrolled sufficient numbers of PRIME study patients to enable the interim analysis to occur in 2023, and expect to report the results of that analysis if and when we are able to do so. If COVID-19 re-emerges as a serious public health threat in the United States and elsewhere, or if another serious pathogen appears, then we may experience additional disruptions that could severely impact our business, preclinical studies, and clinical trials, including potential timing delays.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public health threats like COVID-19, which has caused a broad impact globally, may materially affect us economically, including by causing a significant reduction in laboratory testing volumes. In addition, reimbursements for our tests may also be delayed if third-party payers&#8217; processing is impacted by a public health threat and work-from-home policies and other operational limitations mandated by federal, state, and local governments in response. While the potential economic impact brought by a public health disruption, and the duration of such impact, may be difficult to assess or predict, COVID-19 has shown that a widespread public health threat can result in significant disruption of global financial markets, which could reduce our ability to access capital and negatively affect our future liquidity. In addition, a recession or market correction resulting from a public health threat and related government orders and restrictions could materially affect our business and the value of our Class A common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. Its most severe effects appear to have subsided, but this virus could re-emerge, or new public health threats could appear. The future impact of the COVID-19 pandemic or a similar health disruption is highly uncertain and subject to change. We cannot predict the full extent of potential delays or impacts on our business, our clinical trials, health care systems or the global economy as a whole.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot ensure that our employees will fully adhere to compliance policies and procedures.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented and strive to continuously develop and improve compliance policies and procedures intended to train our sales, billing, marketing, and other personnel regarding compliance with state and federal laws applicable to our business. Our efforts to implement appropriate monitoring of compliance with such policies and procedures are likewise ongoing. Despite our compliance policies and procedures, and related training and monitoring, we may experience situations in which employees may have failed to fully adhere to our policies and applicable laws in the past or in which they fail to adhere to applicable policies and/or laws in the future. Such failures may subject us to administrative, civil, and criminal actions, penalties, damages, fines, individual imprisonment, exclusion from participation in federal health care programs, refunding of payments received by us, and curtailment or cessation of our operations. In addition, commercial third-party payers may refuse to provide all or any reimbursement for tests administered, seek repayment from us of amounts previously reimbursed and harm our ability to secure network contracts with third-party payers. Any of the foregoing could adversely affect our revenue, cash flow, and financial condition, and reduce our growth prospects. As of the date hereof, we are not aware of any noncompliance with any state and federal laws applicable to our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we lose the services of our Chairman, President and Chief Executive Officer or other members of our senior management team, we may not be able to execute our business strategy.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part upon the continued service of our senior management team. In particular, our Chairman, President and Chief Executive Officer, Gregory C. Critchfield, M.D., M.S. is critical to our vision, strategic direction, culture, products and technology. In addition, we do not maintain key-man insurance for Dr. Critchfield or any other member of our senior management team. The loss of our Chairman, President and Chief Executive Officer or one or more other members of our senior management team could have an adverse effect on our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a significant amount of net operating loss, or NOL, carryforwards that can be used to offset potential future taxable income and related income taxes. As of December 31, 2022, we had federal NOL carryforwards of approximately $187.9 million, of which, $70.3 million, if not utilized, begin to expire in 2028. Approximately $117.6 million of these federal NOLs can be carried forward indefinitely. Under Section 382 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a greater than 50% change, by value, in equity ownership over any three-year period), the corporation&#8217;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. We may experience ownership changes in the future as a result of shifts in our stock ownership, some of which may not be within our control. Our ability to use these carryforwards could be limited if we experience an &#8220;ownership change.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our estimates of total addressable market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at a similar rate.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total addressable market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. Our publicly announced estimates and forecasts relating to the size and expected growth of our market may prove to be inaccurate. Even if the market in which we compete meets our size estimates and forecasted growth, our business could fail to grow at similar rates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The inflationary environment could materially adversely impact our business and results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results could be materially impacted by changes in the overall macroeconomic environment and other economic factors that impact customer confidence and spending, including capital spending. Changes in economic conditions, supply chain constraints, logistics challenges, labor shortages, global conflicts, and steps taken by governments and central banks, particularly in response to public health threats as well as other stimulus and spending programs, have led to higher inflation, which is likely, in turn, to lead to an increase in costs and may cause changes in fiscal and monetary policy, including increased interest rates. In a higher inflationary environment, we may be unable to raise the prices of our products sufficiently to keep up with the rate of inflation. Impacts from inflationary pressures could be more pronounced </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and materially adversely impact aspects of our business where revenue streams and cost commitments are linked to contractual agreements that extend further into the future, as we may not be able to quickly or easily adjust pricing, reduce costs, or implement counter measures. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Reimbursement</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If third-party payers do not adequately reimburse for the PreTRM test or any new tests we may develop, such tests may not be purchased or used, which may adversely affect our revenue and profits.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and markets in some other countries, patients generally rely on third-party payers to reimburse all or part of the costs associated with their treatment or tests. Adequate coverage and reimbursement from third-party payers such as federal and state health care programs (e.g., Medicare and Medicaid) and commercial insurers is critical to new product acceptance. Our business depends on our ability to obtain or maintain adequate reimbursement from third-party payers. We expect third-party payers such as commercial insurers to be our most significant source of payment in the near future. In particular, we believe that for our company to achieve commercial success, it will be necessary to gain acceptance from third-party payers for the PreTRM test, and to obtain positive coverage determinations and favorable reimbursement rates from third-party payers for our tests over time. We do not yet know, however, whether and to what extent certain of our products, including those under development, will be covered or reimbursed. If we are unable to obtain or maintain coverage or adequate reimbursement from, or achieve in-network status with, third-party payers for our existing or future tests or other products, our ability to generate revenues will be limited. For example, health care providers may be reluctant to order our tests or other products due to the possibility that a patient may incur substantial costs if coverage or reimbursement is unavailable or insufficient. Such coverage and reimbursement may depend upon a number of factors, including the determination that the test and its use or administration for a particular patient are:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a covered benefit;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safe, effective, and medically necessary;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriate for the specific patient;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supported by guidelines established by the relevant professional societies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approved in any states where specific assay approval is necessary;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cost-effective; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">neither experimental nor investigational.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Centers for Medicare &amp; Medicaid Services, or CMS, an agency within the United States Department of Health and Human Services, or HHS, and its Medicare Administrative Contractors make decisions regarding Medicare coverage for new tests. Other third-party payers, including commercial insurers, often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates, and both CMS and certain commercial insurers may have sufficient market power to demand significant price reductions. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining coverage and reimbursement approval for a test from each third-party payer is a time-consuming and costly process that could require us to provide to each payer supporting scientific, clinical, patient insurance eligibility and benefits, and billing-related information. We may not be able to provide data sufficient to satisfy third-party payers that the test should be covered and reimbursed. There is substantial uncertainty whether any particular payer will cover and reimburse the use of any test incorporating new technology. Even when a payer determines that a test is eligible for reimbursement, the payer may impose coverage limitations that preclude payment under certain circumstances or for certain patient populations. Moreover, eligibility for coverage does not imply that any test will be reimbursed in all cases or at a rate that allows us to make a profit or even cover our costs. Interim payments for new tests, if applicable, may also not be sufficient to cover our costs and may not be made permanent. In some instances, payment may only be obtained by obtaining prior authorization and/or engaging in lengthy and costly appeals processes. Reimbursement rates may vary, for example, according to the use of the test and the clinical setting in which it is used, and may reflect budgetary constraints and/or imperfections in Medicare, Medicaid or other data used to calculate these rates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been, and we expect that there will continue to be, federal and state proposals to constrain expenditures for health care products and services, which may affect payments for our tests. Third-party payers, including the Medicare program, frequently change coverage policies, product and service codes and payment methodologies and reimbursement amounts. Due in part to actions by third-party payers, the health care industry is experiencing a trend toward containing or reducing costs through various means, including lowering reimbursement rates and negotiating reduced payment schedules with service providers for certain products and/or services.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inability to promptly obtain coverage and profitable reimbursement rates from third-party payers for our tests could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, leading professional societies may recommend alternatives to our tests, which may provide a basis for third-party payers not to cover or reimburse our tests. In making coverage determinations, third-party payers often rely on practice guidelines issued by professional societies. Test-ordering providers may also rely on such guidelines when deciding whether to order testing for their patients. If any relevant professional societies issue guidelines suggesting, or otherwise make recommendations, that providers not use our tests or instead use alternatives to our tests, payers may make unfavorable coverage and reimbursement decisions and test-ordering providers may not order our tests. Any such outcomes could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New reimbursement methodologies applicable to the PreTRM test, and other future tests, including new CPT codes, may decrease reimbursement rates from third-party payers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If eligible for reimbursement, laboratory tests are generally classified for reimbursement purposes under CMS&#8217;s Healthcare Common Procedure Coding System, or HCPCS, and the American Medical Association&#8217;s, or AMA, Current Procedural Terminology, or CPT, coding systems. We, and payers, generally must use these coding systems to bill, and pay for, testing, respectively. Once an HCPCS or CPT code is created or established, CMS establishes payment rates and in some cases coverage rules for that code under Medicare. Commercial insurers likewise typically establish their own payment rates and coverage rules for that code.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AMA has issued a unique CPT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Laboratory Analysis, or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLA, code for the PreTRM test. CMS priced this code at $750 in November 2021. Before the AMA issued a CPT PLA code for the PreTRM test, we submitted claims for reimbursement using CPT codes existing at the time based on the guidance of external coding experts.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that we will be able to negotiate favorable rates for our unique code, nor can we guarantee that we will receive reimbursement at all, especially if we are unable to collect and publish additional data and obtain positive coverage determinations for the PreTRM test or our other future tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have specific CPT codes assigned for any of our other tests under development and there is a risk that we may not be able to obtain such codes or, if obtained, we may not be able to negotiate favorable rates for such codes.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, third-party payers may not establish positive coverage policies for our tests or adequately reimburse for any CPT code we may use, or seek recoupment for testing previously performed, which is a common occurrence in our industry.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Billing disputes with third-party payers, including disagreement regarding the selection and use of CPT codes when submitting claims, may decrease realized revenue and may lead to requests for recoupment of past amounts paid.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that payers could dispute our billing or coding from time to time. Payers may likewise seek to recoup reimbursements already paid, and we expect that such disputes and requests for recoupment may arise. Third-party payers may also decide to deny payment or recoup payment for testing that they contend to have been not medically necessary, against their coverage determinations, or for which they have otherwise overpaid. There is also a risk that the CPT codes we previously submitted, are currently submitting, or will submit in the future on claims will be rejected or withdrawn or that third-party payers will seek refunds of amounts that they claim were inappropriately billed based on, for example, the CPT code used, the modifier attached, or the number of units billed. Claims for recoupment require the time and attention of our management and other key personnel, which can be a distraction from operating our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If third-party payers deny payment for testing, reimbursement revenue for our testing could decline. If a third-party payer successfully challenges that payment for prior testing was in breach of contract or otherwise contrary to policy or law, they may recoup payment, which amounts could be significant and would impact our operating results and financial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condition, and it may decrease reimbursement going forward. We may also decide to negotiate and settle with a third-party payer in order to resolve an allegation of overpayment. Any of these outcomes, including recoupment or reimbursements, might also require us to restate our financials from a prior period, any of which could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with laws and regulations related to submission of claims for our services could result in substantial financial penalties and/or potential civil or criminal liability.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of complex federal and state laws and regulations applicable to the submission of claims for payment for our services. If a third-party payer or a regulatory or enforcement agency, or, in some cases, a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relator, believes or alleges that we engaged in improper billing practices&#8212;including, but not limited to, not adequately pursuing patient cost share responsibilities, submitting improper CPT codes, multipliers or modifiers on our claims&#8212;we may be subject to investigation and/or enforcement actions under federal and/or state law.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responding to and defending such investigations and/or enforcement actions may require significant time and attention from management and key personnel, include significant expenditures, and result in significant penalties, damages, fees, and reputational harm, all of which could have a material adverse effect on our business, operating results, and financial condition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See &#8220;&#8212; Risks Related to Government Regulation&#8201;&#8212;&#8201;If we, or our employees or contractors on our behalf, engage in conduct that violates health care laws, are suspected or accused of engaging in such conduct, or are subject to investigation for actual or alleged such conduct, we could face substantial penalties and damage to our reputation, and our business operations and financial condition could be adversely affected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Most favored nation&#8221; provisions in contracts with third-party payers may limit potential for revenue growth and may lead to claims for recoupment.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our contracts with third-party payers may in the future contain &#8220;most favored nation&#8221; provisions, pursuant to which we typically agree that we will not bill the third-party payer more than we bill any other third-party payer. These contract provisions limit the amount we are able to charge for our products and can negatively impact revenue. We monitor our billing and claims submissions for compliance with these contractual requirements with third-party payers. If we do not successfully manage compliance with these most favored nation provisions, we may be required to forego revenues from some third-party payers or reduce the amount we bill to each third-party payer with a most favored nation clause in its contract that is violated, which would adversely affect our business, operating results, and financial condition. This situation could also subject us to claims for recoupment, which could ultimately result in an obligation to repay amounts previously earned.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">When third-party payers deny coverage, we are often unable to collect from the patient or any other source and risk disputes if we attempt to do so.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a third-party payer denies coverage, or if the patient has a large deductible or co-insurance amount, it may be difficult for us to collect from the patient, and we may not be successful in doing so. If we are in-network, we may be contractually prohibited from seeking payment beyond applicable deductibles, co-insurance, or co-payments from the patient. If we are out-of-network, we may be unable to collect the full amount of a patient&#8217;s responsibility, despite our good faith efforts to collect. As a result, we may not always be able to collect the full amount due for our tests if third-party payers deny coverage or cover only a portion of the billed amount or if the patient has a large deductible, which could cause payers to raise questions regarding our billing policies and patient collection practices.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our practices with respect to billing and collecting patient responsibility amounts are compliant with applicable laws; however, we may in the future receive inquiries from third-party payers regarding our practices in these areas. There is no guarantee that we will be successful in addressing such concerns, and if we are unsuccessful, this may result in a third-party payer deciding to reimburse for our tests at a lower rate or not at all, seeking recoupment of amounts previously paid to us, or bringing legal action to seek reimbursement of previous amounts paid. Any such occurrences could cause reimbursement revenue for our testing, which constitutes the large majority of our revenue, to decline. Additionally, if we were required to make a repayment, such repayment could be significant, which could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenues may be adversely impacted if third-party payers withdraw coverage or provide lower levels of reimbursement due to changing policies, billing complexities or other factors.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we become an in-network provider by entering into an agreement with any of the third-party payers from which we receive reimbursement, this means that we will have an agreement that governs approval or payment terms. However, such a contract would not guarantee reimbursement for all testing we perform.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the terms of any such agreement may require a physician or qualified practitioner&#8217;s signature on test requisitions or require other controls and procedures prior to conducting a test. In particular, third-party payers have been increasingly requiring prior authorization to be obtained prior to conducting a test as a condition to reimbursing for the test. If the payers were to do so for the PreTRM test, it could place a burden on our billing operations and require us to dedicate resources to monitoring that these prior authorization requirements are met. To the extent we or the health care providers ordering our tests do not follow the prior authorization requirements, we may be subject to claims for recoupment of reimbursement amounts previously paid to us, or may not receive some or all of the reimbursement amounts to which we would otherwise be entitled. This may occur in the future, which could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are considered to be an out-of-network provider, which we expect to be the case with at least some of the largest third-party payers from which we may receive reimbursement in the future, such third-party payers could withdraw coverage and decline to reimburse for our tests, for any reason. They can also impose prior authorization requirements through the terms of the patients&#8217; health plans. Managing reimbursement on a case-by-case basis is time-consuming and contributes to an increase in the number of days it takes us to collect on accounts, which also increases our risk of non-payment. Negotiating reimbursement on a case-by-case basis also typically results in the receipt of reimbursement at a significant discount to the list price of our tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are being reimbursed for our tests, third-party payers may unilaterally review and adjust the rate of reimbursement, require co-payments from patients or stop paying for our tests. Federal and state health care programs as well as commercial insurers continue to increase their efforts to control the cost, utilization, and delivery of health care services by demanding price discounts or rebates and limiting coverage of, and amounts they will pay for, molecular tests. These measures have resulted in reduced payment rates and decreased utilization in the clinical laboratory industry. Because of these cost-containment measures, third-party payers&#8201;&#8212;&#8201;including those that may reimburse our tests in the future&#8201;&#8212;&#8201;may reduce, suspend, revoke or discontinue payments or coverage at any time. Reduced reimbursement of our tests may harm our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billing for clinical laboratory testing services is complex. We perform tests in advance of payment and without certainty as to the outcome of the billing process. In cases where we expect to receive a fixed fee per test due to our reimbursement arrangements, we may nevertheless encounter variable reimbursement, leading to disputes over pricing and billing. Each third-party payer typically has different billing requirements, and the billing requirements of many payers have become increasingly difficult to meet. Among the factors complicating our billing of third-party payers are:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disparity in coverage among various payers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disparity in information and billing requirements among payers, including with respect to prior authorization requirements and procedures and establishing medical necessity; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incorrect or missing billing information, which is required to be provided by the ordering health care provider.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks related to billing complexities, and the associated uncertainty in obtaining payment for our tests, could harm our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Status as an out-of-network provider with a large commercial insurer may cause health care providers to avoid recommending our tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be considered to be an out-of-network provider with respect to the large commercial insurers from which we may receive reimbursement from in the future. Physician groups and other health care providers may view this negatively and may insist upon only using laboratories that are in-network with their patients&#8217; insurance companies. These types of decisions could reduce our revenue and harm our financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in government health care policy could increase our costs and negatively impact coverage and reimbursement for our tests by governmental and other third-party payers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. government is pursuing health care reform and aiming to reduce health care costs. Government health care policy has been, and will likely continue to be, a topic of extensive legislative and executive activity in the U.S. federal government and many U.S. state governments. As a result, our business could be affected by significant and potentially unanticipated changes in government health care policy, which could in turn substantially impact our revenues, increase costs, and divert management attention from our business strategy. We cannot predict the impact of governmental health care policy changes on our future business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Affordable Care Act, or ACA, was signed into law in March 2010 and significantly impacted the U.S. pharmaceutical and medical device industries, including the diagnostics sector, in a number of ways. The ACA restricts insurers from charging higher premiums or denying coverage to individuals with pre-existing conditions, and requires insurers to cover certain preventative services without charging any copayment or coinsurance, including screening for lung, breast, colorectal and cervical cancers. The ACA also created a new system of health insurance &#8220;exchanges&#8221; designed to make health insurance available to individuals and certain groups through state- or federally-administered marketplaces in addition to existing channels for obtaining health insurance coverage. In connection with such exchanges, certain &#8220;essential health benefits&#8221; are intended to be made more consistent across plans, setting a baseline coverage level. The states (and the federal government) have some discretion in determining the definition of &#8220;essential health benefits&#8221; and we do not know whether our tests or other products will fall into a benefit category deemed &#8220;essential&#8221; for coverage purposes across the plans offered in any or all of the exchanges. If any of our tests are not covered by plans offered in the health insurance exchanges, our business, operating results and financial condition could be adversely affected.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been multiple attempts to repeal the ACA or significantly scale back its applicability, as a result of which, certain sections of the ACA have not been fully implemented or were effectively repealed. This could negatively impact reimbursement for our testing, adversely affect our test volumes and adversely affect our business, operating results, and financial condition. However, following several years of litigation in the federal courts, in June 2021, the United States Supreme Court upheld the ACA when it dismissed a legal challenge to the Act&#8217;s constitutionality. Further legislative and regulatory changes to federal health care laws and policies remain possible. Future changes or additions to the ACA, the Medicare and Medicaid programs, and changes stemming from other health care reform measures, especially with regard to health care access, financing or other legislation in individual states, could have a material adverse effect on the health care industry in the U.S. The uncertainty around the future of the ACA and other health care legislation, and in particular the impact to reimbursement levels and the number of insured individuals, may lead to delay in the purchasing decisions of our customers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the ACA, various health care reform proposals have also emerged from federal and state governments. The Protecting Access to Medicare Act of 2014, or PAMA, for example, introduced a multi-year pricing program for services payable under the Clinical Laboratory Fee Schedule, or CLFS, that is designed to bring Medicare allowable amounts in line with the amounts paid by commercial insurers. The rule issued by CMS to implement PAMA required certain laboratories to report third-party payer rates and test volumes, though these reporting requirements have been delayed. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implementation of Medicare rates pursuant to PAMA has negatively impacted overall pricing and reimbursement for many clinical laboratory testing services and may do so in the future. Since January 1, 2018, the Medicare payment rate for such tests is equal to the weighted median private payer rate reported to CMS, which for many tests is lower than the previous CLFS payment rates due to the often lower negotiated commercial insurer rates applicable to large commercial laboratories that were required to report data to CMS. Likewise, because commercial insurers often base their pricing for laboratory testing on a percentage of the price set on the CLFS, PAMA has in turn affected rates paid by commercial insurers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have not historically submitted claims to Medicare or other state and federal health care programs, the rates paid by these programs have been the subject of controversy in the industry, including a lawsuit by the American Clinical Laboratory Association, and it is unclear whether and to what extent the new rates may change.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several state and federal health care programs. This includes aggregate reductions of Medicare payments to providers up to 2% per fiscal year, and, due to subsequent legislative amendments, will remain in effect through 2032 unless additional Congressional action is taken (with the exception of a temporary suspension from May 1, 2020 through March 31, 2022 due to the COVID-19 pandemic). As another example, in January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which among other things, increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether future health care initiatives will be implemented at the federal or state level or how any such future legislation, regulation, or initiative may affect us. Current or potential future federal legislation and the expansion of government&#8217;s role in the U.S. health care industry, as well as changes to the reimbursement amounts paid by third-party payers for our current and future tests, may adversely affect our test volumes and adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the validity of an informed consent from a patient is challenged, we could be precluded from billing for such patient&#8217;s testing, be forced to stop performing certain tests, forced to exclude the patient&#8217;s data or specimens from clinical trial results or be subject to lawsuits or regulatory enforcement.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to ensure that all clinical data and blood specimens that we receive have been collected from subjects who have provided appropriate informed consent for us to perform our testing, both commercially and in clinical trials. Among other things, in our consent forms, we seek to ensure that the subjects from whom the data and specimens are collected do not retain or have conferred on them any proprietary or commercial rights to the data or any discoveries derived from them. A subject&#8217;s informed consent could be challenged in the future, and the informed consent could prove invalid, unlawful or otherwise inadequate for our purposes. Any such findings against us, or our partners, could deny us access to, or force us to stop, testing specimens in a particular territory or could call into question the results of our clinical trials. We could also be precluded from billing third-party payers for tests for which the underlying informed consents are challenged, or we could be requested to refund amounts previously paid by third-party payers for such tests. We could become involved in legal challenges or regulatory enforcement, which could require significant management and financial resources and adversely affect our operating results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely impacted by changes in laws and regulations, or in their application.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care industry in which we operate is highly regulated, and failure to comply with applicable regulatory, supervisory, accreditation, registration, or licensing requirements may adversely affect our business, operating results, and financial condition. The laws and regulations governing our research and marketing efforts are extremely complex and in many instances there are no clear regulatory or judicial interpretations of these laws and regulations, which increases the risk that we may be found to be in violation of these laws.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the industry is growing, and regulatory agencies such as HHS or the FDA may apply heightened scrutiny to new developments. While we have taken steps to ensure compliance with current regulatory frameworks in all material respects as historically enforced by the applicable regulatory agencies, given the highly complex and often unclear guidelines, there could be areas where we are unintentionally and unknowingly noncompliant. Any change in the federal or state laws or regulations relating to our business may require us to implement changes to our business or practices, and we may not be able to do so in a timely or cost-effective manner. Should we be found to be noncompliant with current or future regulatory requirements, we may be subject to sanctions that could include changes to our operations, adverse publicity, substantial financial penalties, exclusion from state and federal health care programs, and criminal proceedings, which may adversely affect our business, operating results, and financial condition by increasing our cost of compliance or limiting our ability to develop, market, and commercialize our products.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there has been a recent trend of increased U.S. federal and state regulation of payments made to physicians, which are governed by laws and regulations including the Stark Law, the federal Anti-Kickback Statute, the Physician Payments Sunshine Act, the Eliminating Kickbacks in Recovery Act of 2018, and the federal False Claims Act, as well as state equivalents of such laws. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have implemented and strive to continuously develop and improve compliance policies and procedures intended to address compliance with applicable federal and state laws and regulations, including applicable fraud and abuse laws and regulations such as those described in this risk factor, the evolving commercial compliance environment and the need to build and maintain robust and scalable systems to comply with regulations in multiple jurisdictions with different compliance and reporting requirements increases the possibility that we could inadvertently violate one or more of these requirements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the way the FDA regulates laboratory developed tests or the reagents, other consumables, and testing equipment we use when developing, validating, and performing our tests could result in delay or additional expense in bringing our tests to market or performing such tests for our customers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the sequencing instruments, reagents, kits, and other consumable products used to perform our testing, as well as the instruments and other capital equipment that enable the testing, are offered for sale as analyte specific reagents, or ASRs, or for research use only, or RUO. ASRs are medical devices and must comply with FDA quality system requirements provisions and other device requirements, but most are exempt from premarket review by the FDA as an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic product. Products that are intended for RUO and are labeled as RUO are exempt from compliance with most FDA requirements, including the approval or clearance and other product quality requirements for medical devices. A product labeled RUO but which is actually intended for clinical diagnostic use may be viewed by the FDA as adulterated and misbranded under the Federal Food, Drug and Cosmetic Act, or the FD&amp;C Act, and subject to FDA enforcement action. The FDA has said that when determining the intended use of a product labeled RUO, it will consider the totality of the circumstances surrounding distribution and use of the product, including how the product is marketed and to whom. The FDA could disagree with a supplier&#8217;s assessment that the supplier&#8217;s products are RUOs, or could conclude that products labeled as RUO are actually intended for clinical diagnostic use, and could take enforcement action against the supplier, including requiring the supplier to cease offering the product while it seeks appropriate marketing authorization from FDA. Suppliers of ASRs and RUO products that we employ in our tests may cease selling their respective products, and we may be unable to obtain an acceptable substitute on commercially reasonable terms or at all, which could significantly and adversely affect our ability to provide timely testing results to our customers or could significantly increase our costs of conducting business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with federal and/or state laboratory licensing requirements, we could lose the ability to perform our tests or experience disruptions to our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a clinical laboratory, our business is subject to regulation by CMS through its Clinical Laboratory Improvement Amendments of 1988, or CLIA, program. The CLIA program regulates the quality of most laboratory testing performed on human specimens in the United States. CLIA regulations establish quality standards for laboratory testing in an effort to ensure the accuracy, reliability, and timeliness of patient results. To that same end, CLIA regulations require clinical laboratories to obtain a CLIA certificate and to meet specific standards with respect to operations, personnel, facilities, quality control and assurance, administration, participation in proficiency testing, and patient test management. CLIA certification is also required in order for us to be eligible to bill federal and state health care programs, as well as commercial insurers for our tests. To renew and maintain our CLIA certification, we are subject to survey and inspection every two years. Our laboratory holds a CLIA Certificate of Accreditation. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our laboratory is also accredited by the College of American Pathologists, or CAP. CMS has deemed CAP standards to be equally or more stringent than CLIA regulations and has approved CAP as a recognized accrediting organization. Inspection by CAP is performed in lieu of inspection by CMS for CAP-accredited laboratories. Because we are accredited by CAP, we are deemed to also comply with CLIA. Many commercial insurers require CAP accreditation as a condition to contracting with clinical laboratories to cover their tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has the authority to impose a wide range of sanctions, including revocation of the CLIA certification, directed plans of correction, onsite monitoring, civil monetary penalties, civil injunctive suits, a bar on the ownership or operation of a CLIA-certified laboratory by any owners or operators of the deficient laboratory, and many others, depending on the nature of the CLIA violation. Any sanction imposed under CLIA and its implementing regulations, including but not limited to those applicable to proficiency testing, or our failure to renew a CLIA certificate, could have a material and adverse effect on our business, operating results and financial condition. If we were to lose our CLIA certification, we would not be able to operate our clinical laboratory or conduct our testing, which would adversely impact our business, operating results, and financial condition. In such case, even if we were able to bring our laboratory back into compliance, we could incur significant expenses and lose revenue while doing so. Failure to maintain CAP accreditation could likewise have a material adverse effect on the sales of our tests and the results of our operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our laboratory is located in Salt Lake City, Utah. Utah requires that laboratories located in this state hold a CLIA certificate (which we do), as well as approval from the Utah Department of Health, or UT DOH, to operate a laboratory. In addition to meeting CLIA requirements and holding a valid CLIA certificate, Utah requires that our laboratory timely notify the UT DOH of certain changes and demonstrate successful performance of proficiency testing in an approved proficiency testing program or approved alternative testing program. If our clinical laboratory is out of compliance with these standards, the UT DOH may revoke our approval to perform testing or potentially impose other remedial measures, any of which could materially affect our business. We maintain an approval in good standing with the UT DOH.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, several states require that out-of-state laboratories hold laboratory licenses from those states in order to test specimens from patients, or accept specimens from laboratories, in those states. One such state is New York. As part of the laboratory licensure process, the New York Department of Health, or NY DOH, requires that laboratories seeking licensure establish the analytic and clinical performance characteristics of all tests performed, and also imposes specific review and approval requirements on certain categories of testing, including laboratory developed tests, or LDTs. As an LDT, our PreTRM test is thus subject to this NY DOH review and approval process. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained licenses from states where we believe we are required to be licensed. From time to time, we may become aware of other states that require out-of-state laboratories to obtain licensure in order to accept specimens from those states, and it is possible that other states do have such requirements or will have such requirements in the future. If we identify any other state with such requirements or if we are contacted by any other state advising us of such requirements, we expect to seek to comply with such requirements. However, there is no assurance that we will be able to obtain any such required license for the particular state.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a clinical laboratory is out of compliance with state laboratory licensure laws and regulations, the state authority may suspend, restrict or revoke the license to operate the clinical laboratory, assess substantial civil money penalties, or impose specific corrective action plans. If we were to lose a required state license, we would not be able to operate our clinical laboratory and conduct our tests, in full or in particular states, which would adversely impact our business, operating results, and financial condition. Any such actions could materially affect our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA may undertake rulemaking to regulate Laboratory Developed Tests or Congress may reform the current legal requirements applicable to LDTs, in which case we may become subject to extensive regulatory requirements and may be required to conduct additional clinical trials prior to continuing to sell our existing tests or launching any other tests we may develop, which may increase the cost of conducting, or otherwise harm, our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently market the PreTRM test as an LDT and may in the future market other tests as LDTs. The FDA has adopted a policy of enforcement discretion with respect to LDTs whereby the FDA does not generally actively enforce its regulatory requirements for such tests. However, the FDA has stated its intention to modify its enforcement discretion policy with respect to LDTs in the absence of Congressional action to harmonize their regulatory paradigms applicable to LDTs and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic tests. If there are changes in FDA regulations and legislative authorities such that the agency begins to exercise oversight over LDTs, or if the FDA disagrees that our marketed tests are within the scope of its criteria used for defining LDTs, we may become subject to extensive regulatory requirements and may be required to stop selling our existing test or launching any other tests we may develop and to conduct additional clinical trials or take other actions prior to continuing to market our tests. If the FDA allows our tests to remain on the market but there is uncertainty about our tests, if they are labeled investigational by the FDA or if labeling claims the FDA allows us to make are very limited, orders from health care providers or reimbursement for our tests may decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that we are currently in material compliance with applicable laws and regulations as historically enforced by the FDA with respect to LDTs, we cannot assure you that the FDA will agree with our determination. A determination that we have violated these laws and regulations, or a public announcement that we are being investigated for possible violations, could adversely affect our business, prospects, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if the FDA were to disagree with our conclusion that the PreTRM test falls within the scope of the agency&#8217;s LDT definition and that the PreTRM test is thus subject to FDA&#8217;s medical device authorities and implementing regulations, the agency could require that we obtain premarket approval or another type of device premarket authorization in order for us to commercialize the PreTRM test. As part of this process, we may also be required to conduct additional clinical testing before applying for commercial marketing authorization. Clinical trials must be conducted in compliance with FDA regulations in order to support a marketing submission to the agency for a regulated product, or the FDA may take certain enforcement actions or reject the data. Performing additional, new clinical studies and trials in order to obtain product approval from the FDA, if any were to become necessary, would take a significant amount of time and would substantially </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delay our ability to commercialize the PreTRM test, all of which would adversely impact our business. Any such clinical trial may need to comply with recent amendments to the FD&amp;C Act requiring sponsors of most clinical studies of investigational devices to develop and submit a diversity action plan to the FDA. If we were to be required to develop a diversity action plan for any future clinical trial, such an obligation could result in further costs and potentially delay our ability to begin such a clinical trial. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, since 2017, Congress has been working on legislation to create an LDT and In Vitro Diagnostic, or IVD, regulatory framework that would be separate and distinct from the existing medical device regulatory framework. Most recently, reform legislation called the Verifying Accurate, Leading-edge IVCT Development (VALID) Act has been garnering bipartisan and bicameral support. The VALID Act would codify the term &#8220;in vitro clinical test&#8221;, or IVCT, and create a new medical product category separate from medical devices that includes products currently regulated as IVDs as well as LDTs, among other provisions. The VALID Act would also create a new system for laboratories to use to submit their tests electronically to the FDA for approval, which is aimed at reducing the amount of time it would take for the agency to approve such tests, and establish a new program to expedite the development of diagnostic tests that can be used to address a current unmet need for patients. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Congress were to pass the VALID Act or any other legislation applicable to the FDA&#8217;s regulation of LDTs, or if the FDA were to promulgate new regulations for such products through notice-and-comment rulemaking, we will likely be subject to increased regulatory burdens such as registration and listing requirements, adverse event reporting requirements, and quality control requirements. Any legislation or formal FDA regulatory framework affecting LDTs is also likely to have premarket application requirements prohibiting commercialization without FDA authorization and controls regarding modification to the tests that may require further FDA submissions. Any such process would likely be costly and time-consuming.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome and ultimate impact on our business of any changes to the federal government&#8217;s regulation of LDTs is difficult to predict. Potential future increased regulation of our LDTs could result in increased costs and administrative and legal actions for noncompliance, including warning letters, fines, penalties, product suspensions, product recalls, injunctions and other civil and criminal sanctions, which could have a material and adverse effect upon our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, should it be required in the future, we cannot be sure that the PreTRM test, any new tests that we may develop, or new uses for our products that we may develop, will be reviewed and authorized for marketing by the FDA in a timely or cost-effective manner, if authorized at all. Even if such tests are authorized for marketing by the FDA, the agency could limit the test&#8217;s indications for use, which may significantly limit the market for that product and may adversely affect our business and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Federal Trade Commission and/or state enforcement or regulatory agencies may object to the methods and materials we use to promote our tests and initiate enforcement against us, which could adversely affect our business and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Federal Trade Commission, or FTC, and/or state enforcement or regulatory agencies (including but not limited to the offices of state attorneys general) may object to the materials and methods we use to promote our current tests or other LDTs we may develop in the future, including with respect to the product claims in our promotional materials, and may initiate enforcement actions against us. Enforcement actions by the FTC may include, among others, injunctions, civil penalties, and equitable monetary relief.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards, and other requirements could adversely affect our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global data protection landscape is rapidly evolving, and we are or may become subject to numerous state and federal laws, requirements, and regulations governing the collection, use, disclosure, retention, and security of personal information. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact future laws, regulations or standards or perception of their requirements may have on our business. This evolution may create uncertainty in our business, affect our ability to operate in certain jurisdictions or to collect, store, transfer, use and share personal information, necessitate the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. The cost of compliance with these laws, regulations, and standards is high and is likely to increase in the future. Any failure or perceived failure by us to comply with federal or state laws or regulations, our internal policies and procedures or our contracts governing our use and disclosures of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personal information could result in negative publicity, government investigations and enforcement actions, claims by third parties, and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance, and business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our operations and business grow, we may become subject to or affected by new or additional privacy and security laws and regulations and face increased scrutiny or attention from regulatory authorities. In the United States, the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH (collectively, HIPAA) requires organizations like ours to develop and implement policies and procedures with respect to information that is protected under HIPAA, called protected health information, or PHI, that is used or disclosed in connection with our testing services, including the adoption of administrative, physical, and technical safeguards to protect such information.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA further requires organizations subject to HIPAA, called &#8220;covered entities&#8221; to notify affected individuals without unreasonable delay and in no case later than 60 calendar days following discovery, of certain unauthorized access, uses, or disclosures of PHI. If a breach affects 500 individuals or more in a particular state or jurisdiction, covered entities must report it to the HHS and local media contemporaneously with notice to affected individuals, and HHS will post information regarding the breach, including the name of the entity reporting the breach, on its public website. If a breach affects fewer than 500 individuals, the covered entity must notify HHS within the first 60 days of the following calendar year in which the breach occurred.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Penalties for failure to comply with HIPAA and HITECH are substantial and could include corrective action plans, and/or the imposition of civil monetary or criminal penalties. HIPAA also authorizes state attorneys general to enforce HIPAA on behalf of state residents. Courts can award damages, costs, and attorneys&#8217; fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to sue us in civil court for HIPAA violations, its standards have been used as the basis for a duty of care claim in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have also adopted privacy and security laws and regulations, some of which may be more stringent than HIPAA and/or regulate information other than PHI. Such laws and regulations will be subject to interpretation by various courts and other governmental authorities, thus creating potentially complex compliance issues for us and our future customers and strategic partners. At the state level, for example, California has enacted the California Consumer Privacy Act, or CCPA, an extremely comprehensive and stringent privacy law. The CCPA took effect on January 1, 2020, and became enforceable by the California Attorney General on July 1, 2020. It creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal data. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches. CCPA does not apply to information that is protected by HIPAA, but CCPA still applies to other types of personal information held by HIPAA covered entities, such as personnel or marketing information. The regulations issued under the CCPA have been modified several times, and there is still some uncertainty about how the law will be interpreted and enforced.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, California voters also approved a new privacy law, the California Privacy Rights Act, or CPRA, on November 3, 2020 which went into effect in January 2023 modifying the CCPA significantly, resulting in further uncertainty, additional costs and expenses stemming from efforts to comply, and additional potential for harm and liability for failure to comply. The CPRA imposes additional obligations on companies covered by the legislation and expands consumers&#8217; rights with respect to certain sensitive personal information. The CPRA also creates a new state agency vested with authority to implement and enforce the CCPA and the CPRA. In addition, in February 2021, Virginia and Colorado enacted similar data protection laws and other U.S. states have proposals under consideration, increasing the regulatory compliance risk. Similar laws have also been proposed in other states and at the federal level.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCPA, the CPRA, and similar laws may increase our compliance costs and potential liability. Any liability from failure to comply with the requirements of these laws could adversely affect our financial condition. All U.S. states have implemented data breach notification laws that overlap and often conflict with HIPAA and apply simultaneously. We must comply with all of these laws simultaneously in the event of a data breach which is a complicated and expensive proposition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory framework governing the collection, storage, use, and sharing of certain information, particularly financial and other personal information, is rapidly evolving and is likely to continue to be subject to uncertainty and varying interpretations. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our existing practices. Any failure or perceived failure by us, or any third parties with which we do business, to comply </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with our privacy policies, changing expectations, evolving laws, rules and regulations, industry standards, or contractual obligations to which we or such third parties are or may become subject, may result in actions or other claims against us by governmental entities or private actors, the expenditure of substantial costs, time and other resources or the incurrence of significant fines, penalties or other liabilities. In addition, any such action, particularly to the extent we were found to be guilty of violations or otherwise liable for damages, would damage our reputation and adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work to comply with applicable laws, regulations and standards, our contractual obligations, and other legal obligations, these requirements are evolving and may be modified, interpreted, and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Any failure or perceived failure by us or our employees, representatives, contractors, consultants, Contract Research Organizations, or CROs, collaborators, or other third parties to comply with such requirements or adequately address privacy and security concerns, even if unfounded, could result in additional cost and liability to us, damage our reputation, and adversely affect our business and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches, losses of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, including PHI (such as patient medical records, including test results), and personally identifiable information. We also store business and financial information, intellectual property, research and development information, trade secrets, and other proprietary and business critical information, including that of our customers, payers and collaboration partners. We manage and maintain our data utilizing a combination of on-site systems, managed data center systems and cloud-based data center systems. We are highly dependent on information technology networks and systems, including the internet, to securely process, transmit and store critical information. Although we take measures to protect sensitive information from unauthorized access or disclosure, our information technology and infrastructure, and that of our third-party billing and collections provider and other service providers, may be vulnerable to attacks by hackers, viruses, disruptions and breaches due to employee error or malfeasance.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A security breach or privacy violation that leads to unauthorized access, disclosure or modification of, or prevents access to, patient information, including PHI, could implicate state and federal breach notification laws, subject us to fines and mandatory corrective action and require us to verify the correctness of, or to reconstruct, database contents. Such a breach or violation also could result in legal claims or proceedings brought by a private party or a governmental authority, liability under laws and regulations that protect the privacy of personal information, such as HIPAA, HITECH and laws and regulations of various U.S. states, as well as penalties imposed by the Payment Card Industry Security Standards Council for violations of the Payment Card Industry Data Security Standards. If we are unable to prevent such security breaches or privacy violations or implement satisfactory remedial measures, we may suffer loss of reputation, financial loss, and civil or criminal fines or other penalties. In addition, these breaches and other forms of inappropriate access can be difficult to detect, and any delay in identifying them may lead to increased harm of the type described above.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unauthorized access, loss or dissemination of information could disrupt our operations, including our ability to perform tests, provide test results, bill payers or patients, process claims and appeals, provide customer assistance services, conduct research and development activities, develop and commercialize tests, collect, process and prepare company financial information, provide information about our tests, educate patients and health care providers about our service, and manage the administrative aspects of our business, any of which could damage our reputation and adversely affect our business. Any breach could also result in the compromise of our trade secrets and other proprietary information, which could adversely affect our competitive position.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, health-related, privacy, and data protection laws and regulations in the U.S. are subject to interpretation and enforcement by various governmental authorities and courts, resulting in complex compliance issues and the potential for varying or even conflicting interpretations, particularly as laws and regulations in this area are in flux. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our practices. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business and our reputation. Complying with these laws could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business, operating results, and financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with privacy, confidentiality, data security or similar obligations, or any data security incidents or other security breaches that result in the accidental, unlawful or unauthorized access to, use of, release of, or transfer of sensitive information, including personally identifiable information, or PHI, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including class action lawsuits, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations. While we have implemented data security measures intended to protect our information, data, information technology systems, applications and infrastructure, there can be no assurance that such measures will successfully prevent service interruptions or data security incidents or that these measures will be satisfactory to regulatory authorities in the event of an audit, investigation or complaint.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we, or our employees or contractors on our behalf, engage in conduct that violates health care laws, are suspected or accused of engaging in such conduct, or are subject to investigation for actual or alleged such conduct, we could face substantial penalties and damage to our reputation, and our business operations and financial condition could be adversely affected.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one of the most highly regulated industries in the United States. Our business activities are, or may in the future be, subject to comprehensive compliance obligations under state and federal laws and regulations, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal and state laws governing laboratory testing, including but not limited to the Clinical Laboratory Improvement Amendments of 1988 and state laboratory licensure and related laws.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Anti-Kickback Statute, or AKS, which generally prohibits, among other things knowingly and willfully offering, paying, soliciting, or receiving any remuneration, directly or indirectly, covertly or overtly, in cash or in kind in return for (i) referring an individual to a person for the furnishing or arranging of any item or service, or (ii) purchasing, leasing, ordering, or arranging for or recommending the purchasing, leasing, or ordering of any good, facility, service, or item, for which payment may be made by federal health care programs. A person or entity does not need to have actual knowledge of the AKS or specific intent to violate it to have committed a violation. Safe harbors and exceptions to the AKS protect specified arrangements and conduct if every element of the applicable safe harbor or exception is met. However, failure to satisfy each such requirement does not necessarily mean that the arrangement or conduct at issue violates the AKS. In such circumstances, a facts-and-circumstances analysis is necessary to determine AKS compliance or lack thereof. Violations of the AKS are subject to civil and criminal fines and penalties for each violation, plus up to three times the remuneration involved, imprisonment, and exclusion from federal health care programs. In addition, claims submitted to federal health care programs for items or services resulting from a violation of the AKS are deemed to be false or fraudulent claims for purposes of the False Claims Act, or FCA.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Stark Law, also known as the physician self-referral prohibition, which, unless an exception applies, generally prohibits physicians or an immediate family member from making referrals for certain designated health services covered by Medicare or Medicaid, including clinical laboratory services, if the physician or an immediate family member has a prohibited financial relationship with the entity providing the services at issue. State enforcement agencies may assert that a claim including items or services resulting from a violation of the state physician self-referral law constitutes a false or fraudulent claim for purposes of any state false claims statute. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal False Claims Act, which imposes civil liability on any person or entity that, among other things, knowingly presents, or causes to be presented, to the federal government, claims for payment that are false or fraudulent; and/or knowingly makes, uses, or causes to be made or used, a false statement of record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government. The FCA also prohibits the knowing retention of overpayments (sometimes referred to as &#8220;reverse false claims&#8221;) and permits private individuals acting as &#8220;whistleblowers&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. The federal government may elect or decline to intervene in such matters, but if the government declines intervention, the whistleblower may still proceed with the litigation on the government&#8217;s behalf.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Civil Monetary Penalties Law, or CMP Law, which, unless an exception applies, prohibits, among other things, (1) the offering or transfer of remuneration to a beneficiary of Medicare or a state health care program, if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program; (2) employing or contracting with an individual or entity that the provider knows or should know is excluded from </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">participation in a federal health care program; (3) billing for services requested by an unlicensed physician or an excluded provider; and (4) billing for medically unnecessary services.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal health care fraud statute, which imposes criminal liability for knowingly and willfully executing or attempting to execute a scheme to defraud any health care benefit program (which includes commercial insurers). Violations of this statute are punishable by imprisonment, fines, or both.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal statute prohibiting false statements relating to health care matters, which criminalizes knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false, fictitious, or fraudulent statements or representations in connection with the delivery of, or payment for, health care benefits, items or services relating to health care matters. Violations of this statute are punishable by imprisonment, fines, or both.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by HITECH and their respective implementing regulations, including the Final Omnibus Rule published in January 2013, which impose requirements on certain covered health care providers, health plans, and health care clearinghouses as well as their respective business associates. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, there are additional federal, state, and non-U.S. laws which govern the privacy and security of health and other personal information, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Eliminating Kickbacks in Recovery Act of 2018, or EKRA, which is an all-payer anti-kickback law that criminalizes the offer, payment, solicitation or receipt of any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in return for referring, to induce referrals of, or in exchange for referring patients to recovery homes, clinical treatment facilities, or laboratories, unless an exception applies. Most of the safe harbors applicable under the AKS are not reiterated under EKRA&#8217;s exceptions. Therefore, compliance with an AKS safe harbor may not guarantee protection under the EKRA. EKRA thus could be interpreted to potentially expand the universe of arrangements that could be subject to enforcement under federal fraud and abuse laws, as well as substantial penalties.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State data privacy and security laws, which may be more stringent than HIPAA. For example, the CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal data. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches. The CCPA is expected to increase data breach litigation and may increase our compliance costs and potential liability. Many similar laws have been proposed at the federal level and in other states; in the event that we are subject to or affected by any such privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal, state, and local regulations relating to the handling and disposal of regulated medical waste, hazardous waste, and biohazardous waste and workplace safety for health care employees.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Laws and regulations relating to health and safety, labor and employment, public reporting, taxation, and other areas applicable to businesses generally, all of which are subject to change, including, for example, the significant changes to the taxation of business entities were enacted in December 2017.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additionally, we are subject to state equivalents of each of the health care laws and regulations described above, among others, some of which may be broader in scope and may apply regardless of the payer. Many U.S. states have adopted laws similar to the AKS, Stark Law, and FCA, which may apply to our business practices, including, but not limited to, research, distribution, sales or marketing arrangements, and claims involving health care items or services reimbursed by commercial insurers. In addition, many states have fraud and abuse laws, such as fee-splitting restrictions, insurance fraud laws, anti-markup laws, prohibitions on waiving coinsurance, copayments, deductibles and other amounts owed by patients, and prohibitions on the provision of tests at no or discounted cost to induce physician or patient adoption. Some states also prohibit certain health care practices, such as billing physicians for tests that they order and business corporations practicing medicine or employing or engaging physicians to practice medicine. There are ambiguities as to what is required to comply with these state requirements and if we fail to comply with an applicable state law requirement, we could be subject to penalties. Finally, there are state and foreign laws governing the privacy and security of health information, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we develop our LDTs solely for use by or within our own laboratory, we believe we are exempt from the reporting requirements imposed under the federal Physician Payments Sunshine Act, or the Sunshine Act. The Sunshine Act requires, among other things, certain manufacturers of drugs, devices, biologics, and medical supplies reimbursed under Medicare, Medicaid or the Children&#8217;s Health Insurance Program to collect and report annually to CMS certain data and information related to payments and other transfers of value provided to physicians, teaching hospitals, and advanced non-physician health care practitioners, as well as ownership and investment interests, including such ownership and investment interests held by a physician&#8217;s immediate family members. For reporting beginning January 1, 2022, U.S.-licensed physicians assistants, clinical nurse specialists, certified nurse anesthetists, certified nurse midwives, and nurse practitioners must be included in the types of providers subject to Sunshine Act reporting. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that the Sunshine Act does not apply to our business, we cannot guarantee that the federal government or other regulators will agree with our determination. Moreover, we could become subject to Sunshine Act reporting requirements if the FDA requires us to obtain premarket authorization for our tests as medical devices or Congress enacts legislative reforms to the federal oversight of LDTs to subject them to FDA regulation and/or the reporting requirements of the Sunshine Act. A determination that we have violated these laws and related CMS regulations, or a public announcement that we are being investigated for possible violations, could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, rapid growth and expansion of our business may increase the risk of violating applicable health care laws or related internal compliance policies and procedures, as well as the possibility that we may be accused of and/or investigated for violating these laws, regulations, and related internal policies and procedures. We likewise may be accused of, and subject to investigation and/or enforcement for, violating these laws on the basis of conduct engaged in by our employees, contractors and/or other related third parties. Such accusations and investigations may stem from allegations made by whistleblowers under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the FCA or state law equivalents, as well as investigative efforts undertaken by state and federal regulatory and enforcement agencies. The evolving interpretations of these laws and regulations by courts and regulators increase the risk that we may be alleged to be, or in fact found to be, in violation of these or other laws and regulations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge and may not comply under one or more of such laws, regulations, and guidance. Law enforcement authorities are increasingly focused on enforcing fraud and abuse laws, and it is possible that some of our practices may be challenged under these laws. Efforts to ensure that our current and future business arrangements with third parties, and our business generally, will comply with applicable health care laws and regulations will involve substantial costs. If our operations, including our arrangements with physicians and other health care providers, are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, contractual damages, reputational harm, diminished profits and future earnings, the curtailment or restructuring of our operations, exclusion from participation in federal and state health care programs (such as Medicare and Medicaid), and imprisonment, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our financial results.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies in our industry occasionally receive investigative demands, subpoenas, or other requests for information from state and federal governmental agencies. We cannot predict the occurrence, timing, outcome, or impact of any such investigations. Any adverse outcome in one or more of these investigations could include the commencement of civil and/or criminal proceedings, substantial fines, penalties, administrative remedies and/or entry into corporate integrity agreements with governmental agencies, among other penalties. In addition, resolution of any of these matters could involve the imposition of additional costly compliance obligations. These potential consequences, as well as any adverse outcome from government investigations, could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to obtain, maintain, and enforce our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success and ability to compete depend, in part, on our ability to obtain, maintain, and enforce patents, trade secrets, trademarks, and other intellectual property rights and to operate without having third parties infringe, misappropriate, or circumvent the rights that we own or license. If we are unable to obtain, maintain, and enforce </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intellectual property protection covering our current and future tests or technology, others may be able to make, use or sell tests or technology that are substantially the same as ours without incurring the sizeable development costs that we have incurred, which would adversely affect our ability to compete in the market. Our ability to stop third parties from making, using, selling, offering to sell or importing our tests or technology is dependent upon the extent to which we have rights under valid and enforceable patents that cover these activities. However, the patent positions of diagnostic companies, including ours, can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved. The U.S. Supreme Court and U.S. Court of Appeals for the Federal Circuit have in recent years issued a number of decisions relating to the patent-eligibility of diagnostic method claims. We cannot predict what impact these decisions may have on our ability to obtain or enforce patents relating to diagnostic methods in the future. We believe that no consistent policy regarding the scope of valid patent claims in these fields has emerged to date in the United States. The patent situation in the diagnostics industry outside the United States also is uncertain at least in a number of countries. Moreover, U.S. patent laws frequently change, including changes regarding how patent laws are interpreted, and the U.S. Patent and Trademark Office, or USPTO, frequently issues new procedures to the patent system. We cannot accurately predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law. Those changes may materially affect our patents or our ability to obtain patents. Therefore, there can be no assurance that any current or future patent applications will result in the issuance of patents or that we will develop additional proprietary tests or technology which are patentable. Moreover, patents or pending applications that may issue in the future may not provide us with any competitive advantage. Our patent position is subject to numerous additional risks, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may fail to seek patent protection for inventions that are important to our success;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any current or future patent applications may not result in issued patents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we cannot be certain that we were the first to file patent applications for the inventions covered by pending patent applications and, if we are not, we may be subject to priority or derivation disputes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to disclaim part or all of the term of certain patents or part or all of the term of certain patent applications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may file patent applications but have claims restricted or we may not be able to supply sufficient data to support our claims and, as a result, may not obtain the original claims desired or we may receive restricted claims. Alternatively, it is possible that we may not receive any patent protection from an application;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could inadvertently abandon a patent or patent application, resulting in the loss of protection of certain intellectual property rights in a particular country. We or our patent counsel may take action resulting in a patent or patent application becoming abandoned which may not be able to be reinstated or if reinstated, may suffer patent term adjustments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the claims of our issued patents or patent applications when issued may not cover our tests or technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no assurance can be given that our patents would be declared by a court to be valid and enforceable or that a competitor&#8217;s test or technology would be found by a court to infringe our patents. Our patents or patent applications may be challenged by third parties in patent litigation or in proceedings before the USPTO or its foreign counterparts, and may ultimately be declared invalid or unenforceable, or narrowed in scope;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there may be prior art of which we are not aware that may affect the validity of a patent claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, which may, nonetheless, ultimately be found to do so;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third parties may develop tests or technology that have the same or similar effect as our tests and technology without infringing our patents. Such third parties may also intentionally circumvent our patents by means of alternate designs or processes or file applications or be granted patents that would block or hurt our efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there may be patents relevant to our tests or technology of which we are not aware;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain of our intellectual property was partly supported by a U.S. government grant awarded by the National Institutes of Health, and the government accordingly has certain rights in this intellectual property, including a non-exclusive, non-transferable, irrevocable worldwide license to use applicable inventions for any governmental purpose. Such rights also include &#8220;march-in&#8221; rights, which refer to the right of the U.S. government to require us to grant a license to the technology to a responsible applicant if we fail to achieve practical application of the technology or if action is necessary to alleviate health or safety needs, to meet requirements of federal regulations or to give preference to U.S. industry;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our patent counsel, lawyers or advisors may have given us, or may in the future give us incorrect advice or counsel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patent and patent enforcement laws of some foreign jurisdictions may not protect intellectual property rights to the same extent as laws in the United States, and many companies have encountered significant difficulties in protecting and defending such rights in foreign jurisdictions. If we encounter such difficulties or we are otherwise precluded from effectively protecting our intellectual property rights in foreign jurisdictions, our business prospects could be substantially harmed, and we may not pursue or obtain patent protection in all major markets; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not develop additional tests or technology that are patentable.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors could hurt our ability to gain patent protection for our tests and technology.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issued patents covering our tests and technology could be found invalid or unenforceable, if challenged.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patents and patent applications may be subject to validity, enforceability and priority disputes. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Some of our patents or patent applications may be challenged at a future point in time in opposition, derivation, reexamination, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review or interference or other similar proceedings. Any successful third-party challenge to our patents in this or any other proceeding could result in the unenforceability or invalidity of such patents, which may lead to increased competition to our business, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. In addition, if we initiate legal proceedings against a third party to enforce a patent covering our tests or technology, the defendant could counterclaim that such patent covering our tests or technology, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. There are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the relevant patent office, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex parte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> re-examination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review, derivation and equivalent proceedings in non-U.S. jurisdictions, such as opposition proceedings. Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer cover and protect our tests or technology. With respect to the validity of our patents, for example, we cannot be certain that there is no invalidating prior art of which we, our licensor, our or its patent counsel and the patent examiner were unaware during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant or other third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on certain aspects of our tests and technology, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license intellectual property or develop or commercialize current or future tests and technology.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be aware of all third-party intellectual property rights potentially relating to our tests or technology. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We might not have been the first to make the inventions covered by each of our pending patent applications and we might not have been the first to file patent applications for these inventions. To determine the priority of these inventions, we may have to participate in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO, or other similar proceedings in non-U.S. jurisdictions, that could result in substantial cost to us and the loss of valuable patent protection. The outcome of such proceedings is uncertain. No assurance can be given that other patent applications will not have priority over our patent applications. In addition, changes to the patent laws of the United States allow for various post-grant opposition proceedings that have not been extensively tested, and their outcome is therefore uncertain. Furthermore, if third parties bring these proceedings against our patents, regardless of the merit of such proceedings and regardless of whether we are successful, we could experience significant costs and our management may be distracted. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property may be infringed by a third party.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may infringe one or more of our patents, trademarks or other intellectual property rights. We cannot predict if, when or where a third party may infringe our intellectual property rights. To counter infringement, we may be required to file infringement lawsuits, which can be expensive and time consuming. There is no assurance that we would be successful in a court of law in proving that a third party is infringing one or more of our issued patents or trademarks. Any claims we assert against perceived infringers could also provoke these parties to assert counterclaims against us, alleging that we infringe their intellectual property. In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly and/or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question, any of which may adversely affect our business. Even if we are successful in proving in a court of law that a third party is infringing our intellectual property rights, there can be no assurance that we would be successful in halting their infringing activities, for example, through a permanent injunction, or that we would be fully or even partially financially compensated for any harm to our business. We may be forced to enter into a license or other agreement with the infringing third party at terms less profitable or otherwise commercially acceptable to us than if the license or agreement were negotiated under conditions between those of a willing licensee and a willing licensor. We may not become aware of a third-party infringer within legal timeframes for compensation or at all, thereby possibly losing the ability to be compensated for any harm to our business. Such a third party may be operating in a foreign country where the infringer is difficult to locate and/or the intellectual property laws may be more difficult to enforce. Some third-party infringers may be able to sustain the costs of complex infringement litigation more effectively than we can because they have substantially greater resources. Any inability to stop third-party infringement could result in loss in market share of some of our tests and technology or even lead to a delay, reduction and/or inhibition of the development, manufacture or sale of certain tests and technology by us. There is no assurance that a test or technology produced and sold by a third-party infringer would meet our or other regulatory standards or would be safe for use. Such third-party infringer tests or technology could irreparably harm the reputation of our tests or technology thereby resulting in substantial loss in our market share and profits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Developments or uncertainty in the patent statute, patent case law or USPTO rules and regulations may impact the validity of our patent rights.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patent rights may be affected by developments or uncertainty in the patent statute, patent case law or USPTO rules and regulations. For example, the patent position of companies engaged in the development and commercialization of diagnostic tests are particularly uncertain. Changes in either the patent laws or interpretation of the patent laws in the United States or in other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. For instance, under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application is entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. These changes include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to challenge the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review and derivation proceedings. The America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various courts, including the U.S. Supreme Court, have rendered decisions that impact the scope of patentability of certain inventions or discoveries relating to the life sciences technology. Specifically, these decisions stand for the proposition that patent claims that recite laws of nature are not themselves patentable unless those patent claims have sufficient additional features that provide practical assurance that the processes are genuine inventive applications of those laws rather than patent drafting efforts designed to monopolize the law of nature itself. What constitutes a &#8220;sufficient&#8221; additional feature is uncertain. Furthermore, in view of these decisions, since December 2014, the USPTO has published and continues to publish revised guidelines for patent examiners to apply when examining process claims for patent eligibility.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that may have a material adverse effect on our ability to obtain new patents and to defend and enforce our existing patents and patents that we might obtain in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that our patent portfolio will not be negatively impacted by the current uncertain state of the law, new court rulings or changes in guidance or procedures issued by the USPTO or other similar patent offices around the world. From time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability, scope and validity of patents within the life sciences technology and any such changes, or any similar adverse changes in the patent laws of other jurisdictions, could have a negative impact on our business, financial condition, prospects, and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims that former employees, collaborators or other third parties have an interest in our patents, trade secrets or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our tests and technology. In addition, counterparties to our consulting, sponsored research, software development and other agreements may assert that they have an ownership interest in intellectual property developed under such arrangements. In particular, certain software development agreements pursuant to which certain third parties have developed parts of our proprietary software may not include provisions that expressly assign to us ownership of all intellectual property developed for us by such third parties. As such, we may not have the right to use all such developed intellectual property under such agreements, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain such licenses and such licenses are necessary for the development, manufacture, and commercialization of our tests and technology, we may need to cease the development, manufacture, and commercialization of our tests and technology. Litigation may be necessary to defend against these and other claims challenging inventorship of our patents, trade secrets or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our business, including our software, workflows, consumables, and reagent kits. In such an event, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture, and commercialization of our tests and technology. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and certain customers or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ individuals who were previously employed at other biotechnology or diagnostic companies. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information of our employees&#8217; former employers or other third parties. We may also be subject to claims that former employers or other third parties have an ownership interest in our patents. Litigation may be necessary to defend against these claims. There is no guarantee of success in defending these claims, and if we do not prevail, we could be required to pay substantial damages and could lose rights to important intellectual property. Even if we are successful, litigation could result in substantial cost and be a distraction to our management and other employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to prevent disclosure of our trade secrets and other proprietary information, the value of our tests and technology could be significantly diminished.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on trade secret protection to protect our interests in proprietary know-how and in processes for which patents are difficult to obtain or enforce, including the proprietary algorithm that we use for our tests and technology, including the PreTRM test. We may not be able to protect our trade secrets adequately. We have a policy of requiring our consultants, advisors, and collaborators to enter into confidentiality agreements and our employees to enter into invention, non-disclosure, and non-compete agreements. However, no assurance can be given that we have entered into appropriate agreements with all parties that have had access to our trade secrets, know-how or other proprietary information. There is also no assurance that such agreements will provide for a meaningful protection of our trade secrets, know-how or other proprietary information in the event of any unauthorized use or disclosure of information. Furthermore, we cannot provide assurance that any of our employees, consultants, contract personnel or collaborators, either accidentally or through willful misconduct, will not cause serious damage to our programs and our strategy, for example by disclosing important trade secrets, know-how or proprietary information to our competitors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that our trade secrets, know-how or other proprietary information could be obtained by third parties as a result of breaches of our physical or electronic security systems. Any disclosure of confidential data into the public domain or to third parties could allow our competitors to learn our trade secrets and use the information in competition against us. In addition, others may independently discover our trade secrets and proprietary information. Any action to enforce our rights is likely to be time consuming and expensive, and may ultimately be unsuccessful, or may result in a remedy that is not commercially valuable. These risks are accentuated in foreign countries where laws or law enforcement practices may not protect proprietary rights as fully as in the United States or Europe. Any unauthorized disclosure of our trade secrets or proprietary information could harm our competitive position.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Class A Common Stock</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our Class A common stock may be volatile, and you could lose all or part of your investment.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our Class A common stock is likely to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this report, these factors include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully meet our obligations under our commercial agreement with Elevance Health and obtain broader market adoption of our PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated variations in our and our competitors&#8217; results of operations, as well as how those results compare to analyst and investor expectations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to successfully commercialize our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of new products, significant acquisitions, other strategic transactions, including strategic and commercial partnerships and relationships, joint ventures, divestitures, collaborations or capital commitments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in reimbursement practices by current or potential payers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of analysts to initiate or maintain coverage of our company, issuance of new securities analysts&#8217; reports or changed recommendations for our Class A common stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">forward-looking statements related to our financial guidance or projections, our failure to meet or exceed our financial guidance or projections or changes in our financial guidance or projections;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in regulatory oversight of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">development of disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement of, or our involvement in, litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcement or expectation of additional debt or equity financing efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any major change in our management;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to establish collaborations, if needed;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of key scientific or management personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to effectively manage our growth;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overall performance of the equity markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our common stock by us, our directors and officers, or our other stockholders in the future;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trading volume of our Class A common stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting practices;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ineffectiveness of our internal controls;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general political and economic conditions; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other events or factors, many of which are beyond our control.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market in general, and the market for diagnostics companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the companies, including as a result of the COVID-19 pandemic and inflationary pressures. Broad market and industry factors may negatively affect the market price of our Class A common stock, regardless of our actual operating performance. In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#8217;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management&#8217;s attention and resources.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends on our Class A common stock, so any returns will be limited to the value of our Class A common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Furthermore, future debt or other financing arrangements may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our Class A common stock. Any return to stockholders will therefore be limited to the appreciation of their stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our executive officers, directors and their affiliates and our stockholders holding 5% or more of our common stock own a significant percentage of our Class A common stock and will be able to exert significant control over matters subject to stockholder approval.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers, directors and our stockholders holding 5% or more of our common stock and their affiliates beneficially hold a significant percentage of our outstanding Class A common stock. These stockholders, acting together, would be able to significantly influence our management and affairs and the outcome of matters submitted to our stockholders for approval, including the election of directors and any sale, merger, consolidation, or sale of all or substantially all of our assets. This concentration of ownership control may adversely affect the market price of our Class A common stock by:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delaying, deferring or preventing a change in control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">entrenching our management and the board of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impeding a merger, consolidation, takeover or other business combination involving us that other stockholders may desire; and/or</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The dual class structure of our common stock may limit your ability to influence corporate matters and may limit your visibility with respect to certain transactions.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dual class structure of our common stock may limit your ability to influence corporate matters. Holders of our Class A common stock are entitled to one vote per share, while holders of our Class B common stock are not entitled to any votes per share. Nonetheless, each share of our Class B common stock may be converted at any time into one share of our Class A common stock at the option of its holder by providing written notice to us, subject to the limitations provided for in our amended and restated certificate of incorporation. Consequently, if holders of our Class B common stock exercise their option to make this conversion, this will have the effect of increasing the relative voting power of those prior holders of our Class B common stock, and correspondingly decreasing the voting power of the holders of our Class A common stock, which may limit your ability to influence corporate matters. Additionally, stockholders who hold, in the aggregate, more than 10% of our Class A common stock and Class B common stock, but 10% or less of our Class A common stock, and are not otherwise an insider, may not be required to report changes in their ownership due to transactions in our Class B common stock pursuant to Section 16(a) of the Exchange Act, and may not be subject to the short-swing profit provisions of Section 16(b) of the Exchange Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an emerging growth company and a smaller reporting company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our Class A common stock less attractive to investors.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company, or EGC, as defined in the JOBS Act. For as long as we continue to be an EGC, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not EGCs, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in this report and our periodic reports and proxy statements and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. We may remain an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EGC until the earliest to occur of: (1) the last day of the fiscal year in which we have at least $1.235 billion in annual revenue; (2) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) December 31, 2026.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a smaller reporting company, meaning that the market value of our Class A common stock held by non-affiliates plus the approximate aggregate amount of gross proceeds to us as a result of our IPO is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (1) the market value of our Class A common stock held by non-affiliates is less than $250.0 million or (2) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our Class A common stock held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an EGC we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may choose to take advantage of some, but not all, of the available exemptions. We have taken advantage of reduced reporting burdens in this report. In particular, we have not included all of the executive compensation information that would be required if we were not an EGC. We cannot predict whether investors will find our Class A common stock less attractive if we rely on certain or all of these exemptions. If some investors find our Class A common stock less attractive as a result, there may be a less active trading market for our Class A common stock and our stock price may be more volatile.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the JOBS Act, EGCs can also delay adopting new or revised accounting standards until such time as those standards apply to private companies, which may make our financial statements less comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our Class A common stock by our existing stockholders in the public market could cause our stock price to decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our shares of Class A common stock and Class B common stock are eligible for public sale, if they are registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or if they qualify for an exemption from registration under the Securities Act, including under Rules 144 or 701. If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our Class A common stock in the public market, the trading price of our Class A common stock could decline. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain holders of shares of our common stock will be entitled to rights with respect to the registration of their shares under the Securities Act as provided under the terms of an investors&#8217; rights agreement between us and the holders of our stock. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule 144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have registered on Form S-8 all shares of common stock that are issuable under our existing equity compensation plan, including the 2011 Employee, Director and Consultant Equity Incentive Plan, as amended, or the 2011 Plan, which expired in 2021, the 2021 Equity Incentive Plan, or the 2021 Plan, and the 2021 Employee Stock Purchase Plan, or the 2021 ESPP, as well as the shares of common stock underlying option awards outstanding under the 2011 Plan. Additionally, the number of shares of our Class A common stock reserved for issuance under our 2021 Equity Plan automatically increases on January 1 of each year, beginning on January 1, 2022, by 4% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Furthermore, the number of shares of our Class A common stock reserved for issuance under our 2021 ESPP automatically increases on January 1 of each year, beginning on January 1, 2022, by 1% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Unless our board of directors elects not to increase the number of shares available for future grant each year, our stockholders may experience </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional dilution. As a consequence, these shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions under our charter documents and Delaware law could delay or prevent a change in control which could limit the market price of our Class A common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent a change in control of our company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a board of directors divided into three classes serving staggered three-year terms, such that not all members of the board will be elected at one time;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken at a meeting of our stockholders;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a requirement that special meetings of stockholders be called only by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice requirements for stockholder proposals and nominations for election to our board of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a requirement that no member of our board of directors may be removed from office by our stockholders except for cause and, in addition to any other vote required by law, upon the approval of not less than two-thirds of all outstanding shares of our voting stock then entitled to vote in the election of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a requirement of approval of not less than two-thirds of all outstanding shares of our voting stock to amend any bylaws by stockholder action or to amend specific provisions of our certificate of incorporation; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the authority of the board of directors to issue convertible preferred stock on terms determined by the board of directors without stockholder approval and which convertible preferred stock may include rights superior to the rights of the holders of common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the General Corporation Law of the State of Delaware, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These anti-takeover provisions and other provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could also delay or impede a merger, tender offer or proxy contest involving our company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take other corporate actions you desire. Any delay or prevention of a change in control transaction or changes in our board of directors could cause the market price of our Class A common stock to decline.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our Class A common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. If few analysts commence coverage of us, the trading of our stock would likely decrease. Even if we do obtain sufficient analyst coverage, there can be no assurance that analysts will provide favorable coverage. If one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated certificate of incorporation designates certain courts as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation provides that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action or proceeding asserting a claim of breach of fiduciary duty owed by any of our current or former directors, officers and employees, to us or our stockholders, (iii) any </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action or proceeding asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware, our amended and restated certificate of incorporation or our bylaws (in each case, as they may be amended from time to time), (iv) any action or proceeding to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or bylaws, (v) any action or proceeding as to which the Delaware General Corporation Law confers jurisdiction to the Court of Chancery of the State of Delaware, or (vi) any action asserting a claim against us or any of our directors, officers or employees that is governed by the internal affairs doctrine; provided, however, that this exclusive forum provision will not apply to any causes of action arising under the Exchange Act. Our amended and restated certificate of incorporation will further provide that, unless we consent in writing to an alternative forum, the United States District Court for the District of Utah will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. We have chosen the United States District Court for the District of Utah as the exclusive forum for such Securities Act causes of action because our principal executive offices are located in Salt Lake City, Utah. In addition, our amended and restated certificate of incorporation will provide that any person or entity purchasing or otherwise acquiring any interest in shares of our Class A common stock is deemed to have notice of and consented to the foregoing provisions. We recognize that the forum selection clause in our amended and restated certificate of incorporation may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware or the State of Utah, as applicable. Additionally, the forum selection clause in our amended and restated certificate of incorporation may limit our stockholders&#8217; ability to bring a claim in a forum that they find favorable for disputes with us or our directors, officers, or employees, which may discourage such lawsuits against us and our directors, officers, and employees even though an action, if successful, might benefit our stockholders. The Court of Chancery of the State of Delaware or the United States District Court for the District of Utah may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders. Alternatively, if a court were to find the choice of forum provisions contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the applicability of the exclusive forum provision is limited to the extent permitted by applicable law, we do not intend that the exclusive forum provision would apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. We also acknowledge that Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder and that there is uncertainty as to whether a court would enforce an exclusive forum provision for actions arising under the Securities Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain reporting requirements of the Exchange Act. Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized, and reported within the time periods specified in the rules and even if we are successful in remediating our material weakness, any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to continue incurring significant costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we expect to continue incurring significant legal, accounting, and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, which require, among other things that we file with the SEC annual, quarterly, and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and The Nasdaq Global Market to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial reporting controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act concerning areas such as &#8220;say on pay&#8221; and proxy access. EGCs are permitted to implement many of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these requirements over a longer period, which may be up to five years from the pricing of our IPO. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rules and regulations applicable to public companies have substantially increased and are expected to increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have an adverse effect on our business. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, these rules and regulations make it more difficult and more expensive for us to obtain director and officer liability insurance and we incur substantial costs to maintain the same or similar coverage as when we were a private company. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our Class A common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose changes made in our internal controls and procedures on a quarterly basis and our management are required to assess the effectiveness of these controls annually. However, for as long as we are an EGC, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404. We could be an EGC for up to five years. An independent assessment of the effectiveness of our internal controls over financial reporting could detect problems that our management&#8217;s assessment might not. Undetected material weaknesses in our internal controls over financial reporting could lead to restatements of our financial statements and require us to incur the expense of remediation.</span></div><div id="i4308cf9785ac4015a6c4393be0d820f4_130"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;Sales of Unregistered Securities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Use of Proceeds from Public Offering of Class A Common Stock</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 19, 2021, we completed our IPO, which resulted in the sale of 4,687,500 shares of our Class A common stock, at a price to the public of $16.00 per share. The offer and sale of the shares in our IPO was made pursuant to the Registration Statement on Form S-1 (File No. 333-257038) which was declared effective by the SEC. Shares of our Class A common stock began trading on The Nasdaq Global Market on July 15, 2021. The offering closed on July 19, 2021.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters of our IPO were Citigroup Global Markets Inc., Cowen and Company, LLC and William Blair &amp; Company, L.L.C.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid to the underwriters of our initial public offering an underwriting discount totaling approximately $5.3 million. In addition, we incurred expenses of approximately $3.1 million. We received net proceeds, after deducting underwriting discounts and offering expenses, of approximately $66.6 million. No offering expenses were paid directly or indirectly to any of our directors or officers (or their associates) or person owning 10% or more of any class of our equity securities or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to any other affiliates. There has been no material change in the planned use of proceeds from our IPO from those that were described in our final prospectus dated as of July 14, 2021 and filed with the SEC pursuant to Rule 424(b) under the Securities Act on July 16, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">68</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Description</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921094030/tm2122556d1_ex3-1.htm">Amended and Restated Certificate of Incorporation of Sera Prognostics, Inc., as amended (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-40606) filed with the SEC on July 20, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921094030/tm2122556d1_ex3-2.htm">Restated Bylaws of Sera Prognostics, Inc. (incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-40606) filed with the SEC on July 20, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921089973/tm2110724d14_ex4-1.htm">Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-257038) filed on July 8, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-2.htm">Form of Common Stock Purchase Warrant&#8201;&#8211;&#8201;I (incorporated by reference to Exhibit 4.2 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-3.htm">Form of Common Stock Purchase Warrant&#8201;&#8211;&#8201;II (incorporated by reference to Exhibit 4.3 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-4.htm">Form of Series E Warrant (incorporated by reference to Exhibit 4.4 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-5.htm">Fourth Amended and Restated Investors&#8217; Rights Agreement, dated as of February 23, 2021 (incorporated by reference to Exhibit 4.5 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sera-20230331x10qxex311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sera-20230331x10qxex312.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sera-20230331x10qxex321.htm">Certification of Principal Executive Officer and Principal Financial Officer and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;The Certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Sera Prognostics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">69</span></div></div></div><div id="i4308cf9785ac4015a6c4393be0d820f4_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4308cf9785ac4015a6c4393be0d820f4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt;padding-left:0.5pt;padding-right:0.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">SERA PROGNOSTICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: May&#160;10, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Gregory C. Critchfield, M.D., M.S.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gregory C. Critchfield, M.D., M.S.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chairman, President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: May&#160;10, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Jay Moyes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jay Moyes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(Principal Accounting Officer and Principal Financial Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">70</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>sera-20230331x10qxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iad8bd942f4f443ba960735229f629fa1_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Gregory C. Critchfield, M.D., M.S., certify that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Sera Prognostics, Inc.&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;10, 2023</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>sera-20230331x10qxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i94c00b0b59c640cdbc4f1c51d4f656ea_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jay Moyes, certify that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Sera Prognostics, Inc.&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;10, 2023</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Jay Moyes</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jay Moyes</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Accounting Officer and Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>sera-20230331x10qxex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i572674fd025b46fb9a663512afcc0b91_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Sera Prognostics, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;10, 2023</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;10, 2023</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Jay Moyes</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jay Moyes</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal Accounting Officer and Principal Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sera-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b6fd7582-a32b-479d-9964-70f04b6c290c,g:3cb67c47-ddd7-494a-a3a9-536b1cbe927e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sera="http://www.seraprognostics.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.seraprognostics.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.seraprognostics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheetsunaudited" roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited">
        <link:definition>0000002 - Statement - Condensed Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheetsunauditedParenthetical" roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical">
        <link:definition>0000003 - Statement - Condensed Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofOperationsandComprehensiveLossunaudited" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited">
        <link:definition>0000004 - Statement - Condensed Statements of Operations and Comprehensive Loss (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited">
        <link:definition>0000005 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical">
        <link:definition>0000006 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofCashFlowsunaudited" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited">
        <link:definition>0000007 - Statement - Condensed Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandFinancialCondition" roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition">
        <link:definition>0000008 - Disclosure - Description of Business and Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.seraprognostics.com/role/SignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecurities" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities">
        <link:definition>0000010 - Disclosure - Cash, Cash Equivalents and Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.seraprognostics.com/role/PropertyandEquipment">
        <link:definition>0000011 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilities" roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities">
        <link:definition>0000012 - Disclosure - Accrued and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenet" roleURI="http://www.seraprognostics.com/role/OtherIncomenet">
        <link:definition>0000013 - Disclosure - Other Income, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.seraprognostics.com/role/FairValueMeasurements">
        <link:definition>0000014 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactions">
        <link:definition>0000015 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructure" roleURI="http://www.seraprognostics.com/role/CapitalStructure">
        <link:definition>0000016 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.seraprognostics.com/role/StockBasedCompensation">
        <link:definition>0000017 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://www.seraprognostics.com/role/Warrants">
        <link:definition>0000018 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingences" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingences">
        <link:definition>0000019 - Disclosure - Commitments and Contingences</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Netlosspershare" roleURI="http://www.seraprognostics.com/role/Netlosspershare">
        <link:definition>0000020 - Disclosure - Net loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000021 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesTables" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables">
        <link:definition>0000022 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentTables">
        <link:definition>0000023 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesTables" roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables">
        <link:definition>0000024 - Disclosure - Accrued and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenetTables" roleURI="http://www.seraprognostics.com/role/OtherIncomenetTables">
        <link:definition>0000025 - Disclosure - Other Income, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsTables">
        <link:definition>0000026 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureTables" roleURI="http://www.seraprognostics.com/role/CapitalStructureTables">
        <link:definition>0000027 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationTables">
        <link:definition>0000028 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://www.seraprognostics.com/role/WarrantsTables">
        <link:definition>0000029 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesTables" roleURI="http://www.seraprognostics.com/role/CommitmentandContingenciesTables">
        <link:definition>0000030 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareTables" roleURI="http://www.seraprognostics.com/role/NetlosspershareTables">
        <link:definition>0000031 - Disclosure - Net loss per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandFinancialConditionDetails" roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails">
        <link:definition>0000032 - Disclosure - Description of Business and Financial Condition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails">
        <link:definition>0000033 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails">
        <link:definition>0000034 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesNarrativeDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails">
        <link:definition>0000035 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails">
        <link:definition>0000036 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails">
        <link:definition>0000037 - Disclosure - Property and Equipment - Components of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNarrativeDetails" roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails">
        <link:definition>0000038 - Disclosure - Property and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesDetails" roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails">
        <link:definition>0000039 - Disclosure - Accrued and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenetDetails" roleURI="http://www.seraprognostics.com/role/OtherIncomenetDetails">
        <link:definition>0000040 - Disclosure - Other Income, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>0000041 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails">
        <link:definition>0000042 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureNarrativeDetails" roleURI="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails">
        <link:definition>0000043 - Disclosure - Capital Structure - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureCommonStockDetails" roleURI="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails">
        <link:definition>0000044 - Disclosure - Capital Structure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>0000045 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionsDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails">
        <link:definition>0000046 - Disclosure - Stock-Based Compensation - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedStockUnitsDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails">
        <link:definition>0000047 - Disclosure - Stock-Based Compensation - Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationExpenseDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails">
        <link:definition>0000048 - Disclosure - Stock-Based Compensation - Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationUnrecognizedCostDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails">
        <link:definition>0000049 - Disclosure - Stock-Based Compensation - Unrecognized Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsCommonStockWarrantsOutstandingDetails" roleURI="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails">
        <link:definition>0000050 - Disclosure - Warrants - Common Stock Warrants Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesLeasesinFinancialStatementDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails">
        <link:definition>0000051 - Disclosure - Commitments and Contingences - Leases in Financial Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesLeaseCostandOtherInformationDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails">
        <link:definition>0000052 - Disclosure - Commitments and Contingences - Lease Cost and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails">
        <link:definition>0000053 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>0000053 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesNarrativeDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails">
        <link:definition>0000054 - Disclosure - Commitments and Contingences - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" roleURI="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails">
        <link:definition>0000055 - Disclosure - Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" abstract="false" name="PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommonStockWarrantAt520SharePriceMember" abstract="true" name="CommonStockWarrantAt520SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CommonStockWarrantAt1238SharePriceMember" abstract="true" name="CommonStockWarrantAt1238SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CommonStockWarrantAt10.84SharePriceMember" abstract="true" name="CommonStockWarrantAt10.84SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" abstract="true" name="CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CurrentMarketableSecuritiesMember" abstract="true" name="CurrentMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" abstract="false" name="ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="sera_CapitalSharesReservedForFutureIssuanceAxis" abstract="true" name="CapitalSharesReservedForFutureIssuanceAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sera_RightOfUseAssetAbstract" abstract="true" name="RightOfUseAssetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" abstract="false" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" abstract="true" name="CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_NumberOfVotesPerShare" abstract="false" name="NumberOfVotesPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sera_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_RelatedPartyTransactionCashReceivedFromRelatedParty" abstract="false" name="RelatedPartyTransactionCashReceivedFromRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_MasterServicesAgreementMember" abstract="true" name="MasterServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" abstract="false" name="LeaseLiabilityToBePaidRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_LaboratoryServicesAgreementMember" abstract="true" name="LaboratoryServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseLiabilityPaymentDue" abstract="false" name="LeaseLiabilityPaymentDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseLiabilityPaymentDueAbstract" abstract="true" name="LeaseLiabilityPaymentDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_LeaseLiabilityNoncurrent" abstract="false" name="LeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseOtherInformationAbstract" abstract="true" name="LeaseOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" abstract="false" name="FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_RightOfUseAssetTotal" abstract="false" name="RightOfUseAssetTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" abstract="false" name="LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="sera_LeaseLiabilityCurrent" abstract="false" name="LeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CarelonResearchMember" abstract="true" name="CarelonResearchMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsAmortizedCost" abstract="false" name="CashAndCashEquivalentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommercialCollaborationAgreementMember" abstract="true" name="CommercialCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" abstract="false" name="CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidYearOne" abstract="false" name="LeaseLiabilityToBePaidYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_FinanceLeasesOtherInformationAbstract" abstract="true" name="FinanceLeasesOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_Plan2011Member" abstract="true" name="Plan2011Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CommonStockWarrantAt9.03SharePriceMember" abstract="true" name="CommonStockWarrantAt9.03SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidYearTwo" abstract="false" name="LeaseLiabilityToBePaidYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_OperatingLeasesOtherInformationAbstract" abstract="true" name="OperatingLeasesOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_ElevanceHealthIncMember" abstract="true" name="ElevanceHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CommonStockWarrantAt2077SharePriceMember" abstract="true" name="CommonStockWarrantAt2077SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_LeaseLiabilitiesTotal" abstract="false" name="LeaseLiabilitiesTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_IndemnificationLiability" abstract="false" name="IndemnificationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CapitalSharesReservedForFutureIssuanceDomain" abstract="true" name="CapitalSharesReservedForFutureIssuanceDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_LeaseLiabilitiesAbstract" abstract="true" name="LeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_Plan2021Member" abstract="true" name="Plan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_NumberOfCommonStockClassesAuthorized" abstract="false" name="NumberOfCommonStockClassesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sera_WarrantsTextBlock" abstract="false" name="WarrantsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidYearThreeAndThereafter" abstract="false" name="LeaseLiabilityToBePaidYearThreeAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_OfficeAndLaboratorySpaceMember" abstract="true" name="OfficeAndLaboratorySpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_PlanEspp2021Member" abstract="true" name="PlanEspp2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_WarrantsToPurchaseCommonStockMember" abstract="true" name="WarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sera_CommonStockConversionRatio" abstract="false" name="CommonStockConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" abstract="false" name="RelatedPartyTransactionCommercialCollaborationAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sera_NonCurrentMarketableSecuritiesMember" abstract="true" name="NonCurrentMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>sera-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b6fd7582-a32b-479d-9964-70f04b6c290c,g:3cb67c47-ddd7-494a-a3a9-536b1cbe927e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_70dfdccd-d3b4-41c9-8db7-c7ff0acea547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_00b7f1cc-ade4-4f8f-ae3f-36c0eab43dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70dfdccd-d3b4-41c9-8db7-c7ff0acea547" xlink:to="loc_us-gaap_AdditionalPaidInCapital_00b7f1cc-ade4-4f8f-ae3f-36c0eab43dcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9b2546b0-cd32-4429-a6db-7c992614724f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70dfdccd-d3b4-41c9-8db7-c7ff0acea547" xlink:to="loc_us-gaap_CommonStockValue_9b2546b0-cd32-4429-a6db-7c992614724f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a69471e2-4af6-41cc-b467-ec8720c8d14d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70dfdccd-d3b4-41c9-8db7-c7ff0acea547" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a69471e2-4af6-41cc-b467-ec8720c8d14d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a999c428-659f-42f7-b0fa-3040ccda33e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70dfdccd-d3b4-41c9-8db7-c7ff0acea547" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a999c428-659f-42f7-b0fa-3040ccda33e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_80f43a41-b021-4385-a261-db909990de2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5646b19e-6a8c-4d63-8d4f-db8efc373698" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_80f43a41-b021-4385-a261-db909990de2b" xlink:to="loc_us-gaap_StockholdersEquity_5646b19e-6a8c-4d63-8d4f-db8efc373698" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_30557178-ea21-4f33-a662-7d720f6bca90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_80f43a41-b021-4385-a261-db909990de2b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_30557178-ea21-4f33-a662-7d720f6bca90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_70a4e95f-130c-4c34-af1a-7ec6bffef756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_80f43a41-b021-4385-a261-db909990de2b" xlink:to="loc_us-gaap_Liabilities_70a4e95f-130c-4c34-af1a-7ec6bffef756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a2ad8330-1cfd-46e0-a156-6991b68d6346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_82f1586c-9b84-407f-98dd-87d7b01f00e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a2ad8330-1cfd-46e0-a156-6991b68d6346" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_82f1586c-9b84-407f-98dd-87d7b01f00e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_5de1a732-8cfd-4749-b48d-15d39b45b9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a2ad8330-1cfd-46e0-a156-6991b68d6346" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_5de1a732-8cfd-4749-b48d-15d39b45b9e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_70e79700-dfff-417b-bc8c-9524b771f745" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a2ad8330-1cfd-46e0-a156-6991b68d6346" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_70e79700-dfff-417b-bc8c-9524b771f745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_fcb2839f-5fd5-4ba5-b1e0-cc4e0dab898f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a2ad8330-1cfd-46e0-a156-6991b68d6346" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_fcb2839f-5fd5-4ba5-b1e0-cc4e0dab898f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2b3687ed-83d4-448b-9434-8381f7e5bd12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a2ad8330-1cfd-46e0-a156-6991b68d6346" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2b3687ed-83d4-448b-9434-8381f7e5bd12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_13c33bd6-f1ec-45cf-bbe9-fb9b5c6dddb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e528b596-a454-459d-929c-6d200bcfec99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_13c33bd6-f1ec-45cf-bbe9-fb9b5c6dddb1" xlink:to="loc_us-gaap_AssetsCurrent_e528b596-a454-459d-929c-6d200bcfec99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b1eb4b23-c31f-45e9-804a-af70130d1014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_13c33bd6-f1ec-45cf-bbe9-fb9b5c6dddb1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b1eb4b23-c31f-45e9-804a-af70130d1014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_1ef8fb7e-12a6-4288-9529-8fe1a25209fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_13c33bd6-f1ec-45cf-bbe9-fb9b5c6dddb1" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_1ef8fb7e-12a6-4288-9529-8fe1a25209fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8ab73e7f-01fa-41a4-840e-c7ea43582639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_13c33bd6-f1ec-45cf-bbe9-fb9b5c6dddb1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8ab73e7f-01fa-41a4-840e-c7ea43582639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_455b0c85-7d9b-41b1-9fc8-db0734bc67c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_e3df1406-7313-49e5-8138-1c72f5fa70b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_455b0c85-7d9b-41b1-9fc8-db0734bc67c4" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_e3df1406-7313-49e5-8138-1c72f5fa70b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_ea93dff5-5e4f-4902-8f62-fa88e21ee172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_455b0c85-7d9b-41b1-9fc8-db0734bc67c4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_ea93dff5-5e4f-4902-8f62-fa88e21ee172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3161a305-8b1c-4ebb-ada8-553c3e1d0345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_455b0c85-7d9b-41b1-9fc8-db0734bc67c4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3161a305-8b1c-4ebb-ada8-553c3e1d0345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5a535223-ab45-4795-b908-abce7242959b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_455b0c85-7d9b-41b1-9fc8-db0734bc67c4" xlink:to="loc_us-gaap_AccountsPayableCurrent_5a535223-ab45-4795-b908-abce7242959b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_17f53b83-58a2-4c93-af3f-01f1f56aa1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3dffd444-8cf9-4521-82c8-e2023c93f04a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17f53b83-58a2-4c93-af3f-01f1f56aa1c1" xlink:to="loc_us-gaap_LiabilitiesCurrent_3dffd444-8cf9-4521-82c8-e2023c93f04a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a1a06e5e-6641-4568-ac4a-a57119fe7b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17f53b83-58a2-4c93-af3f-01f1f56aa1c1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a1a06e5e-6641-4568-ac4a-a57119fe7b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3b71cd66-6c46-443a-af91-54d624cd9756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_17f53b83-58a2-4c93-af3f-01f1f56aa1c1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3b71cd66-6c46-443a-af91-54d624cd9756" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofOperationsandComprehensiveLossunaudited"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_effc77d0-e8ce-4265-87b3-5b2011ae7ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_40a530fc-a05b-421d-adeb-7df9aa0e78f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_effc77d0-e8ce-4265-87b3-5b2011ae7ea3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_40a530fc-a05b-421d-adeb-7df9aa0e78f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_052230b0-f858-4cf2-8261-481640cfe6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_88c2b1f4-07a9-4617-89ae-a747b7357856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_052230b0-f858-4cf2-8261-481640cfe6f5" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_88c2b1f4-07a9-4617-89ae-a747b7357856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a55ce5f3-c389-425e-a3a3-6fb8604cfa9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_052230b0-f858-4cf2-8261-481640cfe6f5" xlink:to="loc_us-gaap_InterestExpense_a55ce5f3-c389-425e-a3a3-6fb8604cfa9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4d8892d1-ef16-49e2-bf61-12cfa00cbda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_052230b0-f858-4cf2-8261-481640cfe6f5" xlink:to="loc_us-gaap_OperatingIncomeLoss_4d8892d1-ef16-49e2-bf61-12cfa00cbda4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8ca9adb4-3d99-40ae-ac91-493802babe26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_987c21bc-e6a9-4c3f-81a5-f0dc46fc057d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8ca9adb4-3d99-40ae-ac91-493802babe26" xlink:to="loc_us-gaap_OperatingExpenses_987c21bc-e6a9-4c3f-81a5-f0dc46fc057d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f476a93-4fdf-4f53-a07f-d3f3933e647c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8ca9adb4-3d99-40ae-ac91-493802babe26" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f476a93-4fdf-4f53-a07f-d3f3933e647c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_92e9067b-fec5-497b-bbfe-cd12b5dc10c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8b920700-9192-42b2-b72d-3c63218648d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_92e9067b-fec5-497b-bbfe-cd12b5dc10c5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8b920700-9192-42b2-b72d-3c63218648d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e386b2dd-c981-485b-aea0-c37a39a8f89c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_92e9067b-fec5-497b-bbfe-cd12b5dc10c5" xlink:to="loc_us-gaap_NetIncomeLoss_e386b2dd-c981-485b-aea0-c37a39a8f89c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c4d09313-89ce-4c30-98ea-ffd4a91d8322" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_aa480707-f511-4b8c-90f5-f7a4bcba13f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c4d09313-89ce-4c30-98ea-ffd4a91d8322" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_aa480707-f511-4b8c-90f5-f7a4bcba13f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_587be29b-23ee-425d-a672-830b3f6f2e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c4d09313-89ce-4c30-98ea-ffd4a91d8322" xlink:to="loc_us-gaap_SellingAndMarketingExpense_587be29b-23ee-425d-a672-830b3f6f2e24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6d99b43d-8e05-47fe-876c-d5a870893d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c4d09313-89ce-4c30-98ea-ffd4a91d8322" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6d99b43d-8e05-47fe-876c-d5a870893d1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_d3dcd087-ab6c-433a-8e11-9f6bedb7ba0e" xlink:href="sera-20230331.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c4d09313-89ce-4c30-98ea-ffd4a91d8322" xlink:to="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_d3dcd087-ab6c-433a-8e11-9f6bedb7ba0e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9cfeca59-c201-4ad0-a400-e65104bee0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9cfeca59-c201-4ad0-a400-e65104bee0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_adf0c1c4-ea3b-4849-87ab-a43d1774eb48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_PaidInKindInterest_adf0c1c4-ea3b-4849-87ab-a43d1774eb48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_c1035e65-b288-4baf-abe0-c6cf0d2e6194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_c1035e65-b288-4baf-abe0-c6cf0d2e6194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0bb7f479-7c0e-4ddf-bf79-d506379a5de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0bb7f479-7c0e-4ddf-bf79-d506379a5de0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_78fa13c0-7e9a-4c4c-955f-b78f0b7ddf10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_78fa13c0-7e9a-4c4c-955f-b78f0b7ddf10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd170d31-ab3f-4b79-b5a2-376da2d37879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_NetIncomeLoss_dd170d31-ab3f-4b79-b5a2-376da2d37879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d06d1dad-326f-44ed-a33f-f64f98bd020d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_ShareBasedCompensation_d06d1dad-326f-44ed-a33f-f64f98bd020d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_791fbef2-b7d4-4d17-bb4b-6a2658e7c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_791fbef2-b7d4-4d17-bb4b-6a2658e7c8b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8c4d1b3a-4154-45b4-b8be-0c0e579ba1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8c4d1b3a-4154-45b4-b8be-0c0e579ba1a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cd39ca30-ff85-49cf-be68-c9a358343312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cd39ca30-ff85-49cf-be68-c9a358343312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_13dd7cca-3f39-418b-8537-f67fecc94ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_13dd7cca-3f39-418b-8537-f67fecc94ebf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_583db9b2-1b20-44b2-9808-0de80420be98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0757af5-cb5f-4838-802a-4f7bb8629efe" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_583db9b2-1b20-44b2-9808-0de80420be98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1cde2813-5cb8-45f5-9876-5b962b603652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_81f10f41-680c-4be1-8314-4ab6945c0bee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1cde2813-5cb8-45f5-9876-5b962b603652" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_81f10f41-680c-4be1-8314-4ab6945c0bee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a03c938-6524-40c3-89a7-f84f54d97fab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1cde2813-5cb8-45f5-9876-5b962b603652" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a03c938-6524-40c3-89a7-f84f54d97fab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d805dffb-cee6-459d-bc6c-6b507e371565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1cde2813-5cb8-45f5-9876-5b962b603652" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d805dffb-cee6-459d-bc6c-6b507e371565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e572f6b-0b61-4450-a178-7adbfccdf059" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_41478f02-cb5c-4125-8f7d-924568f0b790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e572f6b-0b61-4450-a178-7adbfccdf059" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_41478f02-cb5c-4125-8f7d-924568f0b790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_be97aac2-d9e1-43e2-a02d-2b141bd6e098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e572f6b-0b61-4450-a178-7adbfccdf059" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_be97aac2-d9e1-43e2-a02d-2b141bd6e098" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5b8ab257-7cea-428e-a1d9-935f89a4a6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e6cbaf29-faf6-4652-b947-6331c54265d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5b8ab257-7cea-428e-a1d9-935f89a4a6c6" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e6cbaf29-faf6-4652-b947-6331c54265d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_96fdba15-e806-4c83-a92d-59f8178eca25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5b8ab257-7cea-428e-a1d9-935f89a4a6c6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_96fdba15-e806-4c83-a92d-59f8178eca25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_23a7c243-52a1-4a3e-aa3a-62edb148a400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5b8ab257-7cea-428e-a1d9-935f89a4a6c6" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_23a7c243-52a1-4a3e-aa3a-62edb148a400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ef789f08-56e3-4e1f-a0b5-867b79c0a789" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5b8ab257-7cea-428e-a1d9-935f89a4a6c6" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ef789f08-56e3-4e1f-a0b5-867b79c0a789" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost_42854dc3-9a40-4bd4-8939-5c994c98881e" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_1d71aa5a-6c10-4c88-b244-b7e857f19b44" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost_42854dc3-9a40-4bd4-8939-5c994c98881e" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_1d71aa5a-6c10-4c88-b244-b7e857f19b44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7b37f3c3-e924-42a0-a4b0-e61b8f93843d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost_42854dc3-9a40-4bd4-8939-5c994c98881e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7b37f3c3-e924-42a0-a4b0-e61b8f93843d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_1acafbcf-b78f-44c1-9af4-9211621f5233" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost_42854dc3-9a40-4bd4-8939-5c994c98881e" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_1acafbcf-b78f-44c1-9af4-9211621f5233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c1745d3e-8f51-41f9-a46a-dbba48090c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_70fcc2a8-5f33-4bce-b3f2-60b805327c01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c1745d3e-8f51-41f9-a46a-dbba48090c5b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_70fcc2a8-5f33-4bce-b3f2-60b805327c01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_03a5e0ce-cbbc-41c6-9cc8-2778722de948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c1745d3e-8f51-41f9-a46a-dbba48090c5b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_03a5e0ce-cbbc-41c6-9cc8-2778722de948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c196d3c5-7ec5-4690-a6a6-5fdafb26c44b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c1745d3e-8f51-41f9-a46a-dbba48090c5b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c196d3c5-7ec5-4690-a6a6-5fdafb26c44b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28d7381a-6403-4845-a62e-5171190736de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a5e0a48f-817d-41ea-9018-e9243fc6012a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28d7381a-6403-4845-a62e-5171190736de" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a5e0a48f-817d-41ea-9018-e9243fc6012a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_dadb4d9d-d103-48ee-ab15-66222851aede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28d7381a-6403-4845-a62e-5171190736de" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_dadb4d9d-d103-48ee-ab15-66222851aede" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ae2e3bcd-1117-44cc-acb0-20ed6f9f8e15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_4f62ed1c-31e1-44f4-9d83-178066dd410d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ae2e3bcd-1117-44cc-acb0-20ed6f9f8e15" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_4f62ed1c-31e1-44f4-9d83-178066dd410d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2c4e6e5c-f5c4-4182-90ed-9da67922f5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ae2e3bcd-1117-44cc-acb0-20ed6f9f8e15" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2c4e6e5c-f5c4-4182-90ed-9da67922f5c7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_05396bf8-0ee4-4b4f-ac2f-725de995b3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_065b2c55-14c7-44e3-8385-e30c045c6bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_05396bf8-0ee4-4b4f-ac2f-725de995b3a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_065b2c55-14c7-44e3-8385-e30c045c6bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b0741ca0-1c04-48c9-9f97-72388485b5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_05396bf8-0ee4-4b4f-ac2f-725de995b3a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b0741ca0-1c04-48c9-9f97-72388485b5b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_8216a65d-8b48-4413-aaf8-b649414eda71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9f95c359-0a83-4900-8afe-3cead40e0950" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_8216a65d-8b48-4413-aaf8-b649414eda71" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9f95c359-0a83-4900-8afe-3cead40e0950" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_0ec258fe-80fe-4e67-a7ac-809e37cde2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_8216a65d-8b48-4413-aaf8-b649414eda71" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_0ec258fe-80fe-4e67-a7ac-809e37cde2c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_10e2b59e-d672-41c5-a68a-453465f5e8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_8216a65d-8b48-4413-aaf8-b649414eda71" xlink:to="loc_us-gaap_AccruedVacationCurrent_10e2b59e-d672-41c5-a68a-453465f5e8ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_db2eb9f5-fe96-4b6c-a711-84e4c8f10b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_8216a65d-8b48-4413-aaf8-b649414eda71" xlink:to="loc_us-gaap_AccruedSalariesCurrent_db2eb9f5-fe96-4b6c-a711-84e4c8f10b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6532e0e2-025e-492c-8515-4a4ec29dfda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_8216a65d-8b48-4413-aaf8-b649414eda71" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6532e0e2-025e-492c-8515-4a4ec29dfda4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#OtherIncomenetDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4452849a-8c10-4f45-8069-23e6fc0e5a57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_29260702-5f8a-4e78-bb79-5745aeaefc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4452849a-8c10-4f45-8069-23e6fc0e5a57" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_29260702-5f8a-4e78-bb79-5745aeaefc9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_cfa0f523-8c14-43b4-a2fc-2bfd7f24f0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4452849a-8c10-4f45-8069-23e6fc0e5a57" xlink:to="loc_us-gaap_InterestIncomeOther_cfa0f523-8c14-43b4-a2fc-2bfd7f24f0d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c420d3b7-d453-4d4e-8089-7c199bd8e325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_04fc1681-209f-4275-ae55-c3db22eef4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c420d3b7-d453-4d4e-8089-7c199bd8e325" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_04fc1681-209f-4275-ae55-c3db22eef4b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fd82a798-ac2f-4768-af90-9eea42aefc03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c420d3b7-d453-4d4e-8089-7c199bd8e325" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fd82a798-ac2f-4768-af90-9eea42aefc03" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesLeasesinFinancialStatementDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetTotal_9ef2e6e1-f71c-4e64-8109-9782f498dc03" xlink:href="sera-20230331.xsd#sera_RightOfUseAssetTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_74bfd638-556b-429b-9e66-a34134ba9bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_RightOfUseAssetTotal_9ef2e6e1-f71c-4e64-8109-9782f498dc03" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_74bfd638-556b-429b-9e66-a34134ba9bf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_81fad2d4-2184-44f9-8917-e03fac6cf169" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_RightOfUseAssetTotal_9ef2e6e1-f71c-4e64-8109-9782f498dc03" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_81fad2d4-2184-44f9-8917-e03fac6cf169" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_240fc65c-70ac-4e71-b18d-370a3202758d" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d9d1f4bd-df58-452c-a9aa-3822bef98991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_240fc65c-70ac-4e71-b18d-370a3202758d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d9d1f4bd-df58-452c-a9aa-3822bef98991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7a72f98d-20ab-49ea-8294-52072edf1ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_240fc65c-70ac-4e71-b18d-370a3202758d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7a72f98d-20ab-49ea-8294-52072edf1ece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1cd629f4-a46c-429c-92a1-92cd6e4e4f06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_240fc65c-70ac-4e71-b18d-370a3202758d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1cd629f4-a46c-429c-92a1-92cd6e4e4f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_9a6c03d5-a2fc-4dab-8b19-c1af83dbf1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_240fc65c-70ac-4e71-b18d-370a3202758d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_9a6c03d5-a2fc-4dab-8b19-c1af83dbf1ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesLeaseCostandOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_2b8c4c0e-c15c-4153-a2bc-5c9ff2d8cd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_7185b2ee-6341-4a04-ade4-5407de62c053" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2b8c4c0e-c15c-4153-a2bc-5c9ff2d8cd4f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_7185b2ee-6341-4a04-ade4-5407de62c053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_df8265a7-692c-44c1-8103-e569e75a5824" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2b8c4c0e-c15c-4153-a2bc-5c9ff2d8cd4f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_df8265a7-692c-44c1-8103-e569e75a5824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_baa1ce9c-88fd-4851-b090-5998de979e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2b8c4c0e-c15c-4153-a2bc-5c9ff2d8cd4f" xlink:to="loc_us-gaap_OperatingLeaseCost_baa1ce9c-88fd-4851-b090-5998de979e39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c5bba377-a969-4f2d-ba35-4210db6aa5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_de0b4cce-fcb0-4643-bcb9-b13b9692a871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c5bba377-a969-4f2d-ba35-4210db6aa5b8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_de0b4cce-fcb0-4643-bcb9-b13b9692a871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_05f8deca-f61f-41d4-a959-9ae6bc51649c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c5bba377-a969-4f2d-ba35-4210db6aa5b8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_05f8deca-f61f-41d4-a959-9ae6bc51649c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2166b5da-8d16-4c1c-8eb1-08efccab6ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_f315c9a4-60a5-4a48-bd67-13b15980138a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2166b5da-8d16-4c1c-8eb1-08efccab6ebb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_f315c9a4-60a5-4a48-bd67-13b15980138a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2b9aea25-0dd3-4efb-8dc7-b256cb9d679c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2166b5da-8d16-4c1c-8eb1-08efccab6ebb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2b9aea25-0dd3-4efb-8dc7-b256cb9d679c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_85a91a25-44ac-46a1-a890-71d1143502bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2166b5da-8d16-4c1c-8eb1-08efccab6ebb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_85a91a25-44ac-46a1-a890-71d1143502bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_fc5a3614-82dd-448d-babd-45f4b4713889" xlink:href="sera-20230331.xsd#sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2166b5da-8d16-4c1c-8eb1-08efccab6ebb" xlink:to="loc_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_fc5a3614-82dd-448d-babd-45f4b4713889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_23060648-08b7-4442-8e7c-aa07b7d5ce11" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityCurrent_41e78ad2-2f77-4e84-960b-f3382153e122" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_23060648-08b7-4442-8e7c-aa07b7d5ce11" xlink:to="loc_sera_LeaseLiabilityCurrent_41e78ad2-2f77-4e84-960b-f3382153e122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityNoncurrent_4567a9e2-4a99-49af-add6-528898a599d2" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_23060648-08b7-4442-8e7c-aa07b7d5ce11" xlink:to="loc_sera_LeaseLiabilityNoncurrent_4567a9e2-4a99-49af-add6-528898a599d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue_b4d7fe97-66b0-4d22-96b8-649ca9d62334" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearThreeAndThereafter_783b05ef-88b1-447c-acdd-f60dc2db1953" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_b4d7fe97-66b0-4d22-96b8-649ca9d62334" xlink:to="loc_sera_LeaseLiabilityToBePaidYearThreeAndThereafter_783b05ef-88b1-447c-acdd-f60dc2db1953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_a5d83c11-f240-4272-9a10-7e5fb7e1dd46" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_b4d7fe97-66b0-4d22-96b8-649ca9d62334" xlink:to="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_a5d83c11-f240-4272-9a10-7e5fb7e1dd46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearTwo_b4c5ea49-777f-482f-820e-92baa9f7f0b9" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_b4d7fe97-66b0-4d22-96b8-649ca9d62334" xlink:to="loc_sera_LeaseLiabilityToBePaidYearTwo_b4c5ea49-777f-482f-820e-92baa9f7f0b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearOne_13f76941-5797-4811-9182-cae40b3e9b49" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearOne"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_b4d7fe97-66b0-4d22-96b8-649ca9d62334" xlink:to="loc_sera_LeaseLiabilityToBePaidYearOne_13f76941-5797-4811-9182-cae40b3e9b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd4f6172-cd03-41aa-af01-29baf27b6533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9aeff468-b16a-4c65-a275-a98a87e1ba34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd4f6172-cd03-41aa-af01-29baf27b6533" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9aeff468-b16a-4c65-a275-a98a87e1ba34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_08a4ad51-024b-4c30-a7e7-96c167decf74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd4f6172-cd03-41aa-af01-29baf27b6533" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_08a4ad51-024b-4c30-a7e7-96c167decf74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b6155363-667c-481c-a605-66991f2060d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd4f6172-cd03-41aa-af01-29baf27b6533" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b6155363-667c-481c-a605-66991f2060d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_16a2cb4e-7d1a-47c5-80cc-4f7a473b545a" xlink:href="sera-20230331.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dd4f6172-cd03-41aa-af01-29baf27b6533" xlink:to="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_16a2cb4e-7d1a-47c5-80cc-4f7a473b545a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4c48ef60-7381-447f-b70d-0dce7174c66e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c7ca8bab-7995-403a-942c-acf1f8b3d00b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_4c48ef60-7381-447f-b70d-0dce7174c66e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c7ca8bab-7995-403a-942c-acf1f8b3d00b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c0a48cc7-d45e-4d37-9aea-0dccc92ed90e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_4c48ef60-7381-447f-b70d-0dce7174c66e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c0a48cc7-d45e-4d37-9aea-0dccc92ed90e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e2d0cf5d-3026-48bc-a99a-19443db24e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_184ac1ec-31ad-403e-92d9-cddd925a7cee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e2d0cf5d-3026-48bc-a99a-19443db24e6b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_184ac1ec-31ad-403e-92d9-cddd925a7cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c1a65114-da36-4ba3-a8e1-053a31cc6c40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e2d0cf5d-3026-48bc-a99a-19443db24e6b" xlink:to="loc_us-gaap_FinanceLeaseLiability_c1a65114-da36-4ba3-a8e1-053a31cc6c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue_d9845643-ce44-48a7-b234-151dc3600965" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_5b0c0ca0-5826-413d-9675-b5cd63c5ef78" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_d9845643-ce44-48a7-b234-151dc3600965" xlink:to="loc_sera_LeaseLiabilitiesTotal_5b0c0ca0-5826-413d-9675-b5cd63c5ef78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityUndiscountedExcessAmount_14d3bad4-f294-43cb-83db-1f134352fd95" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_d9845643-ce44-48a7-b234-151dc3600965" xlink:to="loc_sera_LeaseLiabilityUndiscountedExcessAmount_14d3bad4-f294-43cb-83db-1f134352fd95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18e1bf12-f09a-497b-9190-b9cef6dabf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8179347e-6243-4548-80e8-6fabfbda6c10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18e1bf12-f09a-497b-9190-b9cef6dabf1c" xlink:to="loc_us-gaap_OperatingLeaseLiability_8179347e-6243-4548-80e8-6fabfbda6c10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_83b0e3b3-4257-477e-9eb5-d0d60c63e4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18e1bf12-f09a-497b-9190-b9cef6dabf1c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_83b0e3b3-4257-477e-9eb5-d0d60c63e4e4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>sera-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b6fd7582-a32b-479d-9964-70f04b6c290c,g:3cb67c47-ddd7-494a-a3a9-536b1cbe927e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Cover" xlink:type="simple" xlink:href="sera-20230331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/Cover" xlink:type="extended" id="ie56142ffbe4649ef8054653621d903e4_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d7bb6a24-75d5-4caa-8d8f-1ede5d0723fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentType_d7bb6a24-75d5-4caa-8d8f-1ede5d0723fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5cd2a9b5-7e82-4532-b4b6-6af44d63c14e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentQuarterlyReport_5cd2a9b5-7e82-4532-b4b6-6af44d63c14e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a8ae6785-c84d-48ac-b36d-fba4e2b6d0c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentPeriodEndDate_a8ae6785-c84d-48ac-b36d-fba4e2b6d0c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b893cca4-1af1-468d-93c7-63585177f475" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentTransitionReport_b893cca4-1af1-468d-93c7-63585177f475" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_33575245-f687-4616-b0bc-b7152d3c4f19" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityFileNumber_33575245-f687-4616-b0bc-b7152d3c4f19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b91e428b-af95-422a-ba81-1295a1570cab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityRegistrantName_b91e428b-af95-422a-ba81-1295a1570cab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_107b8c7d-6a9c-47d7-8b6e-5e0ad4f9986b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityIncorporationStateCountryCode_107b8c7d-6a9c-47d7-8b6e-5e0ad4f9986b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b8d244c3-af92-449f-943b-cd8acf103292" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityTaxIdentificationNumber_b8d244c3-af92-449f-943b-cd8acf103292" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_24e4658c-47c5-4d1d-94b2-3c9fb861fd87" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressAddressLine1_24e4658c-47c5-4d1d-94b2-3c9fb861fd87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_b34f21b9-d9e9-4bf5-801d-e1e4535d1de7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressAddressLine2_b34f21b9-d9e9-4bf5-801d-e1e4535d1de7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1863e1e8-70fa-4b85-8c9f-155d002e10f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressCityOrTown_1863e1e8-70fa-4b85-8c9f-155d002e10f2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5427947b-74fb-46d9-86b4-eff46bf14db5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressStateOrProvince_5427947b-74fb-46d9-86b4-eff46bf14db5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_faf3f239-542b-4be6-aa07-3512b4e0c8f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressPostalZipCode_faf3f239-542b-4be6-aa07-3512b4e0c8f0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a47a085d-4574-47a9-adf3-4ddf1caf6c75" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_CityAreaCode_a47a085d-4574-47a9-adf3-4ddf1caf6c75" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_27ce47db-86ec-405e-a33e-9ae39485c39b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_LocalPhoneNumber_27ce47db-86ec-405e-a33e-9ae39485c39b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_86e6b2fb-7228-42f3-b61a-7188843dcde5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_Security12bTitle_86e6b2fb-7228-42f3-b61a-7188843dcde5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3a9fcfee-b3b6-4f30-85b8-4c0948abe79d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_TradingSymbol_3a9fcfee-b3b6-4f30-85b8-4c0948abe79d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_60f3a357-7922-4a9e-8ba9-19a2a22b587d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_SecurityExchangeName_60f3a357-7922-4a9e-8ba9-19a2a22b587d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_12454537-4f2c-4fe5-aca7-c6b24ea79c16" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityCurrentReportingStatus_12454537-4f2c-4fe5-aca7-c6b24ea79c16" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_53fa3cb8-f5e5-49a8-acce-65b6ce2f2f1c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityInteractiveDataCurrent_53fa3cb8-f5e5-49a8-acce-65b6ce2f2f1c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_76c88d12-939c-4d99-a181-e16f57b84d15" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityFilerCategory_76c88d12-939c-4d99-a181-e16f57b84d15" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b8db74c7-2a71-40ec-af8f-494b0d154ed8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntitySmallBusiness_b8db74c7-2a71-40ec-af8f-494b0d154ed8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7af2784b-1c7b-4a99-8ac7-434116d74e0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityEmergingGrowthCompany_7af2784b-1c7b-4a99-8ac7-434116d74e0d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_d4ec5e02-e47c-4223-9600-aa5da8abd008" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityExTransitionPeriod_d4ec5e02-e47c-4223-9600-aa5da8abd008" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_52d763cd-33ef-4560-a06e-500e278e6a9d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityShellCompany_52d763cd-33ef-4560-a06e-500e278e6a9d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c0d2fda8-ac66-4cf2-be1f-c7daeead1cca" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c0d2fda8-ac66-4cf2-be1f-c7daeead1cca" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2beb3d55-cdb2-4791-bfd0-34cd6fa4e6d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityCentralIndexKey_2beb3d55-cdb2-4791-bfd0-34cd6fa4e6d0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dd03fa15-8a64-4914-9dfc-81702ef6108f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_CurrentFiscalYearEndDate_dd03fa15-8a64-4914-9dfc-81702ef6108f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7dcdaaa5-6b00-4603-bd40-5154a17c6599" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentFiscalYearFocus_7dcdaaa5-6b00-4603-bd40-5154a17c6599" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7858dea2-80dc-4b25-be49-19c2c4333c58" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7858dea2-80dc-4b25-be49-19c2c4333c58" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8f91ff3d-b2c0-4d4b-a9b5-c58bf0f46c35" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_AmendmentFlag_8f91ff3d-b2c0-4d4b-a9b5-c58bf0f46c35" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_3a6f0956-88a5-4371-a8fd-b51f0c295ad4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentInformationTable_3a6f0956-88a5-4371-a8fd-b51f0c295ad4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_3a6f0956-88a5-4371-a8fd-b51f0c295ad4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6" xlink:to="loc_us-gaap_ClassOfStockDomain_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6" xlink:to="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_43979dcf-e62a-44a6-b7e2-8df6601c8353" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:to="loc_us-gaap_CommonClassAMember_43979dcf-e62a-44a6-b7e2-8df6601c8353" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_5ed0d928-b517-4cfc-ab73-ab04864d6e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:to="loc_us-gaap_CommonClassBMember_5ed0d928-b517-4cfc-ab73-ab04864d6e3f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedBalanceSheetsunauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="extended" id="ib67fd6fb07ac4eb5a55f27d3b4a4b9e9_CondensedBalanceSheetsunauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3ce0e9-bf6b-4cfd-bd06-d45b14dd7530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3ce0e9-bf6b-4cfd-bd06-d45b14dd7530" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_77da34f9-e01d-49a8-9a13-11abf3039884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_77da34f9-e01d-49a8-9a13-11abf3039884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6b6fb8b5-73fc-4266-93c7-677ebe50f4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockSharesIssued_6b6fb8b5-73fc-4266-93c7-677ebe50f4e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4b941f89-4e76-4b95-9a28-b2d248e34fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4b941f89-4e76-4b95-9a28-b2d248e34fe9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a378560d-43c0-4bc1-9a62-8e573c3b0c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_StatementTable_a378560d-43c0-4bc1-9a62-8e573c3b0c50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_36baf942-a4d0-4536-9bae-6c2f34176835" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a378560d-43c0-4bc1-9a62-8e573c3b0c50" xlink:to="loc_us-gaap_StatementClassOfStockAxis_36baf942-a4d0-4536-9bae-6c2f34176835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_36baf942-a4d0-4536-9bae-6c2f34176835_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36baf942-a4d0-4536-9bae-6c2f34176835" xlink:to="loc_us-gaap_ClassOfStockDomain_36baf942-a4d0-4536-9bae-6c2f34176835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36baf942-a4d0-4536-9bae-6c2f34176835" xlink:to="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_dd0a2468-0c72-4c96-99de-002064495041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:to="loc_us-gaap_CommonClassAMember_dd0a2468-0c72-4c96-99de-002064495041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_1a62570b-d717-42f1-86c1-608ea0d4097f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:to="loc_us-gaap_CommonClassBMember_1a62570b-d717-42f1-86c1-608ea0d4097f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="extended" id="i4e7ca621f1ca41789f902e57c8e13a65_CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f36b28d0-d107-479e-8989-00d7aceace56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f36b28d0-d107-479e-8989-00d7aceace56" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e6804fe7-f30e-4aa1-9b11-be9d3f7c2d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_CommonStockSharesIssued_e6804fe7-f30e-4aa1-9b11-be9d3f7c2d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4aec46f2-f59c-4b76-9b15-4e77d01ad2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_StockholdersEquity_4aec46f2-f59c-4b76-9b15-4e77d01ad2b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e856749-449d-4d9d-818e-878e14f7e389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e856749-449d-4d9d-818e-878e14f7e389" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a5f24b87-8f15-49ba-b868-2435724df44d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a5f24b87-8f15-49ba-b868-2435724df44d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ae8e5f1-abc5-4768-a48d-38cbf0e5e8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ae8e5f1-abc5-4768-a48d-38cbf0e5e8ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc8eb5d1-3c79-4dbf-aac8-2680dd88fdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc8eb5d1-3c79-4dbf-aac8-2680dd88fdb3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e3d49d8d-a13c-4094-9eba-e5ee7faac189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_NetIncomeLoss_e3d49d8d-a13c-4094-9eba-e5ee7faac189" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_43d0ada4-2c2b-480b-ae17-87c3eced43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3f560c3-6b6b-4fc3-8b65-9ae59d824377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ceeee8db-a5e9-40d5-887b-93b5b51cea44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f36b28d0-d107-479e-8989-00d7aceace56" xlink:to="loc_us-gaap_StatementTable_ceeee8db-a5e9-40d5-887b-93b5b51cea44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_89476b7e-811a-4437-ba67-c1abc4a434b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ceeee8db-a5e9-40d5-887b-93b5b51cea44" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_89476b7e-811a-4437-ba67-c1abc4a434b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_89476b7e-811a-4437-ba67-c1abc4a434b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89476b7e-811a-4437-ba67-c1abc4a434b9" xlink:to="loc_us-gaap_EquityComponentDomain_89476b7e-811a-4437-ba67-c1abc4a434b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89476b7e-811a-4437-ba67-c1abc4a434b9" xlink:to="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4ebefc38-9eff-47d2-9b77-cd41eccedcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_CommonStockMember_4ebefc38-9eff-47d2-9b77-cd41eccedcfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b90822f6-443d-4429-83cd-a22e1e07f83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b90822f6-443d-4429-83cd-a22e1e07f83f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0a331a1a-6128-42cb-996c-98186a591c78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0a331a1a-6128-42cb-996c-98186a591c78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d9163b7f-efb1-4e04-8bb9-4c91d36ff3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_RetainedEarningsMember_d9163b7f-efb1-4e04-8bb9-4c91d36ff3ef" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="extended" id="i1e7738a8e0be478c852d4a786626ce4d_CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_525c142e-7d60-4bf4-ba0c-7aa594b45915" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_525c142e-7d60-4bf4-ba0c-7aa594b45915" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3db3c333-099d-4711-80b8-dfbc6f8ea5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3db3c333-099d-4711-80b8-dfbc6f8ea5b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a34d7e8c-adc5-4b19-848c-798ea272c2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a34d7e8c-adc5-4b19-848c-798ea272c2fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c192d87-7bfa-4c63-98a1-2657a7f29e74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c192d87-7bfa-4c63-98a1-2657a7f29e74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_60c5e849-8db5-44ea-8959-a328934c4b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_StatementTable_60c5e849-8db5-44ea-8959-a328934c4b3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_60c5e849-8db5-44ea-8959-a328934c4b3d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c" xlink:to="loc_us-gaap_EquityComponentDomain_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c" xlink:to="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9cd5b376-f753-48b6-ad1b-9e92f7ce28a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:to="loc_us-gaap_CommonStockMember_9cd5b376-f753-48b6-ad1b-9e92f7ce28a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_06635561-6d2d-4613-a786-a83009d370e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_06635561-6d2d-4613-a786-a83009d370e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1bdf35d7-2683-40ac-a148-ab6112167250" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1bdf35d7-2683-40ac-a148-ab6112167250" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="extended" id="idec3a3d4b4934265ab7cbd023661c24e_CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost_39de98ae-0f25-4d74-9fea-005754b3d00b" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsAmortizedCost_39de98ae-0f25-4d74-9fea-005754b3d00b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_f4f871df-9904-4658-bda0-6f194146036d" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_f4f871df-9904-4658-bda0-6f194146036d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_e293a0df-43ed-4784-89b8-09677fdfb2a8" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_e293a0df-43ed-4784-89b8-09677fdfb2a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9c2ba1a9-9da5-4d49-a02c-12a08b407832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9c2ba1a9-9da5-4d49-a02c-12a08b407832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2aad5302-4dcd-4ebe-9b02-7f690d84b901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2aad5302-4dcd-4ebe-9b02-7f690d84b901" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6834fb-3ba4-4091-b3f1-5f2a15bc0d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6834fb-3ba4-4091-b3f1-5f2a15bc0d7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_09d4996c-da20-4dbf-8be1-58a150a84e81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_09d4996c-da20-4dbf-8be1-58a150a84e81" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_710f8e7a-94e2-4fa0-a54e-d7ecbd752387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_710f8e7a-94e2-4fa0-a54e-d7ecbd752387" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_1c44abe0-4226-4d57-b3ff-f9f0142b8004" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_1c44abe0-4226-4d57-b3ff-f9f0142b8004" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_5e553b5d-5663-49a4-9fb3-b68dd39f38ef" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_5e553b5d-5663-49a4-9fb3-b68dd39f38ef" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_5579b7f2-7fa7-485c-b5f8-e8ce9b0a3499" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_5579b7f2-7fa7-485c-b5f8-e8ce9b0a3499" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_698d6825-be4a-43e9-a55b-f70a321200b7" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_698d6825-be4a-43e9-a55b-f70a321200b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_74e72e65-4952-40a7-806a-56f8b09a6956" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_74e72e65-4952-40a7-806a-56f8b09a6956" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_74e72e65-4952-40a7-806a-56f8b09a6956_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74e72e65-4952-40a7-806a-56f8b09a6956" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_74e72e65-4952-40a7-806a-56f8b09a6956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74e72e65-4952-40a7-806a-56f8b09a6956" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_0c4b2704-a043-4657-aefa-09535f6b3448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_0c4b2704-a043-4657-aefa-09535f6b3448" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CurrentMarketableSecuritiesMember_145417c2-3fe9-444a-9871-bf620b4060a8" xlink:href="sera-20230331.xsd#sera_CurrentMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:to="loc_sera_CurrentMarketableSecuritiesMember_145417c2-3fe9-444a-9871-bf620b4060a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NonCurrentMarketableSecuritiesMember_9aa791bb-2446-463c-af95-3cfea8b85449" xlink:href="sera-20230331.xsd#sera_NonCurrentMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:to="loc_sera_NonCurrentMarketableSecuritiesMember_9aa791bb-2446-463c-af95-3cfea8b85449" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_ed1917d1-b857-418a-b249-e75a6d486506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_ed1917d1-b857-418a-b249-e75a6d486506" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed1917d1-b857-418a-b249-e75a6d486506_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ed1917d1-b857-418a-b249-e75a6d486506" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ed1917d1-b857-418a-b249-e75a6d486506_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ed1917d1-b857-418a-b249-e75a6d486506" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_a3eff6e1-e773-4e6a-b40b-9bbcf3105e59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_CashMember_a3eff6e1-e773-4e6a-b40b-9bbcf3105e59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_d2a4f5a1-b389-4262-9c5d-9e7cc66e35a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_MoneyMarketFundsMember_d2a4f5a1-b389-4262-9c5d-9e7cc66e35a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_32c5ee84-5c57-428b-a945-5023e918a12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_CommercialPaperMember_32c5ee84-5c57-428b-a945-5023e918a12a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_68c91f16-4ba3-405a-a3aa-ada02304d8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_68c91f16-4ba3-405a-a3aa-ada02304d8b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_017ecdde-f156-4c59-9eac-7555099eb632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:to="loc_us-gaap_FinancialInstrumentAxis_017ecdde-f156-4c59-9eac-7555099eb632" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_017ecdde-f156-4c59-9eac-7555099eb632_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_017ecdde-f156-4c59-9eac-7555099eb632" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_017ecdde-f156-4c59-9eac-7555099eb632_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_017ecdde-f156-4c59-9eac-7555099eb632" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9c096b24-c7ca-4b26-9d37-3a239af7a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_CommercialPaperMember_9c096b24-c7ca-4b26-9d37-3a239af7a49f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c311513a-5fb0-4c97-bee4-1932238111f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c311513a-5fb0-4c97-bee4-1932238111f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0d2644e8-2021-406a-9b1c-4fe4071868ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0d2644e8-2021-406a-9b1c-4fe4071868ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_408ead85-d727-4bab-aea6-791a3c39410d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_408ead85-d727-4bab-aea6-791a3c39410d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="extended" id="iaefe324ef09e45faa9ee1a024723a6a6_CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_76e80b3d-f0be-4ffc-9ef0-a28ab8952dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_76e80b3d-f0be-4ffc-9ef0-a28ab8952dbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b9f6850-a614-4f1d-9344-6448f1b08d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b9f6850-a614-4f1d-9344-6448f1b08d4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_79af83c4-c9f1-4aed-957d-0748139f8ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_79af83c4-c9f1-4aed-957d-0748139f8ac6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_445b5999-27a3-4906-98f5-bc654f94768c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_445b5999-27a3-4906-98f5-bc654f94768c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a13947e5-1753-48a8-9449-d47df3c561e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a13947e5-1753-48a8-9449-d47df3c561e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8ea4b869-babc-4ae8-864a-5a7606a1628d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8ea4b869-babc-4ae8-864a-5a7606a1628d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_614780ae-33aa-4793-99f8-dc7ef12dc423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_614780ae-33aa-4793-99f8-dc7ef12dc423" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a83566b3-9581-4f02-8662-a4cef06b2d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_614780ae-33aa-4793-99f8-dc7ef12dc423" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a83566b3-9581-4f02-8662-a4cef06b2d9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a83566b3-9581-4f02-8662-a4cef06b2d9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a83566b3-9581-4f02-8662-a4cef06b2d9e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a83566b3-9581-4f02-8662-a4cef06b2d9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a83566b3-9581-4f02-8662-a4cef06b2d9e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9f0a4882-d14f-4ca3-999c-17b3e8da7241" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_CommercialPaperMember_9f0a4882-d14f-4ca3-999c-17b3e8da7241" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_77780123-1bc5-498b-8916-6fe0351cce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_77780123-1bc5-498b-8916-6fe0351cce5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_449d81c2-bf5a-4014-a131-c52edc8436d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_449d81c2-bf5a-4014-a131-c52edc8436d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_f2f487b0-37d6-437e-b5b3-954d11b814b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_f2f487b0-37d6-437e-b5b3-954d11b814b8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="extended" id="i423ad997981541c0b19fc17854a652f3_PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_093e50ea-4fb7-403d-99ce-85bbdf64cb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_093e50ea-4fb7-403d-99ce-85bbdf64cb7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5419dcfa-5e1e-4538-88c6-7b08cb76a481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5419dcfa-5e1e-4538-88c6-7b08cb76a481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a79c2b7f-5a4a-460d-b5f7-03c9a47d3d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a79c2b7f-5a4a-460d-b5f7-03c9a47d3d7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6ab4e7b-71c2-49ca-a36c-e4eca49726a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6ab4e7b-71c2-49ca-a36c-e4eca49726a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59681a50-2527-471a-b32d-e2faba577d27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6ab4e7b-71c2-49ca-a36c-e4eca49726a8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59681a50-2527-471a-b32d-e2faba577d27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59681a50-2527-471a-b32d-e2faba577d27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59681a50-2527-471a-b32d-e2faba577d27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59681a50-2527-471a-b32d-e2faba577d27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59681a50-2527-471a-b32d-e2faba577d27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryEquipmentMember_391cf2ef-fd4f-4269-8d29-f0ad1c24921f" xlink:href="sera-20230331.xsd#sera_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_sera_LaboratoryEquipmentMember_391cf2ef-fd4f-4269-8d29-f0ad1c24921f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_308049b6-a170-4b1e-97b3-80597579fa88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_ComputerEquipmentMember_308049b6-a170-4b1e-97b3-80597579fa88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_023edcac-0ce1-48ea-a883-0eb0609cf343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_023edcac-0ce1-48ea-a883-0eb0609cf343" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_da44b224-f534-486c-a7a6-b25dc42ffc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_da44b224-f534-486c-a7a6-b25dc42ffc0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_71577eff-2f42-4c14-93b6-f1e30b3e58bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_71577eff-2f42-4c14-93b6-f1e30b3e58bb" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i140fd419d42e457a917b4cea7b405098_FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2f41f420-dce8-41d3-9e92-dee1bb352183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2f41f420-dce8-41d3-9e92-dee1bb352183" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1be28e03-535b-420d-a886-70bbb2497675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1be28e03-535b-420d-a886-70bbb2497675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d59e464d-2eff-40e7-946b-4f157d65021e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d59e464d-2eff-40e7-946b-4f157d65021e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ebf601be-37ae-46db-a785-9147d1abdc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ebf601be-37ae-46db-a785-9147d1abdc0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2f41f420-dce8-41d3-9e92-dee1bb352183" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77af848c-295c-456a-964b-56a1819bd6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77af848c-295c-456a-964b-56a1819bd6eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77af848c-295c-456a-964b-56a1819bd6eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77af848c-295c-456a-964b-56a1819bd6eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77af848c-295c-456a-964b-56a1819bd6eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77af848c-295c-456a-964b-56a1819bd6eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3e05a1b2-31c4-4c82-831c-aa853ecafc48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3e05a1b2-31c4-4c82-831c-aa853ecafc48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7493dfd0-a825-4009-bb80-d61f7587f054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7493dfd0-a825-4009-bb80-d61f7587f054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_51944ed2-93bb-4ed0-a8f0-1a5f646f0f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_51944ed2-93bb-4ed0-a8f0-1a5f646f0f8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c20b90b1-c606-4171-bdf3-9f18483911fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c20b90b1-c606-4171-bdf3-9f18483911fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c20b90b1-c606-4171-bdf3-9f18483911fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c20b90b1-c606-4171-bdf3-9f18483911fa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c20b90b1-c606-4171-bdf3-9f18483911fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cff5bea9-189d-491c-9be2-c6fc67c3c4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c20b90b1-c606-4171-bdf3-9f18483911fa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cff5bea9-189d-491c-9be2-c6fc67c3c4e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_11302a8b-0169-4c22-89b7-75436ae1228d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cff5bea9-189d-491c-9be2-c6fc67c3c4e6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_11302a8b-0169-4c22-89b7-75436ae1228d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_3da975bf-4d31-4030-8794-ee94e9235530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_3da975bf-4d31-4030-8794-ee94e9235530" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3da975bf-4d31-4030-8794-ee94e9235530_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_3da975bf-4d31-4030-8794-ee94e9235530" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3da975bf-4d31-4030-8794-ee94e9235530_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_3da975bf-4d31-4030-8794-ee94e9235530" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f69c9d43-fa3a-499b-b444-2fdc4bc17c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f69c9d43-fa3a-499b-b444-2fdc4bc17c6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_328d722d-d4e3-4f5f-9575-d5df0e221f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:to="loc_us-gaap_CommercialPaperMember_328d722d-d4e3-4f5f-9575-d5df0e221f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_854f4a42-fed2-4237-8514-735b1a01cdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_854f4a42-fed2-4237-8514-735b1a01cdfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7a6b8f06-4763-40e1-917a-7c0cd70050c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7a6b8f06-4763-40e1-917a-7c0cd70050c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7a6b8f06-4763-40e1-917a-7c0cd70050c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a6b8f06-4763-40e1-917a-7c0cd70050c8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7a6b8f06-4763-40e1-917a-7c0cd70050c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a6b8f06-4763-40e1-917a-7c0cd70050c8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_138e4372-773f-4b6b-ad5c-0c07f728dc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_CommercialPaperMember_138e4372-773f-4b6b-ad5c-0c07f728dc2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d561ee05-502a-4e59-8450-c59b62b16bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d561ee05-502a-4e59-8450-c59b62b16bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ba8ded4c-f89b-4205-a85d-e38306b8338d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ba8ded4c-f89b-4205-a85d-e38306b8338d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_f9ab09b4-87e9-4303-aad1-91df29481755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_f9ab09b4-87e9-4303-aad1-91df29481755" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="i83b5d97096454430a61e2db9c254ed58_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_044e58ec-4330-4450-906c-535b267b91a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_us-gaap_OperatingExpenses_044e58ec-4330-4450-906c-535b267b91a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e0b448a-0db3-4d31-9aa4-cf2d020ef307" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e0b448a-0db3-4d31-9aa4-cf2d020ef307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_49e61ea2-c8f4-4550-82fe-b1ece3c8fa9f" xlink:href="sera-20230331.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_49e61ea2-c8f4-4550-82fe-b1ece3c8fa9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_198afdda-d77c-46fa-9163-b7a24cedcba3" xlink:href="sera-20230331.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_198afdda-d77c-46fa-9163-b7a24cedcba3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b098e42b-901a-4d6d-9e87-ef5588026659" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b098e42b-901a-4d6d-9e87-ef5588026659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b098e42b-901a-4d6d-9e87-ef5588026659_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b098e42b-901a-4d6d-9e87-ef5588026659" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b098e42b-901a-4d6d-9e87-ef5588026659_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b098e42b-901a-4d6d-9e87-ef5588026659" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_MasterServicesAgreementMember_87a0a49d-155f-4338-8294-25d9fe1f5117" xlink:href="sera-20230331.xsd#sera_MasterServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:to="loc_sera_MasterServicesAgreementMember_87a0a49d-155f-4338-8294-25d9fe1f5117" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryServicesAgreementMember_1660040f-ff73-46f9-89fd-9ae0a63bbf93" xlink:href="sera-20230331.xsd#sera_LaboratoryServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:to="loc_sera_LaboratoryServicesAgreementMember_1660040f-ff73-46f9-89fd-9ae0a63bbf93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommercialCollaborationAgreementMember_7edc7696-a975-446a-877d-6038e00103be" xlink:href="sera-20230331.xsd#sera_CommercialCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:to="loc_sera_CommercialCollaborationAgreementMember_7edc7696-a975-446a-877d-6038e00103be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis_d70429cd-da63-4d02-9693-383c661f80d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:to="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis_d70429cd-da63-4d02-9693-383c661f80d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_d70429cd-da63-4d02-9693-383c661f80d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis_d70429cd-da63-4d02-9693-383c661f80d7" xlink:to="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_d70429cd-da63-4d02-9693-383c661f80d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_54984439-df87-4f89-aa96-c4aff917dc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis_d70429cd-da63-4d02-9693-383c661f80d7" xlink:to="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_54984439-df87-4f89-aa96-c4aff917dc7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_97dc36eb-58ec-473d-af04-247e90d33fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_54984439-df87-4f89-aa96-c4aff917dc7f" xlink:to="loc_us-gaap_RelatedPartyMember_97dc36eb-58ec-473d-af04-247e90d33fdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:to="loc_srt_CounterpartyNameAxis_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CarelonResearchMember_a92f7a47-b783-42ca-b7f1-62fff6d99640" xlink:href="sera-20230331.xsd#sera_CarelonResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:to="loc_sera_CarelonResearchMember_a92f7a47-b783-42ca-b7f1-62fff6d99640" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ElevanceHealthIncMember_3e58422e-b2f5-4547-99b8-2e5f11059f66" xlink:href="sera-20230331.xsd#sera_ElevanceHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:to="loc_sera_ElevanceHealthIncMember_3e58422e-b2f5-4547-99b8-2e5f11059f66" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CapitalStructureNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="extended" id="i9b6f07708ab34ccfb71db4aadee15723_CapitalStructureNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfCommonStockClassesAuthorized_ab723c5e-4687-4354-8053-e86a83289bce" xlink:href="sera-20230331.xsd#sera_NumberOfCommonStockClassesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:to="loc_sera_NumberOfCommonStockClassesAuthorized_ab723c5e-4687-4354-8053-e86a83289bce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfVotesPerShare_ca0068ba-4f5b-4241-886e-dc1a4cac2105" xlink:href="sera-20230331.xsd#sera_NumberOfVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:to="loc_sera_NumberOfVotesPerShare_ca0068ba-4f5b-4241-886e-dc1a4cac2105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockConversionRatio_dc74e465-a5dd-4f72-9de5-ba4536bad407" xlink:href="sera-20230331.xsd#sera_CommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:to="loc_sera_CommonStockConversionRatio_dc74e465-a5dd-4f72-9de5-ba4536bad407" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_89be81fd-1c6e-4b75-b332-1e769693fbab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_89be81fd-1c6e-4b75-b332-1e769693fbab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_404770c4-26de-4ff3-a8da-a58c7d781326" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_89be81fd-1c6e-4b75-b332-1e769693fbab" xlink:to="loc_us-gaap_StatementClassOfStockAxis_404770c4-26de-4ff3-a8da-a58c7d781326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_404770c4-26de-4ff3-a8da-a58c7d781326_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_404770c4-26de-4ff3-a8da-a58c7d781326" xlink:to="loc_us-gaap_ClassOfStockDomain_404770c4-26de-4ff3-a8da-a58c7d781326_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_404770c4-26de-4ff3-a8da-a58c7d781326" xlink:to="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4443db5b-ff89-4ff8-a88f-df8d174d9bef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:to="loc_us-gaap_CommonClassAMember_4443db5b-ff89-4ff8-a88f-df8d174d9bef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_613d2228-c11d-4d05-9758-aa04e2a2b83a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:to="loc_us-gaap_CommonClassBMember_613d2228-c11d-4d05-9758-aa04e2a2b83a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CapitalStructureCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="extended" id="i96b42ed143b543cf808105191aa889d5_CapitalStructureCommonStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_03234432-adb6-451f-8b44-c0eaa79abdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7f50a7ff-d9a9-4121-a773-83bdf601b4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_03234432-adb6-451f-8b44-c0eaa79abdaa" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7f50a7ff-d9a9-4121-a773-83bdf601b4c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_03234432-adb6-451f-8b44-c0eaa79abdaa" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9658a5d9-a52e-488e-8ad7-c61a589fcbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9658a5d9-a52e-488e-8ad7-c61a589fcbe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9658a5d9-a52e-488e-8ad7-c61a589fcbe6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9658a5d9-a52e-488e-8ad7-c61a589fcbe6" xlink:to="loc_us-gaap_ClassOfStockDomain_9658a5d9-a52e-488e-8ad7-c61a589fcbe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1ee2f272-948b-4695-8190-1aa00f3c70a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9658a5d9-a52e-488e-8ad7-c61a589fcbe6" xlink:to="loc_us-gaap_ClassOfStockDomain_1ee2f272-948b-4695-8190-1aa00f3c70a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_e151e5aa-8658-4f71-ae93-514b25170d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1ee2f272-948b-4695-8190-1aa00f3c70a8" xlink:to="loc_us-gaap_CommonClassAMember_e151e5aa-8658-4f71-ae93-514b25170d8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_a0e956f4-e5b4-4ad1-b145-ca848b453b80" xlink:href="sera-20230331.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_a0e956f4-e5b4-4ad1-b145-ca848b453b80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_a0e956f4-e5b4-4ad1-b145-ca848b453b80_default" xlink:href="sera-20230331.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_a0e956f4-e5b4-4ad1-b145-ca848b453b80" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_a0e956f4-e5b4-4ad1-b145-ca848b453b80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:href="sera-20230331.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_a0e956f4-e5b4-4ad1-b145-ca848b453b80" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_027451de-5180-4170-93d0-dc05ba1f704c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_027451de-5180-4170-93d0-dc05ba1f704c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_8c079b1b-c32d-4eec-89c1-ad95c7e61874" xlink:href="sera-20230331.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_8c079b1b-c32d-4eec-89c1-ad95c7e61874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fea53a6d-c5a8-4c62-b88a-bafab25ea1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fea53a6d-c5a8-4c62-b88a-bafab25ea1cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_8ece2bb0-9214-4d03-a52a-40fed2a62978" xlink:href="sera-20230331.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_8ece2bb0-9214-4d03-a52a-40fed2a62978" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_b0aac49a-9a65-4007-81c5-b499101e7d09" xlink:href="sera-20230331.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_b0aac49a-9a65-4007-81c5-b499101e7d09" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="i38898fe44cdc4ffeb8c01c5e3a88062f_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5bf714d-f5c9-4f1d-a6f6-ec1eae4f680d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5bf714d-f5c9-4f1d-a6f6-ec1eae4f680d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e7d1af2-0469-4e97-9528-fdc319695947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e7d1af2-0469-4e97-9528-fdc319695947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0b4e9072-bfcf-46dc-84d7-d935b6ab44cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0b4e9072-bfcf-46dc-84d7-d935b6ab44cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fdd01f16-6171-4f08-b511-1d953755a5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:to="loc_us-gaap_PlanNameAxis_fdd01f16-6171-4f08-b511-1d953755a5f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fdd01f16-6171-4f08-b511-1d953755a5f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_fdd01f16-6171-4f08-b511-1d953755a5f7" xlink:to="loc_us-gaap_PlanNameDomain_fdd01f16-6171-4f08-b511-1d953755a5f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_fdd01f16-6171-4f08-b511-1d953755a5f7" xlink:to="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2011Member_bd2375d1-0eeb-4135-b702-0901c50f0c64" xlink:href="sera-20230331.xsd#sera_Plan2011Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:to="loc_sera_Plan2011Member_bd2375d1-0eeb-4135-b702-0901c50f0c64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2021Member_b930d73b-41b5-4022-9173-d0c1b4b9503d" xlink:href="sera-20230331.xsd#sera_Plan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:to="loc_sera_Plan2021Member_b930d73b-41b5-4022-9173-d0c1b4b9503d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PlanEspp2021Member_5fe6f040-302a-475a-994a-ed2dadcd9e01" xlink:href="sera-20230331.xsd#sera_PlanEspp2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:to="loc_sera_PlanEspp2021Member_5fe6f040-302a-475a-994a-ed2dadcd9e01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c" xlink:to="loc_us-gaap_ClassOfStockDomain_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d072aa5a-2724-4600-a8f5-64718f55ff16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c" xlink:to="loc_us-gaap_ClassOfStockDomain_d072aa5a-2724-4600-a8f5-64718f55ff16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b68723d8-27a0-4d0e-9198-84ee299b1dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d072aa5a-2724-4600-a8f5-64718f55ff16" xlink:to="loc_us-gaap_CommonClassAMember_b68723d8-27a0-4d0e-9198-84ee299b1dbe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="extended" id="i00fda07f61a94362a75744c40606f0b0_StockBasedCompensationRestrictedStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d3ec8a6-cb01-426b-889b-37a93986b5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d3ec8a6-cb01-426b-889b-37a93986b5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbd70415-772a-4099-b700-bec0c86bebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbd70415-772a-4099-b700-bec0c86bebfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28ad51e9-9d00-4917-afca-7f8e056a55c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28ad51e9-9d00-4917-afca-7f8e056a55c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eed5f91d-63c2-4926-91bf-b03e0f393a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eed5f91d-63c2-4926-91bf-b03e0f393a10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_469e3ab0-56aa-4f73-b970-db1338168aba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2dcb310-7663-4429-9984-1ee0633f0339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2dcb310-7663-4429-9984-1ee0633f0339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e18b308b-cfb2-4f9d-aecb-59eb5568db26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e18b308b-cfb2-4f9d-aecb-59eb5568db26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8351792d-a895-453c-b9ac-e7cacc8e50d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8351792d-a895-453c-b9ac-e7cacc8e50d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_68635afb-2363-431b-b005-cc424f62a1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_68635afb-2363-431b-b005-cc424f62a1c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6522b218-3391-41ee-9259-db1b804e3879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c737d85-d751-4bf1-9ebd-54186b0960cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c737d85-d751-4bf1-9ebd-54186b0960cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f91badc9-42c6-4d97-9b82-035cd2f03cac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c737d85-d751-4bf1-9ebd-54186b0960cd" xlink:to="loc_us-gaap_AwardTypeAxis_f91badc9-42c6-4d97-9b82-035cd2f03cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f91badc9-42c6-4d97-9b82-035cd2f03cac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f91badc9-42c6-4d97-9b82-035cd2f03cac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f91badc9-42c6-4d97-9b82-035cd2f03cac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8997373-5501-4581-acf2-f810e4aaa079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f91badc9-42c6-4d97-9b82-035cd2f03cac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8997373-5501-4581-acf2-f810e4aaa079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6ae00e57-753e-46ce-9b57-5ce4a3897dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8997373-5501-4581-acf2-f810e4aaa079" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6ae00e57-753e-46ce-9b57-5ce4a3897dc6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="extended" id="iecd3c25a51b64eaa984375aa10d95c18_StockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_404fcc68-bacd-4e02-8dca-bbce008ca7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3b02f50d-6e98-46bf-a708-87831a198255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_404fcc68-bacd-4e02-8dca-bbce008ca7eb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3b02f50d-6e98-46bf-a708-87831a198255" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b7daa06a-9e38-4844-af9e-0bdf451512b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_404fcc68-bacd-4e02-8dca-bbce008ca7eb" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b7daa06a-9e38-4844-af9e-0bdf451512b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b7daa06a-9e38-4844-af9e-0bdf451512b4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fc8e9ed0-0986-4af9-8eb8-661e58946d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fc8e9ed0-0986-4af9-8eb8-661e58946d73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_541b65b5-9b91-41f4-bd71-f5e83de6e097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_541b65b5-9b91-41f4-bd71-f5e83de6e097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_bb7c9de8-3f13-45c6-89e9-1470f8bf7800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_bb7c9de8-3f13-45c6-89e9-1470f8bf7800" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationUnrecognizedCostDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails" xlink:type="extended" id="i24fee72922694e22a37eafee646c2c05_StockBasedCompensationUnrecognizedCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_af2400bd-f9b3-40ad-b6f0-d307ad62c76a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_af2400bd-f9b3-40ad-b6f0-d307ad62c76a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10bdda7-f6ab-4302-ba4e-1e8d0702bfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10bdda7-f6ab-4302-ba4e-1e8d0702bfcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_409e9ab2-3dd3-4157-b804-04882a7f48b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_409e9ab2-3dd3-4157-b804-04882a7f48b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6b695e9f-536b-4acc-b3c8-31040d578d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6b695e9f-536b-4acc-b3c8-31040d578d93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_176c8e33-cd28-4743-8637-ddf6e8086f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_176c8e33-cd28-4743-8637-ddf6e8086f1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_176c8e33-cd28-4743-8637-ddf6e8086f1b" xlink:to="loc_us-gaap_AwardTypeAxis_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc92b10f-be3a-4b00-9c4b-d796123846e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc92b10f-be3a-4b00-9c4b-d796123846e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_486f4748-6170-4cb9-94b1-869bd02ca238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc92b10f-be3a-4b00-9c4b-d796123846e5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_486f4748-6170-4cb9-94b1-869bd02ca238" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#WarrantsCommonStockWarrantsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="extended" id="i28f154ac0be1445a9ae97af97b3cd018_WarrantsCommonStockWarrantsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8bda5550-a5f1-4713-8c30-1087dd6f553c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8bda5550-a5f1-4713-8c30-1087dd6f553c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2b048296-c983-46eb-b895-eea4c787f25f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2b048296-c983-46eb-b895-eea4c787f25f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_21c2e459-41a6-454e-92a8-88f3c77fdf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_21c2e459-41a6-454e-92a8-88f3c77fdf4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_92e4a522-8abc-43a3-aab5-2bd340767dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_21c2e459-41a6-454e-92a8-88f3c77fdf4c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_92e4a522-8abc-43a3-aab5-2bd340767dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92e4a522-8abc-43a3-aab5-2bd340767dfa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_92e4a522-8abc-43a3-aab5-2bd340767dfa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92e4a522-8abc-43a3-aab5-2bd340767dfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_92e4a522-8abc-43a3-aab5-2bd340767dfa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember_7d4acea8-b7c0-4527-be72-c3145999b33a" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt520SharePriceMember_7d4acea8-b7c0-4527-be72-c3145999b33a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt9.03SharePriceMember_4303af92-48d7-453e-9c3b-e8e9a9e2eedc" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt9.03SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt9.03SharePriceMember_4303af92-48d7-453e-9c3b-e8e9a9e2eedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt10.84SharePriceMember_aef477c6-85d0-4b21-974f-4f2904c7fa6c" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt10.84SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt10.84SharePriceMember_aef477c6-85d0-4b21-974f-4f2904c7fa6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt1238SharePriceMember_9be12316-8926-4c0e-8434-d071d3da3985" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt1238SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt1238SharePriceMember_9be12316-8926-4c0e-8434-d071d3da3985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt2077SharePriceMember_3488cd77-55ca-48d3-9654-6283dd454a95" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt2077SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt2077SharePriceMember_3488cd77-55ca-48d3-9654-6283dd454a95" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="extended" id="ib5f2ab307ac44b0b8ab6fb98171ce41c_CommitmentsandContingencesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:href="sera-20230331.xsd#sera_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_6826cd6e-b580-45c7-bd91-fbcb4627e18b" xlink:href="sera-20230331.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:to="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_6826cd6e-b580-45c7-bd91-fbcb4627e18b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IndemnificationLiability_f28484e2-c163-46a2-ba2f-0a5e7bc19508" xlink:href="sera-20230331.xsd#sera_IndemnificationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:to="loc_sera_IndemnificationLiability_f28484e2-c163-46a2-ba2f-0a5e7bc19508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesTable_bf77684b-f1a2-49a5-8a1a-9361afd58378" xlink:href="sera-20230331.xsd#sera_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:to="loc_sera_CommitmentsAndContingenciesTable_bf77684b-f1a2-49a5-8a1a-9361afd58378" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7b2511c2-3dde-481f-b9a7-72277292d991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sera_CommitmentsAndContingenciesTable_bf77684b-f1a2-49a5-8a1a-9361afd58378" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7b2511c2-3dde-481f-b9a7-72277292d991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7b2511c2-3dde-481f-b9a7-72277292d991_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7b2511c2-3dde-481f-b9a7-72277292d991" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7b2511c2-3dde-481f-b9a7-72277292d991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_534117fb-aec2-436a-9dc8-63916bdbce0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7b2511c2-3dde-481f-b9a7-72277292d991" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_534117fb-aec2-436a-9dc8-63916bdbce0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OfficeAndLaboratorySpaceMember_6cb947da-62ac-4795-81b4-3c41dc3cd689" xlink:href="sera-20230331.xsd#sera_OfficeAndLaboratorySpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_534117fb-aec2-436a-9dc8-63916bdbce0a" xlink:to="loc_sera_OfficeAndLaboratorySpaceMember_6cb947da-62ac-4795-81b4-3c41dc3cd689" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="extended" id="ibc02ecc1c3954cb480b83b06f1f3ffb8_NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_42e2d98e-d4e6-480f-969b-686444e7265a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_163349f7-9547-4de3-9317-e142b5e458ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_42e2d98e-d4e6-480f-969b-686444e7265a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_163349f7-9547-4de3-9317-e142b5e458ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5c34bdc7-35a4-4f52-abeb-4d1d62210991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_42e2d98e-d4e6-480f-969b-686444e7265a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5c34bdc7-35a4-4f52-abeb-4d1d62210991" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1fdd5169-1699-4be5-86f2-d6dcef570dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5c34bdc7-35a4-4f52-abeb-4d1d62210991" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1fdd5169-1699-4be5-86f2-d6dcef570dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1fdd5169-1699-4be5-86f2-d6dcef570dd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1fdd5169-1699-4be5-86f2-d6dcef570dd0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1fdd5169-1699-4be5-86f2-d6dcef570dd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1fdd5169-1699-4be5-86f2-d6dcef570dd0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_450fc36a-1260-4cc2-bdd8-53ebd45f78d8" xlink:href="sera-20230331.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_450fc36a-1260-4cc2-bdd8-53ebd45f78d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_db4b3623-4213-421f-8f95-4a4de81c3813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_db4b3623-4213-421f-8f95-4a4de81c3813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_785ccc6a-1be9-4b2a-9847-05b58e2ac1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_785ccc6a-1be9-4b2a-9847-05b58e2ac1d9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>sera-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b6fd7582-a32b-479d-9964-70f04b6c290c,g:3cb67c47-ddd7-494a-a3a9-536b1cbe927e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_sera_CurrentMarketableSecuritiesMember_f2885601-22cc-45d8-9693-09cb761dd98d_terseLabel_en-US" xlink:label="lab_sera_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current marketable securities:</link:label>
    <link:label id="lab_sera_CurrentMarketableSecuritiesMember_label_en-US" xlink:label="lab_sera_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Marketable Securities [Member]</link:label>
    <link:label id="lab_sera_CurrentMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_sera_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CurrentMarketableSecuritiesMember" xlink:href="sera-20230331.xsd#sera_CurrentMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CurrentMarketableSecuritiesMember" xlink:to="lab_sera_CurrentMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_8d062c7b-4ee0-4208-b26f-797cf117ae3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_c427b398-289c-41b4-94b5-f03d308c276f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_FinanceLeasesOtherInformationAbstract_31cc8aee-c0d9-4ece-8b72-cd4678ef9fe4_terseLabel_en-US" xlink:label="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_sera_FinanceLeasesOtherInformationAbstract_label_en-US" xlink:label="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases, Other Information [Abstract]</link:label>
    <link:label id="lab_sera_FinanceLeasesOtherInformationAbstract_documentation_en-US" xlink:label="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases, Other Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeasesOtherInformationAbstract" xlink:href="sera-20230331.xsd#sera_FinanceLeasesOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract" xlink:to="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_984d9ac0-5322-4e2f-a4ab-c4cd8d5fafaf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_b69fb0e4-42c7-49e6-bfcc-03a02075abc6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bc1225a6-02be-4fcb-9780-28649d9aed24_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_1dec12ab-f8ea-4ab8-829e-e966060556d9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e365c7b2-b2dd-4294-adbe-0a58707c615d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RightOfUseAssetAbstract_b7c98fa9-eab5-43ce-91d5-886c624e620e_terseLabel_en-US" xlink:label="lab_sera_RightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets:</link:label>
    <link:label id="lab_sera_RightOfUseAssetAbstract_label_en-US" xlink:label="lab_sera_RightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset [Abstract]</link:label>
    <link:label id="lab_sera_RightOfUseAssetAbstract_documentation_en-US" xlink:label="lab_sera_RightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetAbstract" xlink:href="sera-20230331.xsd#sera_RightOfUseAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RightOfUseAssetAbstract" xlink:to="lab_sera_RightOfUseAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c8419ffb-35f0-4532-9e6c-de00cada0f5f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2611557a-aa7b-423e-a726-08d3bedddc32_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_fa391736-eacd-4fe1-a400-c7618801cf9f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net, Amortization of Discount and Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:to="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_353d152a-525b-486e-81a5-8c3c811afc37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_c9a03994-3372-40ff-b837-c06855393e44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_76714c14-7ee8-4f2c-889e-6c8392d4fa6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_34a49028-e54b-4551-af28-22a2abd60751_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_1670da2d-3eaf-4897-a8cf-026b5f197100_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_968b83a0-ba9c-4fd1-9531-d3b9e9466f9b_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d1ce1488-ef34-413d-a8ff-cf9233b9f40a_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_2fca51b6-79f6-426d-b919-56061bb19585_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_70116d2d-09ce-41c9-8314-ab0cb3fff58e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearThreeAndThereafter_38217b6e-f22a-466d-9e6c-34afb98847ad_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearThreeAndThereafter_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearThreeAndThereafter_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:to="lab_sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_a720bdc0-d089-465c-98ca-1cf27552bee3_terseLabel_en-US" xlink:label="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leases in Financial Statement</link:label>
    <link:label id="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leases In Statement Of Financial Position [Table Text Block]</link:label>
    <link:label id="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_documentation_en-US" xlink:label="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leases In Statement Of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:href="sera-20230331.xsd#sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:to="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_14f118a5-c0a7-4b4b-b1e5-b71c7a5200b8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Structure</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_796cb6b1-a320-4cea-ab5e-80e402957dbf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest at the end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_171c528e-56d7-4358-82ad-b56df0b68299_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_07e4d39d-b293-4773-aa62-a37a28858b56_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b9c0bd90-dae3-4d80-addb-0a44a4cbe161_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f206cc93-aff3-433e-af78-13d9bb4aab52_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b0303d9-38d6-4e8b-9265-f56c596124e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d66c2753-37ac-4ef2-ae98-af1f29ab0e20_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_32b14974-1103-4673-b48b-b1a18d5de8da_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt520SharePriceMember_d878ad7a-9cdf-4864-ae71-0075221a9fdf_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.20</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt520SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 5.20 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt520SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 5.20 Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt520SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_38aa88ec-7303-4439-8a8f-bc1f076e84b1_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_10897be0-650a-49df-8ce9-a79c937a974c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_14311e39-89f2-462b-a531-5690a6a2b28c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_2733ebdb-9fcc-4cb8-8929-2b34d19e7fe6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1c14afc0-78c9-4590-8387-81c929212bf6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_175b1aa8-e108-4321-8e2b-b51196850bf3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b1edcaaa-b59e-4656-ae70-c02de979fdf1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e99fe93a-17c2-48cf-9769-52ce52ab97d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_2f20514d-1ad7-472a-bcbb-8cf4396e26b5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued 401(k) matching contributions</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bc0986cf-fe5c-46b4-8abf-ae37557fba94_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1f5abcf8-7168-4b3b-b7d5-8e608e6758f1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_72d72420-7ae3-49ba-a4d3-0f646de21535_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_eae1ec4d-ef03-4fe7-9f4f-635fee42160e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d68b09ee-c7bd-4ad0-b54f-e612ed082e09_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_488cb477-1fe1-4934-9cfe-f383cee941a5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2778847d-29c8-43d3-8ace-6a3b91d066ee_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b21a0314-7448-48bf-a564-6d444d2d481e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_051c03b1-f999-4e64-9652-80f9f8ef4bf9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_b1197735-85ca-4162-b0c8-2b4e8db9264f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_27a2cd78-8086-4094-af9c-0fbc3f256671_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_5dee8529-96ed-435c-ba6a-a5456c77ea58_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_6767ce58-01cf-411f-b308-dd3c10e82990_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fd5f6cc5-48da-4ce7-856e-27486ecc8761_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_0ca6fb6b-a0bc-4ba6-b6f5-fcc018a17716_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_19e0db3f-feb1-4e15-9d23-a4e114d72696_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_024a54fd-7225-4f85-8aa5-7bf0ab6e3b3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c24a6cfe-2c7b-4f4a-ab9b-cbe051ab3f8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_957122c4-5f39-4a3b-ad49-de641d807166_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9c0b77e5-754c-4376-9c31-96950d7c3066_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2bdcb28e-effe-4892-9fa0-f1dc16029bec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_51060856-f602-425a-87aa-0a8890c857df_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class B common stock</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_55da370b-7ce2-463c-8c24-279308d2debe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_2361c8be-6c01-4d8b-bd3d-482642103bcf_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c589dc4e-5917-499c-a7fb-fdf8718a3f56_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e7c64c62-cdd5-4af5-9afc-c77ea7960463_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_c52d96a0-ab1a-43ac-9eea-f31a2f8e44c4_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_b0c70077-9aa9-4691-bbc5-a4dba0b1e66a_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5919c3ab-65b8-4648-a7a3-46a5a7322637_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3fff01e8-7a15-49b2-931f-6c36f81f1538_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ebfab737-9bd4-4bae-a7f0-f130cdf36082_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_604e08ce-d91f-4ca2-a7e2-6a6654d08ec8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a70982af-c1ea-461c-ae3f-1dfea04082af_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1d7346db-619d-4d5f-8320-679903f848b7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_758b679b-7836-4333-bcff-02d0a34a3e2e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommitmentsAndContingenciesTable_c08466e3-93e0-4b99-91bf-bc748af53202_terseLabel_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the table relating to information of commitments and contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesTable" xlink:href="sera-20230331.xsd#sera_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommitmentsAndContingenciesTable" xlink:to="lab_sera_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_0650d022-a09e-4a91-a48d-89c5105e362a_terseLabel_en-US" xlink:label="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of agreement</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_label_en-US" xlink:label="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Commercial Collaboration Agreement Term</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_documentation_en-US" xlink:label="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:href="sera-20230331.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:to="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt2077SharePriceMember_b3d86f56-37a2-4ed7-840d-6bab481e1e2b_verboseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">20.77</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt2077SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 20.77 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt2077SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant issued by the company that allows the purchase of shares of common stock at a price of $20.77 per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt2077SharePriceMember" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt2077SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt2077SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_25da310a-dbe0-483b-8d82-aa6dd4049af9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_80b27866-5712-4589-8ee8-93f09055de0b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_3b7b29ae-1924-4d5d-9b10-8d22eb3192c1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities Classified by Contractual Maturities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_dc43db30-1d16-4b99-886f-6ef6c10897d1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_a244357a-eb0d-461f-9ae0-b723e68848ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_2e4f2946-1d43-4c58-bd19-1b761a2ccd66_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_OperatingLeasesOtherInformationAbstract_873b3686-e973-4dd2-8849-0dba036d35b8_terseLabel_en-US" xlink:label="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_sera_OperatingLeasesOtherInformationAbstract_label_en-US" xlink:label="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Other Information [Abstract]</link:label>
    <link:label id="lab_sera_OperatingLeasesOtherInformationAbstract_documentation_en-US" xlink:label="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Other Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OperatingLeasesOtherInformationAbstract" xlink:href="sera-20230331.xsd#sera_OperatingLeasesOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract" xlink:to="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_OfficeAndLaboratorySpaceMember_2dff0c61-c5d8-4490-b03d-380831c1f3fb_terseLabel_en-US" xlink:label="lab_sera_OfficeAndLaboratorySpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and laboratory space</link:label>
    <link:label id="lab_sera_OfficeAndLaboratorySpaceMember_label_en-US" xlink:label="lab_sera_OfficeAndLaboratorySpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And Laboratory Space [Member]</link:label>
    <link:label id="lab_sera_OfficeAndLaboratorySpaceMember_documentation_en-US" xlink:label="lab_sera_OfficeAndLaboratorySpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to office and laboratory space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OfficeAndLaboratorySpaceMember" xlink:href="sera-20230331.xsd#sera_OfficeAndLaboratorySpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_OfficeAndLaboratorySpaceMember" xlink:to="lab_sera_OfficeAndLaboratorySpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ElevanceHealthIncMember_98d2a575-2060-4a1d-984d-9246d4c53730_terseLabel_en-US" xlink:label="lab_sera_ElevanceHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elevance Health, Inc</link:label>
    <link:label id="lab_sera_ElevanceHealthIncMember_label_en-US" xlink:label="lab_sera_ElevanceHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elevance Health, Inc [Member]</link:label>
    <link:label id="lab_sera_ElevanceHealthIncMember_documentation_en-US" xlink:label="lab_sera_ElevanceHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elevance Health, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ElevanceHealthIncMember" xlink:href="sera-20230331.xsd#sera_ElevanceHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ElevanceHealthIncMember" xlink:to="lab_sera_ElevanceHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d12a8047-330f-4f02-b2af-e21ff7048bd3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f24f9983-5a4c-4eb6-a8a2-60fdc2625327_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsAmortizedCost_25ab0422-767f-45d4-a61c-c1e7f85a1bc7_totalLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAmortizedCost_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAmortizedCost_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost" xlink:to="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4f7a1c87-f582-4c7d-a99e-7f7adcd2afae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_caa84d68-1954-4f27-ae3e-d071b08e26f6_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b8d89577-e3d2-436c-b705-7ceb74b28fa8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_97a8485b-fc7a-498a-9c58-f4c535527f91_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Cost and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_483ebbfd-18f1-4eec-8c5c-d8d29a510f25_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79e218d9-faa4-4174-b5e9-fa606a897983_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseOtherInformationAbstract_916288d4-3692-42d7-b1f5-130831721f55_terseLabel_en-US" xlink:label="lab_sera_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other information</link:label>
    <link:label id="lab_sera_LeaseOtherInformationAbstract_label_en-US" xlink:label="lab_sera_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Other Information [Abstract]</link:label>
    <link:label id="lab_sera_LeaseOtherInformationAbstract_documentation_en-US" xlink:label="lab_sera_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Other Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseOtherInformationAbstract" xlink:href="sera-20230331.xsd#sera_LeaseOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseOtherInformationAbstract" xlink:to="lab_sera_LeaseOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6feefdeb-77ff-4ee0-a38f-3da9fd981fc6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f0fcd90d-ad7e-44a0-9544-f97751938f1a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f3ce39c8-9132-4e39-a9f2-2618395fc9ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_939655a8-bcab-457f-a6e9-183dab8f7786_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_beff5c2f-8571-4137-9740-37539ddc2827_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_25f52b31-8410-46e5-aa06-ae66568c95e2_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing information</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c08cbca8-5794-47eb-94da-2f5cb74fcc4f_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_484e02e2-4ca6-4d4f-b35d-c5895adb6b3c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityNoncurrent_5c3b6b96-c371-4d1d-88b1-747021db14b1_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_sera_LeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_sera_LeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Noncurrent</link:label>
    <link:label id="lab_sera_LeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityNoncurrent" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityNoncurrent" xlink:to="lab_sera_LeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_365dbcaf-b1c7-4482-ad08-53e024cb9e6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_2871ee18-5d18-4203-b93e-904f4f72833a_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_845a5c75-1a64-4441-b36e-e0eb0a3ac3be_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5bb0c42f-24f1-445e-bb59-cd90bd74ab66_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life, outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_9f8f2144-ffc9-4e2c-92f0-b3de2a060a61_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ffe1e34a-5f59-420e-9ddf-58e7572e981c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_00514a7f-d6c8-4a4a-9582-80ac1fbd3902_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_9fc18dde-7a77-47d6-a5cd-fcd0cdd41b5f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f43bdabe-ef7f-4271-a6d5-3484731d6bda_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ba9dc07f-5da2-4d37-b22b-36393fe25842_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b203d404-8a98-461d-a50f-fc023c4b899e_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b9a8fdf7-91aa-4ba6-9101-69720a5b204c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_aad11f97-4e82-4025-ab5a-cdb7f50039b2_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_NumberOfVotesPerShare_0782d395-73b8-49e7-b870-5d574429bddb_terseLabel_en-US" xlink:label="lab_sera_NumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share</link:label>
    <link:label id="lab_sera_NumberOfVotesPerShare_label_en-US" xlink:label="lab_sera_NumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes Per Share</link:label>
    <link:label id="lab_sera_NumberOfVotesPerShare_documentation_en-US" xlink:label="lab_sera_NumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfVotesPerShare" xlink:href="sera-20230331.xsd#sera_NumberOfVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_NumberOfVotesPerShare" xlink:to="lab_sera_NumberOfVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_34b3b834-01bb-4884-8635-a2c726fdfbef_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_634ca049-133a-4886-a558-f72601e5b7d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceDomain_face6bc1-c04a-448d-8a67-a851e24a63f3_terseLabel_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved for Future Issuance [Domain]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceDomain_label_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved For Future Issuance [Domain]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceDomain_documentation_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information on capital stock reserved for future issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:href="sera-20230331.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_62e20b83-61b4-435b-a161-f3bbf4477856_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_IndemnificationLiability_b016c2fe-89ed-4b56-9692-845aabb573c0_terseLabel_en-US" xlink:label="lab_sera_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liability</link:label>
    <link:label id="lab_sera_IndemnificationLiability_label_en-US" xlink:label="lab_sera_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Liability</link:label>
    <link:label id="lab_sera_IndemnificationLiability_documentation_en-US" xlink:label="lab_sera_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of indemnification liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IndemnificationLiability" xlink:href="sera-20230331.xsd#sera_IndemnificationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_IndemnificationLiability" xlink:to="lab_sera_IndemnificationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_MasterServicesAgreementMember_749d997c-ef11-4cec-bcbc-ae0fecdcb0ca_terseLabel_en-US" xlink:label="lab_sera_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Master services agreement</link:label>
    <link:label id="lab_sera_MasterServicesAgreementMember_label_en-US" xlink:label="lab_sera_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Master Services Agreement [Member]</link:label>
    <link:label id="lab_sera_MasterServicesAgreementMember_documentation_en-US" xlink:label="lab_sera_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the master services agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_MasterServicesAgreementMember" xlink:href="sera-20230331.xsd#sera_MasterServicesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_MasterServicesAgreementMember" xlink:to="lab_sera_MasterServicesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_78ba9e0f-57ec-4909-a8d4-1a83fcee9bab_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_caa21602-f0d5-4e19-bcbd-48b7433da270_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f4f4ab2-2fb1-4538-adb7-8680d8eb6b52_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8099dd49-e5a3-4122-ad3a-e29c07f569ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6873e71c-5ba3-4508-8ccc-c6f9411cfd40_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_b64ec358-7260-420f-8707-2e8870c0b5ff_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_76a5e205-32d4-471f-888d-f67807c05c28_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_09aead39-485b-4ba5-8ecf-4f67965454c3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_25551a64-4f63-4f59-a828-166a287f60a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c080c8dc-b1f8-4087-8446-baa4f08fa12a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the ending (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_748c0abb-baa4-40a9-b898-6ec9e85bf6af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_2fa1b712-afe0-4ca9-9f82-e8a7692d1da9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a87b23fb-486f-4342-b17c-2b6cf8b6faa9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_bc10f8e6-548c-4c41-99a0-a90657c84e34_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c636b30d-6fa4-41ba-9027-f639e45a5937_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_0dad0c72-52e7-45cf-8584-771ad22e154b_terseLabel_en-US" xlink:label="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_label_en-US" xlink:label="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Cash Received From Related Party</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_documentation_en-US" xlink:label="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Cash Received From Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:href="sera-20230331.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:to="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2431e2a5-1819-4ec9-833c-a65fc3e1f3e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5cea7053-b911-486c-a439-5768169143ff_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase Class A common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_fdd889ae-1f49-482f-9381-1ba4438684f2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cbcba1fb-620e-44bb-9983-bddf88b955f7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_72bed746-c0d3-438f-99bb-398715a47469_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4d34959-2182-41b0-b206-ffc8a0e6b586_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_382b7470-691a-4a6c-9c83-e3106152828a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c3a245ff-8a37-4c9f-9cda-507c0bfb73aa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_63af9d9d-bca7-42b7-88a0-0425180317d6_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_39ffcc87-1ad1-49c2-9a53-adcdfed9bf24_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1fc81687-3920-4e43-90e0-67b9b6618752_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_936c6869-78e5-44e5-97f9-f3286ce5320d_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_809fef03-7e97-4e71-86ee-0e32ef659c18_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9f9c6fc3-33ec-4ecb-b49a-f3399aebd00c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_a4c701c9-a4cc-4902-af09-e7d129388a12_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4dcd7fd5-4547-4aa9-b773-2f4b35d99a35_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_f6cb6d49-1297-4a61-81af-407d4622cfd2_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_0573bb58-647d-452e-9c17-5949cccdf86d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cb5393b8-9399-40b2-938c-b4e367ca1209_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9cc57aa6-0ae6-4f18-a0d4-a7900ede2b0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommitmentsAndContingenciesLineItems_58fe60ea-75f6-4aca-a0ee-d727b30c2ad2_terseLabel_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesLineItems" xlink:href="sera-20230331.xsd#sera_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems" xlink:to="lab_sera_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_14cc6e63-316c-477e-8010-3550da9613d7_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6956565b-14e5-46ac-b87a-8abd71355f77_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_784a0a57-5018-40eb-be96-56e2aa7fb7cd_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_dc32ba8a-29fe-48bb-bb9d-3adc4f6f8d98_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_Plan2011Member_cba03025-697d-4034-a72d-5433a24ee311_terseLabel_en-US" xlink:label="lab_sera_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan</link:label>
    <link:label id="lab_sera_Plan2011Member_label_en-US" xlink:label="lab_sera_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan2011 [Member]</link:label>
    <link:label id="lab_sera_Plan2011Member_documentation_en-US" xlink:label="lab_sera_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to 2011 Employee, Director and Consultant Equity Incentive Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2011Member" xlink:href="sera-20230331.xsd#sera_Plan2011Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_Plan2011Member" xlink:to="lab_sera_Plan2011Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_ff4c758a-4ecf-43cf-aa38-f68601e3d5c4_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d059d8fe-7b4e-47e3-8e8c-64689bec77d0_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b00374ad-c365-477e-90ca-5c87bda7db61_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_946e448d-6252-4622-8f3e-b7431cdb669b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bd2376c0-e476-47cc-a387-e7849842dc8b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_1deadd21-4513-415b-be49-e2681bdec477_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LaboratoryServicesAgreementMember_c8099473-9c64-4531-8c8c-4c23bc2d5c47_terseLabel_en-US" xlink:label="lab_sera_LaboratoryServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Services Agreement</link:label>
    <link:label id="lab_sera_LaboratoryServicesAgreementMember_label_en-US" xlink:label="lab_sera_LaboratoryServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Services Agreement [Member]</link:label>
    <link:label id="lab_sera_LaboratoryServicesAgreementMember_documentation_en-US" xlink:label="lab_sera_LaboratoryServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the laboratory services agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryServicesAgreementMember" xlink:href="sera-20230331.xsd#sera_LaboratoryServicesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LaboratoryServicesAgreementMember" xlink:to="lab_sera_LaboratoryServicesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9f5c13f-a88f-427b-a497-237a7385e235_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_WarrantsToPurchaseCommonStockMember_6fabaad5-9b37-475a-9c31-f440d25c060f_terseLabel_en-US" xlink:label="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase Class A common stock</link:label>
    <link:label id="lab_sera_WarrantsToPurchaseCommonStockMember_label_en-US" xlink:label="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants To Purchase Common Stock [Member]</link:label>
    <link:label id="lab_sera_WarrantsToPurchaseCommonStockMember_documentation_en-US" xlink:label="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember" xlink:href="sera-20230331.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_WarrantsToPurchaseCommonStockMember" xlink:to="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1829558a-ce55-4d71-a56d-69c60ad50895_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_790445b9-4a6f-4548-a162-e5a5de7f0514_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_618e82d6-5d8e-4c77-a6ec-86f5e562f312_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_dad93ab3-0c22-41be-b301-8166e9b96ead_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_370c25ab-dbe8-4547-bff3-8d604dd18602_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_a6c56118-dd79-4fca-95b2-edb34adc031f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b9014cb3-f29e-4d48-b9f2-459b9d019d04_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedAndNonrelatedPartyStatusAxis_819a5912-30f8-475e-b871-d4e75424ead7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedAndNonrelatedPartyStatusAxis_label_en-US" xlink:label="lab_us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:to="lab_us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LaboratoryEquipmentMember_cd7334d7-a4f7-4e40-b788-dae38d1f0eef_terseLabel_en-US" xlink:label="lab_sera_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_sera_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_sera_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_sera_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_sera_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to laboratory equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryEquipmentMember" xlink:href="sera-20230331.xsd#sera_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LaboratoryEquipmentMember" xlink:to="lab_sera_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b927b0eb-4f19-4714-9daf-b9239957df96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_016ceb3e-49ce-4218-bdca-1dd0a1fa5d36_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_a292b255-e4a6-4ee3-9ec5-630e6ad12901_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Other Income, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6b186694-09d0-4695-9bf0-a4ab194235f4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_287a77a1-9f9e-4328-b83a-670383c6b6d7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5668c159-bb89-4b17-a639-b11ef7b48b8c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityPaymentDueAbstract_91ea4bb5-d33e-411f-b418-cb2071fe9ba7_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDueAbstract_label_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDueAbstract_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDueAbstract" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityPaymentDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract" xlink:to="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_971ca872-762d-4244-b2e5-1848ba9d6ddb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3e27ed2e-2591-4308-bd46-2ad2aa667038_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_8ddb61ef-e2f5-499d-97b1-b0badbd369ae_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_b171d308-53e2-4f30-8229-4eb3ed34bc66_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fbd5a2ce-1d58-45af-96e3-7376e49b1845_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_27b911a2-a25a-4766-a21c-fa3219a9719c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c67fc304-1784-43d2-9373-1423ba9e0e59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_f65a35cc-0642-42ad-a3ba-1702774aca8a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b55c53ad-bf42-4a62-8ddc-eaa96a2a3026_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cdfc39d9-0606-4bad-a76c-57c87ff97e6c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_c74db101-c138-429f-94ba-5f125f95555d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceAxis_5e6a178f-4266-41ef-ba66-f65b90f2400d_terseLabel_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved for Future Issuance [Axis]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceAxis_label_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved for Future Issuance [Axis]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceAxis_documentation_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The table relating to information on capital stock reserved for future issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:href="sera-20230331.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:to="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_337fcfa4-be1c-478c-8ab3-fbd507051e8d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2ccd8b3e-cbcd-40b7-8e3b-6c787308b04b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_4508a8ee-408d-4f72-a55c-33f13fb37c4c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_310d5af7-f1f3-45b5-956f-e25e616e06da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares Subject to Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_fab6923a-fedf-41ba-ae55-995002077cc0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_b8f14322-9d96-4538-b900-db3a1d17f689_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_6bc7dfae-c6f5-4cb9-9ac1-9d3923bffedc_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_NonCurrentMarketableSecuritiesMember_b4769bf0-c477-477b-9968-74a6fc7d65f9_terseLabel_en-US" xlink:label="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable securities:</link:label>
    <link:label id="lab_sera_NonCurrentMarketableSecuritiesMember_label_en-US" xlink:label="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Marketable Securities [Member]</link:label>
    <link:label id="lab_sera_NonCurrentMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NonCurrentMarketableSecuritiesMember" xlink:href="sera-20230331.xsd#sera_NonCurrentMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_NonCurrentMarketableSecuritiesMember" xlink:to="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_f9cedb44-ee9a-482c-9c83-2fe79ff79289_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business and Financial Condition</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c8004709-9c4b-404c-a719-f7e26062252c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_f3bd00e9-0922-484f-8b43-4ba39a618955_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, vested and exercisable at the end (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_085da67e-95f3-44bc-bdfa-3b60e8bd92b7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_beb9150a-6c86-49c3-87d7-8d89ebc62cca_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d6e064cc-1b41-42d6-a047-323a95a1703e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e1b87d63-11f5-4272-b7b6-15e20f3b9da6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_be301946-4017-4374-9747-c3429cc7df78_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_0e5d80eb-7325-4e89-8768-808091bb8b60_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d4e8ac21-47e4-43e8-9a61-f1abe951afd3_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_6fb1a7d4-f577-4526-9b70-30dab9cb1308_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityPaymentDue_8a6ee42d-7220-4b4d-9e67-ef83b7e73aca_totalLabel_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDue_label_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDue_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityPaymentDue" xlink:to="lab_sera_LeaseLiabilityPaymentDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_4fae3c54-abce-4b68-9b93-48732870a952_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3f5347cf-2cb7-46d7-a660-bbcb67fa2f64_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_a1b08cfb-ca9b-4108-8a98-59a6b72937fc_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_cad7b935-8025-40bd-b02e-0f45f81b68ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value; 150,000,000 Class A shares authorized; 29,616,781 and 29,612,687 Class A shares issued and outstanding as of March&#160;31, 2023 and December&#160;31, 2022, respectively; 1,500,000 Class B shares authorized; 1,405,259 Class B shares issued and outstanding as of March&#160;31, 2023 and December&#160;31, 2022.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_a2edc35a-38da-4d52-a44e-c76eb468ae1d_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f6401c49-a580-4d0e-957d-20cd8e3f3c7f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_ce88d96e-d031-42e7-8d6d-6770377a95c5_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_264b7272-ecb4-49e4-b619-b4610df505b6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_adca43ac-affc-4d8a-9a56-6ea8e11a47bf_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d0ce0e5d-35c0-4c9a-b597-aff7239c1492_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_d144b8e3-6aab-44b5-b53a-072cb6b05b27_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_676b56a5-088d-4a41-9c37-e2176960b715_negatedLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_b388f9dc-154e-48d8-bf2e-8ca433af939c_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease principal payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_128a0c09-93dd-413b-b73a-4d9c2b35a041_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash outflows</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_f77bda0c-d689-416f-a00b-fec536839802_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_583102b9-5a06-4803-964e-d73846261838_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_db72fa21-7538-4aa7-a6d6-6e177d3c5417_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5f04b1d9-0e16-48c5-9192-946a1c7fe92b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8f5ac8ac-7f09-4f54-b78f-e1d20d6f67b4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0cf24bc6-14e6-4374-bf72-306f5a4ad1b6_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_Plan2021Member_3032864b-3c2c-4980-8c18-46687deeaf47_terseLabel_en-US" xlink:label="lab_sera_Plan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Plan</link:label>
    <link:label id="lab_sera_Plan2021Member_label_en-US" xlink:label="lab_sera_Plan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan2021 [Member]</link:label>
    <link:label id="lab_sera_Plan2021Member_documentation_en-US" xlink:label="lab_sera_Plan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to 2021 Equity Incentive Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2021Member" xlink:href="sera-20230331.xsd#sera_Plan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_Plan2021Member" xlink:to="lab_sera_Plan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_NumberOfCommonStockClassesAuthorized_317288ef-2d8f-4f34-ac35-823e4f2dd2e1_terseLabel_en-US" xlink:label="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock classes authorized</link:label>
    <link:label id="lab_sera_NumberOfCommonStockClassesAuthorized_label_en-US" xlink:label="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Common Stock Classes Authorized</link:label>
    <link:label id="lab_sera_NumberOfCommonStockClassesAuthorized_documentation_en-US" xlink:label="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Common Stock Classes Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfCommonStockClassesAuthorized" xlink:href="sera-20230331.xsd#sera_NumberOfCommonStockClassesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_NumberOfCommonStockClassesAuthorized" xlink:to="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_330df98f-c1ca-4387-ae47-74913c788063_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_bbd39570-b5df-4423-8c62-e2c75032ac74_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4b38d1cb-a0e0-4f2d-9167-9f493e953519_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_ddc5fbec-7f66-4810-a5cd-f9c64265d474_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c80503e0-65f2-4fef-b7aa-b7e5e7805e6a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6ad4aee3-7a36-46c1-9aaf-8156b8f4d3c7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_38375c90-ddbb-489a-b16f-a0db27f6efb5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt10.84SharePriceMember_f07c52dc-8c76-4f3e-adec-9bc85d9a76e8_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10.84</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt10.84SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At10.84 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt10.84SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant issued by the company that allows the purchase of shares of common stock at a price of $10.84 per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt10.84SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_17db54df-fb8a-4e44-8fa8-c8254b40ddf0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_ddb475c1-0602-4c47-8ff2-93ca5e686285_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_61719876-bb01-4af8-847d-6b1001f7b9eb_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_bee02c4e-3ee6-4ae8-b839-98bf1417b07b_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_80fbf2fc-f000-4c88-9cec-5e4c0a6f7129_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CarelonResearchMember_0e178a35-d116-454f-9cb4-076a56a50ca6_terseLabel_en-US" xlink:label="lab_sera_CarelonResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcore Inc</link:label>
    <link:label id="lab_sera_CarelonResearchMember_label_en-US" xlink:label="lab_sera_CarelonResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carelon Research [Member]</link:label>
    <link:label id="lab_sera_CarelonResearchMember_documentation_en-US" xlink:label="lab_sera_CarelonResearchMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Carelon Research, a wholly-owned subsidiary of Elevance Health, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CarelonResearchMember" xlink:href="sera-20230331.xsd#sera_CarelonResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CarelonResearchMember" xlink:to="lab_sera_CarelonResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_45b3ec92-b52e-42e0-a075-6d9262e5052a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_777a6a97-7283-4447-add7-d5ee6dcaae1b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_7abaa225-89dd-4531-8363-e67a4e8c0b31_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c786c3af-c734-4666-9e33-da657cbe4cfa_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c87b42f4-31de-471b-ac8c-df708796fc4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c6a8d6a5-e1e6-44a7-a8f8-228e94f52aba_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_290003a5-b63d-423c-892f-15ae3c25b400_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_baa99299-ce10-4826-817c-7c6aaefcabc2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_d614d027-49c0-43ff-bb39-aa4be484f847_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f17c4016-da4d-45d4-be9f-ed0f6f29a6ce_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5b0a6148-483e-4b8d-a8bd-d52b12a5cb5e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockConversionRatio_59dc743c-80da-4241-aada-37ed87d37930_terseLabel_en-US" xlink:label="lab_sera_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, conversion ratio</link:label>
    <link:label id="lab_sera_CommonStockConversionRatio_label_en-US" xlink:label="lab_sera_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:label id="lab_sera_CommonStockConversionRatio_documentation_en-US" xlink:label="lab_sera_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockConversionRatio" xlink:href="sera-20230331.xsd#sera_CommonStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockConversionRatio" xlink:to="lab_sera_CommonStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e089f9a8-fcff-4ebf-9d47-9f6d8aa9c02b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_8fd25b6b-f253-48fe-998a-fe58cb4b9562_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_05cd5847-efa3-4e8c-9641-eb3a09fc034b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b52a8883-56e5-4f60-887f-61aac8872c4c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_afebd376-4f10-47df-ab35-2a282a5e21e0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_4f194ddd-9df6-46f6-a34a-031992e4db3f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a342a8d2-ae74-4bb9-8249-e3e014745645_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee00d890-6072-495d-bc85-18a4f3484148_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_77237a40-a7c6-4b87-ba7f-1f53e4a35cae_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d6c74793-77bc-4b64-b332-aa5bd9b8e0f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_b40b62b1-8b24-44c0-a8a4-5f58df8209d9_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_34f4653f-7c76-4058-ad7b-ece205922305_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock (Class A and B)</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c0609cda-fcd3-4aad-aba7-3ab2a1102aab_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9d016d68-8488-4078-97cf-54c3d1a18def_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_82f95e01-8690-47d2-bf53-9eeef2e63fc3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_6db52ac4-0b4f-49fc-a096-2af515601366_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_2ef67e76-c123-4326-94fd-9ef12ebfb0e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6f73ed9a-5586-42a4-90e9-c4493f668614_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_5d47856f-f63c-4e3f-8c0e-12ebd4355e24_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued vacation</link:label>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Vacation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedVacationCurrent" xlink:to="lab_us-gaap_AccruedVacationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_864934d2-61bd-4a82-98e8-daf93a219969_verboseLabel_en-US" xlink:label="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment in accounts payable and accruals</link:label>
    <link:label id="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities</link:label>
    <link:label id="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:href="sera-20230331.xsd#sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:to="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearOne_e7dc63eb-1175-4701-b388-b0738bba0b02_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearOne_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year One</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearOne_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearOne" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidYearOne" xlink:to="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e5d7aa25-b44c-4584-97c6-0e9be215e74e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Options Granted and Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f9dc8132-b2b7-42d7-987e-e5e5c40dc5ed_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_039d412d-c7aa-41c3-bbbd-874037322390_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_c00b6e7b-c669-4402-ab31-67925e576d2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Warrants or Rights</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_52ce8a0b-a1d1-4ec4-8c2d-fb9225bb0c47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_WarrantsTextBlock_9e8e789d-69f7-4307-910f-e47b6055e5ae_terseLabel_en-US" xlink:label="lab_sera_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_sera_WarrantsTextBlock_label_en-US" xlink:label="lab_sera_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants [Text Block]</link:label>
    <link:label id="lab_sera_WarrantsTextBlock_documentation_en-US" xlink:label="lab_sera_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsTextBlock" xlink:href="sera-20230331.xsd#sera_WarrantsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_WarrantsTextBlock" xlink:to="lab_sera_WarrantsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b4fbee8c-c62a-4ee8-b5be-6d18decece8b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2b1442a3-a620-477c-9548-c011943649a4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ab8f1ae-571d-4050-86c5-0ef2679da0a2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5ae4018c-10e2-46bc-8c03-3348154bf43c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingences</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_38658ae8-fc10-415c-bb10-08abfd7f4d26_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearTwo_9f4eaffe-efae-410e-b80d-c65252f198d4_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearTwo_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearTwo_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearTwo" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidYearTwo" xlink:to="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f87b2b00-4034-4a1b-9261-6e8abc0a75e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impact of Stock-based Compensation Expense in the Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_022a8290-65ab-42bb-8a94-3df239ba5282_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_34326718-c587-477d-9782-b10f5fb31144_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a4ad8d07-0e5e-484e-80ca-fec0463ca5aa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_44834b67-873a-4468-81a6-c1a0fa44b2e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1397ce5a-649e-4d29-ba49-05575e5ffc32_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_85bbffff-0590-4570-bf11-f36d23026aa0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized stock-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_34f78c7b-be52-46e8-9f1f-6564f78eb97b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_79bc41a2-3e7f-409b-9d16-fae6371decf6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_54ee7243-5029-49ab-8ed6-c56b026d5c0d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_14cc48fe-45bf-40a8-8494-5138f09c3443_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities and Cash Equivalents in Unrealized Loss Positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9fd2d8eb-c4dd-4da1-9594-cec20c1c88a4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_ba85397a-5cf3-4726-b6f6-828044220100_terseLabel_en-US" xlink:label="lab_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_label_en-US" xlink:label="lab_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
    <link:label id="lab_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_documentation_en-US" xlink:label="lab_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:href="sera-20230331.xsd#sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:to="lab_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_6d70aed2-d0ac-4306-a4f9-6b740e3430c4_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityCurrent_9713ac11-fd55-4a1a-a20f-6fa3c0fce989_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_sera_LeaseLiabilityCurrent_label_en-US" xlink:label="lab_sera_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Current</link:label>
    <link:label id="lab_sera_LeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityCurrent" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityCurrent" xlink:to="lab_sera_LeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_81e5e82a-b9eb-4ac2-b7d8-ee673908a3c5_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life, vested and expected to vest at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_44175fa7-ad63-47e6-988b-3d21922f7c3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subject to options outstanding, vested and exercisable at the end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_70a6fcb4-83bf-43bc-a65b-aeeb636f22c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_af0cbb78-af94-4dd9-9446-bd3f1626500f_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:to="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2f9ceb2c-9314-4f9c-8abf-a93ea259c90a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ed72a33a-740c-4d0e-b1a0-277f52c581dd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities and sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_31d50a3d-81d3-4d21-b6e5-f911e063ecc9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7a7c2391-d6a0-4169-a66a-b0dd1b765768_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cffb0fc9-7311-41ab-be47-c5794397be2a_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_223a3cc8-1e13-4aac-91d0-73c1aed6d83b_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_84adc627-c717-4f9e-a3fe-cea070a84d5c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_40e0c77a-a736-4c54-9f9d-7adba340ddd0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_37a4f7d2-97c2-4d41-8d47-dea269fdb6fa_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_be265b2a-ef73-4fd7-870f-fccefd309ceb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0efb046f-38d8-4be4-a7b6-eaf45cb38bb0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityUndiscountedExcessAmount_6c92d9a4-2df7-4c62-8d3f-68330be6b149_negatedTerseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_sera_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_sera_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_f0fa20d7-63d5-41d3-8622-f1898ab19832_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d90ebe7-108d-4c58-895b-afa577764dde_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_ef9b23a6-e510-43e8-99c8-b907a8555936_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_919f91f0-fba0-4407-aa86-12a3471d7a9f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_3b456823-ec0e-4d6e-926b-88f3e791006f_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt1238SharePriceMember_d6ee05b5-4c18-4cff-ba91-ae8f4be1eeb9_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12.38</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt1238SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 12.38 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt1238SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 12.38 Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt1238SharePriceMember" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt1238SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt1238SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f773f806-1cd6-423b-9bb5-8380f74de378_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_PlanEspp2021Member_4691859a-7dc2-4573-8475-b28663cd892f_terseLabel_en-US" xlink:label="lab_sera_PlanEspp2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP</link:label>
    <link:label id="lab_sera_PlanEspp2021Member_label_en-US" xlink:label="lab_sera_PlanEspp2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Espp2021 [Member]</link:label>
    <link:label id="lab_sera_PlanEspp2021Member_documentation_en-US" xlink:label="lab_sera_PlanEspp2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to 2021 Employee Stock Purchase Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PlanEspp2021Member" xlink:href="sera-20230331.xsd#sera_PlanEspp2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_PlanEspp2021Member" xlink:to="lab_sera_PlanEspp2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt9.03SharePriceMember_0309edd5-76b3-4815-84ae-e29806e5b5de_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">9.03</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt9.03SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At9.03 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt9.03SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant issued by the company that allows the purchase of shares of common stock at a price of $9.03 per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt9.03SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_71b297bc-7263-4b69-91f5-1d9900b7d7e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_a50c05d5-4e03-47a0-a324-4eb1a749bf90_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_754813c6-7e69-484a-99cd-62dfc99ee99c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_cbaceaef-d5a5-4ebf-804a-cd47b528784c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_8959ed00-f1d9-400d-bc3b-67fc100884d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_505297ff-64d9-40bd-8c29-e7901aa087a4_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3382b1c8-375b-4e30-b48c-ed3d46acba2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_e7db6946-f87b-4b7c-a4a3-eab52658511a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7cfacf3f-b1ef-4ca2-ae59-f4626102a11a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f2f5af42-e866-491e-be9b-d380de360ac4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RightOfUseAssetTotal_30206f60-c01b-4f5d-964f-f781a70c342e_totalLabel_en-US" xlink:label="lab_sera_RightOfUseAssetTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total right-of-use assets</link:label>
    <link:label id="lab_sera_RightOfUseAssetTotal_label_en-US" xlink:label="lab_sera_RightOfUseAssetTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset, Total</link:label>
    <link:label id="lab_sera_RightOfUseAssetTotal_documentation_en-US" xlink:label="lab_sera_RightOfUseAssetTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetTotal" xlink:href="sera-20230331.xsd#sera_RightOfUseAssetTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RightOfUseAssetTotal" xlink:to="lab_sera_RightOfUseAssetTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilitiesTotal_5bef58f8-06e0-444b-abe8-b99f3d8eeaf4_totalLabel_en-US" xlink:label="lab_sera_LeaseLiabilitiesTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesTotal_label_en-US" xlink:label="lab_sera_LeaseLiabilitiesTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Total</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesTotal_documentation_en-US" xlink:label="lab_sera_LeaseLiabilitiesTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilitiesTotal" xlink:to="lab_sera_LeaseLiabilitiesTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4c32f4ba-4bfc-4f5f-82cb-648562683d9f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_3d849148-b181-481c-82db-87a1ceaf1005_negatedLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_2a7f6adf-888a-4fed-8eda-1f80271c03cc_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9a629d34-0b25-4c65-8c26-5e09fe7f1cbb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_a23a21cf-b9a1-47d8-bb6f-d0bed7d62a7b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_8ef9ca04-9228-40dd-abe4-1d4332e95dd8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilitiesAbstract_ffd0f2bd-a250-467e-9000-b99316b827e5_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities:</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_sera_LeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_sera_LeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesAbstract" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilitiesAbstract" xlink:to="lab_sera_LeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c238553e-25aa-4628-9090-40373c55d1bf_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommercialCollaborationAgreementMember_fb08f6af-4f9e-4836-b32d-c31ad4e436e2_terseLabel_en-US" xlink:label="lab_sera_CommercialCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Collaboration Agreement</link:label>
    <link:label id="lab_sera_CommercialCollaborationAgreementMember_label_en-US" xlink:label="lab_sera_CommercialCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Collaboration Agreement [Member]</link:label>
    <link:label id="lab_sera_CommercialCollaborationAgreementMember_documentation_en-US" xlink:label="lab_sera_CommercialCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the Commercial Collaboration Agreement with Anthem and its affiliates (the "Commercial Collaboration Agreement").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommercialCollaborationAgreementMember" xlink:href="sera-20230331.xsd#sera_CommercialCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommercialCollaborationAgreementMember" xlink:to="lab_sera_CommercialCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_7c05ca93-194b-45bb-b243-96e7fa8f4859_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_97c24ce5-1a9e-4230-99ea-f85cd60bc55e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_9d10f8de-edee-4667-add7-c99b792c0d15_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4a8d079a-bc5f-4f48-b132-ed8c94d720ae_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_79855b0e-2ad2-4a93-b3ef-d0c58466519c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total employee stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_debda58e-5e7f-4582-9028-f6c9017462b6_terseLabel_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock available for future grants under the 2021 Equity Incentive Plan</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:href="sera-20230331.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:to="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_9dbe0e7f-3596-4482-9e5d-1b1f060d3bb9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_37c8939d-aa9c-4f6d-a3b2-9898e3dafece_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_e7ab0688-3243-40e5-b15d-9985e0f1bd98_terseLabel_en-US" xlink:label="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Reserved for Future Issuance</link:label>
    <link:label id="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_label_en-US" xlink:label="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Reserved For Future Issuance [Table Text Block]</link:label>
    <link:label id="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_documentation_en-US" xlink:label="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The tabular disclosure of common stock reserved for future issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:href="sera-20230331.xsd#sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_6350a4a7-400d-4878-a5bd-1bb6601a36a1_terseLabel_en-US" xlink:label="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_label_en-US" xlink:label="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_documentation_en-US" xlink:label="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:href="sera-20230331.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:to="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_32428b2b-6bbf-4c4b-9ad9-01f9a53018cb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f664bc15-11a3-4439-8853-96ded6b750d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a78b4095-8236-4372-b479-6bbc78453372_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_03ab4ff3-4ad9-4dfb-983a-ddd5b6c6ed90_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_867da1e5-0f8c-4565-bedb-692cf4416c88_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_856a7f98-7462-4233-beb6-567ad0407ae4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_609741e4-dd76-4609-b490-60fed45f3b61_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_796b099d-d901-444c-af42-1805f84755c0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_7032ac44-9cdb-4fc3-91b9-6e093aa87a3f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_866af228-d0d5-4e3e-8d21-b3b7732ee899_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1099d512-af1a-4187-97c9-e1e2e53d5244_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f2af06d4-d252-4c58-8ab5-a3d01a16fe40_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_5180a300-da6e-4ae5-aa74-f0739811df92_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_09db7e09-de53-4cf9-9c19-54cbffb4d61f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_882a4bc4-f523-4a7b-a074-02dd03288589_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_48617c53-c65c-4f62-9698-f13dbf6d2a70_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_ecdc8fa3-d636-47d5-ae35-a971fbbe707a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing expense</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedAndNonrelatedPartyStatusDomain_9844696f-d3d5-4ee6-81b0-fe2cd2ba0a3c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedAndNonrelatedPartyStatusDomain_label_en-US" xlink:label="lab_us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:to="lab_us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d877935d-9930-4dd4-b15e-b579687c482a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares of common stock outstanding, diluted (In shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_d0ca1f44-ef53-4fc6-ab7f-2df2fa2b5e6a_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_160145ee-96bf-4b31-9305-6c7876a597d8_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_e944543c-1f6e-4f8b-b532-7f8312e8dda1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_93a05d22-33c6-4d52-96e5-e40fb2d8f657_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9f6ef596-8962-4ef0-b236-39afe01d997e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1c920755-df70-41f2-bb2d-7b92f4e78e2e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_f00724ee-524a-471f-b600-f99d9ff8f58f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7061d992-70c7-451c-ae24-20de6c8e7571_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_e6489779-7a59-4ff5-b827-544477d91b0e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f08a1eb5-8939-438c-820e-7a97fcfc3b4d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_23e84305-43ab-4168-826e-f829939d13b0_terseLabel_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_label_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Employee Stock [Member]</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_documentation_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:href="sera-20230331.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:to="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_7b1c206f-f7c1-447f-90f4-a440d18f4af5_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_d91b0961-daeb-45bf-8cae-546a29be9a48_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life, vested and exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a14e122d-769f-4830-a5a2-8aafe449aee8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f2abf3bc-5f16-4cb8-bcb2-ea4b8c014452_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_33644d70-d3d7-48a3-b309-8f8d634d7e50_terseLabel_en-US" xlink:label="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</link:label>
    <link:label id="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_documentation_en-US" xlink:label="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:href="sera-20230331.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:to="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_588790be-13b2-4f33-907d-ca074ee4c651_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_e776d924-616c-429b-8e9c-7da83cb6d3b3_terseLabel_en-US" xlink:label="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of square feet under lease</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_label_en-US" xlink:label="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Area Of Leased Space Office And Laboratory</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_documentation_en-US" xlink:label="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The area of leased office and laboratory space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:href="sera-20230331.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:to="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9b9e7dd1-22c5-408d-803b-49dcbeac9db2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_434bdf45-d6d1-4a3f-9344-97ab1fc03074_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_fb3d9c93-aacb-4338-b428-f122a1de6105_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_4f8abd1c-a288-4368-b7ee-a2538d581c57_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a1fcc317-a9a9-4a7f-8ba1-cc41b4a5b766_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_815cb139-2a1d-4cc3-a22c-911211d7ce2e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_1b067b0d-031c-4f0b-80a5-e2baa81dbb61_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_67df7139-7fdb-49fb-bb18-af137c6fb419_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation, current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_46f36757-37e7-4a11-b711-554d6301ee66_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a661021b-0b35-4093-b80b-de399fe11705_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares of common stock outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_658b6c7c-6abf-441d-85de-37b427187c86_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_883d0c72-9ca3-4b22-9c76-3331afe81b8f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_fb408ad2-3ae4-4e10-9e5c-90062e9eaa20_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_12da13df-6640-4a98-b125-117378fc72b7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e263d41f-167e-4001-99a9-3eaa657307ed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_670c86a5-7876-4bdb-aadc-520014879ff0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ca7c2020-a5ba-4d36-a47f-c5b184e07298_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_9c592b99-2b65-412a-8d19-426625eb1bf8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_a05581c0-0507-4482-ab09-c5ee232a5be5_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>sera-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b6fd7582-a32b-479d-9964-70f04b6c290c,g:3cb67c47-ddd7-494a-a3a9-536b1cbe927e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Cover" xlink:type="simple" xlink:href="sera-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_89e0cbf2-3bfe-46e8-96d5-29eb98cc36b6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_3a6f0956-88a5-4371-a8fd-b51f0c295ad4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_89e0cbf2-3bfe-46e8-96d5-29eb98cc36b6" xlink:to="loc_dei_DocumentInformationTable_3a6f0956-88a5-4371-a8fd-b51f0c295ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_3a6f0956-88a5-4371-a8fd-b51f0c295ad4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e1a8fabe-5fa2-4f06-9a7b-003d6eeeb8d6" xlink:to="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_43979dcf-e62a-44a6-b7e2-8df6601c8353" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:to="loc_us-gaap_CommonClassAMember_43979dcf-e62a-44a6-b7e2-8df6601c8353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_5ed0d928-b517-4cfc-ab73-ab04864d6e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_43bdc62c-8069-4e10-8f9e-0f0eb9c72cea" xlink:to="loc_us-gaap_CommonClassBMember_5ed0d928-b517-4cfc-ab73-ab04864d6e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_3a6f0956-88a5-4371-a8fd-b51f0c295ad4" xlink:to="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d7bb6a24-75d5-4caa-8d8f-1ede5d0723fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentType_d7bb6a24-75d5-4caa-8d8f-1ede5d0723fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5cd2a9b5-7e82-4532-b4b6-6af44d63c14e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentQuarterlyReport_5cd2a9b5-7e82-4532-b4b6-6af44d63c14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a8ae6785-c84d-48ac-b36d-fba4e2b6d0c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentPeriodEndDate_a8ae6785-c84d-48ac-b36d-fba4e2b6d0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b893cca4-1af1-468d-93c7-63585177f475" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentTransitionReport_b893cca4-1af1-468d-93c7-63585177f475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_33575245-f687-4616-b0bc-b7152d3c4f19" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityFileNumber_33575245-f687-4616-b0bc-b7152d3c4f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b91e428b-af95-422a-ba81-1295a1570cab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityRegistrantName_b91e428b-af95-422a-ba81-1295a1570cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_107b8c7d-6a9c-47d7-8b6e-5e0ad4f9986b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityIncorporationStateCountryCode_107b8c7d-6a9c-47d7-8b6e-5e0ad4f9986b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b8d244c3-af92-449f-943b-cd8acf103292" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityTaxIdentificationNumber_b8d244c3-af92-449f-943b-cd8acf103292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_24e4658c-47c5-4d1d-94b2-3c9fb861fd87" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressAddressLine1_24e4658c-47c5-4d1d-94b2-3c9fb861fd87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_b34f21b9-d9e9-4bf5-801d-e1e4535d1de7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressAddressLine2_b34f21b9-d9e9-4bf5-801d-e1e4535d1de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1863e1e8-70fa-4b85-8c9f-155d002e10f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressCityOrTown_1863e1e8-70fa-4b85-8c9f-155d002e10f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5427947b-74fb-46d9-86b4-eff46bf14db5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressStateOrProvince_5427947b-74fb-46d9-86b4-eff46bf14db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_faf3f239-542b-4be6-aa07-3512b4e0c8f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityAddressPostalZipCode_faf3f239-542b-4be6-aa07-3512b4e0c8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a47a085d-4574-47a9-adf3-4ddf1caf6c75" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_CityAreaCode_a47a085d-4574-47a9-adf3-4ddf1caf6c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_27ce47db-86ec-405e-a33e-9ae39485c39b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_LocalPhoneNumber_27ce47db-86ec-405e-a33e-9ae39485c39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_86e6b2fb-7228-42f3-b61a-7188843dcde5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_Security12bTitle_86e6b2fb-7228-42f3-b61a-7188843dcde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3a9fcfee-b3b6-4f30-85b8-4c0948abe79d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_TradingSymbol_3a9fcfee-b3b6-4f30-85b8-4c0948abe79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_60f3a357-7922-4a9e-8ba9-19a2a22b587d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_SecurityExchangeName_60f3a357-7922-4a9e-8ba9-19a2a22b587d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_12454537-4f2c-4fe5-aca7-c6b24ea79c16" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityCurrentReportingStatus_12454537-4f2c-4fe5-aca7-c6b24ea79c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_53fa3cb8-f5e5-49a8-acce-65b6ce2f2f1c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityInteractiveDataCurrent_53fa3cb8-f5e5-49a8-acce-65b6ce2f2f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_76c88d12-939c-4d99-a181-e16f57b84d15" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityFilerCategory_76c88d12-939c-4d99-a181-e16f57b84d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b8db74c7-2a71-40ec-af8f-494b0d154ed8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntitySmallBusiness_b8db74c7-2a71-40ec-af8f-494b0d154ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7af2784b-1c7b-4a99-8ac7-434116d74e0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityEmergingGrowthCompany_7af2784b-1c7b-4a99-8ac7-434116d74e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_d4ec5e02-e47c-4223-9600-aa5da8abd008" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityExTransitionPeriod_d4ec5e02-e47c-4223-9600-aa5da8abd008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_52d763cd-33ef-4560-a06e-500e278e6a9d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityShellCompany_52d763cd-33ef-4560-a06e-500e278e6a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c0d2fda8-ac66-4cf2-be1f-c7daeead1cca" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c0d2fda8-ac66-4cf2-be1f-c7daeead1cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2beb3d55-cdb2-4791-bfd0-34cd6fa4e6d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_EntityCentralIndexKey_2beb3d55-cdb2-4791-bfd0-34cd6fa4e6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dd03fa15-8a64-4914-9dfc-81702ef6108f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_CurrentFiscalYearEndDate_dd03fa15-8a64-4914-9dfc-81702ef6108f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7dcdaaa5-6b00-4603-bd40-5154a17c6599" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentFiscalYearFocus_7dcdaaa5-6b00-4603-bd40-5154a17c6599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7858dea2-80dc-4b25-be49-19c2c4333c58" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7858dea2-80dc-4b25-be49-19c2c4333c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8f91ff3d-b2c0-4d4b-a9b5-c58bf0f46c35" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ecfc427a-fbbb-4177-8cf5-5ef754d5e480" xlink:to="loc_dei_AmendmentFlag_8f91ff3d-b2c0-4d4b-a9b5-c58bf0f46c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f207fc1e-5ba1-4d07-87df-3ba687880183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f6379deb-8696-4857-ac64-82a51ca6c6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f207fc1e-5ba1-4d07-87df-3ba687880183" xlink:to="loc_us-gaap_AssetsAbstract_f6379deb-8696-4857-ac64-82a51ca6c6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f6379deb-8696-4857-ac64-82a51ca6c6a3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32de75bf-6726-4400-b33a-375ed4175777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32de75bf-6726-4400-b33a-375ed4175777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e966d1b8-364c-4601-a96e-fbb79424ed07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e966d1b8-364c-4601-a96e-fbb79424ed07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0258fa66-d179-45b2-a094-cd49337fd337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0258fa66-d179-45b2-a094-cd49337fd337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_251f5e75-3b9e-43fc-8622-fb3c8ac163e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_251f5e75-3b9e-43fc-8622-fb3c8ac163e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0185c00d-5a53-4433-9f4b-15b6fea3ce1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0185c00d-5a53-4433-9f4b-15b6fea3ce1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ce2ef787-5243-4105-a462-7198587e8339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bca65d72-8539-4cf4-ba5c-d8a116ed5146" xlink:to="loc_us-gaap_AssetsCurrent_ce2ef787-5243-4105-a462-7198587e8339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9f3d8353-7c80-4d3c-b9f4-0b3d50870463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f6379deb-8696-4857-ac64-82a51ca6c6a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9f3d8353-7c80-4d3c-b9f4-0b3d50870463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_524916ef-fceb-47c5-abff-3b5e22bad76f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f6379deb-8696-4857-ac64-82a51ca6c6a3" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_524916ef-fceb-47c5-abff-3b5e22bad76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_52265dad-5398-4939-8b5e-d2ecfdc49393" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f6379deb-8696-4857-ac64-82a51ca6c6a3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_52265dad-5398-4939-8b5e-d2ecfdc49393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_502f7492-9190-466a-843e-785a81c9c1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f6379deb-8696-4857-ac64-82a51ca6c6a3" xlink:to="loc_us-gaap_Assets_502f7492-9190-466a-843e-785a81c9c1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f207fc1e-5ba1-4d07-87df-3ba687880183" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fb3d47c3-2cfd-4431-9365-8e307b120e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fb3d47c3-2cfd-4431-9365-8e307b120e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6f94bd58-e3fa-4bc7-9fa9-c89a1b59626d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fb3d47c3-2cfd-4431-9365-8e307b120e6e" xlink:to="loc_us-gaap_AccountsPayableCurrent_6f94bd58-e3fa-4bc7-9fa9-c89a1b59626d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_2eefb84d-719d-406a-9470-37e8c17482ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fb3d47c3-2cfd-4431-9365-8e307b120e6e" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_2eefb84d-719d-406a-9470-37e8c17482ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_65f9c9c8-6c39-4e5e-8a35-3a180f2749d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fb3d47c3-2cfd-4431-9365-8e307b120e6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_65f9c9c8-6c39-4e5e-8a35-3a180f2749d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_163714b7-8a55-4f23-9246-c307c66b49c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fb3d47c3-2cfd-4431-9365-8e307b120e6e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_163714b7-8a55-4f23-9246-c307c66b49c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_76c1412f-dca6-4e87-a928-6f25efc06550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fb3d47c3-2cfd-4431-9365-8e307b120e6e" xlink:to="loc_us-gaap_LiabilitiesCurrent_76c1412f-dca6-4e87-a928-6f25efc06550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_44303f9c-ede6-4d35-aee2-43b3a220acb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_44303f9c-ede6-4d35-aee2-43b3a220acb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cc5ec42a-399c-4380-b7d6-156def057f50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cc5ec42a-399c-4380-b7d6-156def057f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6fda011c-c186-4632-9b11-132e3332a0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:to="loc_us-gaap_Liabilities_6fda011c-c186-4632-9b11-132e3332a0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b2fdebdb-6596-44de-b91e-f08fc2fd4e32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b2fdebdb-6596-44de-b91e-f08fc2fd4e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2767ba0d-eb9f-4cb1-96ac-01b6028dbe29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2767ba0d-eb9f-4cb1-96ac-01b6028dbe29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_df4862bb-d4cd-4527-a5ce-619199f8eeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2767ba0d-eb9f-4cb1-96ac-01b6028dbe29" xlink:to="loc_us-gaap_CommonStockValue_df4862bb-d4cd-4527-a5ce-619199f8eeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5f736e75-ca48-4c32-8299-2a1ae14c5d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2767ba0d-eb9f-4cb1-96ac-01b6028dbe29" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5f736e75-ca48-4c32-8299-2a1ae14c5d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43df4575-c0cd-4ada-8812-c819939a7ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2767ba0d-eb9f-4cb1-96ac-01b6028dbe29" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43df4575-c0cd-4ada-8812-c819939a7ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e7d59e80-5ffa-49a7-9425-8044c6f51bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2767ba0d-eb9f-4cb1-96ac-01b6028dbe29" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e7d59e80-5ffa-49a7-9425-8044c6f51bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_558975b1-961e-448a-bcbe-cfd6f9e0836c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2767ba0d-eb9f-4cb1-96ac-01b6028dbe29" xlink:to="loc_us-gaap_StockholdersEquity_558975b1-961e-448a-bcbe-cfd6f9e0836c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_07d3727f-ea57-4ffd-8886-8481f4b54e52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8811af46-04a0-4e7d-8d53-51128d112e46" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_07d3727f-ea57-4ffd-8886-8481f4b54e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8451c231-024b-479c-bf04-67f2c9fc8e85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a378560d-43c0-4bc1-9a62-8e573c3b0c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8451c231-024b-479c-bf04-67f2c9fc8e85" xlink:to="loc_us-gaap_StatementTable_a378560d-43c0-4bc1-9a62-8e573c3b0c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_36baf942-a4d0-4536-9bae-6c2f34176835" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a378560d-43c0-4bc1-9a62-8e573c3b0c50" xlink:to="loc_us-gaap_StatementClassOfStockAxis_36baf942-a4d0-4536-9bae-6c2f34176835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36baf942-a4d0-4536-9bae-6c2f34176835" xlink:to="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_dd0a2468-0c72-4c96-99de-002064495041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:to="loc_us-gaap_CommonClassAMember_dd0a2468-0c72-4c96-99de-002064495041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_1a62570b-d717-42f1-86c1-608ea0d4097f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_209462d3-eb19-463c-8cbd-ccb3a7a59727" xlink:to="loc_us-gaap_CommonClassBMember_1a62570b-d717-42f1-86c1-608ea0d4097f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a378560d-43c0-4bc1-9a62-8e573c3b0c50" xlink:to="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3ce0e9-bf6b-4cfd-bd06-d45b14dd7530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3ce0e9-bf6b-4cfd-bd06-d45b14dd7530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_77da34f9-e01d-49a8-9a13-11abf3039884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_77da34f9-e01d-49a8-9a13-11abf3039884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6b6fb8b5-73fc-4266-93c7-677ebe50f4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockSharesIssued_6b6fb8b5-73fc-4266-93c7-677ebe50f4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4b941f89-4e76-4b95-9a28-b2d248e34fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5109650-5495-48be-bd20-11cbe906970d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4b941f89-4e76-4b95-9a28-b2d248e34fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofOperationsandComprehensiveLossunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c2fd2127-2c73-4cb4-94d0-cf6d75aec7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c2fd2127-2c73-4cb4-94d0-cf6d75aec7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_b7d6b4de-cab4-4e9e-afbd-b1c348d784b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_b7d6b4de-cab4-4e9e-afbd-b1c348d784b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_79483fd8-ba54-4f9e-9a2b-5c591fde98fa" xlink:href="sera-20230331.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b7d6b4de-cab4-4e9e-afbd-b1c348d784b8" xlink:to="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_79483fd8-ba54-4f9e-9a2b-5c591fde98fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9f9bb945-2d12-4924-a85b-d7c3dd3cce35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b7d6b4de-cab4-4e9e-afbd-b1c348d784b8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9f9bb945-2d12-4924-a85b-d7c3dd3cce35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_606f274f-7307-481b-8c43-5550f48242cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b7d6b4de-cab4-4e9e-afbd-b1c348d784b8" xlink:to="loc_us-gaap_SellingAndMarketingExpense_606f274f-7307-481b-8c43-5550f48242cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_59c69a59-e846-4c0a-9e86-a76bc21e4e32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b7d6b4de-cab4-4e9e-afbd-b1c348d784b8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_59c69a59-e846-4c0a-9e86-a76bc21e4e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e72a2943-e1dd-471b-87a1-32aec78e297c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b7d6b4de-cab4-4e9e-afbd-b1c348d784b8" xlink:to="loc_us-gaap_OperatingExpenses_e72a2943-e1dd-471b-87a1-32aec78e297c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1e932907-e580-47cf-ae35-1f4d3db3c619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_OperatingIncomeLoss_1e932907-e580-47cf-ae35-1f4d3db3c619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_80e126f7-88f2-45bd-bf91-b196c1092326" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_InterestExpense_80e126f7-88f2-45bd-bf91-b196c1092326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5c24d694-d227-472d-a70c-943067b03fca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5c24d694-d227-472d-a70c-943067b03fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f058997c-8867-45b6-84cc-54e73a596888" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_NetIncomeLoss_f058997c-8867-45b6-84cc-54e73a596888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9943dd56-500b-405a-81c2-06a9515b9f17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_EarningsPerShareBasic_9943dd56-500b-405a-81c2-06a9515b9f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1c77ba66-2e51-4234-a35b-cc231b1db616" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1c77ba66-2e51-4234-a35b-cc231b1db616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c4199782-598b-4af6-8bd9-8d6374deb8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c4199782-598b-4af6-8bd9-8d6374deb8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1160f356-f3cb-4bc9-a94f-36d0986be76f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1160f356-f3cb-4bc9-a94f-36d0986be76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fc9b384a-3341-4cb0-be81-49491d92ac73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fc9b384a-3341-4cb0-be81-49491d92ac73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_71d3d5ab-05b0-4d69-b89e-cfd1971a6216" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fc9b384a-3341-4cb0-be81-49491d92ac73" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_71d3d5ab-05b0-4d69-b89e-cfd1971a6216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23529ee3-8b84-4b21-b055-ddbb7662b9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fc9b384a-3341-4cb0-be81-49491d92ac73" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23529ee3-8b84-4b21-b055-ddbb7662b9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2ae416a1-bbd6-438c-9f96-2bfe2cc2a72e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6868ec2d-e5ba-4c54-831a-3f453cc9e15a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2ae416a1-bbd6-438c-9f96-2bfe2cc2a72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_18b6db48-ad9e-4c5c-aae6-59e1330dc197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ceeee8db-a5e9-40d5-887b-93b5b51cea44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_18b6db48-ad9e-4c5c-aae6-59e1330dc197" xlink:to="loc_us-gaap_StatementTable_ceeee8db-a5e9-40d5-887b-93b5b51cea44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_89476b7e-811a-4437-ba67-c1abc4a434b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ceeee8db-a5e9-40d5-887b-93b5b51cea44" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_89476b7e-811a-4437-ba67-c1abc4a434b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89476b7e-811a-4437-ba67-c1abc4a434b9" xlink:to="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4ebefc38-9eff-47d2-9b77-cd41eccedcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_CommonStockMember_4ebefc38-9eff-47d2-9b77-cd41eccedcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b90822f6-443d-4429-83cd-a22e1e07f83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b90822f6-443d-4429-83cd-a22e1e07f83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0a331a1a-6128-42cb-996c-98186a591c78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0a331a1a-6128-42cb-996c-98186a591c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d9163b7f-efb1-4e04-8bb9-4c91d36ff3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1506e06-70cc-4d8d-8370-930e6e9bbf66" xlink:to="loc_us-gaap_RetainedEarningsMember_d9163b7f-efb1-4e04-8bb9-4c91d36ff3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f36b28d0-d107-479e-8989-00d7aceace56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ceeee8db-a5e9-40d5-887b-93b5b51cea44" xlink:to="loc_us-gaap_StatementLineItems_f36b28d0-d107-479e-8989-00d7aceace56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f36b28d0-d107-479e-8989-00d7aceace56" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e6804fe7-f30e-4aa1-9b11-be9d3f7c2d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_CommonStockSharesIssued_e6804fe7-f30e-4aa1-9b11-be9d3f7c2d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4aec46f2-f59c-4b76-9b15-4e77d01ad2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_StockholdersEquity_4aec46f2-f59c-4b76-9b15-4e77d01ad2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e856749-449d-4d9d-818e-878e14f7e389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e856749-449d-4d9d-818e-878e14f7e389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a5f24b87-8f15-49ba-b868-2435724df44d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a5f24b87-8f15-49ba-b868-2435724df44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ae8e5f1-abc5-4768-a48d-38cbf0e5e8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ae8e5f1-abc5-4768-a48d-38cbf0e5e8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc8eb5d1-3c79-4dbf-aac8-2680dd88fdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc8eb5d1-3c79-4dbf-aac8-2680dd88fdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e3d49d8d-a13c-4094-9eba-e5ee7faac189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_NetIncomeLoss_e3d49d8d-a13c-4094-9eba-e5ee7faac189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_43d0ada4-2c2b-480b-ae17-87c3eced43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_CommonStockSharesIssued_43d0ada4-2c2b-480b-ae17-87c3eced43a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3f560c3-6b6b-4fc3-8b65-9ae59d824377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_272058a1-87e4-4af4-9161-8d4da5155385" xlink:to="loc_us-gaap_StockholdersEquity_b3f560c3-6b6b-4fc3-8b65-9ae59d824377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a1b8836d-c151-4676-812b-e344322546f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_60c5e849-8db5-44ea-8959-a328934c4b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a1b8836d-c151-4676-812b-e344322546f0" xlink:to="loc_us-gaap_StatementTable_60c5e849-8db5-44ea-8959-a328934c4b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_60c5e849-8db5-44ea-8959-a328934c4b3d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4d0e5b79-2f1d-4f39-99c4-ef1e8ae8f57c" xlink:to="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9cd5b376-f753-48b6-ad1b-9e92f7ce28a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:to="loc_us-gaap_CommonStockMember_9cd5b376-f753-48b6-ad1b-9e92f7ce28a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_06635561-6d2d-4613-a786-a83009d370e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_06635561-6d2d-4613-a786-a83009d370e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1bdf35d7-2683-40ac-a148-ab6112167250" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e0e2e637-7e55-4cff-9f07-0824440f367c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1bdf35d7-2683-40ac-a148-ab6112167250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_60c5e849-8db5-44ea-8959-a328934c4b3d" xlink:to="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_525c142e-7d60-4bf4-ba0c-7aa594b45915" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_525c142e-7d60-4bf4-ba0c-7aa594b45915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3db3c333-099d-4711-80b8-dfbc6f8ea5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3db3c333-099d-4711-80b8-dfbc6f8ea5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a34d7e8c-adc5-4b19-848c-798ea272c2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a34d7e8c-adc5-4b19-848c-798ea272c2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c192d87-7bfa-4c63-98a1-2657a7f29e74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7e60a4c-29a7-4254-9fe9-82b96e6f4545" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c192d87-7bfa-4c63-98a1-2657a7f29e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="sera-20230331.xsd#CondensedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_91193875-eccf-4650-9f81-da541c8ea9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_91193875-eccf-4650-9f81-da541c8ea9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ef371f93-74d5-4fb5-8377-a95974a995b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_91193875-eccf-4650-9f81-da541c8ea9e2" xlink:to="loc_us-gaap_NetIncomeLoss_ef371f93-74d5-4fb5-8377-a95974a995b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_91193875-eccf-4650-9f81-da541c8ea9e2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8273b951-80e1-4805-b3a2-ccba105ae540" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8273b951-80e1-4805-b3a2-ccba105ae540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_040eb4c6-1faf-4d4c-b74c-2b397de5456e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_040eb4c6-1faf-4d4c-b74c-2b397de5456e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d8bb4564-15b2-48ac-bc38-acf46e3847b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:to="loc_us-gaap_ShareBasedCompensation_d8bb4564-15b2-48ac-bc38-acf46e3847b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_2779baf0-4392-42e8-ad88-5ab90e705ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:to="loc_us-gaap_PaidInKindInterest_2779baf0-4392-42e8-ad88-5ab90e705ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_430a5191-d882-4fd4-ac05-11db3794e9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_430a5191-d882-4fd4-ac05-11db3794e9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5da88719-09f2-4326-bdf8-5ec5a95eaf88" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_935ae7c0-b1e9-4647-b40f-4f8c10bc05f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_935ae7c0-b1e9-4647-b40f-4f8c10bc05f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_a1175aba-57d9-434b-8839-9b3e6b9321c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_a1175aba-57d9-434b-8839-9b3e6b9321c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6299ca86-4e75-485e-a8d5-3a7b8dd3b837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6299ca86-4e75-485e-a8d5-3a7b8dd3b837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_09598907-ae5a-40a0-bebf-97bcbc964d95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_09598907-ae5a-40a0-bebf-97bcbc964d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_364c0560-75db-4b55-954d-cbc6074888c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_364c0560-75db-4b55-954d-cbc6074888c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_ea5628c7-17dd-4de6-8376-1fbd8763758c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2454b3c1-1ee5-4b03-a25c-220fb6ac78cb" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_ea5628c7-17dd-4de6-8376-1fbd8763758c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d89b473b-cf83-4c67-81a9-297e66e5b302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_91193875-eccf-4650-9f81-da541c8ea9e2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d89b473b-cf83-4c67-81a9-297e66e5b302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c17e3430-61d9-4bc2-a837-dcd26efd303d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c17e3430-61d9-4bc2-a837-dcd26efd303d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_bf93e1e8-d443-4569-82ce-24764d8658c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c17e3430-61d9-4bc2-a837-dcd26efd303d" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_bf93e1e8-d443-4569-82ce-24764d8658c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_05413bb9-f4c4-4716-afca-8de6b7767c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c17e3430-61d9-4bc2-a837-dcd26efd303d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_05413bb9-f4c4-4716-afca-8de6b7767c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08ba69a2-c718-4cfa-a75d-ce671ddbb4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c17e3430-61d9-4bc2-a837-dcd26efd303d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08ba69a2-c718-4cfa-a75d-ce671ddbb4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_204c5c49-a872-46b7-8915-eac120cfd262" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c17e3430-61d9-4bc2-a837-dcd26efd303d" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_204c5c49-a872-46b7-8915-eac120cfd262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b386da3b-1330-45da-9b57-76bb7a03c21b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c17e3430-61d9-4bc2-a837-dcd26efd303d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b386da3b-1330-45da-9b57-76bb7a03c21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67c4fe35-83d0-46b0-a150-b5a6f0901d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67c4fe35-83d0-46b0-a150-b5a6f0901d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_939d108f-080b-4652-a611-4827874d7aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67c4fe35-83d0-46b0-a150-b5a6f0901d82" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_939d108f-080b-4652-a611-4827874d7aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_65ea8fc5-be20-448e-97cf-c6f547d4677e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67c4fe35-83d0-46b0-a150-b5a6f0901d82" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_65ea8fc5-be20-448e-97cf-c6f547d4677e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_715a4197-723f-4e64-8201-e5f965d14161" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67c4fe35-83d0-46b0-a150-b5a6f0901d82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_715a4197-723f-4e64-8201-e5f965d14161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_92fb7d11-90f0-45f6-9769-bba36415a6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_92fb7d11-90f0-45f6-9769-bba36415a6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d757e59f-773b-49fa-8481-d989bf16ac40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d757e59f-773b-49fa-8481-d989bf16ac40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a120b6db-3089-464f-91c7-b1c7270ca4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a120b6db-3089-464f-91c7-b1c7270ca4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3df1e8a-aa8e-4a78-beef-5fb414d8b767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3df1e8a-aa8e-4a78-beef-5fb414d8b767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0a7fad78-c53b-4807-9a03-f5e6444ef08a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3df1e8a-aa8e-4a78-beef-5fb414d8b767" xlink:to="loc_us-gaap_InterestPaidNet_0a7fad78-c53b-4807-9a03-f5e6444ef08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3fb79b1-14b2-4335-887d-3a4e087bcec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_24fec956-eb49-4e04-a21a-ce05cdb0aa41" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3fb79b1-14b2-4335-887d-3a4e087bcec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_6f0deed0-ce01-4ce9-92d1-472dce524adc" xlink:href="sera-20230331.xsd#sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3fb79b1-14b2-4335-887d-3a4e087bcec6" xlink:to="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_6f0deed0-ce01-4ce9-92d1-472dce524adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition" xlink:type="simple" xlink:href="sera-20230331.xsd#DescriptionofBusinessandFinancialCondition"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_361537f0-ebf0-4d0d-b042-f3af5ff678dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b33710f9-d127-4b32-bc27-7d1a2283f259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_361537f0-ebf0-4d0d-b042-f3af5ff678dd" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b33710f9-d127-4b32-bc27-7d1a2283f259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="sera-20230331.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f3a8291d-b5c5-4ade-8295-d80e53402c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_00c0cfde-2120-4a9f-b53b-376e35710348" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3a8291d-b5c5-4ade-8295-d80e53402c1c" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_00c0cfde-2120-4a9f-b53b-376e35710348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_d332b7c1-1c80-4806-8652-780d2883d8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_631488fc-c8ba-4e42-b659-11d1c78d300b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d332b7c1-1c80-4806-8652-780d2883d8a4" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_631488fc-c8ba-4e42-b659-11d1c78d300b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="sera-20230331.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_daee71b1-f190-42bf-af6c-3a31981f7f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_45665edc-92b1-4fcf-a7bd-950d8ed6d94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_daee71b1-f190-42bf-af6c-3a31981f7f19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_45665edc-92b1-4fcf-a7bd-950d8ed6d94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities" xlink:type="simple" xlink:href="sera-20230331.xsd#AccruedandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_d4c53da3-b657-49ae-a059-e9821fd76e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_bbf04337-88a4-48ac-9637-74aba7bf874b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_d4c53da3-b657-49ae-a059-e9821fd76e87" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_bbf04337-88a4-48ac-9637-74aba7bf874b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenet" xlink:type="simple" xlink:href="sera-20230331.xsd#OtherIncomenet"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_ae8dc3af-dbfe-427a-8e4c-0f26d6517c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_e3aaeddf-52a1-4911-9b81-6314f9b09b53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ae8dc3af-dbfe-427a-8e4c-0f26d6517c3b" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_e3aaeddf-52a1-4911-9b81-6314f9b09b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="sera-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e97b57f1-cc91-4079-ac52-3725f6920f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c14eb048-67bb-43d0-a9d2-9da0f18da99c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e97b57f1-cc91-4079-ac52-3725f6920f71" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c14eb048-67bb-43d0-a9d2-9da0f18da99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="sera-20230331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_81ab9b42-6358-416b-9e44-18ef41469f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3d78916d-8c95-4456-a765-d8396372a952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_81ab9b42-6358-416b-9e44-18ef41469f68" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3d78916d-8c95-4456-a765-d8396372a952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructure" xlink:type="simple" xlink:href="sera-20230331.xsd#CapitalStructure"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4c35ca09-3ba5-49e5-83f9-38891e063afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b092e8da-f0a1-4ee8-a15c-9178a77d9fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4c35ca09-3ba5-49e5-83f9-38891e063afc" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b092e8da-f0a1-4ee8-a15c-9178a77d9fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a9f9b4f-e980-4e99-ae78-f0125361e303" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0ace6116-4a61-4f03-8e17-c3fda41a0043" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a9f9b4f-e980-4e99-ae78-f0125361e303" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0ace6116-4a61-4f03-8e17-c3fda41a0043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Warrants" xlink:type="simple" xlink:href="sera-20230331.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_ae45608d-96c4-434f-8064-212de06ccde9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsTextBlock_eb9f9673-11e9-4466-b19e-dcec2cce56d2" xlink:href="sera-20230331.xsd#sera_WarrantsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_ae45608d-96c4-434f-8064-212de06ccde9" xlink:to="loc_sera_WarrantsTextBlock_eb9f9673-11e9-4466-b19e-dcec2cce56d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingences" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingences"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingences" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aed49623-209b-4072-a00c-10c19f54116f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b811c1cf-b2e5-4e53-8683-043c5473b307" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aed49623-209b-4072-a00c-10c19f54116f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b811c1cf-b2e5-4e53-8683-043c5473b307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Netlosspershare" xlink:type="simple" xlink:href="sera-20230331.xsd#Netlosspershare"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/Netlosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c0670800-2332-4385-bbf4-153cc99d62e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f1de90bf-245d-4682-9e7a-0cc419541757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c0670800-2332-4385-bbf4-153cc99d62e5" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f1de90bf-245d-4682-9e7a-0cc419541757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sera-20230331.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4d3eecd5-1e44-4777-8bf4-16d63e187312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_84cb83ad-45f3-4ac9-939e-b2009f7d0d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d3eecd5-1e44-4777-8bf4-16d63e187312" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_84cb83ad-45f3-4ac9-939e-b2009f7d0d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_8efd24b1-234e-4633-a7bf-b6461cc71003" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d3eecd5-1e44-4777-8bf4-16d63e187312" xlink:to="loc_us-gaap_UseOfEstimates_8efd24b1-234e-4633-a7bf-b6461cc71003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_7ddc24bd-25bc-4778-a3eb-39a183a9cf80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_218e0095-7db7-425c-9d61-03359cfbce4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_7ddc24bd-25bc-4778-a3eb-39a183a9cf80" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_218e0095-7db7-425c-9d61-03359cfbce4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_b83b1842-75a2-41ef-a7f9-21f8168aae68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_7ddc24bd-25bc-4778-a3eb-39a183a9cf80" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_b83b1842-75a2-41ef-a7f9-21f8168aae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_0985d8a4-c998-457e-a039-29da67c82c30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_7ddc24bd-25bc-4778-a3eb-39a183a9cf80" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_0985d8a4-c998-457e-a039-29da67c82c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="sera-20230331.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1acde2f6-18e2-4a3e-ba77-013b3d49de1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b65834ca-f814-481a-a737-a2beff76e491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1acde2f6-18e2-4a3e-ba77-013b3d49de1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b65834ca-f814-481a-a737-a2beff76e491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="sera-20230331.xsd#AccruedandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_452da4ec-ac17-408c-9585-7335d93444cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_52bb06ab-1865-42ca-8abc-aaea252932e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_452da4ec-ac17-408c-9585-7335d93444cd" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_52bb06ab-1865-42ca-8abc-aaea252932e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenetTables" xlink:type="simple" xlink:href="sera-20230331.xsd#OtherIncomenetTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_792bd057-fd24-4d93-b32d-3872ad5a9481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_d9356a4a-b10e-40c0-89c0-294ad8b65893" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_792bd057-fd24-4d93-b32d-3872ad5a9481" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_d9356a4a-b10e-40c0-89c0-294ad8b65893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="sera-20230331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fef9bf07-ff0d-4823-990f-5fccbcc51923" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_52b826dc-7523-4a71-93c0-71965487c07a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fef9bf07-ff0d-4823-990f-5fccbcc51923" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_52b826dc-7523-4a71-93c0-71965487c07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureTables" xlink:type="simple" xlink:href="sera-20230331.xsd#CapitalStructureTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0160d704-33ef-4714-b9b8-ae56a034b705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_b2de36a6-c0b8-4527-8991-5292d67f18b5" xlink:href="sera-20230331.xsd#sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0160d704-33ef-4714-b9b8-ae56a034b705" xlink:to="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_b2de36a6-c0b8-4527-8991-5292d67f18b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b433f5a-49af-4ab3-889c-646a9c665031" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c90200c7-3cbc-4d68-803b-02c7dc9c7e93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b433f5a-49af-4ab3-889c-646a9c665031" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c90200c7-3cbc-4d68-803b-02c7dc9c7e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_99bbdf3e-d809-411b-a85f-c52e923c128a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b433f5a-49af-4ab3-889c-646a9c665031" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_99bbdf3e-d809-411b-a85f-c52e923c128a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0a623176-403b-44f3-9467-5131ac6b5c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b433f5a-49af-4ab3-889c-646a9c665031" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0a623176-403b-44f3-9467-5131ac6b5c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_abc3aa21-3a8f-448c-bf59-e1b472f122ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b433f5a-49af-4ab3-889c-646a9c665031" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_abc3aa21-3a8f-448c-bf59-e1b472f122ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsTables" xlink:type="simple" xlink:href="sera-20230331.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_025e68f0-0070-4b75-b594-bd81d4337c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_2d238527-bd42-4b24-95de-799434b88060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_025e68f0-0070-4b75-b594-bd81d4337c6f" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_2d238527-bd42-4b24-95de-799434b88060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d94cfbf4-f45f-4bdd-856b-b8a978bf6cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_75d3880a-5e47-4765-a210-71f45431042b" xlink:href="sera-20230331.xsd#sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d94cfbf4-f45f-4bdd-856b-b8a978bf6cd3" xlink:to="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_75d3880a-5e47-4765-a210-71f45431042b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_7c2654b9-87ae-4358-b0f8-efd6d011ccc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d94cfbf4-f45f-4bdd-856b-b8a978bf6cd3" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_7c2654b9-87ae-4358-b0f8-efd6d011ccc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c172176f-f4f5-46a0-9e7f-d9fd669619e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d94cfbf4-f45f-4bdd-856b-b8a978bf6cd3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c172176f-f4f5-46a0-9e7f-d9fd669619e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_bf0f6359-d6e2-4188-9037-93012fb482f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d94cfbf4-f45f-4bdd-856b-b8a978bf6cd3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_bf0f6359-d6e2-4188-9037-93012fb482f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareTables" xlink:type="simple" xlink:href="sera-20230331.xsd#NetlosspershareTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2bfc04e5-303d-4f88-9541-12e18bee6117" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1433de4c-ef4a-4239-a0c6-08903d24f173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2bfc04e5-303d-4f88-9541-12e18bee6117" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1433de4c-ef4a-4239-a0c6-08903d24f173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#DescriptionofBusinessandFinancialConditionDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1abda87f-4a44-4c82-8957-fbaea412be46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_065d1127-9caf-46c8-90d6-303c77a8013d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1abda87f-4a44-4c82-8957-fbaea412be46" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_065d1127-9caf-46c8-90d6-303c77a8013d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_66828d1a-4688-4d8f-abe8-1fd62709fd90" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1abda87f-4a44-4c82-8957-fbaea412be46" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_66828d1a-4688-4d8f-abe8-1fd62709fd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_43ec7f7d-6c9c-4fb7-8bb2-f0da6953a606" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_43ec7f7d-6c9c-4fb7-8bb2-f0da6953a606" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_74e72e65-4952-40a7-806a-56f8b09a6956" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_74e72e65-4952-40a7-806a-56f8b09a6956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74e72e65-4952-40a7-806a-56f8b09a6956" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_0c4b2704-a043-4657-aefa-09535f6b3448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_0c4b2704-a043-4657-aefa-09535f6b3448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CurrentMarketableSecuritiesMember_145417c2-3fe9-444a-9871-bf620b4060a8" xlink:href="sera-20230331.xsd#sera_CurrentMarketableSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:to="loc_sera_CurrentMarketableSecuritiesMember_145417c2-3fe9-444a-9871-bf620b4060a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NonCurrentMarketableSecuritiesMember_9aa791bb-2446-463c-af95-3cfea8b85449" xlink:href="sera-20230331.xsd#sera_NonCurrentMarketableSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_200bd7ec-d4b1-4d21-b8ad-9d6b345cf114" xlink:to="loc_sera_NonCurrentMarketableSecuritiesMember_9aa791bb-2446-463c-af95-3cfea8b85449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_ed1917d1-b857-418a-b249-e75a6d486506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_ed1917d1-b857-418a-b249-e75a6d486506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ed1917d1-b857-418a-b249-e75a6d486506" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_a3eff6e1-e773-4e6a-b40b-9bbcf3105e59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_CashMember_a3eff6e1-e773-4e6a-b40b-9bbcf3105e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_d2a4f5a1-b389-4262-9c5d-9e7cc66e35a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_MoneyMarketFundsMember_d2a4f5a1-b389-4262-9c5d-9e7cc66e35a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_32c5ee84-5c57-428b-a945-5023e918a12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_CommercialPaperMember_32c5ee84-5c57-428b-a945-5023e918a12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_68c91f16-4ba3-405a-a3aa-ada02304d8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61bb3fcb-c1a0-4a80-b0d7-77c7c7aa9498" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_68c91f16-4ba3-405a-a3aa-ada02304d8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_017ecdde-f156-4c59-9eac-7555099eb632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:to="loc_us-gaap_FinancialInstrumentAxis_017ecdde-f156-4c59-9eac-7555099eb632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_017ecdde-f156-4c59-9eac-7555099eb632" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9c096b24-c7ca-4b26-9d37-3a239af7a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_CommercialPaperMember_9c096b24-c7ca-4b26-9d37-3a239af7a49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c311513a-5fb0-4c97-bee4-1932238111f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c311513a-5fb0-4c97-bee4-1932238111f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0d2644e8-2021-406a-9b1c-4fe4071868ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0d2644e8-2021-406a-9b1c-4fe4071868ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_408ead85-d727-4bab-aea6-791a3c39410d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e1dd0bad-2e68-4e80-bb0d-a0c5ed140d78" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_408ead85-d727-4bab-aea6-791a3c39410d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d4856a13-94c9-4ac9-8b93-69bd9c313108" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost_39de98ae-0f25-4d74-9fea-005754b3d00b" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsAmortizedCost_39de98ae-0f25-4d74-9fea-005754b3d00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_f4f871df-9904-4658-bda0-6f194146036d" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_f4f871df-9904-4658-bda0-6f194146036d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_e293a0df-43ed-4784-89b8-09677fdfb2a8" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_e293a0df-43ed-4784-89b8-09677fdfb2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9c2ba1a9-9da5-4d49-a02c-12a08b407832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9c2ba1a9-9da5-4d49-a02c-12a08b407832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2aad5302-4dcd-4ebe-9b02-7f690d84b901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2aad5302-4dcd-4ebe-9b02-7f690d84b901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6834fb-3ba4-4091-b3f1-5f2a15bc0d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6834fb-3ba4-4091-b3f1-5f2a15bc0d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_09d4996c-da20-4dbf-8be1-58a150a84e81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_09d4996c-da20-4dbf-8be1-58a150a84e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_710f8e7a-94e2-4fa0-a54e-d7ecbd752387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_710f8e7a-94e2-4fa0-a54e-d7ecbd752387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_1c44abe0-4226-4d57-b3ff-f9f0142b8004" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_1c44abe0-4226-4d57-b3ff-f9f0142b8004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_5e553b5d-5663-49a4-9fb3-b68dd39f38ef" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_5e553b5d-5663-49a4-9fb3-b68dd39f38ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_5579b7f2-7fa7-485c-b5f8-e8ce9b0a3499" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_5579b7f2-7fa7-485c-b5f8-e8ce9b0a3499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_698d6825-be4a-43e9-a55b-f70a321200b7" xlink:href="sera-20230331.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e17e085d-ed52-44b5-b5d4-6b49c4fadd21" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_698d6825-be4a-43e9-a55b-f70a321200b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_2b97f9fc-a2e3-483b-b1f0-f47f90612cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_614780ae-33aa-4793-99f8-dc7ef12dc423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_2b97f9fc-a2e3-483b-b1f0-f47f90612cd0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_614780ae-33aa-4793-99f8-dc7ef12dc423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a83566b3-9581-4f02-8662-a4cef06b2d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_614780ae-33aa-4793-99f8-dc7ef12dc423" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a83566b3-9581-4f02-8662-a4cef06b2d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a83566b3-9581-4f02-8662-a4cef06b2d9e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9f0a4882-d14f-4ca3-999c-17b3e8da7241" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_CommercialPaperMember_9f0a4882-d14f-4ca3-999c-17b3e8da7241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_77780123-1bc5-498b-8916-6fe0351cce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_77780123-1bc5-498b-8916-6fe0351cce5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_449d81c2-bf5a-4014-a131-c52edc8436d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_449d81c2-bf5a-4014-a131-c52edc8436d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_f2f487b0-37d6-437e-b5b3-954d11b814b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640ee6f2-2527-4079-86f1-a686524bda6c" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_f2f487b0-37d6-437e-b5b3-954d11b814b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_614780ae-33aa-4793-99f8-dc7ef12dc423" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_76e80b3d-f0be-4ffc-9ef0-a28ab8952dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_76e80b3d-f0be-4ffc-9ef0-a28ab8952dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b9f6850-a614-4f1d-9344-6448f1b08d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b9f6850-a614-4f1d-9344-6448f1b08d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_79af83c4-c9f1-4aed-957d-0748139f8ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_79af83c4-c9f1-4aed-957d-0748139f8ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_445b5999-27a3-4906-98f5-bc654f94768c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_445b5999-27a3-4906-98f5-bc654f94768c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a13947e5-1753-48a8-9449-d47df3c561e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a13947e5-1753-48a8-9449-d47df3c561e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8ea4b869-babc-4ae8-864a-5a7606a1628d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c39def89-237b-4404-89d7-6787b188c15b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8ea4b869-babc-4ae8-864a-5a7606a1628d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_409668bf-15ab-4f13-9cd3-4d979a4ca334" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_66bf74f5-aa45-47e5-b8ef-94bc2de37ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_409668bf-15ab-4f13-9cd3-4d979a4ca334" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_66bf74f5-aa45-47e5-b8ef-94bc2de37ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8ef3914c-ed00-482a-9d62-81483dc078c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_409668bf-15ab-4f13-9cd3-4d979a4ca334" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8ef3914c-ed00-482a-9d62-81483dc078c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_34681010-7826-4b9b-89c8-bdb49f98e188" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_902817b1-c2c7-42e6-8ad7-750be21ec465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_34681010-7826-4b9b-89c8-bdb49f98e188" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_902817b1-c2c7-42e6-8ad7-750be21ec465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_e6d508f7-8f69-45ac-9cc0-a61ed56126a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_902817b1-c2c7-42e6-8ad7-750be21ec465" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_e6d508f7-8f69-45ac-9cc0-a61ed56126a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_3a3243de-8a26-4f15-b365-52072b055349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_902817b1-c2c7-42e6-8ad7-750be21ec465" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_3a3243de-8a26-4f15-b365-52072b055349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9b272e1e-ac30-48a0-8c01-9b5cf4e4d139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_902817b1-c2c7-42e6-8ad7-750be21ec465" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9b272e1e-ac30-48a0-8c01-9b5cf4e4d139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0455c071-9082-4487-98c0-44e82299d5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_34681010-7826-4b9b-89c8-bdb49f98e188" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0455c071-9082-4487-98c0-44e82299d5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_6a172d90-c8c5-4fad-b31f-2f20fdccdbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0455c071-9082-4487-98c0-44e82299d5f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_6a172d90-c8c5-4fad-b31f-2f20fdccdbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0d12cbd3-84ec-4587-ba34-b8bf83b9620a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0455c071-9082-4487-98c0-44e82299d5f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0d12cbd3-84ec-4587-ba34-b8bf83b9620a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8d588559-2d9a-4909-98b4-0f0a38f5a8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0455c071-9082-4487-98c0-44e82299d5f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8d588559-2d9a-4909-98b4-0f0a38f5a8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4bb51787-02e3-4fb1-8c5d-655d818d0377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6ab4e7b-71c2-49ca-a36c-e4eca49726a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4bb51787-02e3-4fb1-8c5d-655d818d0377" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6ab4e7b-71c2-49ca-a36c-e4eca49726a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59681a50-2527-471a-b32d-e2faba577d27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6ab4e7b-71c2-49ca-a36c-e4eca49726a8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59681a50-2527-471a-b32d-e2faba577d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59681a50-2527-471a-b32d-e2faba577d27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryEquipmentMember_391cf2ef-fd4f-4269-8d29-f0ad1c24921f" xlink:href="sera-20230331.xsd#sera_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_sera_LaboratoryEquipmentMember_391cf2ef-fd4f-4269-8d29-f0ad1c24921f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_308049b6-a170-4b1e-97b3-80597579fa88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_ComputerEquipmentMember_308049b6-a170-4b1e-97b3-80597579fa88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_023edcac-0ce1-48ea-a883-0eb0609cf343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_023edcac-0ce1-48ea-a883-0eb0609cf343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_da44b224-f534-486c-a7a6-b25dc42ffc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_da44b224-f534-486c-a7a6-b25dc42ffc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_71577eff-2f42-4c14-93b6-f1e30b3e58bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f5f88b1-1925-4eb3-9ea8-43666fc57976" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_71577eff-2f42-4c14-93b6-f1e30b3e58bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6ab4e7b-71c2-49ca-a36c-e4eca49726a8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_093e50ea-4fb7-403d-99ce-85bbdf64cb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_093e50ea-4fb7-403d-99ce-85bbdf64cb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5419dcfa-5e1e-4538-88c6-7b08cb76a481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5419dcfa-5e1e-4538-88c6-7b08cb76a481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a79c2b7f-5a4a-460d-b5f7-03c9a47d3d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc720b55-d52a-4563-b03d-0c68efc81dd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a79c2b7f-5a4a-460d-b5f7-03c9a47d3d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_61488952-d799-4f90-ad49-3cce91882b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_92db76fd-b162-49b6-b61f-f0b129eaea1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_61488952-d799-4f90-ad49-3cce91882b93" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_92db76fd-b162-49b6-b61f-f0b129eaea1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_8a6ca8eb-a792-4d61-a2b7-a7d59cd56041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_dabc012d-6d82-4753-ba5c-62cfb2c6ea60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_8a6ca8eb-a792-4d61-a2b7-a7d59cd56041" xlink:to="loc_us-gaap_AccruedSalariesCurrent_dabc012d-6d82-4753-ba5c-62cfb2c6ea60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_4b90da0e-56c6-4f28-8242-adb9bed567f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_8a6ca8eb-a792-4d61-a2b7-a7d59cd56041" xlink:to="loc_us-gaap_AccruedVacationCurrent_4b90da0e-56c6-4f28-8242-adb9bed567f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_6b3a32dd-17cf-48fb-b7be-83f68316a891" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_8a6ca8eb-a792-4d61-a2b7-a7d59cd56041" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_6b3a32dd-17cf-48fb-b7be-83f68316a891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_939da5ba-f013-4db5-87cf-85c4d33fc97d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_8a6ca8eb-a792-4d61-a2b7-a7d59cd56041" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_939da5ba-f013-4db5-87cf-85c4d33fc97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e4b88ec6-675b-446c-a9b7-7fbc5e018ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_8a6ca8eb-a792-4d61-a2b7-a7d59cd56041" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e4b88ec6-675b-446c-a9b7-7fbc5e018ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_21a78898-a9b2-4560-b5c0-4844c73b9499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_8a6ca8eb-a792-4d61-a2b7-a7d59cd56041" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_21a78898-a9b2-4560-b5c0-4844c73b9499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#OtherIncomenetDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_487f25ce-2978-44d5-bcd2-16a42f697b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_2f551fb9-a2c9-4a30-9821-9c960ca8f06a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_487f25ce-2978-44d5-bcd2-16a42f697b1f" xlink:to="loc_us-gaap_InterestIncomeOther_2f551fb9-a2c9-4a30-9821-9c960ca8f06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_78fd1ecf-6836-4737-a510-eab494156c25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_487f25ce-2978-44d5-bcd2-16a42f697b1f" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_78fd1ecf-6836-4737-a510-eab494156c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_22e42799-63e7-41df-abbb-0c7fc221ccf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_487f25ce-2978-44d5-bcd2-16a42f697b1f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_22e42799-63e7-41df-abbb-0c7fc221ccf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_02b90bb4-ef49-4881-9239-bbf24a263eba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_02b90bb4-ef49-4881-9239-bbf24a263eba" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77af848c-295c-456a-964b-56a1819bd6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77af848c-295c-456a-964b-56a1819bd6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77af848c-295c-456a-964b-56a1819bd6eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3e05a1b2-31c4-4c82-831c-aa853ecafc48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3e05a1b2-31c4-4c82-831c-aa853ecafc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7493dfd0-a825-4009-bb80-d61f7587f054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7493dfd0-a825-4009-bb80-d61f7587f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_51944ed2-93bb-4ed0-a8f0-1a5f646f0f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab50b5d8-d9f5-4b97-a174-622a943fcfb7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_51944ed2-93bb-4ed0-a8f0-1a5f646f0f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c20b90b1-c606-4171-bdf3-9f18483911fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c20b90b1-c606-4171-bdf3-9f18483911fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cff5bea9-189d-491c-9be2-c6fc67c3c4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c20b90b1-c606-4171-bdf3-9f18483911fa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cff5bea9-189d-491c-9be2-c6fc67c3c4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_11302a8b-0169-4c22-89b7-75436ae1228d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cff5bea9-189d-491c-9be2-c6fc67c3c4e6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_11302a8b-0169-4c22-89b7-75436ae1228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_3da975bf-4d31-4030-8794-ee94e9235530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_3da975bf-4d31-4030-8794-ee94e9235530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_3da975bf-4d31-4030-8794-ee94e9235530" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f69c9d43-fa3a-499b-b444-2fdc4bc17c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f69c9d43-fa3a-499b-b444-2fdc4bc17c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_328d722d-d4e3-4f5f-9575-d5df0e221f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:to="loc_us-gaap_CommercialPaperMember_328d722d-d4e3-4f5f-9575-d5df0e221f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_854f4a42-fed2-4237-8514-735b1a01cdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ccc8672-1a00-4f48-a35c-5c651d876aa3" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_854f4a42-fed2-4237-8514-735b1a01cdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7a6b8f06-4763-40e1-917a-7c0cd70050c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7a6b8f06-4763-40e1-917a-7c0cd70050c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a6b8f06-4763-40e1-917a-7c0cd70050c8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_138e4372-773f-4b6b-ad5c-0c07f728dc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_CommercialPaperMember_138e4372-773f-4b6b-ad5c-0c07f728dc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d561ee05-502a-4e59-8450-c59b62b16bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d561ee05-502a-4e59-8450-c59b62b16bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ba8ded4c-f89b-4205-a85d-e38306b8338d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ba8ded4c-f89b-4205-a85d-e38306b8338d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_f9ab09b4-87e9-4303-aad1-91df29481755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ddc7c6cf-2fe2-4572-acf3-d5b80d86f361" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_f9ab09b4-87e9-4303-aad1-91df29481755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2f41f420-dce8-41d3-9e92-dee1bb352183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f161d3e6-ac3a-49df-a0d1-ab20e2deac74" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2f41f420-dce8-41d3-9e92-dee1bb352183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2f41f420-dce8-41d3-9e92-dee1bb352183" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1be28e03-535b-420d-a886-70bbb2497675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1be28e03-535b-420d-a886-70bbb2497675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d59e464d-2eff-40e7-946b-4f157d65021e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d59e464d-2eff-40e7-946b-4f157d65021e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ebf601be-37ae-46db-a785-9147d1abdc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_6c07b77f-96db-4def-bb03-b242dcf69098" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ebf601be-37ae-46db-a785-9147d1abdc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_f61a306f-9752-4324-8d01-361fec32f673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_f61a306f-9752-4324-8d01-361fec32f673" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b098e42b-901a-4d6d-9e87-ef5588026659" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b098e42b-901a-4d6d-9e87-ef5588026659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b098e42b-901a-4d6d-9e87-ef5588026659" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_MasterServicesAgreementMember_87a0a49d-155f-4338-8294-25d9fe1f5117" xlink:href="sera-20230331.xsd#sera_MasterServicesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:to="loc_sera_MasterServicesAgreementMember_87a0a49d-155f-4338-8294-25d9fe1f5117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryServicesAgreementMember_1660040f-ff73-46f9-89fd-9ae0a63bbf93" xlink:href="sera-20230331.xsd#sera_LaboratoryServicesAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:to="loc_sera_LaboratoryServicesAgreementMember_1660040f-ff73-46f9-89fd-9ae0a63bbf93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommercialCollaborationAgreementMember_7edc7696-a975-446a-877d-6038e00103be" xlink:href="sera-20230331.xsd#sera_CommercialCollaborationAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7cea7a99-0fae-4d72-a27c-8a314caae274" xlink:to="loc_sera_CommercialCollaborationAgreementMember_7edc7696-a975-446a-877d-6038e00103be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis_d70429cd-da63-4d02-9693-383c661f80d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:to="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis_d70429cd-da63-4d02-9693-383c661f80d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_54984439-df87-4f89-aa96-c4aff917dc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusAxis_d70429cd-da63-4d02-9693-383c661f80d7" xlink:to="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_54984439-df87-4f89-aa96-c4aff917dc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_97dc36eb-58ec-473d-af04-247e90d33fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_54984439-df87-4f89-aa96-c4aff917dc7f" xlink:to="loc_us-gaap_RelatedPartyMember_97dc36eb-58ec-473d-af04-247e90d33fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:to="loc_srt_CounterpartyNameAxis_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f1a11bb4-fdd6-4be4-8443-7ef05a7f988c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CarelonResearchMember_a92f7a47-b783-42ca-b7f1-62fff6d99640" xlink:href="sera-20230331.xsd#sera_CarelonResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:to="loc_sera_CarelonResearchMember_a92f7a47-b783-42ca-b7f1-62fff6d99640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ElevanceHealthIncMember_3e58422e-b2f5-4547-99b8-2e5f11059f66" xlink:href="sera-20230331.xsd#sera_ElevanceHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_71289a02-40b2-49dd-bd77-ef180d3ed254" xlink:to="loc_sera_ElevanceHealthIncMember_3e58422e-b2f5-4547-99b8-2e5f11059f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ffbc9c75-da51-4400-8e5a-749f4ffcf306" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_044e58ec-4330-4450-906c-535b267b91a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_us-gaap_OperatingExpenses_044e58ec-4330-4450-906c-535b267b91a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e0b448a-0db3-4d31-9aa4-cf2d020ef307" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e0b448a-0db3-4d31-9aa4-cf2d020ef307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_49e61ea2-c8f4-4550-82fe-b1ece3c8fa9f" xlink:href="sera-20230331.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_49e61ea2-c8f4-4550-82fe-b1ece3c8fa9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_198afdda-d77c-46fa-9163-b7a24cedcba3" xlink:href="sera-20230331.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ed00980b-0768-4455-97c6-386456acf802" xlink:to="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_198afdda-d77c-46fa-9163-b7a24cedcba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CapitalStructureNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5145aa53-3002-4844-901b-4ba064653bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_89be81fd-1c6e-4b75-b332-1e769693fbab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5145aa53-3002-4844-901b-4ba064653bdb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_89be81fd-1c6e-4b75-b332-1e769693fbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_404770c4-26de-4ff3-a8da-a58c7d781326" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_89be81fd-1c6e-4b75-b332-1e769693fbab" xlink:to="loc_us-gaap_StatementClassOfStockAxis_404770c4-26de-4ff3-a8da-a58c7d781326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_404770c4-26de-4ff3-a8da-a58c7d781326" xlink:to="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4443db5b-ff89-4ff8-a88f-df8d174d9bef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:to="loc_us-gaap_CommonClassAMember_4443db5b-ff89-4ff8-a88f-df8d174d9bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_613d2228-c11d-4d05-9758-aa04e2a2b83a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_16d3d65d-2397-48de-9c47-4b557d615b7c" xlink:to="loc_us-gaap_CommonClassBMember_613d2228-c11d-4d05-9758-aa04e2a2b83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_89be81fd-1c6e-4b75-b332-1e769693fbab" xlink:to="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfCommonStockClassesAuthorized_ab723c5e-4687-4354-8053-e86a83289bce" xlink:href="sera-20230331.xsd#sera_NumberOfCommonStockClassesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:to="loc_sera_NumberOfCommonStockClassesAuthorized_ab723c5e-4687-4354-8053-e86a83289bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfVotesPerShare_ca0068ba-4f5b-4241-886e-dc1a4cac2105" xlink:href="sera-20230331.xsd#sera_NumberOfVotesPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:to="loc_sera_NumberOfVotesPerShare_ca0068ba-4f5b-4241-886e-dc1a4cac2105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockConversionRatio_dc74e465-a5dd-4f72-9de5-ba4536bad407" xlink:href="sera-20230331.xsd#sera_CommonStockConversionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_64f11079-9d52-4d39-b5b2-74841b5dc101" xlink:to="loc_sera_CommonStockConversionRatio_dc74e465-a5dd-4f72-9de5-ba4536bad407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CapitalStructureCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c583d561-649b-425b-a130-05b6074a4cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c583d561-649b-425b-a130-05b6074a4cd3" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9658a5d9-a52e-488e-8ad7-c61a589fcbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9658a5d9-a52e-488e-8ad7-c61a589fcbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1ee2f272-948b-4695-8190-1aa00f3c70a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9658a5d9-a52e-488e-8ad7-c61a589fcbe6" xlink:to="loc_us-gaap_ClassOfStockDomain_1ee2f272-948b-4695-8190-1aa00f3c70a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_e151e5aa-8658-4f71-ae93-514b25170d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1ee2f272-948b-4695-8190-1aa00f3c70a8" xlink:to="loc_us-gaap_CommonClassAMember_e151e5aa-8658-4f71-ae93-514b25170d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_a0e956f4-e5b4-4ad1-b145-ca848b453b80" xlink:href="sera-20230331.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_a0e956f4-e5b4-4ad1-b145-ca848b453b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:href="sera-20230331.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_a0e956f4-e5b4-4ad1-b145-ca848b453b80" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_027451de-5180-4170-93d0-dc05ba1f704c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_027451de-5180-4170-93d0-dc05ba1f704c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_8c079b1b-c32d-4eec-89c1-ad95c7e61874" xlink:href="sera-20230331.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_8c079b1b-c32d-4eec-89c1-ad95c7e61874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fea53a6d-c5a8-4c62-b88a-bafab25ea1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fea53a6d-c5a8-4c62-b88a-bafab25ea1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_8ece2bb0-9214-4d03-a52a-40fed2a62978" xlink:href="sera-20230331.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_8ece2bb0-9214-4d03-a52a-40fed2a62978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_b0aac49a-9a65-4007-81c5-b499101e7d09" xlink:href="sera-20230331.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_caeddfdf-c1d5-4557-8ec6-62e6d777bd66" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_b0aac49a-9a65-4007-81c5-b499101e7d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_03234432-adb6-451f-8b44-c0eaa79abdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b6995c3-2de9-43b6-89f4-a545070d5c7b" xlink:to="loc_us-gaap_ClassOfStockLineItems_03234432-adb6-451f-8b44-c0eaa79abdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7f50a7ff-d9a9-4121-a773-83bdf601b4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_03234432-adb6-451f-8b44-c0eaa79abdaa" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7f50a7ff-d9a9-4121-a773-83bdf601b4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dac9b7f7-d0d6-4f18-9e9c-d2eb0fa6ede7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dac9b7f7-d0d6-4f18-9e9c-d2eb0fa6ede7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fdd01f16-6171-4f08-b511-1d953755a5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:to="loc_us-gaap_PlanNameAxis_fdd01f16-6171-4f08-b511-1d953755a5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_fdd01f16-6171-4f08-b511-1d953755a5f7" xlink:to="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2011Member_bd2375d1-0eeb-4135-b702-0901c50f0c64" xlink:href="sera-20230331.xsd#sera_Plan2011Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:to="loc_sera_Plan2011Member_bd2375d1-0eeb-4135-b702-0901c50f0c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2021Member_b930d73b-41b5-4022-9173-d0c1b4b9503d" xlink:href="sera-20230331.xsd#sera_Plan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:to="loc_sera_Plan2021Member_b930d73b-41b5-4022-9173-d0c1b4b9503d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PlanEspp2021Member_5fe6f040-302a-475a-994a-ed2dadcd9e01" xlink:href="sera-20230331.xsd#sera_PlanEspp2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a5fb9fc4-81b3-4b26-94b1-e589d195e182" xlink:to="loc_sera_PlanEspp2021Member_5fe6f040-302a-475a-994a-ed2dadcd9e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d072aa5a-2724-4600-a8f5-64718f55ff16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e9146d8-a85c-4c7c-8ef7-56a61cb97d5c" xlink:to="loc_us-gaap_ClassOfStockDomain_d072aa5a-2724-4600-a8f5-64718f55ff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b68723d8-27a0-4d0e-9198-84ee299b1dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d072aa5a-2724-4600-a8f5-64718f55ff16" xlink:to="loc_us-gaap_CommonClassAMember_b68723d8-27a0-4d0e-9198-84ee299b1dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d7188de-7a1f-4b23-b498-ed10e3b3e7a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5bf714d-f5c9-4f1d-a6f6-ec1eae4f680d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5bf714d-f5c9-4f1d-a6f6-ec1eae4f680d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e7d1af2-0469-4e97-9528-fdc319695947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e7d1af2-0469-4e97-9528-fdc319695947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0b4e9072-bfcf-46dc-84d7-d935b6ab44cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1cd9dd81-4fa0-45d0-a92d-0a8f4bb664c8" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0b4e9072-bfcf-46dc-84d7-d935b6ab44cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d5fda801-0b46-470b-bdb9-902f1c2784e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d5fda801-0b46-470b-bdb9-902f1c2784e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe35c15c-b0ec-4d2b-9943-3dca952c8e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe35c15c-b0ec-4d2b-9943-3dca952c8e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_62784d6e-0343-4e49-8152-508d94c279b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_62784d6e-0343-4e49-8152-508d94c279b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7f76510e-950f-4e67-925d-ffd3fdb3da83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7f76510e-950f-4e67-925d-ffd3fdb3da83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6d56d6c6-c28b-444f-b016-e0670fa10f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6d56d6c6-c28b-444f-b016-e0670fa10f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a5e72b9f-f134-4cbd-8a52-08142a1efffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_01d31e05-4dd0-4969-a4a4-e59c9fdfbf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a5e72b9f-f134-4cbd-8a52-08142a1efffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c4c1810f-3394-478d-ae00-934d23eab81e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c4c1810f-3394-478d-ae00-934d23eab81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7a06429e-47d9-4887-aaa7-5b5634349754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7a06429e-47d9-4887-aaa7-5b5634349754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6235b139-79ca-445d-9a8e-00bef370afd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6235b139-79ca-445d-9a8e-00bef370afd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6e6d85cf-bc06-4cef-b760-a89f8de9da06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6e6d85cf-bc06-4cef-b760-a89f8de9da06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7d928222-0ba8-4693-94b5-12042c5a8bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7d928222-0ba8-4693-94b5-12042c5a8bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1cae6b98-8182-43c6-91ed-a4c0d93bedd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1cae6b98-8182-43c6-91ed-a4c0d93bedd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_571b5600-4df5-4dfe-85a0-75250a4ee804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_571b5600-4df5-4dfe-85a0-75250a4ee804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84667793-6e2a-4de6-9d0b-af227d00c308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7576fe70-429a-4f43-a7b1-28199aa22481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_84667793-6e2a-4de6-9d0b-af227d00c308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7caa7116-6aa3-48a5-b967-6d9fb5de3fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7caa7116-6aa3-48a5-b967-6d9fb5de3fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_3634f94e-0496-4585-bb83-050a1dbc90f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_3634f94e-0496-4585-bb83-050a1dbc90f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d420cc56-d46f-4a90-9518-0a57b20095ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5746e880-f463-41c1-8786-bc1cc7c0e349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5746e880-f463-41c1-8786-bc1cc7c0e349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_48dd1a9c-d858-4eea-93d3-56ca22fed603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_48dd1a9c-d858-4eea-93d3-56ca22fed603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_c41ba9f9-08d9-43e1-aaac-d74881be95cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_c41ba9f9-08d9-43e1-aaac-d74881be95cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ca3ecd9a-61ee-4a17-ae1d-923704705a19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ca3ecd9a-61ee-4a17-ae1d-923704705a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4206137a-a624-4cda-978d-3f0418092c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4206137a-a624-4cda-978d-3f0418092c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_088c2048-cea4-4a4d-8a5f-136720de75ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b8b74955-53f3-43b8-8ae2-0a45beae6db3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_088c2048-cea4-4a4d-8a5f-136720de75ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_478586de-5b20-425c-99e1-9a66bc7cf7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c737d85-d751-4bf1-9ebd-54186b0960cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_478586de-5b20-425c-99e1-9a66bc7cf7a9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c737d85-d751-4bf1-9ebd-54186b0960cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f91badc9-42c6-4d97-9b82-035cd2f03cac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c737d85-d751-4bf1-9ebd-54186b0960cd" xlink:to="loc_us-gaap_AwardTypeAxis_f91badc9-42c6-4d97-9b82-035cd2f03cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8997373-5501-4581-acf2-f810e4aaa079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f91badc9-42c6-4d97-9b82-035cd2f03cac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8997373-5501-4581-acf2-f810e4aaa079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6ae00e57-753e-46ce-9b57-5ce4a3897dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8997373-5501-4581-acf2-f810e4aaa079" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6ae00e57-753e-46ce-9b57-5ce4a3897dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c737d85-d751-4bf1-9ebd-54186b0960cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d3ec8a6-cb01-426b-889b-37a93986b5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d3ec8a6-cb01-426b-889b-37a93986b5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbd70415-772a-4099-b700-bec0c86bebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbd70415-772a-4099-b700-bec0c86bebfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28ad51e9-9d00-4917-afca-7f8e056a55c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28ad51e9-9d00-4917-afca-7f8e056a55c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eed5f91d-63c2-4926-91bf-b03e0f393a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eed5f91d-63c2-4926-91bf-b03e0f393a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_469e3ab0-56aa-4f73-b970-db1338168aba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68ef0051-be78-46ad-b8aa-d357664c3fc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_469e3ab0-56aa-4f73-b970-db1338168aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed3fbe2-5e84-4881-9144-597d84f42f37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2dcb310-7663-4429-9984-1ee0633f0339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2dcb310-7663-4429-9984-1ee0633f0339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e18b308b-cfb2-4f9d-aecb-59eb5568db26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e18b308b-cfb2-4f9d-aecb-59eb5568db26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8351792d-a895-453c-b9ac-e7cacc8e50d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8351792d-a895-453c-b9ac-e7cacc8e50d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_68635afb-2363-431b-b005-cc424f62a1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_68635afb-2363-431b-b005-cc424f62a1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6522b218-3391-41ee-9259-db1b804e3879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_399f5d52-fde1-4d5a-8532-1661cac86087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6522b218-3391-41ee-9259-db1b804e3879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d2942d20-3088-4906-a92d-8fc86952a477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b7daa06a-9e38-4844-af9e-0bdf451512b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d2942d20-3088-4906-a92d-8fc86952a477" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b7daa06a-9e38-4844-af9e-0bdf451512b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b7daa06a-9e38-4844-af9e-0bdf451512b4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3b8546a9-ee2a-47d2-b5fd-d56afa73fad7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fc8e9ed0-0986-4af9-8eb8-661e58946d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fc8e9ed0-0986-4af9-8eb8-661e58946d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_541b65b5-9b91-41f4-bd71-f5e83de6e097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_541b65b5-9b91-41f4-bd71-f5e83de6e097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_bb7c9de8-3f13-45c6-89e9-1470f8bf7800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3520597a-967a-44ce-8bb1-5ffe349cdfc7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_bb7c9de8-3f13-45c6-89e9-1470f8bf7800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_404fcc68-bacd-4e02-8dca-bbce008ca7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b7daa06a-9e38-4844-af9e-0bdf451512b4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_404fcc68-bacd-4e02-8dca-bbce008ca7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3b02f50d-6e98-46bf-a708-87831a198255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_404fcc68-bacd-4e02-8dca-bbce008ca7eb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3b02f50d-6e98-46bf-a708-87831a198255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#StockBasedCompensationUnrecognizedCostDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1442e9c0-de68-4bb9-883b-10f239122d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_176c8e33-cd28-4743-8637-ddf6e8086f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1442e9c0-de68-4bb9-883b-10f239122d41" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_176c8e33-cd28-4743-8637-ddf6e8086f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_176c8e33-cd28-4743-8637-ddf6e8086f1b" xlink:to="loc_us-gaap_AwardTypeAxis_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc92b10f-be3a-4b00-9c4b-d796123846e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bf08ee9b-a8dc-4b86-a6f4-75e4749ba72c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc92b10f-be3a-4b00-9c4b-d796123846e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_486f4748-6170-4cb9-94b1-869bd02ca238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc92b10f-be3a-4b00-9c4b-d796123846e5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_486f4748-6170-4cb9-94b1-869bd02ca238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_176c8e33-cd28-4743-8637-ddf6e8086f1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_af2400bd-f9b3-40ad-b6f0-d307ad62c76a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_af2400bd-f9b3-40ad-b6f0-d307ad62c76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10bdda7-f6ab-4302-ba4e-1e8d0702bfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10bdda7-f6ab-4302-ba4e-1e8d0702bfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_409e9ab2-3dd3-4157-b804-04882a7f48b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_409e9ab2-3dd3-4157-b804-04882a7f48b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6b695e9f-536b-4acc-b3c8-31040d578d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b045b7-2ccc-423d-b9a3-c937b4dcf448" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6b695e9f-536b-4acc-b3c8-31040d578d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#WarrantsCommonStockWarrantsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_473222fd-44f1-4faa-a1c5-1df1dc6e977f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_21c2e459-41a6-454e-92a8-88f3c77fdf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_473222fd-44f1-4faa-a1c5-1df1dc6e977f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_21c2e459-41a6-454e-92a8-88f3c77fdf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_92e4a522-8abc-43a3-aab5-2bd340767dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_21c2e459-41a6-454e-92a8-88f3c77fdf4c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_92e4a522-8abc-43a3-aab5-2bd340767dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_92e4a522-8abc-43a3-aab5-2bd340767dfa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember_7d4acea8-b7c0-4527-be72-c3145999b33a" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt520SharePriceMember_7d4acea8-b7c0-4527-be72-c3145999b33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt9.03SharePriceMember_4303af92-48d7-453e-9c3b-e8e9a9e2eedc" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt9.03SharePriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt9.03SharePriceMember_4303af92-48d7-453e-9c3b-e8e9a9e2eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt10.84SharePriceMember_aef477c6-85d0-4b21-974f-4f2904c7fa6c" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt10.84SharePriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt10.84SharePriceMember_aef477c6-85d0-4b21-974f-4f2904c7fa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt1238SharePriceMember_9be12316-8926-4c0e-8434-d071d3da3985" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt1238SharePriceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt1238SharePriceMember_9be12316-8926-4c0e-8434-d071d3da3985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt2077SharePriceMember_3488cd77-55ca-48d3-9654-6283dd454a95" xlink:href="sera-20230331.xsd#sera_CommonStockWarrantAt2077SharePriceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec88ed91-90cd-4b5f-8800-82187e5dd054" xlink:to="loc_sera_CommonStockWarrantAt2077SharePriceMember_3488cd77-55ca-48d3-9654-6283dd454a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_21c2e459-41a6-454e-92a8-88f3c77fdf4c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8bda5550-a5f1-4713-8c30-1087dd6f553c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8bda5550-a5f1-4713-8c30-1087dd6f553c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2b048296-c983-46eb-b895-eea4c787f25f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_611517ab-0683-42fe-b007-ee74591fc489" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2b048296-c983-46eb-b895-eea4c787f25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesLeasesinFinancialStatementDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f38e06d2-6daa-4e56-a903-de5c2df11b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetAbstract_c8347582-2416-4c4b-8ba8-b6e5a6d27921" xlink:href="sera-20230331.xsd#sera_RightOfUseAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f38e06d2-6daa-4e56-a903-de5c2df11b18" xlink:to="loc_sera_RightOfUseAssetAbstract_c8347582-2416-4c4b-8ba8-b6e5a6d27921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_01c07f88-ac71-4d37-adb7-03f3517982c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_RightOfUseAssetAbstract_c8347582-2416-4c4b-8ba8-b6e5a6d27921" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_01c07f88-ac71-4d37-adb7-03f3517982c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_73dadd90-7b65-4d4d-ad8c-8d6a975d00ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_RightOfUseAssetAbstract_c8347582-2416-4c4b-8ba8-b6e5a6d27921" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_73dadd90-7b65-4d4d-ad8c-8d6a975d00ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetTotal_2d462908-ac7c-4c9b-b495-aa5decf166f7" xlink:href="sera-20230331.xsd#sera_RightOfUseAssetTotal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_RightOfUseAssetAbstract_c8347582-2416-4c4b-8ba8-b6e5a6d27921" xlink:to="loc_sera_RightOfUseAssetTotal_2d462908-ac7c-4c9b-b495-aa5decf166f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesAbstract_5b378552-942d-415b-bff1-f154787b3508" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f38e06d2-6daa-4e56-a903-de5c2df11b18" xlink:to="loc_sera_LeaseLiabilitiesAbstract_5b378552-942d-415b-bff1-f154787b3508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d709c78b-b19b-4ecc-a9cb-5669d09d322d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_5b378552-942d-415b-bff1-f154787b3508" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d709c78b-b19b-4ecc-a9cb-5669d09d322d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4584a150-fcb7-41d8-a963-195651a2da5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_5b378552-942d-415b-bff1-f154787b3508" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4584a150-fcb7-41d8-a963-195651a2da5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_41f57776-3327-4c64-9d49-fab428febc32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_5b378552-942d-415b-bff1-f154787b3508" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_41f57776-3327-4c64-9d49-fab428febc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ad7b9b32-47e6-458f-bd79-b4c9298230d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_5b378552-942d-415b-bff1-f154787b3508" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ad7b9b32-47e6-458f-bd79-b4c9298230d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_8de60936-2986-47cd-b674-5eac6a5e0554" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_5b378552-942d-415b-bff1-f154787b3508" xlink:to="loc_sera_LeaseLiabilitiesTotal_8de60936-2986-47cd-b674-5eac6a5e0554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_3b6081c9-b711-4bb0-b77a-3a2def5b5a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f38e06d2-6daa-4e56-a903-de5c2df11b18" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_3b6081c9-b711-4bb0-b77a-3a2def5b5a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_27718167-5a30-4230-8776-ece8dbde3009" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f38e06d2-6daa-4e56-a903-de5c2df11b18" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_27718167-5a30-4230-8776-ece8dbde3009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7ad95b23-c760-4aa4-a9d0-630a50099ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f38e06d2-6daa-4e56-a903-de5c2df11b18" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7ad95b23-c760-4aa4-a9d0-630a50099ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesLeaseCostandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8def70c-4e9b-4959-baff-0bb2984f8d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_54abbce0-1657-46f2-8a37-4a5da3824b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8def70c-4e9b-4959-baff-0bb2984f8d6d" xlink:to="loc_us-gaap_LeaseCostAbstract_54abbce0-1657-46f2-8a37-4a5da3824b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_20cadee3-d637-4370-8fb3-0a43532948c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_54abbce0-1657-46f2-8a37-4a5da3824b54" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_20cadee3-d637-4370-8fb3-0a43532948c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_07bb5f77-8710-4d9b-8cc4-212710857577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_54abbce0-1657-46f2-8a37-4a5da3824b54" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_07bb5f77-8710-4d9b-8cc4-212710857577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_aae379de-41da-4a9c-ba76-79338d9b08a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_54abbce0-1657-46f2-8a37-4a5da3824b54" xlink:to="loc_us-gaap_OperatingLeaseCost_aae379de-41da-4a9c-ba76-79338d9b08a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ddc5d871-75a5-4d93-87fe-532a6eab909c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_54abbce0-1657-46f2-8a37-4a5da3824b54" xlink:to="loc_us-gaap_LeaseCost_ddc5d871-75a5-4d93-87fe-532a6eab909c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseOtherInformationAbstract_32a0cfd8-4756-4e00-aaaa-2c393d77f11a" xlink:href="sera-20230331.xsd#sera_LeaseOtherInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8def70c-4e9b-4959-baff-0bb2984f8d6d" xlink:to="loc_sera_LeaseOtherInformationAbstract_32a0cfd8-4756-4e00-aaaa-2c393d77f11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeasesOtherInformationAbstract_101131e9-1f35-4e19-a95a-5bbd1cbf0fd6" xlink:href="sera-20230331.xsd#sera_FinanceLeasesOtherInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseOtherInformationAbstract_32a0cfd8-4756-4e00-aaaa-2c393d77f11a" xlink:to="loc_sera_FinanceLeasesOtherInformationAbstract_101131e9-1f35-4e19-a95a-5bbd1cbf0fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_92475fe9-8687-4c61-a51f-fa3f98f3663f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_101131e9-1f35-4e19-a95a-5bbd1cbf0fd6" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_92475fe9-8687-4c61-a51f-fa3f98f3663f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_614840b8-caea-4b52-b23c-def8c901d8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_101131e9-1f35-4e19-a95a-5bbd1cbf0fd6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_614840b8-caea-4b52-b23c-def8c901d8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_40de01f6-0b2e-4666-9909-9d73bcee7e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_101131e9-1f35-4e19-a95a-5bbd1cbf0fd6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_40de01f6-0b2e-4666-9909-9d73bcee7e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_43cf3c80-ab1a-46c7-b9ef-a9674f9aec99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_101131e9-1f35-4e19-a95a-5bbd1cbf0fd6" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_43cf3c80-ab1a-46c7-b9ef-a9674f9aec99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_974e4a6a-33c4-4b63-ad7f-d55919f04632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_101131e9-1f35-4e19-a95a-5bbd1cbf0fd6" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_974e4a6a-33c4-4b63-ad7f-d55919f04632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OperatingLeasesOtherInformationAbstract_6a2641f8-c3eb-43e8-90b1-45c4f67d0095" xlink:href="sera-20230331.xsd#sera_OperatingLeasesOtherInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseOtherInformationAbstract_32a0cfd8-4756-4e00-aaaa-2c393d77f11a" xlink:to="loc_sera_OperatingLeasesOtherInformationAbstract_6a2641f8-c3eb-43e8-90b1-45c4f67d0095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ba0524a7-1a75-4e09-9f47-a2d87aa24608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_6a2641f8-c3eb-43e8-90b1-45c4f67d0095" xlink:to="loc_us-gaap_OperatingLeasePayments_ba0524a7-1a75-4e09-9f47-a2d87aa24608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_477acc1d-ee13-4f5d-95cc-3ead4d83514a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_6a2641f8-c3eb-43e8-90b1-45c4f67d0095" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_477acc1d-ee13-4f5d-95cc-3ead4d83514a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_82a0fd82-f37d-42b8-a141-27b0c44219dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_6a2641f8-c3eb-43e8-90b1-45c4f67d0095" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_82a0fd82-f37d-42b8-a141-27b0c44219dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c710f5b5-a113-4778-bb4b-2c360b28a7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_6a2641f8-c3eb-43e8-90b1-45c4f67d0095" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c710f5b5-a113-4778-bb4b-2c360b28a7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_776b2b0a-2961-47e8-a3e9-ae23a899e0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_776b2b0a-2961-47e8-a3e9-ae23a899e0c3" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_3727f7e3-a6b5-4dcb-ac9c-f215cdc48754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_3727f7e3-a6b5-4dcb-ac9c-f215cdc48754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_00f5404e-82ac-4721-bb1e-390f71e18ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_00f5404e-82ac-4721-bb1e-390f71e18ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_00511bf4-8367-4250-8c6d-de3499d25e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_00511bf4-8367-4250-8c6d-de3499d25e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_547834cf-af39-470c-9e2e-360ea59951eb" xlink:href="sera-20230331.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_547834cf-af39-470c-9e2e-360ea59951eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fad9f44e-d12a-4d22-a541-053c5e80a4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fad9f44e-d12a-4d22-a541-053c5e80a4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0cc88bb9-c64a-4b07-bf92-e925b5a59674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0cc88bb9-c64a-4b07-bf92-e925b5a59674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5db72ed6-3317-49d9-a02a-473046872b44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_OperatingLeaseLiability_5db72ed6-3317-49d9-a02a-473046872b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4f16f090-ed16-46c7-913c-1bf27d747588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4f16f090-ed16-46c7-913c-1bf27d747588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4633b219-e4cf-4685-b8b3-f0ea95475079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_790df572-0f18-4fec-ab57-cd068ab7750a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4633b219-e4cf-4685-b8b3-f0ea95475079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_776b2b0a-2961-47e8-a3e9-ae23a899e0c3" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6aedf5c8-404f-4120-8380-b86925dabc46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6aedf5c8-404f-4120-8380-b86925dabc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_4f5b585e-2e89-4b6f-b6bf-c96821f988ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_4f5b585e-2e89-4b6f-b6bf-c96821f988ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_69bd9e8a-d8d1-4923-9105-c53140b2b718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_69bd9e8a-d8d1-4923-9105-c53140b2b718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_443c5493-f433-4a27-aa09-a62ba9886a3a" xlink:href="sera-20230331.xsd#sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_443c5493-f433-4a27-aa09-a62ba9886a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_799c1853-d54b-4c84-837f-6c53b00bbcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_799c1853-d54b-4c84-837f-6c53b00bbcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9c3ed1c3-4049-412c-bdc9-2fb4ef6ad68b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9c3ed1c3-4049-412c-bdc9-2fb4ef6ad68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d027fcbd-48e4-465a-840b-14038f2474e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiability_d027fcbd-48e4-465a-840b-14038f2474e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_f9bb589f-b028-4feb-82d7-af00f0b69b74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_f9bb589f-b028-4feb-82d7-af00f0b69b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9b3c5d87-9b8d-4e97-a4ca-313c4379f0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_24038b85-47db-432b-960e-5606ce95e086" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9b3c5d87-9b8d-4e97-a4ca-313c4379f0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityPaymentDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_776b2b0a-2961-47e8-a3e9-ae23a899e0c3" xlink:to="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_d28d3a68-2093-40a6-97a7-5921beca9a22" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_d28d3a68-2093-40a6-97a7-5921beca9a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearOne_83a55646-605e-481f-b95a-fd215b8e074a" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityToBePaidYearOne_83a55646-605e-481f-b95a-fd215b8e074a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearTwo_9d8e4021-6a97-42a7-9894-b2175b3ad7ea" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityToBePaidYearTwo_9d8e4021-6a97-42a7-9894-b2175b3ad7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearThreeAndThereafter_036f23f3-2a74-44f2-bbb6-64fc1e4bd697" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityToBePaidYearThreeAndThereafter"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityToBePaidYearThreeAndThereafter_036f23f3-2a74-44f2-bbb6-64fc1e4bd697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue_97fedf59-f244-4637-9b8e-20578af8c59f" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityPaymentDue_97fedf59-f244-4637-9b8e-20578af8c59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityUndiscountedExcessAmount_83e139d2-0004-44de-8629-b520426d91b3" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityUndiscountedExcessAmount_83e139d2-0004-44de-8629-b520426d91b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_487072cf-e81e-4a81-9a03-d4afef19a33d" xlink:href="sera-20230331.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilitiesTotal_487072cf-e81e-4a81-9a03-d4afef19a33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityCurrent_15491420-70cc-44e0-b9e3-db89232f0a93" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityCurrent_15491420-70cc-44e0-b9e3-db89232f0a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityNoncurrent_c1fccdb9-679d-4526-bc07-47703d3767ef" xlink:href="sera-20230331.xsd#sera_LeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_3f5b0eeb-7bff-470f-a139-0f8c6e6f67ff" xlink:to="loc_sera_LeaseLiabilityNoncurrent_c1fccdb9-679d-4526-bc07-47703d3767ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#CommitmentsandContingencesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a45e3a59-0d20-4f6d-8f49-244a6d39e108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesTable_bf77684b-f1a2-49a5-8a1a-9361afd58378" xlink:href="sera-20230331.xsd#sera_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a45e3a59-0d20-4f6d-8f49-244a6d39e108" xlink:to="loc_sera_CommitmentsAndContingenciesTable_bf77684b-f1a2-49a5-8a1a-9361afd58378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7b2511c2-3dde-481f-b9a7-72277292d991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesTable_bf77684b-f1a2-49a5-8a1a-9361afd58378" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7b2511c2-3dde-481f-b9a7-72277292d991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_534117fb-aec2-436a-9dc8-63916bdbce0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7b2511c2-3dde-481f-b9a7-72277292d991" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_534117fb-aec2-436a-9dc8-63916bdbce0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OfficeAndLaboratorySpaceMember_6cb947da-62ac-4795-81b4-3c41dc3cd689" xlink:href="sera-20230331.xsd#sera_OfficeAndLaboratorySpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_534117fb-aec2-436a-9dc8-63916bdbce0a" xlink:to="loc_sera_OfficeAndLaboratorySpaceMember_6cb947da-62ac-4795-81b4-3c41dc3cd689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:href="sera-20230331.xsd#sera_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesTable_bf77684b-f1a2-49a5-8a1a-9361afd58378" xlink:to="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_6826cd6e-b580-45c7-bd91-fbcb4627e18b" xlink:href="sera-20230331.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:to="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_6826cd6e-b580-45c7-bd91-fbcb4627e18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IndemnificationLiability_f28484e2-c163-46a2-ba2f-0a5e7bc19508" xlink:href="sera-20230331.xsd#sera_IndemnificationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_89855552-eecb-4782-9f7e-7c9e10e54265" xlink:to="loc_sera_IndemnificationLiability_f28484e2-c163-46a2-ba2f-0a5e7bc19508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="sera-20230331.xsd#NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_28f18dfa-ad94-4b63-b82e-af1c7e5fd984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5c34bdc7-35a4-4f52-abeb-4d1d62210991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_28f18dfa-ad94-4b63-b82e-af1c7e5fd984" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5c34bdc7-35a4-4f52-abeb-4d1d62210991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1fdd5169-1699-4be5-86f2-d6dcef570dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5c34bdc7-35a4-4f52-abeb-4d1d62210991" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1fdd5169-1699-4be5-86f2-d6dcef570dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1fdd5169-1699-4be5-86f2-d6dcef570dd0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_450fc36a-1260-4cc2-bdd8-53ebd45f78d8" xlink:href="sera-20230331.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_450fc36a-1260-4cc2-bdd8-53ebd45f78d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_db4b3623-4213-421f-8f95-4a4de81c3813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_db4b3623-4213-421f-8f95-4a4de81c3813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_785ccc6a-1be9-4b2a-9847-05b58e2ac1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4850d80e-ac1d-4c3c-b2ae-97ac2402817d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_785ccc6a-1be9-4b2a-9847-05b58e2ac1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_42e2d98e-d4e6-480f-969b-686444e7265a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5c34bdc7-35a4-4f52-abeb-4d1d62210991" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_42e2d98e-d4e6-480f-969b-686444e7265a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_163349f7-9547-4de3-9317-e142b5e458ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_42e2d98e-d4e6-480f-969b-686444e7265a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_163349f7-9547-4de3-9317-e142b5e458ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345175728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SERA PROGNOSTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1911522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2749 East Parleys Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">990-0520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SERA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,646,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512338863952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 27,201<span></span>
</td>
<td class="nump">$ 29,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">43,587<span></span>
</td>
<td class="nump">52,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">72,110<span></span>
</td>
<td class="nump">90,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">2,907<span></span>
</td>
<td class="nump">3,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term marketable securities</a></td>
<td class="nump">28,917<span></span>
</td>
<td class="nump">21,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,676<span></span>
</td>
<td class="nump">1,816<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">105,610<span></span>
</td>
<td class="nump">116,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="nump">2,692<span></span>
</td>
<td class="nump">4,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligation, current portion</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">9,067<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="nump">15,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligation, net of current portion</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">15,400<span></span>
</td>
<td class="nump">17,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 150,000,000 Class A shares authorized; 29,616,781 and 29,612,687 Class A shares issued and outstanding as of March&#160;31, 2023 and December&#160;31, 2022, respectively; 1,500,000 Class B shares authorized; 1,405,259 Class B shares issued and outstanding as of March&#160;31, 2023 and December&#160;31, 2022.</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">311,883<span></span>
</td>
<td class="nump">310,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(457)<span></span>
</td>
<td class="num">(981)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(221,219)<span></span>
</td>
<td class="num">(210,654)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">90,210<span></span>
</td>
<td class="nump">98,943<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 105,610<span></span>
</td>
<td class="nump">$ 116,329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512338852704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in shares)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">29,616,781<span></span>
</td>
<td class="nump">29,612,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">29,616,781<span></span>
</td>
<td class="nump">29,612,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in shares)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,405,259<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,405,259<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512344199760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations and Comprehensive Loss (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense', window );">Cost of revenue</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,103<span></span>
</td>
<td class="nump">3,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,446<span></span>
</td>
<td class="nump">4,538<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">11,429<span></span>
</td>
<td class="nump">12,338<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(11,329)<span></span>
</td>
<td class="num">(12,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,565)<span></span>
</td>
<td class="num">$ (12,208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares of common stock outstanding, basic (in shares)</a></td>
<td class="nump">31,019,311<span></span>
</td>
<td class="nump">30,801,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares of common stock outstanding, diluted (In shares)</a></td>
<td class="nump">31,019,311<span></span>
</td>
<td class="nump">30,801,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on available-for-sale debt securities</a></td>
<td class="nump">$ 524<span></span>
</td>
<td class="num">$ (473)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive gain (loss)</a></td>
<td class="nump">524<span></span>
</td>
<td class="num">(473)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (10,041)<span></span>
</td>
<td class="num">$ (12,681)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339614688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock (Class A and B)</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,774,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="nump">$ 138,564<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 305,212<span></span>
</td>
<td class="num">$ (183)<span></span>
</td>
<td class="num">$ (166,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain</a></td>
<td class="num">(473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,208)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,897,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Mar. 31, 2022</a></td>
<td class="nump">127,203<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">306,532<span></span>
</td>
<td class="num">(656)<span></span>
</td>
<td class="num">(178,676)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,017,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2022</a></td>
<td class="nump">$ 98,943<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">310,575<span></span>
</td>
<td class="num">(981)<span></span>
</td>
<td class="num">(210,654)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="nump">4,094<span></span>
</td>
<td class="nump">4,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain</a></td>
<td class="nump">524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,565)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,022,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Mar. 31, 2023</a></td>
<td class="nump">$ 90,210<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 311,883<span></span>
</td>
<td class="num">$ (457)<span></span>
</td>
<td class="num">$ (221,219)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512344920256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="nump">4,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain</a></td>
<td class="nump">$ 524<span></span>
</td>
<td class="num">$ (473)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock (Class A and B)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="nump">4,094<span></span>
</td>
<td class="nump">123,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain</a></td>
<td class="nump">$ 524<span></span>
</td>
<td class="num">$ (473)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345132528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,565)<span></span>
</td>
<td class="num">$ (12,208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Operating Lease, Right-of-Use Asset, Amortization Expense</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(184)<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="num">(1,893)<span></span>
</td>
<td class="num">(1,942)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(4,881)<span></span>
</td>
<td class="num">(9,557)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(14,735)<span></span>
</td>
<td class="num">(6,614)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities and sales of marketable securities</a></td>
<td class="nump">17,094<span></span>
</td>
<td class="nump">21,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">2,320<span></span>
</td>
<td class="nump">14,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance lease principal payments</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(116)<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(2,677)<span></span>
</td>
<td class="nump">5,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">29,878<span></span>
</td>
<td class="nump">58,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">27,201<span></span>
</td>
<td class="nump">64,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities', window );">Purchases of property and equipment in accounts payable and accruals</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345172528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Financial Condition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of Business and Financial Condition</a></td>
<td class="text">Description of Business and Financial Condition<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sera Prognostics, Inc. (the &#8220;Company&#8221;) is a women&#8217;s health company utilizing its proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests with an initial focus on improving pregnancy outcomes. The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;)-certified laboratory.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company&#8217;s activities have consisted of performing research and development, conducting clinical studies, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of $221.2&#160;million as of March&#160;31, 2023. The Company&#8217;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#8217;s commercialization activities for the PreTRM test, and to support additional clinical and preclinical trials and anticipated research and development activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its diagnostic products and could be required to delay, scale back, or abandon some or all of its development programs and other operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all. Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#8217;s future operations are highly dependent on a combination of factors, including (i) the successful commercial launch and market acceptance of the PreTRM test; (ii) the success of clinical trials and other research and development programs; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#8217;s ability to manage growth of the organization; (v) the Company&#8217;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal sources of the Company&#8217;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#8220;IPO&#8221;), which was completed in July 2021. As of March&#160;31, 2023, the Company had aggregate cash, cash equivalents, and available-for-sale securities of $99.7 million. See Note 3&#8212;Cash, Cash Equivalents and Marketable Securities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these unaudited condensed financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512435974368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. The unaudited interim condensed financial statements have been </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2022, and, in the opinion of the Company&#8217;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial results. The balance sheet as of December&#160;31, 2022 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2023, or any other period.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in the Company&#8217;s significant accounting policies during the three months ended March 31, 2023, as compared with those disclosed in its Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on March 22, 2023. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period&#8217;s presentation. The reclassifications did not have a significant impact on the condensed financial statements. </span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. </span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial statements as of and for the three months ended March&#160;31, 2023 reflect the Company&#8217;s estimates of the impact of the macroeconomic environment, including the impact of inflation, higher interest rates, and the COVID-19 pandemic. The extent to which these conditions will directly or indirectly impact the Company&#8217;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of this filing.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345423488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents and Marketable Securities</a></td>
<td class="text">Cash, Cash Equivalents and Marketable Securities<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its marketable securities as available-for-sale. The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of March&#160;31, 2023 and December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,917&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,015&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of March&#160;31, 2023 and December&#160;31, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,650&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,413&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, the Company had not recorded any allowance for credit losses related to its available-for-sale securities. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities classified by contractual maturities as of March&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.719%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345412256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net, as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,315&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Depreciation and amortization expense was $0.2&#160;million for each of the three months ended March&#160;31, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341370880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued and Other Current Liabilities</a></td>
<td class="text">Accrued and Other Current Liabilities<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of accrued and other current liabilities as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued 401(k) matching contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345416560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Income, net</a></td>
<td class="text">Other Income, net<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of other income, net, for the three months ended March&#160;31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">257</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investment income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">523</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">780</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 610<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//610/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 720<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//720/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341344944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value MeasurementsAs of March&#160;31, 2023 and December&#160;31, 2022, the carrying amounts of the Company&#8217;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds are highly liquid investments and are actively traded. The pricing information on money market funds is readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency bonds, U.S. government bonds, commercial paper, and corporate debt securities are measured at fair value using Level 2 inputs. The Company reviews trading activity and pricing for these investments as of each measurement date. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of March&#160;31, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">99,137&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,618&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341182240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, the Company entered into a master services agreement with Carelon Research, a subsidiary of Elevance Health, Inc. (&#8220;Elevance Health&#8221;). This agreement covers a range of research projects, including Carelon Research&#8217;s role as a contract research organization for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rematurity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">isk Assessment Combined With Clinical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterventions for Improving Neonatal outco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s (&#8220;PRIME&#8221;) study. The Company paid fees related to this agreement of $0.8&#160;million and $0.7&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. The Company recognized revenues related to this agreement of $21&#160;thousand and $19 thousand for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#8220;Commercial Collaboration Agreement&#8221;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#8217;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first three years of the term of the Commercial Collaboration Agreement. The Company received $6.0&#160;million during the three months ended March 31, 2023, which amount related to the minimum payments for the year ended December&#160;31, 2022. Such minimum payments were initially recorded as deferred revenue. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elevance Health has been participating in the Company&#8217;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#8217;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the three months ended March&#160;31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341152704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Structure</a></td>
<td class="text">Capital Structure<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to one share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#8217;s amended and restated certificate of incorporation. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares of Class A common stock were reserved for future issuance:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,875,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,428,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restricted stock units outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,312,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,926,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">894,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">598,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,206,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,729,552&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341217280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2011 Plan&#8221;) and reserved shares of the Company&#8217;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a four-year period and generally expire ten years from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors, and consultants of the Company. Options generally vest over a four-year period, are exercisable only to the extent vested, and generally expire ten years from the date of grant. Restricted stock units (&#8220;RSUs&#8221;) generally vest over a four-year period. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of March&#160;31, 2023, there were 2,312,525 shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of March&#160;31, 2023, there were 894,903 shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 ESPP. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, references to &#8220;options&#8221; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. The following table summarizes information about these options granted and outstanding:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,428,441&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.65&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">612,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(161,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,875,249&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest at March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,497,717&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and exercisable at March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,890,492&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding &#8212; December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding &#8212; March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">349&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">383&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total employee stock-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,304&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,222&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of March&#160;31, 2023 was as follows (in thousands, except years):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Stock-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Period of Recognition (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341209104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_WarrantsTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. The Company&#8217;s common stock warrants outstanding were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of Warrants Outstanding as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341207872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingences<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingences</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#8217;s leases, the Company&#8217;s incremental borrowing rate or the Company&#8217;s intent to exercise or not exercise options available in lease contracts. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease-Related Assets and Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Statement Line Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_6babe0e6-7d50-47d4-ae07-e3d8e9b39332"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_9f65a529-ecfc-438c-ac40-deeaa75b2ba3">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_25937204-c7d0-4da0-b8e8-5206df574dab"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_f6cc0dfd-5c42-43a4-b226-d068765cef24">Property and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_0a2d43e5-22d4-456d-aeb7-ab2c07bd5c2e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_54e9da06-5917-4d9b-92d1-259e176f90a9">Accrued and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of March&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a total of approximately 24,300 square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2025 (as amended, the &#8220;Office Lease&#8221;). The Office Lease includes an early termination right which termination would occur under certain circumstances, as provided in the amended Office Lease, after July 1, 2024, if exercised. The Company is not currently reasonably certain it will exercise the termination right. The implicit rate provided in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#8217;s current finance leases include bargain purchase options that the Company is reasonably certain to </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#8217;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#8217;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has no liabilities recorded for these agreements as of March&#160;31, 2023 and December&#160;31, 2022. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#8217;s future results of operations, cash flows, or financial position.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341211104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net loss per share</a></td>
<td class="text">Net loss per share<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the three months ended March&#160;31, 2023 and 2022, the Company reported net losses and as such, basic and diluted net loss per share are the same. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the liquidation and dividend rights are identical for Class A and Class B common stock, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the three months ended March&#160;31, 2023 and 2022. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,875,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,016,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restricted stock units outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,998,663&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,805,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341229568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. The unaudited interim condensed financial statements have been </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2022, and, in the opinion of the Company&#8217;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial results. The balance sheet as of December&#160;31, 2022 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2023, or any other period.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in the Company&#8217;s significant accounting policies during the three months ended March 31, 2023, as compared with those disclosed in its Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on March 22, 2023. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div>Certain prior period amounts have been reclassified to conform with the current period&#8217;s presentation. The reclassifications did not have a significant impact on the condensed financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. </span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial statements as of and for the three months ended March&#160;31, 2023 reflect the Company&#8217;s estimates of the impact of the macroeconomic environment, including the impact of inflation, higher interest rates, and the COVID-19 pandemic. The extent to which these conditions will directly or indirectly impact the Company&#8217;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of this filing.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512340267888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type</a></td>
<td class="text">The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of March&#160;31, 2023 and December&#160;31, 2022 were as follows (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,917&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,015&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Marketable Securities Classified by Contractual Maturities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities classified by contractual maturities as of March&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.719%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Marketable Securities and Cash Equivalents in Unrealized Loss Positions</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of March&#160;31, 2023 and December&#160;31, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,650&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,413&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341167792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Components of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net, as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,315&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341244416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Components of Accrued and Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of accrued and other current liabilities as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued 401(k) matching contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341207872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Components of Other Income, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of other income, net, for the three months ended March&#160;31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">257</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investment income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">523</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">780</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341207872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of March&#160;31, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">99,137&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,618&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341280672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares of Class A common stock were reserved for future issuance:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,875,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,428,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restricted stock units outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,312,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,926,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">894,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">598,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,206,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,729,552&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of common stock reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512337892240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Options Granted and Outstanding</a></td>
<td class="text">The following table summarizes information about these options granted and outstanding:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,428,441&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.65&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">612,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(161,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,875,249&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest at March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,497,717&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and exercisable at March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,890,492&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding &#8212; December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding &#8212; March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Impact of Stock-based Compensation Expense in the Statements of Operations</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">349&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">383&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total employee stock-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,304&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,222&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Share-Based Payment Arrangement, Nonvested Award, Cost</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of March&#160;31, 2023 was as follows (in thousands, except years):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Stock-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Period of Recognition (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (i)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512341090496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants or Rights</a></td>
<td class="text">The Company&#8217;s common stock warrants outstanding were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of Warrants Outstanding as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512344129664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock', window );">Schedule of Leases in Financial Statement</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease-Related Assets and Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Statement Line Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_6babe0e6-7d50-47d4-ae07-e3d8e9b39332"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_9f65a529-ecfc-438c-ac40-deeaa75b2ba3">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_25937204-c7d0-4da0-b8e8-5206df574dab"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_f6cc0dfd-5c42-43a4-b226-d068765cef24">Property and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_0a2d43e5-22d4-456d-aeb7-ab2c07bd5c2e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_54e9da06-5917-4d9b-92d1-259e176f90a9">Accrued and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost and Other Information</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of March&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of March&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leases In Statement Of Financial Position</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345092080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,875,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,016,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restricted stock units outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">347,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,998,663&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,805,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512342120640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Business and Financial Condition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (221,219)<span></span>
</td>
<td class="num">$ (210,654)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue', window );">Fair Value</a></td>
<td class="nump">$ 99,705<span></span>
</td>
<td class="nump">$ 104,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512338117504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 72,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">72,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">100,162<span></span>
</td>
<td class="nump">$ 105,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(519)<span></span>
</td>
<td class="num">(984)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue', window );">Fair Value</a></td>
<td class="nump">99,705<span></span>
</td>
<td class="nump">104,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">27,206<span></span>
</td>
<td class="nump">29,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">27,201<span></span>
</td>
<td class="nump">29,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">2,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">2,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">25,743<span></span>
</td>
<td class="nump">26,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">25,738<span></span>
</td>
<td class="nump">26,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">43,905<span></span>
</td>
<td class="nump">53,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(318)<span></span>
</td>
<td class="num">(568)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">43,587<span></span>
</td>
<td class="nump">52,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">11,125<span></span>
</td>
<td class="nump">15,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">11,092<span></span>
</td>
<td class="nump">15,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">26,102<span></span>
</td>
<td class="nump">28,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(364)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">25,892<span></span>
</td>
<td class="nump">28,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">6,678<span></span>
</td>
<td class="nump">8,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">6,603<span></span>
</td>
<td class="nump">8,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">29,051<span></span>
</td>
<td class="nump">21,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(407)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">28,917<span></span>
</td>
<td class="nump">21,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">17,236<span></span>
</td>
<td class="nump">9,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">17,221<span></span>
</td>
<td class="nump">9,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">10,646<span></span>
</td>
<td class="nump">10,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(131)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 10,520<span></span>
</td>
<td class="nump">$ 10,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339383744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">$ 54,755<span></span>
</td>
<td class="nump">$ 64,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">22,598<span></span>
</td>
<td class="nump">34,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">77,353<span></span>
</td>
<td class="nump">99,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">32,187<span></span>
</td>
<td class="nump">40,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">32,187<span></span>
</td>
<td class="nump">40,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">11,898<span></span>
</td>
<td class="nump">12,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">17,946<span></span>
</td>
<td class="nump">25,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">29,844<span></span>
</td>
<td class="nump">38,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">10,670<span></span>
</td>
<td class="nump">10,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">4,652<span></span>
</td>
<td class="nump">8,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">15,322<span></span>
</td>
<td class="nump">19,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512340574400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">$ 22,598,000<span></span>
</td>
<td class="nump">$ 34,413,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Debt Securities, Available-for-Sale, Allowance for Credit Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512338843664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 43,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">29,051<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">72,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">43,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">28,917<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 72,504<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339327696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Components of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="nump">$ 9,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(6,493)<span></span>
</td>
<td class="num">(6,256)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">2,907<span></span>
</td>
<td class="nump">3,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">5,990<span></span>
</td>
<td class="nump">5,914<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">1,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512342594352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512338845632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 744<span></span>
</td>
<td class="nump">$ 2,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued vacation</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued 401(k) matching contributions</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current portion</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">655<span></span>
</td>
<td class="nump">637<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued and other current liabilities</a></td>
<td class="nump">$ 2,692<span></span>
</td>
<td class="nump">$ 4,444<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483070/710-10-25-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345185440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">$ 257<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium', window );">Investment income, net</a></td>
<td class="nump">523<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 780<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339105504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">$ 72,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">$ 2,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">2,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">99,137<span></span>
</td>
<td class="nump">100,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">11,092<span></span>
</td>
<td class="nump">15,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">43,113<span></span>
</td>
<td class="nump">38,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">17,123<span></span>
</td>
<td class="nump">19,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">25,738<span></span>
</td>
<td class="nump">26,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512345105664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,429<span></span>
</td>
<td class="nump">$ 12,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember', window );">Master services agreement | Related Party | Healthcore Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember', window );">Laboratory Services Agreement | Related Party | Elevance Health, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember', window );">Commercial Collaboration Agreement | Related Party | Elevance Health, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm', window );">Term of agreement</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RelatedPartyTransactionCashReceivedFromRelatedParty', window );">Cash receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RelatedPartyTransactionCashReceivedFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Cash Received From Related Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RelatedPartyTransactionCashReceivedFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sera_CarelonResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sera_CarelonResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sera_ElevanceHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sera_ElevanceHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339427408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Structure - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>vote </div>
<div>common_stock_class</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_NumberOfCommonStockClassesAuthorized', window );">Number of common stock classes authorized | common_stock_class</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommonStockConversionRatio', window );">Common stock, conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_NumberOfVotesPerShare', window );">Number of votes per share | vote</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_NumberOfCommonStockClassesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Common Stock Classes Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_NumberOfCommonStockClassesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_NumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_NumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512340538576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Structure - Common Stock (Details) - Class A common stock - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">15,206,091<span></span>
</td>
<td class="nump">13,729,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">347,436<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Warrants to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,775,978<span></span>
</td>
<td class="nump">2,775,978<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Options to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">8,875,249<span></span>
</td>
<td class="nump">8,428,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock available for future grants under the 2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,312,525<span></span>
</td>
<td class="nump">1,926,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">894,903<span></span>
</td>
<td class="nump">598,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512340492960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2011</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,206,091<span></span>
</td>
<td class="nump">13,729,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2011Member', window );">2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan | Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,312,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_PlanEspp2021Member', window );">2021 ESPP | Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_Plan2011Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_Plan2011Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_Plan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_Plan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_PlanEspp2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_PlanEspp2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512340493056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Options (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares Subject to Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning (in shares)</a></td>
<td class="nump">8,428,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">612,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(161,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(4,094)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end (in shares)</a></td>
<td class="nump">8,875,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)</a></td>
<td class="nump">8,497,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of shares subject to options outstanding, vested and exercisable at the end</a></td>
<td class="nump">4,890,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning (in usd per share)</a></td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share)</a></td>
<td class="nump">3.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in usd per share)</a></td>
<td class="nump">6.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="nump">0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end (in usd per share)</a></td>
<td class="nump">3.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)</a></td>
<td class="nump">3.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price per share, vested and exercisable at the end (in usd per share)</a></td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, outstanding</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, vested and expected to vest at the end</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, vested and exercisable at the end</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="nump">$ 9,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at the end</a></td>
<td class="nump">9,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, vested and exercisable at the end</a></td>
<td class="nump">$ 7,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339441600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Units (Details) - Restricted Stock Units (RSUs)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">347,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(388)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">347,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">3.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">3.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339303248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">$ 1,304<span></span>
</td>
<td class="nump">$ 1,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512342075696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Unrecognized Cost (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized stock-based compensation cost</a></td>
<td class="nump">$ 10,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 11,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 1,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512344190176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Common Stock Warrants Outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">2,775,978<span></span>
</td>
<td class="nump">2,775,978<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember', window );">5.20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 5.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">3,473<span></span>
</td>
<td class="nump">3,473<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember', window );">9.03</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 9.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,032,404<span></span>
</td>
<td class="nump">1,032,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember', window );">10.84</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 10.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,009,795<span></span>
</td>
<td class="nump">1,009,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember', window );">12.38</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 12.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">8,083<span></span>
</td>
<td class="nump">8,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt2077SharePriceMember', window );">20.77</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 20.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">722,223<span></span>
</td>
<td class="nump">722,223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt2077SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt2077SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339256448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingences - Leases in Financial Statement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RightOfUseAssetAbstract', window );"><strong>Right-of-use assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">$ 1,579<span></span>
</td>
<td class="nump">$ 1,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">1,234<span></span>
</td>
<td class="nump">1,317<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RightOfUseAssetTotal', window );">Total right-of-use assets</a></td>
<td class="nump">2,813<span></span>
</td>
<td class="nump">3,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligation, current portion</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligation, net of current portion</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesTotal', window );">Total lease liabilities</a></td>
<td class="nump">$ 2,584<span></span>
</td>
<td class="nump">$ 2,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RightOfUseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RightOfUseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RightOfUseAssetTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RightOfUseAssetTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512340538096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingences - Lease Cost and Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_FinanceLeasesOtherInformationAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash outflows</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash outflows</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">630.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_OperatingLeasesOtherInformationAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows</a></td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">450.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_FinanceLeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Leases, Other Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_FinanceLeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_OperatingLeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Other Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_OperatingLeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512337948512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingences - Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(169)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">1,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityPaymentDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearOne', window );">2024</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearTwo', window );">2025</a></td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearThreeAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityPaymentDue', window );">Total minimum lease payments</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesTotal', window );">Total lease liabilities</a></td>
<td class="nump">2,584<span></span>
</td>
<td class="nump">$ 2,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, Year Three and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityPaymentDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityPaymentDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityPaymentDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityPaymentDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Remainder of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearThreeAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year Three and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearThreeAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512339444512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingences - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_IndemnificationLiability', window );">Indemnification liability | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember', window );">Office and laboratory space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory', window );">Number of square feet under lease | ft&#178;</a></td>
<td class="nump">24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_IndemnificationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of indemnification liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_IndemnificationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The area of leased office and laboratory space.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140512342203504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">11,998,663<span></span>
</td>
<td class="nump">10,805,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember', window );">Warrants to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">2,775,978<span></span>
</td>
<td class="nump">2,788,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">8,875,249<span></span>
</td>
<td class="nump">8,016,915<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">347,436<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>sera-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sera="http://www.seraprognostics.com/20230331"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sera-20230331.xsd" xlink:type="simple"/>
    <context id="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i27cc1a39b2364e15ae9b07bafaed08b2_I20230505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="icad9b28978d3427cad4b33b66939a88c_I20230505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="if2f86cfb811b477c983db67e5f541347_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc43b85330464574a0488ebcc9d967d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i44fb940986b84760a203d1102bc5f10c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a6d82be7a45430fb85fd8fb397576f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5d7acae39b0445e2914b0355b32a99e9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id4d3bc1d35134987a7abd9a77560576f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i60cd390e284b4c57b8f9e0990b0772c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3233753d7b7b4837a79035352c82a4f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibdec2990e11742fcac46b167e2f60113_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iebd28250132e4da59b3527f68bcd2be8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i91d61589d78c40e5b1ddd61b6d506e58_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3a6260114f4c4349925d48192e947ea9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib06c86d910fe465187240359ca033ca7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib63e3a10c281463dba0c42a75f266866_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i29e8c63944d94a20a9d6766b70a0c209_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9fe8a51550be47699966c38055bb1d4b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id6871c65cc944ab196c8853108ee6522_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie6969513749542aeafcd5cabd8aff333_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i102890e5579345c7a2782bb6c17ab3d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i759304c058dd41a1a56e8cbcac33058d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib631629e369e46c19c68e6078da4b53d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iabcd47f9f5ed4cbeba9b2fdfbdc1b4e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3eb72449e36d49a0b292d86de7324cfe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4142468cfaf94c8d97f33b6fa3846d59_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf3445dbebdb41acb50360773c5fda39_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7322891383e14b2098410a7e202ed9fe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5ea46d61e8284efc8e56b1f492df7b7e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i867e414c4ecc491ab33db86a734bf4cb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5f2b384898354117be5364c3873188d6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib14c1cf96c624315af3e9139180f2e92_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1c4637a2a61f4b8590e6d478924a5417_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i60661342614546588426a472b8ef53eb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic4f2723f75e0456e8f0fa2a83157de06_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7ae393d120f14bfba0f069e945f76104_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5bda022044a541ba852cd6e4a507ce4e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4abd6f79e2649dea270a120dcbdc006_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1022d938781243e393cbc94f72b676c4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9217e3b057e04c0b8ad6ad0356390301_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i87361057a25b44d5a2e75382401dcee3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3fab6b70134645aeb45e87280e5fab28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibe79aa1340684f9e9f19d3b7afc15826_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ffcd942edee4fe393481beeab7dd9d4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0fd42b824770484b83699c48bd0c8cc7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6fe7f8c3896d4801a873549768ca0361_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cb30e5979214b32b0ec957e0ac792be_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i456d438d68a64c3b8c0f616f14448bf9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iedde383675c6474f9513b3d03ac58c92_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0075a7a5e5c84f4687883ce000262d46_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i875cb27901f440cf9dd94dd0c4f5f742_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2deca7aa011c40308abedfe147f96001_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i310f7526568741c38f0faf45c71f9fde_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd2491cc9c53478d8582d7bf64db387e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idbc319516ea3419a9ab9f009e01ff404_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7861a57d258d4089bf6e3c4e064742cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf90f3640b8b40f28e3c77908d915dfc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0689a9a22417417aa602cdd82583f081_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1a04512600a14358b38ac15e0b2e874e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if8d9fcb90d124c48bf1d71f64aa3bd4e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id6dda952857f4641ac1036d6bfa8fc81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6a5bd83d0814d7f87102db81904b40b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibb3cdc18256f4159ae134effb7028788_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i813380ad283a4a6c88946834430e11fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie590573b76374ef5bb34894c50c9c607_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0cf2635c182d4ec9aecdb319305ba09a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i02380a24291e41fe8beb052dfb3634a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1e6b5e7a18d4714be7dc3cd442de182_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f666d3ee1114f89a06ced8d07c1cac1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i633da3607bf74e6399a271d9b5a872dc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c7078405bba49d8b9ae3c7a24e77d59_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9a4c9f1b7de04945b27590548f7a034a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i42f38e0fd91b4bc9a6edd8c6525262eb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4f0e071eb624dad8e0ef430093db2f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i26ad96634a0944fc8ff1db153b046a32_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id1d1569554ae410b8a9034cde1714135_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6b5c62d74c5e4c13b5b1f9a2db0cb194_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied68b9ca26b446e59b4b4f792f403d2b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if7460c4b611a4c1a8deecbf81c1f906d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id73796b542fb4928ade5f07ade35d66b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f78ab542cac4bd0a4cde222a8e7e773_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i13be094f9c244c158024b56a7cb5ecff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3e5fb142963d40bc9752b25c78058aa4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibf70dfed4cf44986832bd01bae60b309_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i55bf665ab22b48dd84b5f6508b6dc531_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i262be437741d4c54906e37b798c135cd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib13ca83ce3884e60b6458d148f1cdfe4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2277bfa471754111acad933a7e99966c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie9901b75d0bf4b4595246dc12220f857_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i14d03532a9124a129f1031a6ffcab6a8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if3283049b13a48a5b0dbb4875b2c82fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6a86a8c7fd3142b59e9f55ee76ca645f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib17e4dfe8114480a9bd0dd5e85c27414_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1fef988414b43c6b092ed0b459b393c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e6d0b3094cc43ca8063063fc0d62736_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife9e1cfb0901453096411529be5647f8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9909f01379d9443cbe56ab0eacbd84b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb26f6e075f649db844239697d35cf44_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d5bf6251b7b4c75840430bed4b53f15_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i057f6cfcbe9647feaf5cdc6e8b694c95_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0936c84ad3f94183aeff5843d1470ea0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie061ca627cde49dea9441184eba4360a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia61bb82bb96640b6a960d4a434b01d37_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec6934a5de584a6f907ec7efe8ab449b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc6c9adab7224ca2974718d2d132d7c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i602355d9b023442ea2e229223e367f52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic6e649c834f541b1a07b68af95f39792_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i854e50c14d1a416c81e655b988108acc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ida65d68be4234d39ae17f2b0901689e3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d852401dd8c45f8bac931d6391e0d8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4150a09b96f64456861db2de07189a11_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e2b7a1779484a588d3e5dcc2f75c5c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iebe6c97e0a004df6add4d077081e8986_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i25502e94a007481095a51420d5929626_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic6233338a3de4492ac7fc3602d7b3429_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i81e3ed0434cf4e1fb660521a3660854b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iea4329433de54b779062bdcbf483862a_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i5f467c43c88a4619bd1e2b17c7062c3b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie51451f721f248449b164911776d14cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8e8d27e73cfa42b68409d0498a6072d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bac8f889d2845938fb80af53ea359b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i64464d2a8cea488d9bf93bc83aac4914_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5056875ac3244f5dbc3045e076055486_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i008a3034f9504be4bce1130bdf12035d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i721dc8e4c62a42abba54bc026dbfa057_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6df48d3ee72046c1810e7e4afa6e12be_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id97654d11c5a4152b663b94b04260e41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i08ddab687a264ed4a1e0870d43ec1462_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iddd0a6e59f784d5e8a2a70335dc43e4b_D20111101-20111130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-11-01</startDate>
            <endDate>2011-11-30</endDate>
        </period>
    </context>
    <context id="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="if2b38bbfb8c44e16b1a98f32cc4e64da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i10f872c050a642a4bd7b0d7bf50b2c15_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i589f0422795f40b0be50fa589249a5ab_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i77a70c0650fb42628493971aa4f0049c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib678e71d507240f7846a08db78ba061b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0e85b9ebdb094f55a3f434b347ee787f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i93bd5d88af7d410491f05716f1ed0e5f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i52391e73e9df469c9e683c465b16f7c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91b41e5291034c509f187d546c338915_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifd63d2c7f48d408eb0ef89901295964a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia80510f4b99d4483a37744999f4d0341_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97033eb4f8a64db2bc5f6fcfc26a6886_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c737e7bf4884940ada07d1250bbf18e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9359a27c7fc744aca0a2a0f6deb31bd8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i78e203d056cc4c4ca4772af00ea4d039_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i204da10f0e0c49cc8fb8c1a4ead9508e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id725e1f4b6344f8c9931c7da191af02c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i30dc8f5c5dd54233a474c8e03313302d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41ab44e1fd1540469f0224dbf57e43d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i81d9531da7ae47c68f3176caa531bcf5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05a6fd71531c4266a8e69e0f3d9add84_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:OfficeAndLaboratorySpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie0f674f4a02e45538fdadde638cf5023_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5757bb4043fa4bfa81cdae4e0992837e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3457c2e17d7a435d9fb262c2803a96c4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic8b56fe25f1c4153929837bcc4db56ea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if70567ef2894436ab885809a5090432e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaa36120b8dea4505af0c3a1b3720cbf0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="common_stock_class">
        <measure>sera:common_stock_class</measure>
    </unit>
    <unit id="vote">
        <measure>sera:vote</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8wLTEtMS0xLTUwNTMx_22f8f34b-4ba1-4a08-9b4c-9d4f2454f7d9">0001534969</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8xLTEtMS0xLTUwNTMx_f62a20cf-d708-4bbf-a22c-07413f056e5a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8yLTEtMS0xLTUwNTMx_becbee07-ce6a-4715-b868-37587a42adf1">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl8zLTEtMS0xLTUwNTMx_991f3637-d2fc-451a-b735-c90380d8a9bc">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80L2ZyYWc6MjA5NDY3MzEwZDg5NDg1NmI4NWI4OTY2Zjg4MDU0YjMvdGFibGU6YTJmYTQ3NDYzZWU0NGQyMWIyOTVhY2NiNzUzNjZmNmIvdGFibGVyYW5nZTphMmZhNDc0NjNlZTQ0ZDIxYjI5NWFjY2I3NTM2NmY2Yl80LTEtMS0xLTUwNTMx_e1e5a5fb-eef5-4a8c-b161-a707d343e621">false</dei:AmendmentFlag>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_6babe0e6-7d50-47d4-ae07-e3d8e9b39332">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_9f65a529-ecfc-438c-ac40-deeaa75b2ba3">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_25937204-c7d0-4da0-b8e8-5206df574dab">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_f6cc0dfd-5c42-43a4-b226-d068765cef24">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_0a2d43e5-22d4-456d-aeb7-ab2c07bd5c2e">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_54e9da06-5917-4d9b-92d1-259e176f90a9">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY4_7edd7b2e-3892-4a9d-b96d-e4c8da8f1b19">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ODBkNTA3YjlmYjlkNDE1OThlYTllYmFkYTZmYWEyYzUvdGFibGVyYW5nZTo4MGQ1MDdiOWZiOWQ0MTU5OGVhOWViYWRhNmZhYTJjNV8wLTAtMS0xLTUwNTMx_e2bd8f0e-999b-4513-9af6-8e9c0ccda7cc">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8xODc_6e9018b6-95f8-44cd-a904-dc5e10de2a2b">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6Yjk2MjIxMTAwZmM1NDY2MTlhYWQ2NGI3M2JiNGUxZTUvdGFibGVyYW5nZTpiOTYyMjExMDBmYzU0NjYxOWFhZDY0YjczYmI0ZTFlNV8wLTAtMS0xLTUwNTMx_cb932ee4-3765-40b8-bc48-73b0717a5322">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY5_85cc7bb0-8bd2-4fb5-a895-b0eab58247c4">001-40606</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDYz_035633ec-4586-4361-8efa-bafbd5582f4a">SERA PROGNOSTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18wLTAtMS0xLTUwNTMx_8fec0e5f-fc05-43ca-b9cc-c3882fa9ed1a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18wLTItMS0xLTUwNTMx_a807f338-49cb-45eb-836d-e6489b98227e">26-1911522</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfNQ_7ea810ac-6767-4746-b86f-2fde90c88dc4">2749 East Parleys Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfOQ_e9779dfa-1928-4be7-9b14-22754e4bf1dd">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfMTI_91809972-0989-4fb4-89c6-fa38c7bc2910">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTAtMS0xLTUwNTMxL3RleHRyZWdpb246MGZkOTUyY2VmNzQ2NDg0N2ExYmRjZWY1OTc0ODE0NzFfMTY_d07a7ce0-704c-40b5-bdf1-7d51e074f268">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6ZGViMWFlNGY4ZjdmNDU0ODhlMWYxZWM2N2Y2NjBjMDcvdGFibGVyYW5nZTpkZWIxYWU0ZjhmN2Y0NTQ4OGUxZjFlYzY3ZjY2MGMwN18yLTItMS0xLTUwNTMx_d26fb047-5597-40b2-be4b-e524c12b8bd8">84109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY0_698035a7-ec8f-46d1-8f22-0075c3a59709">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY1_e3540ad7-8812-4cf6-b955-d9c6926ae4d4">990-0520</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6OTQyNWM0MWU1MjE3NGQ2NjhkMmFlMGVlOTJkODdiMWIvdGFibGVyYW5nZTo5NDI1YzQxZTUyMTc0ZDY2OGQyYWUwZWU5MmQ4N2IxYl8xLTAtMS0xLTUwNTMx_b1cd40f5-b440-434f-b222-3c18bc65647c">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6OTQyNWM0MWU1MjE3NGQ2NjhkMmFlMGVlOTJkODdiMWIvdGFibGVyYW5nZTo5NDI1YzQxZTUyMTc0ZDY2OGQyYWUwZWU5MmQ4N2IxYl8xLTItMS0xLTUwNTMx_abbf5408-9053-4dde-b2b4-621b499afeaa">SERA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6OTQyNWM0MWU1MjE3NGQ2NjhkMmFlMGVlOTJkODdiMWIvdGFibGVyYW5nZTo5NDI1YzQxZTUyMTc0ZDY2OGQyYWUwZWU5MmQ4N2IxYl8xLTQtMS0xLTUwNTMxL3RleHRyZWdpb246ZmU5MzM2MjI4MzdmNDgxZmIwMTFlMWI0MzY2ZTliMzZfOA_acc38ecf-3a38-4c3c-b877-19a3248188d4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDcw_df0c372f-b4b1-47ee-b5bf-b51fe9c59d63">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDcx_3e10c087-940b-4d47-a55e-f64c1ee33fdb">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6M2M4YTMzZWE1NDFmNDQxNmIyOTE0OTdhMTA2NTRjZGIvdGFibGVyYW5nZTozYzhhMzNlYTU0MWY0NDE2YjI5MTQ5N2ExMDY1NGNkYl8xLTAtMS0xLTUwNTMx_7d51eb08-6e82-4e26-a2d5-516017373121">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6M2M4YTMzZWE1NDFmNDQxNmIyOTE0OTdhMTA2NTRjZGIvdGFibGVyYW5nZTozYzhhMzNlYTU0MWY0NDE2YjI5MTQ5N2ExMDY1NGNkYl8xLTMtMS0xLTUwNTMx_7623cd1c-e082-4aea-93f5-84827087aadd">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGFibGU6M2M4YTMzZWE1NDFmNDQxNmIyOTE0OTdhMTA2NTRjZGIvdGFibGVyYW5nZTozYzhhMzNlYTU0MWY0NDE2YjI5MTQ5N2ExMDY1NGNkYl8yLTMtMS0xLTUwNTMx_293270ed-8a80-4013-99f3-9e54062b416c">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDY3_b8661ae3-f64d-4f61-82d5-6a4de1280d00">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8yMDYy_e620940d-4dba-48c8-890e-59be38911b8a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i27cc1a39b2364e15ae9b07bafaed08b2_I20230505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8xOTUy_d393ff17-e11b-49e6-9a93-f5514d83bf05"
      unitRef="shares">29646843</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="icad9b28978d3427cad4b33b66939a88c_I20230505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xL2ZyYWc6YjYwZGNkNjNjODRhNDMwNDk2NThmZGE1MmU2ODk1ZTkvdGV4dHJlZ2lvbjpiNjBkY2Q2M2M4NGE0MzA0OTY1OGZkYTUyZTY4OTVlOV8xOTU5_32c80571-34d9-4dde-9fba-ef933c030846"
      unitRef="shares">1405259</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMy0xLTEtMS01MDUzMQ_fd611c45-90be-4300-89b6-34691ef4e54b"
      unitRef="usd">27201000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMy0zLTEtMS01MDUzMQ_a8663b1d-c13d-4dc3-9684-477c507b2b66"
      unitRef="usd">29878000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNC0xLTEtMS01MDUzMQ_e5cd3dd0-e7ee-4cbc-ab8f-12264a130dc6"
      unitRef="usd">43587000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNC0zLTEtMS01MDUzMQ_b3c99fd3-dcf3-4ae6-8fa4-41e3da6b66d7"
      unitRef="usd">52826000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNS0xLTEtMS01MDUzMQ_4436d1ae-5f02-4617-924f-abb2ad3bc9c4"
      unitRef="usd">120000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNS0zLTEtMS01MDUzMQ_bcac24ef-873a-49b8-b014-fc8a02b38c73"
      unitRef="usd">113000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNi0xLTEtMS01MDUzMQ_3e6b8b5b-6a01-421a-a0d9-db40d80bc53a"
      unitRef="usd">0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNi0zLTEtMS01MDUzMQ_6557fe7e-e347-460c-ac36-3387d5e4cd54"
      unitRef="usd">6000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNy0xLTEtMS01MDUzMQ_d34bc3d1-9993-408e-8c12-09a86dea72b4"
      unitRef="usd">1202000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfNy0zLTEtMS01MDUzMQ_f55ab9ff-e4e4-474b-9c28-e2080e91cd41"
      unitRef="usd">1308000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOC0xLTEtMS01MDUzMQ_3780bb76-bce6-4ef0-a5c1-f468a5381ea3"
      unitRef="usd">72110000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOC0zLTEtMS01MDUzMQ_02f02528-e953-4382-be59-26b929caf930"
      unitRef="usd">90125000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOS0xLTEtMS01MDUzMQ_4e93333c-99f3-415d-859d-b5da63530e7b"
      unitRef="usd">2907000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfOS0zLTEtMS01MDUzMQ_afb7ff16-ab04-4a20-ac79-efc5d7648304"
      unitRef="usd">3059000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTAtMS0xLTEtNTA1MzE_32ac1d93-680f-4e7a-b5fc-7cee80a40638"
      unitRef="usd">28917000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTAtMy0xLTEtNTA1MzE_fb1a3d68-e81e-4f21-9256-b95839c7d684"
      unitRef="usd">21329000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTEtMS0xLTEtNTA1MzE_bbaf9bf8-b540-42ac-9a12-02fe972b3d43"
      unitRef="usd">1676000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTEtMy0xLTEtNTA1MzE_13aec41a-17f9-4652-b762-5b82f8387ad6"
      unitRef="usd">1816000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTItMS0xLTEtNTA1MzE_2cc57e8d-6b69-4d7f-9060-cd1ce130f4c6"
      unitRef="usd">105610000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTItMy0xLTEtNTA1MzE_72ffca1f-b9fd-408e-92c2-9a73ff8627e1"
      unitRef="usd">116329000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTUtMS0xLTEtNTA1MzE_bc22f7a9-32f9-4672-9758-d5cc1f8df52f"
      unitRef="usd">1590000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTUtMy0xLTEtNTA1MzE_f405e9f8-8668-4757-aff4-87b5d791564a"
      unitRef="usd">1548000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTYtMS0xLTEtNTA1MzE_4f05a9bc-eab2-48ac-81eb-7a10e69bfb86"
      unitRef="usd">2692000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTYtMy0xLTEtNTA1MzE_e9a66d75-1ade-4376-98ad-805dca0cf500"
      unitRef="usd">4444000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTgtMS0xLTEtNTA1MzE_0362aa7e-81ca-4495-981a-f0d9c03eb621"
      unitRef="usd">451000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTgtMy0xLTEtNTA1MzE_72b68705-9537-41c5-9b54-4abfeaa71ce2"
      unitRef="usd">464000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTktMS0xLTEtNTA1MzE_65dd142f-f12d-4ab3-ba80-20edbb42f2a3"
      unitRef="usd">9067000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMTktMy0xLTEtNTA1MzE_e0433dac-acf2-4148-a03f-a34fd0a63918"
      unitRef="usd">9082000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjAtMS0xLTEtNTA1MzE_15c62424-eb37-44e0-8f28-c7a776b9fdd6"
      unitRef="usd">13800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjAtMy0xLTEtNTA1MzE_4de95bf4-a45d-46aa-be6e-cf84dd45b63e"
      unitRef="usd">15538000</us-gaap:LiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMS0xLTEtNTA1MzE_7ed001a2-9f97-4e8e-851c-645ce403a15b"
      unitRef="usd">519000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMy0xLTEtNTA1MzE_22c16f78-e317-4eab-8fec-191f98172482"
      unitRef="usd">626000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMS0xLTEtNTEzNTU_2a763394-d9ad-4c40-a757-41785cff48fc"
      unitRef="usd">1081000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjEtMy0xLTEtNTEzNTU_5b1b830f-dc08-4be2-8a76-82a4ea39d85f"
      unitRef="usd">1222000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjItMS0xLTEtNTA1MzE_d158c290-affc-4571-bb37-5062c5e6405f"
      unitRef="usd">15400000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjItMy0xLTEtNTA1MzE_e54da24a-4463-48f2-a1dd-60a5e32a3f3f"
      unitRef="usd">17386000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjMtMS0xLTEtNTA1MzE_34741ab3-0b29-456c-bed2-fc4f80a8888c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjMtMy0xLTEtNTA1MzE_a0b2ce0f-7f84-4811-a796-294cd05c2432"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_074286c1-4027-4558-8584-fab7c6b717a0"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_5e6105c6-16e5-4b44-a61c-6c2597bcb09c"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_7fb32064-68dc-460d-95c5-f739c431677f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xOA_bfa72896-bfe8-4d3c-8827-85f1a73a6e97"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8zMg_57977e4b-17c0-40d0-ab66-f5dde3634b82"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8zMg_a169f7fa-0b64-4a93-ad8d-fce2fd5a14a2"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV83OA_079bfd78-a8c1-492b-b705-a82edf313019"
      unitRef="shares">29616781</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV83OA_6b28fe5e-dc3e-4ed5-a383-33d493057dd9"
      unitRef="shares">29616781</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV84NQ_a941071c-6abf-4888-976a-c91d7178531d"
      unitRef="shares">29612687</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV84NQ_efa51b77-d4cf-4a9b-a8ce-edd189d9d0b5"
      unitRef="shares">29612687</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xNTc_02afdc16-2cf4-42e5-8f82-b5a5b4df0041"
      unitRef="shares">1500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8xNTc_4800c83d-fdaa-463c-94cb-73131ec1254e"
      unitRef="shares">1500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_04d09fdd-36f0-47de-9828-d97c0e77393e"
      unitRef="shares">1405259</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icc43b85330464574a0488ebcc9d967d5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_2d01cce8-e1b9-4972-8bc7-ee7f3cc3987f"
      unitRef="shares">1405259</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_5013eb0c-66d2-44fc-83f2-9c7b299c8f8f"
      unitRef="shares">1405259</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6a6d82be7a45430fb85fd8fb397576f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMC0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplY2I1ZTI0NDA5MGE0Mzc4OTFiYzY2ZTgzMzJjNDQ0MV8yMDM_54c3a112-3ace-41c0-a1c9-bb8d1d6b1182"
      unitRef="shares">1405259</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMS0xLTEtNTA1MzE_e9eaffb4-200a-405d-977d-83ec0f86e09c"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjUtMy0xLTEtNTA1MzE_e68a838e-6606-47cf-91da-1c0978aef40d"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjYtMS0xLTEtNTA1MzE_4440f282-b022-4aeb-8eb0-004706efaea1"
      unitRef="usd">311883000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjYtMy0xLTEtNTA1MzE_f2542505-a2da-4efb-90eb-3ca52a3c62c0"
      unitRef="usd">310575000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjctMS0xLTEtNTA1MzE_db9d3a7c-5b28-4750-afc4-c6cd7858246f"
      unitRef="usd">-457000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjctMy0xLTEtNTA1MzE_ecb8d4aa-9d23-4d09-bcb2-047cf5ee409b"
      unitRef="usd">-981000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjgtMS0xLTEtNTA1MzE_e866aaa8-8098-46fd-a7b4-429a45a2e49e"
      unitRef="usd">-221219000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjgtMy0xLTEtNTA1MzE_b82e948a-16a7-49b9-80a8-553a3d59b472"
      unitRef="usd">-210654000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjktMS0xLTEtNTA1MzE_ea72505c-9b63-424a-94a4-a058065d8d8a"
      unitRef="usd">90210000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMjktMy0xLTEtNTA1MzE_57282779-34dd-41d7-9576-641b17113bcb"
      unitRef="usd">98943000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMzAtMS0xLTEtNTA1MzE_485ba831-145a-4dfb-8275-3873278cb620"
      unitRef="usd">105610000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8xOS9mcmFnOmEyZWM2OTBhNzA0NTQxMTZhNTA2ZjZmMmE0YjBiZDVmL3RhYmxlOjIzYTQzN2EwMzBlMDQxZDliNzY0ZDhjYTY0ZWM4ZDc1L3RhYmxlcmFuZ2U6MjNhNDM3YTAzMGUwNDFkOWI3NjRkOGNhNjRlYzhkNzVfMzAtMy0xLTEtNTA1MzE_76915d87-c62e-4746-a2ff-8bcf86256de0"
      unitRef="usd">116329000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMi0xLTEtMS01MDUzMQ_5d4b3143-3733-4e26-81ab-cd323be44964"
      unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMi0zLTEtMS01MDUzMQ_4c1b77f7-7dde-49ab-81ab-93745b62e72e"
      unitRef="usd">38000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNC0xLTEtMS01MDUzMQ_fe173191-c55f-481c-a33a-ce7dd77a5b9d"
      unitRef="usd">62000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNC0zLTEtMS01MDUzMQ_7e4b1eb7-c6dc-44a9-aa45-c0549c9912e1"
      unitRef="usd">20000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNS0xLTEtMS01MDUzMQ_6cccb8db-fad5-4ab0-896a-379a35a35fe3"
      unitRef="usd">4103000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNS0zLTEtMS01MDUzMQ_c46cd470-a993-4d06-b6ac-9207d0fec699"
      unitRef="usd">3322000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNi0xLTEtMS01MDUzMQ_6fd50325-d923-45e0-8b13-69d0092f13cf"
      unitRef="usd">2818000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNi0zLTEtMS01MDUzMQ_3689af41-4f5a-45bd-ac1b-963935e055d7"
      unitRef="usd">4458000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNy0xLTEtMS01MDUzMQ_07c9f32e-a315-4f73-9346-5c8d6052dd0f"
      unitRef="usd">4446000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfNy0zLTEtMS01MDUzMQ_922bc64a-c29d-4418-8109-9245826427a1"
      unitRef="usd">4538000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOC0xLTEtMS01MDUzMQ_4f542f12-5582-40f4-995f-a96d25349913"
      unitRef="usd">11429000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOC0zLTEtMS01MDUzMQ_2f6d6a1e-7b57-40c8-ab9b-8f4cb25a7e73"
      unitRef="usd">12338000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOS0xLTEtMS01MDUzMQ_1f0165aa-efe7-4c1a-b9a5-0f9c373ceaf9"
      unitRef="usd">-11329000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfOS0zLTEtMS01MDUzMQ_0ec407f0-f8ca-43c4-8638-234c898349ed"
      unitRef="usd">-12300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTAtMS0xLTEtNTA1MzE_b3bc97c0-df3b-4c05-a79e-82786bb939f0"
      unitRef="usd">16000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTAtMy0xLTEtNTA1MzE_9521a544-c35c-4e05-a50c-54f3c34209c7"
      unitRef="usd">4000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTEtMS0xLTEtNTA1MzE_2b5fe9c0-c334-49fe-bf7b-cd19dc8e2cfb"
      unitRef="usd">780000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTEtMy0xLTEtNTA1MzE_0f5ce87e-9707-471c-aedd-8cc5f75e71e5"
      unitRef="usd">96000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTItMS0xLTEtNTA1MzE_e765f4c1-e409-4f83-9387-cfe4a72feb03"
      unitRef="usd">-10565000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTItMy0xLTEtNTA1MzE_e82a2d35-ba53-4a2f-9caf-dfff1d034dda"
      unitRef="usd">-12208000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMS0xLTEtNTA1MzE_50792cf6-ec2e-4669-8ba3-661b98c7539e"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMS0xLTEtNTA1MzE_761d01b5-f028-4a81-b433-d45751e7a06d"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMy0xLTEtNTA1MzE_b3f592ac-8d73-4b38-a006-70084f551f61"
      unitRef="usdPerShare">-0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTMtMy0xLTEtNTA1MzE_c205603d-0fa0-4f5e-9d63-914c3d7f9281"
      unitRef="usdPerShare">-0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMS0xLTEtNTA1MzE_5a487f19-4999-46e8-973e-a380f7d8df01"
      unitRef="shares">31019311</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMS0xLTEtNTA1MzE_872c76a8-8106-4833-a7bf-f1a1e95fdbf7"
      unitRef="shares">31019311</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMy0xLTEtNTA1MzE_454b3d32-08bf-4e03-aed5-eb6a2d88d4bb"
      unitRef="shares">30801579</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTQtMy0xLTEtNTA1MzE_af998f3c-7731-4914-9d09-e645db052885"
      unitRef="shares">30801579</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTYtMS0xLTEtNTA1MzE_894f8215-968d-452b-a0d1-5c59371a62c2"
      unitRef="usd">524000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTYtMy0xLTEtNTA1MzE_4490728b-3644-46e0-a888-92b96138ae5b"
      unitRef="usd">-473000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTctMS0xLTEtNTA1MzE_c9ccfb34-4896-4743-8e74-cb4144e3db0f"
      unitRef="usd">524000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTctMy0xLTEtNTA1MzE_09cb37c2-d5e1-4e1b-bcec-45b1eaeff67a"
      unitRef="usd">-473000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTgtMS0xLTEtNTA1MzE_bb7bd9f1-eaa7-4712-8f37-60d5b20689c8"
      unitRef="usd">-10041000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yMi9mcmFnOjllNmE1MWI3NWQyMjRjNTdhNDBmMGY3NTk1MDI2OGYxL3RhYmxlOmRiNWI3ZjliZmM5ZTQ1YmI4ZWZmYWMwNmVjMWFkYjM0L3RhYmxlcmFuZ2U6ZGI1YjdmOWJmYzllNDViYjhlZmZhYzA2ZWMxYWRiMzRfMTgtMy0xLTEtNTA1MzE_1c2ddeeb-d0a4-428a-abcc-8daa0be0a9de"
      unitRef="usd">-12681000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="id4d3bc1d35134987a7abd9a77560576f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xMC0xLTEtNTA1MzE_284294cd-d896-4fd2-b297-eab567f35eda"
      unitRef="shares">31017946</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="id4d3bc1d35134987a7abd9a77560576f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xMi0xLTEtNTA1MzE_6a3306ca-e422-4d0d-be86-649a74933a78"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i60cd390e284b4c57b8f9e0990b0772c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xNC0xLTEtNTA1MzE_6b18f2d3-db5a-4fe8-975f-e7985b09faec"
      unitRef="usd">310575000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3233753d7b7b4837a79035352c82a4f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xNi0xLTEtNTA1MzE_912fd701-3a49-45cc-9d7c-9006b2e74118"
      unitRef="usd">-981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibdec2990e11742fcac46b167e2f60113_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0xOC0xLTEtNTA1MzE_e93fae71-fdd3-489f-bcd7-f99197f2254e"
      unitRef="usd">-210654000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMi0yMC0xLTEtNTA1MzE_6cb53ce5-1a57-432f-8050-a5495f8770ac"
      unitRef="usd">98943000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iebd28250132e4da59b3527f68bcd2be8_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMy0xMC0xLTEtNTA1MzE_e5ea616a-9934-40f8-abcc-f9dc1e186ee1"
      unitRef="shares">4094</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i91d61589d78c40e5b1ddd61b6d506e58_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMy0xNC0xLTEtNTA1MzE_5cd37af6-db4f-45ca-970b-44b75ce1d041"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfMy0yMC0xLTEtNTA1MzE_376dfda5-36fa-4bfb-8794-4f47b698e018"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i91d61589d78c40e5b1ddd61b6d506e58_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNC0xNC0xLTEtNTA1MzE_54712f7c-4a17-413d-9af6-e86c54dfc3e8"
      unitRef="usd">1304000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNC0yMC0xLTEtNTA1MzE_3b2a7a40-d59d-46d0-9b65-d08b4b0bfaa9"
      unitRef="usd">1304000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3a6260114f4c4349925d48192e947ea9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNS0xNi0xLTEtNTA1MzE_3e9c192b-e9ac-4230-be05-8f8f280b491f"
      unitRef="usd">524000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNS0yMC0xLTEtNTA1MzE_71999a9c-af93-4361-ae7a-a181870fe86b"
      unitRef="usd">524000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ib06c86d910fe465187240359ca033ca7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNi0xOC0xLTEtNTA1MzE_a96e628d-3634-4df9-aed6-564df917afee"
      unitRef="usd">-10565000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNi0yMC0xLTEtNTA1MzE_369991ac-a93b-40a1-b2e7-25eaed685465"
      unitRef="usd">-10565000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib63e3a10c281463dba0c42a75f266866_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xMC0xLTEtNTA1MzE_f32bd792-9abb-43f7-a7cd-e1ef744a5c78"
      unitRef="shares">31022040</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib63e3a10c281463dba0c42a75f266866_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xMi0xLTEtNTA1MzE_f6a5d6ea-3fb0-46c3-ae62-88b3d8c40f8d"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29e8c63944d94a20a9d6766b70a0c209_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xNC0xLTEtNTA1MzE_43d2c68c-29d9-48d1-ab80-7563c00b2e15"
      unitRef="usd">311883000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9fe8a51550be47699966c38055bb1d4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xNi0xLTEtNTA1MzE_ca02bf3e-7d44-4bad-b164-2d4eed67d5b3"
      unitRef="usd">-457000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id6871c65cc944ab196c8853108ee6522_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0xOC0xLTEtNTA1MzE_b4834f33-2a6b-4180-88d2-bda570b21c22"
      unitRef="usd">-221219000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOjJlY2UyMDc4NGJmNDQ4MmFhNmYwODc2OWRiZGUzYTJmL3RhYmxlcmFuZ2U6MmVjZTIwNzg0YmY0NDgyYWE2ZjA4NzY5ZGJkZTNhMmZfNy0yMC0xLTEtNTA1MzE_6af6076c-6021-4339-b4f4-d8e74efa8fd2"
      unitRef="usd">90210000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie6969513749542aeafcd5cabd8aff333_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xMC0xLTEtNTA1MzE_88282d74-1161-4a4a-9c01-18d59713442b"
      unitRef="shares">30774126</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie6969513749542aeafcd5cabd8aff333_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xMi0xLTEtNTA1MzE_4abf4447-d265-4533-bffd-bbc282e907f9"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i102890e5579345c7a2782bb6c17ab3d8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xNC0xLTEtNTA1MzE_d9654383-58ce-40e6-8a9c-cdb7b748c397"
      unitRef="usd">305212000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i759304c058dd41a1a56e8cbcac33058d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xNi0xLTEtNTA1MzE_7878342a-a071-4445-b1a1-e3c334d3fa85"
      unitRef="usd">-183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib631629e369e46c19c68e6078da4b53d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0xOC0xLTEtNTA1MzE_0034c27a-9df2-42df-87bf-69cf22b62e95"
      unitRef="usd">-166468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iabcd47f9f5ed4cbeba9b2fdfbdc1b4e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfMi0yMC0xLTEtNTA1MzE_aac52567-0ed4-4b70-a7a9-16b986b47e12"
      unitRef="usd">138564000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3eb72449e36d49a0b292d86de7324cfe_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNC0xMC0xLTEtNTA1MzE_04f84187-036e-47be-9879-82e934e78517"
      unitRef="shares">123467</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4142468cfaf94c8d97f33b6fa3846d59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNC0xNC0xLTEtNTA1MzE_19babd2d-fb83-4eac-bdc8-6432ea23c076"
      unitRef="usd">98000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNC0yMC0xLTEtNTA1MzE_b73967b4-d476-4a5c-8ad5-1fe71eb13f9e"
      unitRef="usd">98000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4142468cfaf94c8d97f33b6fa3846d59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNS0xNC0xLTEtNTA1MzE_17bcb2ca-0908-4afe-839f-4ff70c31a11e"
      unitRef="usd">1222000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNS0yMC0xLTEtNTA1MzE_c72da1f0-db05-4801-ba72-7fefa8e30231"
      unitRef="usd">1222000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf3445dbebdb41acb50360773c5fda39_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNi0xNi0xLTEtNTA1MzE_94620d95-4f16-4ba2-a2c4-b1d0fd569125"
      unitRef="usd">-473000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNi0yMC0xLTEtNTA1MzE_19c39774-09d3-4260-a5b9-ac860c53da88"
      unitRef="usd">-473000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i7322891383e14b2098410a7e202ed9fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNy0xOC0xLTEtNTA1MzE_6c1d9b27-6f4b-41f1-b25e-e7d007556c9c"
      unitRef="usd">-12208000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfNy0yMC0xLTEtNTA1MzE_c3a507c6-00a9-4434-83fa-10fb725dc4cc"
      unitRef="usd">-12208000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5ea46d61e8284efc8e56b1f492df7b7e_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xMC0xLTEtNTA1MzE_3bf8e9bd-46e1-4431-b485-60be0b602a4a"
      unitRef="shares">30897593</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5ea46d61e8284efc8e56b1f492df7b7e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xMi0xLTEtNTA1MzE_bdc1d6e5-8f7c-415a-ab1b-8242542f2817"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i867e414c4ecc491ab33db86a734bf4cb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xNC0xLTEtNTA1MzE_35a114e1-8b0e-41b4-a565-5df9592676db"
      unitRef="usd">306532000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f2b384898354117be5364c3873188d6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xNi0xLTEtNTA1MzE_325fac73-ea7a-440c-a703-4bee2934015c"
      unitRef="usd">-656000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib14c1cf96c624315af3e9139180f2e92_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0xOC0xLTEtNTA1MzE_d7f1d984-ad9a-41d6-ac53-58f51991e5b9"
      unitRef="usd">-178676000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yNS9mcmFnOjg3ZDU4MzljMGEwNzRmMDRiNzZjNTU4M2YzYzQyNDBjL3RhYmxlOmExMzIyODU1NGNkOTRmZWJiYjk5MzA1M2I5NjBjZTZlL3RhYmxlcmFuZ2U6YTEzMjI4NTU0Y2Q5NGZlYmJiOTkzMDUzYjk2MGNlNmVfOC0yMC0xLTEtNTA1MzE_0a32df1b-643d-41d5-964f-b929f43ca30f"
      unitRef="usd">127203000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMy0xLTEtMS01MDUzMQ_c7e42871-eada-4c63-bb0c-6c34c724e35b"
      unitRef="usd">-10565000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMy0zLTEtMS01MDUzMQ_e30100f3-0642-4983-a9a4-9cfb78f14a8e"
      unitRef="usd">-12208000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNS0xLTEtMS01MDUzMQ_2b0ba7b8-e93c-428a-a378-b1d1c13072cb"
      unitRef="usd">237000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNS0zLTEtMS01MDUzMQ_ecf86797-ee57-4caa-abca-df06a1314aec"
      unitRef="usd">165000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNi0xLTEtMS01MDUzMQ_39d03e5a-3105-44d7-b5d2-9fd5e2d9d4c4"
      unitRef="usd">1304000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNi0zLTEtMS01MDUzMQ_1f9bfb0c-53d2-4aef-9a70-c8ec15754874"
      unitRef="usd">1222000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNy0xLTEtMS01MDUzMQ_327a1ab7-b423-4bfe-b188-1aab21a44393"
      unitRef="usd">128000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNy0zLTEtMS01MDUzMQ_cb1a05af-2923-47f5-ac59-6b82943b93d5"
      unitRef="usd">111000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:PaidInKindInterest
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfOC0xLTEtMS01MDUzMQ_03c6704f-1ecc-4611-b8b7-c9f47d9a444c"
      unitRef="usd">0</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfOC0zLTEtMS01MDUzMQ_15207d21-cf4d-45f0-962f-af272c7fbeaf"
      unitRef="usd">2000</us-gaap:PaidInKindInterest>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTAtMS0xLTEtNTA1MzE_70410029-79f5-47b4-99d8-1672c3e2b9f5"
      unitRef="usd">184000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTAtMy0xLTEtNTA1MzE_3c3ed938-441d-43d4-96f2-6ee3df4357bd"
      unitRef="usd">-36000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTItMS0xLTEtNTA1MzE_194d3399-47a0-4ace-8c85-2689d63460df"
      unitRef="usd">7000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTItMy0xLTEtNTA1MzE_fcb7093c-d38c-42f2-9463-e79aa7a36864"
      unitRef="usd">12000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTMtMS0xLTEtNTA1MzE_3c6974cf-da44-4242-a01c-afce4caddaec"
      unitRef="usd">-6000000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTMtMy0xLTEtNTA1MzE_b784be6e-5a47-4b66-9ad1-5ce2588b563e"
      unitRef="usd">-3116000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTQtMS0xLTEtNTA1MzE_678b6631-73b7-4f1d-b5d8-976df700f1bb"
      unitRef="usd">-118000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTQtMy0xLTEtNTA1MzE_984895db-0920-4070-9f3e-bbf6cee96f07"
      unitRef="usd">-209000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTUtMS0xLTEtNTA1MzE_8a54d8d3-b76e-41b2-b268-b87b169cbd5a"
      unitRef="usd">-5000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTUtMy0xLTEtNTA1MzE_035b9c92-3e9c-4973-a598-e827962b6d88"
      unitRef="usd">-252000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTYtMS0xLTEtNTA1MzE_660a8984-77d9-4682-a3a2-c48b6005aac8"
      unitRef="usd">-1893000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTYtMy0xLTEtNTA1MzE_dd169cc2-bcba-4301-9fdc-5ef49a65d11c"
      unitRef="usd">-1942000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTgtMS0xLTEtNTA1MzE_4bd696e3-0816-46d8-9fee-e238fc37a472"
      unitRef="usd">-14000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTgtMy0xLTEtNTA1MzE_a3302257-7f28-4a5e-b094-5d1f0c264310"
      unitRef="usd">-4000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTktMS0xLTEtNTA1MzE_8cedb829-526a-43d4-8e46-5a7a9ae38590"
      unitRef="usd">-4881000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMTktMy0xLTEtNTA1MzE_cd47979a-2ece-41d7-9e20-af491520a73b"
      unitRef="usd">-9557000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjEtMS0xLTEtNTA1MzE_0e487e86-7ee6-41ba-9341-9ef83eb76281"
      unitRef="usd">14735000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjEtMy0xLTEtNTA1MzE_5f54e306-2834-421f-9590-2607686c4b0c"
      unitRef="usd">6614000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjItMS0xLTEtNTA1MzE_a994f8b0-69a0-4415-bf74-64c4447c188c"
      unitRef="usd">17094000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjItMy0xLTEtNTA1MzE_ee9da332-65ba-4e57-b925-b8a1a03b4155"
      unitRef="usd">21252000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjMtMS0xLTEtNTA1MzE_66577e82-d01c-4e23-a756-f5f22b0d4a82"
      unitRef="usd">39000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjMtMy0xLTEtNTA1MzE_a0bf3273-71b1-42fa-a7b8-dd2f81562d2e"
      unitRef="usd">7000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjQtMS0xLTEtNTA1MzE_b4254903-168f-4239-8cc2-3c3eef257a61"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjQtMy0xLTEtNTA1MzE_7e35ca34-13ac-41fc-a31a-56a0ec513708"
      unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjUtMS0xLTEtNTA1MzE_d38f1abc-bada-4d78-a00e-e63423c3a694"
      unitRef="usd">2320000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMjUtMy0xLTEtNTA1MzE_51dc4802-99bc-48db-a20b-c63849e11505"
      unitRef="usd">14634000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzAtMS0xLTEtNTA1MzE_b8375e1d-8a8c-4868-8ca7-6549504337eb"
      unitRef="usd">4000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzAtMy0xLTEtNTA1MzE_a7bd7d0a-d0eb-4b96-8411-3aa43ecd79a4"
      unitRef="usd">89000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzMtMS0xLTEtNTA1MzE_17f4c6f0-013c-4462-9174-1e45c3d97374"
      unitRef="usd">120000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzMtMy0xLTEtNTA1MzE_8e4fa3d3-9905-41a6-a4b1-26c562095a76"
      unitRef="usd">18000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzQtMS0xLTEtNTA1MzE_beae6397-50de-42d6-be1a-9d072404961d"
      unitRef="usd">-116000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzQtMy0xLTEtNTA1MzE_efc51335-4548-4837-8caf-29a0ae43f4f4"
      unitRef="usd">71000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzUtMS0xLTEtNTA1MzE_255cd940-7bb1-4be4-8984-702d5cd26d5d"
      unitRef="usd">-2677000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzUtMy0xLTEtNTA1MzE_122555b2-f79b-4639-92fe-f4602f15a55a"
      unitRef="usd">5148000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzYtMS0xLTEtNTA1MzE_14fc92e8-7a8e-4be7-9bba-1b7ed91558ed"
      unitRef="usd">29878000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iabcd47f9f5ed4cbeba9b2fdfbdc1b4e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzYtMy0xLTEtNTA1MzE_8fa41bab-7344-4f8b-804b-2e7d1c985cf1"
      unitRef="usd">58932000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzctMS0xLTEtNTA1MzE_70378a6c-e9fa-41fa-af69-74b2c79f7d0e"
      unitRef="usd">27201000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzctMy0xLTEtNTA1MzE_ad8b23aa-5da0-4b19-80ad-f4022dc1165c"
      unitRef="usd">64080000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzktMS0xLTEtNTA1MzE_4ef36726-3527-48c4-8798-c4caed8f2814"
      unitRef="usd">16000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfMzktMy0xLTEtNTA1MzE_edaccc4d-ef7e-4b11-aa5d-21281d0d2417"
      unitRef="usd">2000</us-gaap:InterestPaidNet>
    <sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNDEtMS0xLTEtNTA1MzE_d84cde00-6055-4d69-8e64-5f88d2b2c63c"
      unitRef="usd">47000</sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities>
    <sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8yOC9mcmFnOmY2NjkyZTExMjI1ZjQ1NTI4NDJiYzA1NGUwYjAwNjA0L3RhYmxlOjA3ZGE1NjU2N2ExZTQ5MWU5ZDU3ZTY2NDFmNThiNDg0L3RhYmxlcmFuZ2U6MDdkYTU2NTY3YTFlNDkxZTlkNTdlNjY0MWY1OGI0ODRfNDEtMy0xLTEtNTA1MzE_c3dc67d1-dd51-4508-8749-1a3ffa435192"
      unitRef="usd">0</sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNC9mcmFnOmMxNWViZGUyZGU1ZDRjZDJiM2E2YTJhNzIyYTljZWYyL3RleHRyZWdpb246YzE1ZWJkZTJkZTVkNGNkMmIzYTZhMmE3MjJhOWNlZjJfMzYzNw_545d2255-d634-4446-8931-524676dc7e38">Description of Business and Financial Condition&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sera Prognostics, Inc. (the &#x201c;Company&#x201d;) is a women&#x2019;s health company utilizing its proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests with an initial focus on improving pregnancy outcomes. The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments (&#x201c;CLIA&#x201d;)-certified laboratory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since its inception, the Company&#x2019;s activities have consisted of performing research and development, conducting clinical studies, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of $221.2&#160;million as of March&#160;31, 2023. The Company&#x2019;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#x2019;s commercialization activities for the PreTRM test, and to support additional clinical and preclinical trials and anticipated research and development activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its diagnostic products and could be required to delay, scale back, or abandon some or all of its development programs and other operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all. Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#x2019;s future operations are highly dependent on a combination of factors, including (i) the successful commercial launch and market acceptance of the PreTRM test; (ii) the success of clinical trials and other research and development programs; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#x2019;s ability to manage growth of the organization; (v) the Company&#x2019;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal sources of the Company&#x2019;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#x201c;IPO&#x201d;), which was completed in July 2021. As of March&#160;31, 2023, the Company had aggregate cash, cash equivalents, and available-for-sale securities of $99.7 million. See Note 3&#x2014;Cash, Cash Equivalents and Marketable Securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these unaudited condensed financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNC9mcmFnOmMxNWViZGUyZGU1ZDRjZDJiM2E2YTJhNzIyYTljZWYyL3RleHRyZWdpb246YzE1ZWJkZTJkZTVkNGNkMmIzYTZhMmE3MjJhOWNlZjJfMTExNQ_7a99765f-df62-4d0e-bb50-27a387a8b1c5"
      unitRef="usd">-221200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNC9mcmFnOmMxNWViZGUyZGU1ZDRjZDJiM2E2YTJhNzIyYTljZWYyL3RleHRyZWdpb246YzE1ZWJkZTJkZTVkNGNkMmIzYTZhMmE3MjJhOWNlZjJfMzQxOQ_3ba771ac-10b2-48df-b3bc-b20025b91444"
      unitRef="usd">99700000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNy9mcmFnOjFmYThjNDk4NjljOTQ3ODc5MzQzZWZhMzZjZTM4NGVlL3RleHRyZWdpb246MWZhOGM0OTg2OWM5NDc4NzkzNDNlZmEzNmNlMzg0ZWVfNjI3MQ_cac29c8e-92e2-430f-889f-92862b88cffe">Significant Accounting Policies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. The unaudited interim condensed financial statements have been &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2022, and, in the opinion of the Company&#x2019;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial results. The balance sheet as of December&#160;31, 2022 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2023, or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no significant changes in the Company&#x2019;s significant accounting policies during the three months ended March 31, 2023, as compared with those disclosed in its Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on March 22, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts have been reclassified to conform with the current period&#x2019;s presentation. The reclassifications did not have a significant impact on the condensed financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial statements as of and for the three months ended March&#160;31, 2023 reflect the Company&#x2019;s estimates of the impact of the macroeconomic environment, including the impact of inflation, higher interest rates, and the COVID-19 pandemic. The extent to which these conditions will directly or indirectly impact the Company&#x2019;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#x2019;s assets or liabilities as of the date of this filing.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNy9mcmFnOjFmYThjNDk4NjljOTQ3ODc5MzQzZWZhMzZjZTM4NGVlL3RleHRyZWdpb246MWZhOGM0OTg2OWM5NDc4NzkzNDNlZmEzNmNlMzg0ZWVfNjI3Mg_764ab0e5-cfda-48c9-aaf8-1df259fc8370">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. The unaudited interim condensed financial statements have been &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2022, and, in the opinion of the Company&#x2019;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial results. The balance sheet as of December&#160;31, 2022 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2023, or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no significant changes in the Company&#x2019;s significant accounting policies during the three months ended March 31, 2023, as compared with those disclosed in its Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on March 22, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;Certain prior period amounts have been reclassified to conform with the current period&#x2019;s presentation. The reclassifications did not have a significant impact on the condensed financial statements.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF8zNy9mcmFnOjFmYThjNDk4NjljOTQ3ODc5MzQzZWZhMzZjZTM4NGVlL3RleHRyZWdpb246MWZhOGM0OTg2OWM5NDc4NzkzNDNlZmEzNmNlMzg0ZWVfNjI3NA_4173e7fd-2747-4ef8-a94d-5523a4c1232f">&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial statements as of and for the three months ended March&#160;31, 2023 reflect the Company&#x2019;s estimates of the impact of the macroeconomic environment, including the impact of inflation, higher interest rates, and the COVID-19 pandemic. The extent to which these conditions will directly or indirectly impact the Company&#x2019;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#x2019;s assets or liabilities as of the date of this filing.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM4MA_712b7e3a-1da8-4186-8577-739487db7302">Cash, Cash Equivalents and Marketable Securities&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its marketable securities as available-for-sale. The Company&#x2019;s cash, cash equivalents and marketable securities by major security type as of March&#160;31, 2023 and December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s available-for-sale debt securities and cash equivalents with unrealized losses as of March&#160;31, 2023 and December&#160;31, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, the Company had not recorded any allowance for credit losses related to its available-for-sale securities. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities classified by contractual maturities as of March&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM4MQ_4fcc72ba-d07b-4c13-8e34-592d356c83ef">The Company&#x2019;s cash, cash equivalents and marketable securities by major security type as of March&#160;31, 2023 and December&#160;31, 2022 were as follows (in thousands):&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i60661342614546588426a472b8ef53eb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy0xLTEtMS01MDUzMQ_9c7b7fdd-b992-4aaf-aff1-b0d0694bdf80"
      unitRef="usd">200000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i60661342614546588426a472b8ef53eb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy0zLTEtMS01MDUzMQ_6f903d0a-3ad9-408f-914d-64c78272eb97"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i60661342614546588426a472b8ef53eb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy01LTEtMS01MDUzMQ_39e4b2fb-4076-4a1b-aea3-40301dfcc7b1"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i60661342614546588426a472b8ef53eb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMy03LTEtMS01MDUzMQ_a84f02f2-7381-4a93-8234-f36e0682769a"
      unitRef="usd">200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC0xLTEtMS01MDUzMQ_229c97fc-7f4c-45d9-9124-da24a1cda3d9"
      unitRef="usd">368000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC0zLTEtMS01MDUzMQ_01a3fda4-16ee-4761-b34b-eebbe766ac89"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC01LTEtMS01MDUzMQ_bc218438-5989-4447-8146-9526869c6365"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic4f2723f75e0456e8f0fa2a83157de06_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNC03LTEtMS01MDUzMQ_f2c7b77c-d630-44e7-bbef-bb0c5bf2628e"
      unitRef="usd">368000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS0xLTEtMS01MDUzMQ_d60ae98e-a501-4938-8246-259e957e9e23"
      unitRef="usd">25743000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS0zLTEtMS01MDUzMQ_f9a27a98-4076-41c1-bec1-dc5e0caea544"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS01LTEtMS01MDUzMQ_6fd3e11f-e5c1-4da4-854e-31f65d1ddfa7"
      unitRef="usd">5000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib0211c2ed3c548929d7ffe7e05c9290c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNS03LTEtMS01MDUzMQ_090ce743-c661-4f66-8224-a38bc04fc462"
      unitRef="usd">25738000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0xLTEtMS01MjAzNQ_2a777b69-6e5c-404b-b4c7-d8dcd624c768"
      unitRef="usd">895000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0zLTEtMS01MjAzNQ_b64cb23f-228d-486a-ae46-5d7f00917a01"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi01LTEtMS01MjAzNQ_c4be651c-6901-4690-bb00-251fca9cc9a3"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7ae393d120f14bfba0f069e945f76104_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi03LTEtMS01MjAzNQ_6a92d6a3-e995-4c18-9d99-5bab0b40c84a"
      unitRef="usd">895000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0xLTEtMS01MDUzMQ_a6c9f06f-86f9-455b-aa68-f3aff881c3d5"
      unitRef="usd">27206000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi0zLTEtMS01MDUzMQ_c6160d1b-29a4-493b-8154-fe8bb097e1ad"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi01LTEtMS01MDUzMQ_03ec136c-c751-4c71-8b8d-1520815284f4"
      unitRef="usd">5000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5bda022044a541ba852cd6e4a507ce4e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfNi03LTEtMS01MDUzMQ_8c8d717a-0b4f-4920-935d-04b71290653a"
      unitRef="usd">27201000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC0xLTEtMS01MDUzMQ_d2a4bee5-539a-4424-8350-e32e0ca439e2"
      unitRef="usd">11125000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC0zLTEtMS01MDUzMQ_974121f4-2b03-46cc-9c67-e39120aabbc0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC01LTEtMS01MDUzMQ_284e6426-bf46-4da2-aea8-0dd7d3d51413"
      unitRef="usd">33000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id13ecfeba4c740c8a40b0c6d768d98f2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfOC03LTEtMS01MDUzMQ_620463af-8840-46ac-8654-87be824ace31"
      unitRef="usd">11092000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtMS0xLTEtNTA1MzE_73f42796-867c-41cc-90d3-49f1273b978f"
      unitRef="usd">26102000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtMy0xLTEtNTA1MzE_e14807b4-19ad-441c-b20d-7104a081da46"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtNS0xLTEtNTA1MzE_d6b471bd-1185-4071-a964-1b0842c79e59"
      unitRef="usd">210000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib4abd6f79e2649dea270a120dcbdc006_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTAtNy0xLTEtNTA1MzE_8a4e048d-912c-4372-837c-db4426db3c5e"
      unitRef="usd">25892000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtMS0xLTEtNTA1MzE_ee5e488c-2a84-4eed-8881-47929eea9d1c"
      unitRef="usd">6678000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtMy0xLTEtNTA1MzE_76c7529f-6144-42ef-a3d7-6f8bcfc3cce7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtNS0xLTEtNTA1MzE_70acefe1-2725-42e5-a58e-a1123bbb79df"
      unitRef="usd">75000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i434d1d7a98ec4fcca8e31de5258e8c12_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTEtNy0xLTEtNTA1MzE_87eae08a-e5c8-438e-a513-ddd9a18ede07"
      unitRef="usd">6603000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1022d938781243e393cbc94f72b676c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItMS0xLTEtNTA1MzE_63d8e088-f9a7-483d-b547-be006e041a0c"
      unitRef="usd">43905000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1022d938781243e393cbc94f72b676c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItMy0xLTEtNTA1MzE_64e6bc5a-c097-452a-bcc6-a2cbdcd829b8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1022d938781243e393cbc94f72b676c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItNS0xLTEtNTA1MzE_7ee3f88b-1259-4fab-aa52-5fac860ff3cd"
      unitRef="usd">318000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1022d938781243e393cbc94f72b676c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTItNy0xLTEtNTA1MzE_ea3087ca-1c11-4381-9b05-53309f6fd599"
      unitRef="usd">43587000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtMS0xLTEtNTA1MzE_4a216493-b5d2-4936-80e3-bb2c164b44b9"
      unitRef="usd">17236000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtMy0xLTEtNTA1MzE_20fdf952-9418-4634-91d1-5cf89c9764c4"
      unitRef="usd">50000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtNS0xLTEtNTA1MzE_d5c841da-8ec0-4b74-b40d-ad1a2307171d"
      unitRef="usd">65000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9217e3b057e04c0b8ad6ad0356390301_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTQtNy0xLTEtNTA1MzE_e89644b9-415a-4cab-bb38-ea6a99585676"
      unitRef="usd">17221000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtMS0xLTEtNTA1MzE_577fc305-39cf-402f-a63d-bf5ac1f7602a"
      unitRef="usd">10646000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtMy0xLTEtNTA1MzE_06e19d3f-6ae1-473c-bd4b-901c30a806a5"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtNS0xLTEtNTA1MzE_3a02b0df-78c2-4cda-bdc7-5995816e3ea9"
      unitRef="usd">131000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87361057a25b44d5a2e75382401dcee3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTUtNy0xLTEtNTA1MzE_1e7d860a-4ae1-4289-b27a-8c4db46b2167"
      unitRef="usd">10520000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMS0xLTEtNTIwNDM_c6433e15-21ba-4a2a-97cb-76491fa6e8b3"
      unitRef="usd">1169000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMy0xLTEtNTIwNDM_fa269825-1079-47a7-9698-4cdb3b618bbb"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNS0xLTEtNTIwNDM_93dc47b7-52df-4863-9cb4-c400f99f78b2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3fab6b70134645aeb45e87280e5fab28_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNy0xLTEtNTIwNDM_4bd65e46-7b12-4ffe-9b7c-84dea1980d55"
      unitRef="usd">1176000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtMS0xLTEtNTA1MzE_b5addaff-f637-491b-bcf2-3920699b30f4"
      unitRef="usd">29051000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtMy0xLTEtNTA1MzE_de797a8b-02d4-4780-bd4e-459eda6f0acc"
      unitRef="usd">62000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtNS0xLTEtNTA1MzE_e95fd83b-0fab-438d-9415-150b17426f9e"
      unitRef="usd">196000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0b0133ac6e954f5990bf3a8cc7a5690d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTYtNy0xLTEtNTA1MzE_767d5419-3631-478f-a323-23377306ea88"
      unitRef="usd">28917000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMS0xLTEtNTA1MzE_d89f1a2f-a05e-4d57-ba95-5bf81acc6380"
      unitRef="usd">100162000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctMy0xLTEtNTA1MzE_2e9e99a0-e009-4d13-954e-91ef1849a038"
      unitRef="usd">62000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNS0xLTEtNTA1MzE_f84cd989-08b0-4e9e-af3f-54d59187e7c6"
      unitRef="usd">519000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmJiOGZjOTJkNWY0MjRiYjE5ZGZkMTYxOGY3MmQ5ZjM5L3RhYmxlcmFuZ2U6YmI4ZmM5MmQ1ZjQyNGJiMTlkZmQxNjE4ZjcyZDlmMzlfMTctNy0xLTEtNTA1MzE_a29a7f8c-8e90-4a93-87ef-73aec6b9cac1"
      unitRef="usd">99705000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy0xLTEtMS01MDUzMQ_1e8aa4e3-693f-44fc-bb59-38d3ac39f1c1"
      unitRef="usd">913000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy0zLTEtMS01MDUzMQ_774800d4-e59e-4d61-b86a-84fc6bfdcbfe"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy01LTEtMS01MDUzMQ_b1717252-0bac-443c-ad01-b9337f5d5d0e"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibe79aa1340684f9e9f19d3b7afc15826_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMy03LTEtMS01MDUzMQ_59d90431-dcf9-4eca-84ba-b90c6212a333"
      unitRef="usd">913000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC0xLTEtMS01MDUzMQ_e50a1491-006a-4bea-9373-2874b75ffa60"
      unitRef="usd">2618000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC0zLTEtMS01MDUzMQ_6e0226b3-9254-4225-a2b9-c54c17d7389c"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC01LTEtMS01MDUzMQ_304e9a77-b596-4db2-b678-b62c9da538ea"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5ffcd942edee4fe393481beeab7dd9d4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNC03LTEtMS01MDUzMQ_7d589818-b752-42e2-b262-d42efb59eb69"
      unitRef="usd">2618000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS0xLTEtMS01MDUzMQ_ae211fc7-0572-4dce-9867-1ffc8ecfae36"
      unitRef="usd">26356000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS0zLTEtMS01MDUzMQ_838dc714-c8f5-4e51-bb3b-2ee5221da6cc"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS01LTEtMS01MDUzMQ_e73b713a-f25b-43da-9752-9d93a5a95c3a"
      unitRef="usd">9000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9a684f8bb66d42a4bdf02aebd6d46105_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNS03LTEtMS01MDUzMQ_10f03224-4333-4699-aa22-2d5bf46a43f6"
      unitRef="usd">26347000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi0xLTEtMS01MDUzMQ_dbe6fbdc-d7e5-4f0a-bc9c-fcc5fbfd6e8f"
      unitRef="usd">29887000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi0zLTEtMS01MDUzMQ_747024c7-ffc7-4338-b0a1-31cc26dfcae8"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi01LTEtMS01MDUzMQ_97ed44b9-8492-42fb-8b51-64bb41b1a2d9"
      unitRef="usd">9000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia48fc3dc815c433f80b1352fc9b97d4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfNi03LTEtMS01MDUzMQ_ea3a8dc3-08e1-4217-b11a-85ae88e60c12"
      unitRef="usd">29878000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC0xLTEtMS01MDUzMQ_25e57eb0-308e-47c0-8a30-f782115d6538"
      unitRef="usd">15219000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC0zLTEtMS01MDUzMQ_d20f9d77-7022-4b00-aa9d-c2b48019d024"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC01LTEtMS01MDUzMQ_c60f976e-e067-4d54-896d-18ba2f77bac4"
      unitRef="usd">66000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0fd42b824770484b83699c48bd0c8cc7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOC03LTEtMS01MDUzMQ_454c77e7-0f95-4fcf-8453-95d1b6e8069b"
      unitRef="usd">15155000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS0xLTEtMS01MDUzMQ_3da2219a-ac30-4ddb-8ee3-aa93fdaa1505"
      unitRef="usd">507000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS0zLTEtMS01MDUzMQ_26abfddd-8ae1-4ced-bc59-404e75e88c7e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS01LTEtMS01MDUzMQ_ac2bf089-44fd-4034-afb2-51e09adac518"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6fe7f8c3896d4801a873549768ca0361_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfOS03LTEtMS01MDUzMQ_5a3e8197-f2ec-4ee5-a32b-71b8dd1cbb15"
      unitRef="usd">502000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMS0xLTEtNTIwNTM_22c6dd89-83a1-401d-b681-dfc48a3f5058"
      unitRef="usd">28964000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMy0xLTEtNTIwNTM_71761ba7-69f0-42cf-bf21-9380dba3bcd3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNS0xLTEtNTIwNTM_57092110-1e91-40fa-a596-87ba2c05e46b"
      unitRef="usd">364000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6cb30e5979214b32b0ec957e0ac792be_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNy0xLTEtNTIwNTM_f46c3493-4d05-4f8c-a432-c6eb891481f5"
      unitRef="usd">28600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtMS0xLTEtNTIwNTM_7e9199b5-2e4a-453b-94de-570ac2d8ccd0"
      unitRef="usd">8702000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtMy0xLTEtNTIwNTM_df4b8981-1979-4548-8715-b4b5f090e7fc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtNS0xLTEtNTIwNTM_9874403a-fb06-4d31-9076-af5bc94dbf0f"
      unitRef="usd">133000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia5f70bb0f76e488d9ac4ca22f39636bc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTEtNy0xLTEtNTIwNTM_42d09c51-8404-4acd-b8ef-32fbcac415e4"
      unitRef="usd">8569000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMS0xLTEtNTA1MzE_c5cbab7a-f0e1-4770-80a9-d8dd6762fa63"
      unitRef="usd">53392000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtMy0xLTEtNTA1MzE_04db5fcd-d4aa-4702-bfb0-7c3083975502"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNS0xLTEtNTA1MzE_dd9cb00e-c5f2-42d5-8e39-e2e142856c56"
      unitRef="usd">568000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i456d438d68a64c3b8c0f616f14448bf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTAtNy0xLTEtNTA1MzE_d2e72b50-0688-449b-8b3c-4ff8a4321bb4"
      unitRef="usd">52826000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItMS0xLTEtNTA1MzE_281d0325-d1f2-4566-9631-bf65adbe9142"
      unitRef="usd">9810000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItMy0xLTEtNTA1MzE_7588758f-eec4-418c-8426-d671c9983fac"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItNS0xLTEtNTA1MzE_f8027ef0-6c0e-49ff-869a-f69cd2a2bf13"
      unitRef="usd">199000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iedde383675c6474f9513b3d03ac58c92_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTItNy0xLTEtNTA1MzE_c2e62bd8-12a5-4350-98dc-95ef64dc9daf"
      unitRef="usd">9611000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtMS0xLTEtNTA1MzE_0ad6a015-31b8-43d8-9b12-04418082ba73"
      unitRef="usd">10770000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtMy0xLTEtNTA1MzE_60354e57-5cff-42db-af5a-0b1a7c1703d3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtNS0xLTEtNTA1MzE_875f0687-5010-4c0a-bf43-9e4ed9d5c0c0"
      unitRef="usd">208000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0075a7a5e5c84f4687883ce000262d46_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTMtNy0xLTEtNTA1MzE_c4d0fe3a-cd4f-4b2d-b7b6-f2c1902bb45f"
      unitRef="usd">10562000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtMS0xLTEtNTA1MzE_bb267c34-666d-4cea-891e-b2376c1646eb"
      unitRef="usd">1156000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtMy0xLTEtNTA1MzE_04379213-f6bb-4e5e-be86-22d7d6af1f79"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtNS0xLTEtNTA1MzE_7b5d075b-e046-4d19-a4ef-8743bf696cbf"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i875cb27901f440cf9dd94dd0c4f5f742_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTQtNy0xLTEtNTA1MzE_1ca97c17-7f3e-410c-a3f1-392608866f17"
      unitRef="usd">1156000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2deca7aa011c40308abedfe147f96001_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtMS0xLTEtNTA1MzE_a861769f-6c22-4c86-b2f1-56a76962b792"
      unitRef="usd">21736000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2deca7aa011c40308abedfe147f96001_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtMy0xLTEtNTA1MzE_10c1f259-213c-46aa-b32f-a0b0ffa15358"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2deca7aa011c40308abedfe147f96001_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtNS0xLTEtNTA1MzE_9c8a2400-bab9-40c2-8eb1-70f8870bcddc"
      unitRef="usd">407000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2deca7aa011c40308abedfe147f96001_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTUtNy0xLTEtNTA1MzE_7b5b1feb-6f29-4928-8482-1f37226f55a1"
      unitRef="usd">21329000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtMS0xLTEtNTA1MzE_9b785ea7-9972-435f-9629-e56781568099"
      unitRef="usd">105015000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtMy0xLTEtNTA1MzE_0dd60049-24b8-4c0e-ad68-29e19c51f2e1"
      unitRef="usd">2000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtNS0xLTEtNTA1MzE_ecd4eb08-0e54-40e4-bc40-f9abf849f99c"
      unitRef="usd">984000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjZGRhY2JmZGI4NjQ5NjhiNjljMDZmY2JlOWY1OTliL3RhYmxlcmFuZ2U6M2NkZGFjYmZkYjg2NDk2OGI2OWMwNmZjYmU5ZjU5OWJfMTYtNy0xLTEtNTA1MzE_ca451b5e-f01b-434c-bf19-f8d08e05e81c"
      unitRef="usd">104033000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM4Mg_829e13a9-d731-48f8-a6d0-ccade567e05e">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s available-for-sale debt securities and cash equivalents with unrealized losses as of March&#160;31, 2023 and December&#160;31, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy0xLTEtMS01MDUzMQ_b0379328-89c2-40f8-af2d-1a6d9616cf35"
      unitRef="usd">32187000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy0zLTEtMS01MDUzMQ_b40e3d5d-2c8d-499a-90d9-f9f25b1f36c5"
      unitRef="usd">38000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy01LTEtMS01MDUzMQ_95f4918d-277f-42ee-a023-9f8118d1d7a7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy03LTEtMS01MDUzMQ_73fe8b3f-e569-41ce-8712-bd4d9cb0ef16"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy05LTEtMS01MDUzMQ_47c16fb9-cc3a-4b18-8c93-f01274e7e860"
      unitRef="usd">32187000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ifdb3dddd72db4cd9b1506e12ea7b9df6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfMy0xMS0xLTEtNTA1MzE_7a1ddb1b-538c-477e-9a7b-6b2c08d72e99"
      unitRef="usd">38000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS0xLTEtMS01MDUzMQ_9373eca4-b8a8-4a39-b749-e5defd6952a1"
      unitRef="usd">11898000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS0zLTEtMS01MDUzMQ_0d521569-4009-47f7-909b-f8a758e563f8"
      unitRef="usd">179000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS01LTEtMS01MDUzMQ_8fb818d3-ff6f-4ab0-a0f3-5a46391275d9"
      unitRef="usd">17946000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS03LTEtMS01MDUzMQ_cf83938f-478b-43c1-a253-5a58f590ca92"
      unitRef="usd">96000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS05LTEtMS01MDUzMQ_6b58ebe1-d4c6-4ba5-b58e-35dc16134d03"
      unitRef="usd">29844000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i310f7526568741c38f0faf45c71f9fde_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNS0xMS0xLTEtNTA1MzE_78eaf7a0-899f-4497-b173-680781d6f827"
      unitRef="usd">275000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi0xLTEtMS01MDUzMQ_87679ddb-9ef9-43b5-a7bd-67c00aa3acaf"
      unitRef="usd">10670000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi0zLTEtMS01MDUzMQ_06274b0d-157a-4698-99f4-c324d4ac4ee2"
      unitRef="usd">156000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi01LTEtMS01MDUzMQ_ffe369c2-fd90-402a-9c8a-aac525998f20"
      unitRef="usd">4652000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi03LTEtMS01MDUzMQ_b25d90e0-772c-4b22-910c-ee44cf183270"
      unitRef="usd">50000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi05LTEtMS01MDUzMQ_fd505361-78b9-47d5-b730-72de1d6f3229"
      unitRef="usd">15322000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="icd2491cc9c53478d8582d7bf64db387e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNi0xMS0xLTEtNTA1MzE_f21541d6-1194-44e9-a2e7-0d34d33d510e"
      unitRef="usd">206000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy0xLTEtMS01MDUzMQ_26360185-317d-46e4-81dd-b137b39c3eb3"
      unitRef="usd">54755000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy0zLTEtMS01MDUzMQ_a31d28d5-4290-4f10-829d-160fc7f2f038"
      unitRef="usd">373000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy01LTEtMS01MDUzMQ_917203ae-8398-4e7f-8a43-d07eadbc4fa2"
      unitRef="usd">22598000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy03LTEtMS01MDUzMQ_4189840a-30f9-4583-b321-78bcf087f4cb"
      unitRef="usd">146000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy05LTEtMS01MDUzMQ_7f2a16b8-22db-47a5-a620-864b9aefd537"
      unitRef="usd">77353000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFiOTA4MWM0NmRlNTQ4MTJhNDg0YjllY2NkZmJmMzQxL3RhYmxlcmFuZ2U6YWI5MDgxYzQ2ZGU1NDgxMmE0ODRiOWVjY2RmYmYzNDFfNy0xMS0xLTEtNTA1MzE_b848e24b-7795-4db3-8620-6f9c8fde3436"
      unitRef="usd">519000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy0xLTEtMS01MjExNg_2d501252-b342-4be8-89a4-f5c18cfd4311"
      unitRef="usd">40063000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy0zLTEtMS01MjExNg_0b9f7ef1-6e34-40a1-b8b3-8fb1908f022f"
      unitRef="usd">75000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy01LTEtMS01MjExNg_0f39cbd2-6234-4f14-9bad-3164ea634644"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy03LTEtMS01MjExNg_25bf5956-e798-4bf9-9981-e334294946b1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy05LTEtMS01MjExNg_cd3fc48e-8bdd-4f8f-b4d3-3b8dd5b92074"
      unitRef="usd">40063000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib4c774e43caa40ef9ff2ef8866648d9c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfMy0xMS0xLTEtNTIxMTY_40bdc140-438e-4327-bc1d-d86220c4124d"
      unitRef="usd">75000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC0xLTEtMS01MjExNg_a28ba361-c932-4c0d-acc0-c8437e42889e"
      unitRef="usd">1156000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC0zLTEtMS01MjExNg_3ad518bb-33b8-4d0b-8df9-a97e28570df2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC01LTEtMS01MjExNg_f816ad48-52ba-4c45-9583-4010cba7296b"
      unitRef="usd">502000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC03LTEtMS01MjExNg_236765fd-b6d8-48ac-a5c2-901c22a9aa34"
      unitRef="usd">5000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC05LTEtMS01MjExNg_9964785b-665c-4bd1-aec4-3172d1a96b1c"
      unitRef="usd">1658000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="idbc319516ea3419a9ab9f009e01ff404_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNC0xMS0xLTEtNTIxMTY_415609a0-8dbb-4145-930a-00873797fc93"
      unitRef="usd">5000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS0xLTEtMS01MjExNg_5669b943-dae7-4be2-bcfb-c978b285beb7"
      unitRef="usd">12869000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS0zLTEtMS01MjExNg_07c6c940-b1c3-4bd8-9f5b-3861589c50a8"
      unitRef="usd">228000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS01LTEtMS01MjExNg_2e5c74d5-4a61-430e-ad26-1e0aa910d083"
      unitRef="usd">25342000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS03LTEtMS01MjExNg_b458b0fe-d557-413b-ab28-1bedb1365d17"
      unitRef="usd">335000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS05LTEtMS01MjExNg_d19e96e5-591a-45ba-974a-ac6c264352ef"
      unitRef="usd">38211000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7861a57d258d4089bf6e3c4e064742cf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNS0xMS0xLTEtNTIxMTY_8d6c0538-298c-4465-bf7d-63f02c0da11f"
      unitRef="usd">563000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi0xLTEtMS01MjExNg_c5be5e4f-9ab9-4476-a0f8-75521a36bcf0"
      unitRef="usd">10562000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi0zLTEtMS01MjExNg_9e1a8f7f-efe5-4b83-976c-fe2850d82135"
      unitRef="usd">208000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi01LTEtMS01MjExNg_7cbf2b22-1663-4b10-84ed-ffd7c1dddc3c"
      unitRef="usd">8569000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi03LTEtMS01MjExNg_34548215-79a8-4ec5-aacd-d69c1decb07f"
      unitRef="usd">133000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi05LTEtMS01MjExNg_aae839ca-f483-40b9-a077-c236e5f6f5b0"
      unitRef="usd">19131000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaf90f3640b8b40f28e3c77908d915dfc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNi0xMS0xLTEtNTIxMTY_17c97747-0742-4a3c-9b1f-b816c42f93e8"
      unitRef="usd">341000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy0xLTEtMS01MjExNg_a343113e-34a2-4a13-bf08-d3b8ade0c6a8"
      unitRef="usd">64650000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy0zLTEtMS01MjExNg_812efba4-baa9-40dd-adce-b9ec2110dd28"
      unitRef="usd">511000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy01LTEtMS01MjExNg_3728078a-0c65-4598-a972-35afb2c9fcc6"
      unitRef="usd">34413000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy03LTEtMS01MjExNg_966f80aa-76b6-4ba5-abf7-d66479726766"
      unitRef="usd">473000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy05LTEtMS01MjExNg_5976efbd-0202-4363-95cb-aca74a031ec9"
      unitRef="usd">99063000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOmFkMDkxMWFkYjVjMzQ1N2RhMDczMjE1ZjVkMzBmNWYyL3RhYmxlcmFuZ2U6YWQwOTExYWRiNWMzNDU3ZGEwNzMyMTVmNWQzMGY1ZjJfNy0xMS0xLTEtNTIxMTY_daa612d4-9737-4c1c-adbe-e70b0e6f0a56"
      unitRef="usd">984000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfNTQ5NzU1ODE1NjY5_1f25f389-f554-4eb2-9052-f2cd32e93268"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfNTQ5NzU1ODE1NjY5_c4dd5978-f970-4766-b445-aa6d298b3462"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RleHRyZWdpb246MTU2MjM3MGUyYjFmNGEzYTlmNjlmMDZlYWIwYTE3MGNfMTM3OQ_ce062d03-9af2-4ea0-9696-f52a72b99972">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities classified by contractual maturities as of March&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMS0xLTEtMS01MDUzMQ_40a50f0e-24da-4795-a740-8403836bb484"
      unitRef="usd">43905000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMS0zLTEtMS01MDUzMQ_401ab95c-215e-4b2e-99fc-a85ff35e3ad8"
      unitRef="usd">43587000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMi0xLTEtMS01MDUzMQ_1c18fecf-a62c-4aa5-bb1e-37bbaddf5a98"
      unitRef="usd">29051000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMi0zLTEtMS01MDUzMQ_e4d265d7-6436-4b01-87dd-6776a53ace2e"
      unitRef="usd">28917000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMy0xLTEtMS01MDUzMQ_cd28667c-bd33-407f-a82e-5b67ee86b9d3"
      unitRef="usd">72956000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80MC9mcmFnOjE1NjIzNzBlMmIxZjRhM2E5ZjY5ZjA2ZWFiMGExNzBjL3RhYmxlOjNjMjg4MDMzNDkyZDQ4MzI4ODMzNjBlMGFjNTIyNzI1L3RhYmxlcmFuZ2U6M2MyODgwMzM0OTJkNDgzMjg4MzM2MGUwYWM1MjI3MjVfMy0zLTEtMS01MDUzMQ_fee3f7fb-ff77-488f-b50d-89be75f839b3"
      unitRef="usd">72504000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMzEw_efc2453b-9eec-4e47-9a35-862a435f3ecf">Property and Equipment&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net, as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Depreciation and amortization expense was $0.2&#160;million for each of the three months ended March&#160;31, 2023 and 2022.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMzEx_4ce25a8b-18bd-48ba-89be-9ddd13fbe1b7">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net, as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i0689a9a22417417aa602cdd82583f081_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMS0xLTEtMS01MDUzMQ_f223abf9-6334-480a-b047-74a38bd167d6"
      unitRef="usd">5990000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i1a04512600a14358b38ac15e0b2e874e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMS0zLTEtMS01MDUzMQ_7792ac43-c8dc-4749-bdb8-4ca9f8be5ce6"
      unitRef="usd">5914000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="if8d9fcb90d124c48bf1d71f64aa3bd4e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMi0xLTEtMS01MDUzMQ_0845878c-14d3-4fbd-8f8b-ab94b7d2fe81"
      unitRef="usd">1239000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="id6dda952857f4641ac1036d6bfa8fc81_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMi0zLTEtMS01MDUzMQ_3bd9a6f5-5261-440e-8064-2ae69ab65090"
      unitRef="usd">1230000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="if6a5bd83d0814d7f87102db81904b40b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMy0xLTEtMS01MDUzMQ_dbfff879-6471-4ffc-9928-f2cd127212a8"
      unitRef="usd">710000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ibb3cdc18256f4159ae134effb7028788_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfMy0zLTEtMS01MDUzMQ_6cd6f3ab-12b0-4797-930d-e188b95d51eb"
      unitRef="usd">710000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i813380ad283a4a6c88946834430e11fe_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNC0xLTEtMS01MDUzMQ_d4b69f66-3a93-4567-994e-e715c2782709"
      unitRef="usd">1141000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ie590573b76374ef5bb34894c50c9c607_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNC0zLTEtMS01MDUzMQ_4ea6c17a-926a-434c-8186-25e534c9e9c1"
      unitRef="usd">1141000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i0cf2635c182d4ec9aecdb319305ba09a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNS0xLTEtMS01MDUzMQ_a2137157-ffed-4ab1-8258-797497d221ec"
      unitRef="usd">320000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i02380a24291e41fe8beb052dfb3634a4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNS0zLTEtMS01MDUzMQ_e1970175-698c-4b4d-b9cb-59a3a658ca35"
      unitRef="usd">320000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNi0xLTEtMS01MDUzMQ_849a7dfb-06ac-4c7b-aa13-41f277947480"
      unitRef="usd">9400000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNi0zLTEtMS01MDUzMQ_33ebd57c-5290-402a-9ce2-8d55af82df04"
      unitRef="usd">9315000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNy0xLTEtMS01MDUzMQ_fd354fe3-0bd5-4f90-8bc3-13c880bffbda"
      unitRef="usd">6493000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfNy0zLTEtMS01MDUzMQ_2f8ae2c0-9643-40dc-9674-dd25dc162a32"
      unitRef="usd">6256000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfOC0xLTEtMS01MDUzMQ_9c6b6106-dc31-4ce7-baf7-46eb7cdbb4f2"
      unitRef="usd">2907000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RhYmxlOjM1MDQzMTMxYTZlMTQxZWJiZGJiMzhiYTliMjA2ZWZiL3RhYmxlcmFuZ2U6MzUwNDMxMzFhNmUxNDFlYmJkYmIzOGJhOWIyMDZlZmJfOC0zLTEtMS01MDUzMQ_cee0a61d-8eac-4ee0-8e60-b5bd9c3630f7"
      unitRef="usd">3059000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMTY0_775c557e-6633-499b-b755-4afd1a5e8ac5"
      unitRef="usd">200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80My9mcmFnOjdlMGE5MzIyZmI2MTQ0NWVhODUxZjAzN2RkNzJiMTNjL3RleHRyZWdpb246N2UwYTkzMjJmYjYxNDQ1ZWE4NTFmMDM3ZGQ3MmIxM2NfMTY0_cc51d413-0309-4226-914c-2e0d1015707c"
      unitRef="usd">200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RleHRyZWdpb246NDg3OWU1Mzc1Y2Y2NGNiOWJhNDYyZmM0MTEyOGIyM2VfMTI5_853998ed-fcdd-46b7-8dd0-f66bc775f0d0">Accrued and Other Current Liabilities&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of accrued and other current liabilities as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued 401(k) matching contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RleHRyZWdpb246NDg3OWU1Mzc1Y2Y2NGNiOWJhNDYyZmM0MTEyOGIyM2VfMTMw_734b2355-4eb0-4dce-904e-8a36a87be1e5">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of accrued and other current liabilities as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued 401(k) matching contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMS0xLTEtMS01MDUzMQ_8ed20570-38ab-4464-ba59-0f2cb8fd581a"
      unitRef="usd">744000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMS0zLTEtMS01MDUzMQ_953fd365-b007-49a2-b456-5d5a6d87c102"
      unitRef="usd">2290000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMi0xLTEtMS01MDUzMQ_4175bfae-4352-49b6-a41a-70891273a890"
      unitRef="usd">590000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfMi0zLTEtMS01MDUzMQ_5e787f19-6710-4856-893b-a6b6ca31c15f"
      unitRef="usd">430000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNC0xLTEtMS01MDUzMQ_f201a19f-b582-414e-8259-942433da7197"
      unitRef="usd">170000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNC0zLTEtMS01MDUzMQ_d2bd61b7-bddc-4b94-a312-7d25c87e9922"
      unitRef="usd">568000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNS0xLTEtMS01MDUzMQ_19e31a06-8b2d-400c-93ff-c5575471335d"
      unitRef="usd">533000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNS0zLTEtMS01MDUzMQ_034a969b-845f-42f3-8215-8e4cf40baa02"
      unitRef="usd">519000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNi0xLTEtMS01MDUzMQ_28170a51-87a3-4434-9981-f2e10d965602"
      unitRef="usd">655000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNi0zLTEtMS01MDUzMQ_d3938b37-3d35-4a19-9017-5390769be1f1"
      unitRef="usd">637000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNy0xLTEtMS01MDUzMQ_20b3766a-79e7-464a-8c86-f0122537c5ed"
      unitRef="usd">2692000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80Ni9mcmFnOjQ4NzllNTM3NWNmNjRjYjliYTQ2MmZjNDExMjhiMjNlL3RhYmxlOjE4Y2YyZjQxMTkzOTQ1NDU4MjhlMDA2ZTQyZTM1Y2M0L3RhYmxlcmFuZ2U6MThjZjJmNDExOTM5NDU0NTgyOGUwMDZlNDJlMzVjYzRfNy0zLTEtMS01MDUzMQ_03b43afc-d235-4dde-b9d4-a011b9fb8f8d"
      unitRef="usd">4444000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RleHRyZWdpb246YTgwNjM4MDg0MDVkNGQ1MTkyNDVlY2UyOWY0NDU3ZDFfMTI4_552dd266-7672-4c3b-b30c-11ce84e96763">Other Income, net&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of other income, net, for the three months ended March&#160;31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;257&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Investment income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;523&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;780&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RleHRyZWdpb246YTgwNjM4MDg0MDVkNGQ1MTkyNDVlY2UyOWY0NDU3ZDFfMTI5_c0206ef0-f6fc-42bd-8299-c8f2b64d184b">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of other income, net, for the three months ended March&#160;31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;257&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Investment income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;523&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;780&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InterestIncomeOther
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMi0xLTEtMS01MDUzMQ_d90f1134-75d2-4f74-b178-4b2e61212cba"
      unitRef="usd">257000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMi0zLTEtMS01MDUzMQ_43b1cb7f-a820-4deb-8bc5-65b52786e7fb"
      unitRef="usd">78000</us-gaap:InterestIncomeOther>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMy0xLTEtMS01MDUzMQ_4b1e6048-75fe-422b-8d78-42ef6a7a5e32"
      unitRef="usd">523000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfMy0zLTEtMS01MDUzMQ_ca7d7a6b-8311-4f5a-b731-a921c42c4510"
      unitRef="usd">18000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfNy0xLTEtMS01MDUzMQ_026a287f-7224-4d1f-a404-a1c166a28bab"
      unitRef="usd">780000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF80OS9mcmFnOmE4MDYzODA4NDA1ZDRkNTE5MjQ1ZWNlMjlmNDQ1N2QxL3RhYmxlOmY2M2EzNzE2ZWY4NjQ0ZWI4ZDc2YzM1MDY5M2RlMmUxL3RhYmxlcmFuZ2U6ZjYzYTM3MTZlZjg2NDRlYjhkNzZjMzUwNjkzZGUyZTFfNy0zLTEtMS01MDUzMQ_3170ad84-1435-434e-b04b-9e703add4ef8"
      unitRef="usd">96000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RleHRyZWdpb246N2JkZjc4ODcxN2IyNDU0OGEzN2FhYzhkYWYxMjM2NTFfMTg5MA_0cc0620d-59cc-4198-8c8c-cced77387290">Fair Value MeasurementsAs of March&#160;31, 2023 and December&#160;31, 2022, the carrying amounts of the Company&#x2019;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds are highly liquid investments and are actively traded. The pricing information on money market funds is readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency bonds, U.S. government bonds, commercial paper, and corporate debt securities are measured at fair value using Level 2 inputs. The Company reviews trading activity and pricing for these investments as of each measurement date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;43,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;99,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RleHRyZWdpb246N2JkZjc4ODcxN2IyNDU0OGEzN2FhYzhkYWYxMjM2NTFfMTg5MQ_23012ecb-0937-49ea-a762-7ff2f5486682">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;43,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;99,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib1e6b5e7a18d4714be7dc3cd442de182_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMy0xLTEtMS01MDUzMQ_037fd38e-9608-4f10-b9ae-6b1460368c10"
      unitRef="usd">368000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9f666d3ee1114f89a06ced8d07c1cac1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMy0zLTEtMS01MDUzMQ_1aa72566-f3c1-4979-a672-345f3abe9412"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i633da3607bf74e6399a271d9b5a872dc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMy01LTEtMS01MDUzMQ_d5c3f738-0dd8-4704-a69e-985d3470cd49"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2c7078405bba49d8b9ae3c7a24e77d59_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNC0xLTEtMS01MDUzMQ_a3bd0823-0f0a-451f-a5db-7686df55ea09"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9a4c9f1b7de04945b27590548f7a034a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNC0zLTEtMS01MDUzMQ_be887e76-33cd-48de-8a71-1f343f09ac54"
      unitRef="usd">25738000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i42f38e0fd91b4bc9a6edd8c6525262eb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNC01LTEtMS01MDUzMQ_65186d31-b1d2-4cab-9f75-b50c12a4a30e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib4f0e071eb624dad8e0ef430093db2f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNS0xLTEtMS01MjMzNw_6484f315-d7e6-4965-82a1-3a42502f21da"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i26ad96634a0944fc8ff1db153b046a32_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNS0zLTEtMS01MjMzNw_2617aaf6-f9c8-4327-9edc-fe6568f51069"
      unitRef="usd">895000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id1d1569554ae410b8a9034cde1714135_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNS01LTEtMS01MjMzNw_126f9f9a-0651-4cef-9719-5a68bcb33c4c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b5c62d74c5e4c13b5b1f9a2db0cb194_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNi0xLTEtMS01MDUzMQ_c0d50c01-17c5-4949-a5a9-39dbd8426eae"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ied68b9ca26b446e59b4b4f792f403d2b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNi0zLTEtMS01MDUzMQ_ccd050bc-6787-4eca-8d0b-53a5a9eae4fd"
      unitRef="usd">11092000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if7460c4b611a4c1a8deecbf81c1f906d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNi01LTEtMS01MDUzMQ_c04240f9-8fef-4753-b7f8-3acda06ed74c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id73796b542fb4928ade5f07ade35d66b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNy0xLTEtMS01MDUzMQ_e562c04a-d266-4456-9dd9-74c394206d5f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f78ab542cac4bd0a4cde222a8e7e773_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNy0zLTEtMS01MDUzMQ_2a9c71aa-28cd-4060-ae82-359bd273a047"
      unitRef="usd">1176000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i13be094f9c244c158024b56a7cb5ecff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfNy01LTEtMS01MDUzMQ_7576605b-664b-4fb6-935b-5e2b30de62cc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3e5fb142963d40bc9752b25c78058aa4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOC0xLTEtMS01MDUzMQ_c76f3bae-4520-4d51-aab7-bc670e553002"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf70dfed4cf44986832bd01bae60b309_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOC0zLTEtMS01MDUzMQ_8e2a61f5-02c6-4384-bdac-f11ac747ac34"
      unitRef="usd">43113000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i55bf665ab22b48dd84b5f6508b6dc531_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOC01LTEtMS01MDUzMQ_8addc2af-31d5-4099-9748-9fad44b0ab75"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i262be437741d4c54906e37b798c135cd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOS0xLTEtMS01MDUzMQ_d0d44ca6-cf45-4d91-83af-87d24f55802f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib13ca83ce3884e60b6458d148f1cdfe4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOS0zLTEtMS01MDUzMQ_dbc4ef1f-a334-4ff3-9ecc-48d61fabe521"
      unitRef="usd">17123000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2277bfa471754111acad933a7e99966c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfOS01LTEtMS01MDUzMQ_d2c28e42-2d78-4123-bf4e-70c15a3fc6d2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie9901b75d0bf4b4595246dc12220f857_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMTAtMS0xLTEtNTA1MzE_e9977f8c-97df-4d8d-aa36-11d7ee4e2c11"
      unitRef="usd">368000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i14d03532a9124a129f1031a6ffcab6a8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMTAtMy0xLTEtNTA1MzE_458d20a8-19d5-429d-826a-5bb3be472c73"
      unitRef="usd">99137000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if3283049b13a48a5b0dbb4875b2c82fe_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjY5ZGE4YThlNTI4ZDRiZjk5NWZiNDY2MWY3NTUwYmYxL3RhYmxlcmFuZ2U6NjlkYThhOGU1MjhkNGJmOTk1ZmI0NjYxZjc1NTBiZjFfMTAtNS0xLTEtNTA1MzE_95a06b3c-db35-4a78-922b-efcaa4184473"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6a86a8c7fd3142b59e9f55ee76ca645f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMy0xLTEtMS01MDUzMQ_59cffab2-2033-48d8-9bcc-73cdc2702da2"
      unitRef="usd">2618000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib17e4dfe8114480a9bd0dd5e85c27414_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMy0zLTEtMS01MDUzMQ_21556fa5-b024-4a8f-80c2-41500c8a7630"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib1fef988414b43c6b092ed0b459b393c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMy01LTEtMS01MDUzMQ_294a93d5-d0e5-4a5a-9c34-ac4c3dff38e1"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4e6d0b3094cc43ca8063063fc0d62736_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNC0xLTEtMS01MDUzMQ_dc945b19-7e62-4575-a957-053e05d3eced"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ife9e1cfb0901453096411529be5647f8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNC0zLTEtMS01MDUzMQ_4039232f-a8a2-488d-93d5-72471a8a07c2"
      unitRef="usd">26347000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9909f01379d9443cbe56ab0eacbd84b4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNC01LTEtMS01MDUzMQ_c9a0dbe1-83b3-40fe-b62e-cd8a41ecb4ed"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb26f6e075f649db844239697d35cf44_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNi0xLTEtMS01MDUzMQ_01ec5113-272e-4b2d-ad3e-5b2f910e054a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2d5bf6251b7b4c75840430bed4b53f15_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNi0zLTEtMS01MDUzMQ_d6debc41-5347-4cd4-8ba7-3dd655599422"
      unitRef="usd">15155000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i057f6cfcbe9647feaf5cdc6e8b694c95_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNi01LTEtMS01MDUzMQ_3610f7fd-c47a-4c1a-89c3-70789c6fef5c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0936c84ad3f94183aeff5843d1470ea0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNy0xLTEtMS01MDUzMQ_c6e20e75-7e4e-49a2-a8f5-e1180e836051"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie061ca627cde49dea9441184eba4360a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNy0zLTEtMS01MDUzMQ_26cb421e-3133-4c8e-a254-88775ef53faa"
      unitRef="usd">1658000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia61bb82bb96640b6a960d4a434b01d37_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfNy01LTEtMS01MDUzMQ_9eb1bcf0-1fc0-4b55-845e-3659a3fb12c7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec6934a5de584a6f907ec7efe8ab449b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOC0xLTEtMS01MDUzMQ_0a6d1504-88e1-41b5-ba17-bbad0d74fb08"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc6c9adab7224ca2974718d2d132d7c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOC0zLTEtMS01MDUzMQ_aeb5866c-22de-478a-98bb-cfa9d094c097"
      unitRef="usd">38211000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i602355d9b023442ea2e229223e367f52_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOC01LTEtMS01MDUzMQ_b3b95ff6-f3d8-4270-92c7-1baf152c2595"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic6e649c834f541b1a07b68af95f39792_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOS0xLTEtMS01MDUzMQ_415bdf22-cd2f-4b9c-bed0-907a3aae9309"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i854e50c14d1a416c81e655b988108acc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOS0zLTEtMS01MDUzMQ_32103c71-15d6-4451-9f56-a005afde1881"
      unitRef="usd">19131000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida65d68be4234d39ae17f2b0901689e3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfOS01LTEtMS01MDUzMQ_0fccd3da-59a2-4500-8eee-c540b21d60fa"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7d852401dd8c45f8bac931d6391e0d8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMTAtMS0xLTEtNTA1MzE_22d4499c-8c94-48cf-bc9f-5e2690763c2f"
      unitRef="usd">2618000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4150a09b96f64456861db2de07189a11_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMTAtMy0xLTEtNTA1MzE_21f1c532-5921-4cf4-9bf5-46671f3be89b"
      unitRef="usd">100502000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4e2b7a1779484a588d3e5dcc2f75c5c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81NS9mcmFnOjdiZGY3ODg3MTdiMjQ1NDhhMzdhYWM4ZGFmMTIzNjUxL3RhYmxlOjBlYzJjODM1ZmNkYTRiMjg5NGNiNTU4YjA4NmUyMTUxL3RhYmxlcmFuZ2U6MGVjMmM4MzVmY2RhNGIyODk0Y2I1NThiMDg2ZTIxNTFfMTAtNS0xLTEtNTA1MzE_8b137ce2-0fac-478d-8b24-9efb8a99355e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfMzg5Nw_6f915529-43e0-4fef-b206-f925f6ccc023">Related Party Transactions&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, the Company entered into a master services agreement with Carelon Research, a subsidiary of Elevance Health, Inc. (&#x201c;Elevance Health&#x201d;). This agreement covers a range of research projects, including Carelon Research&#x2019;s role as a contract research organization for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;P&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rematurity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;R&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;isk Assessment Combined With Clinical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nterventions for Improving Neonatal outco&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ME&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s (&#x201c;PRIME&#x201d;) study. The Company paid fees related to this agreement of $0.8&#160;million and $0.7&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. The Company recognized revenues related to this agreement of $21&#160;thousand and $19 thousand for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#x201c;Commercial Collaboration Agreement&#x201d;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#x2019;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first three years of the term of the Commercial Collaboration Agreement. The Company received $6.0&#160;million during the three months ended March 31, 2023, which amount related to the minimum payments for the year ended December&#160;31, 2022. Such minimum payments were initially recorded as deferred revenue. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Elevance Health has been participating in the Company&#x2019;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#x2019;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#x201c;ASC 808&#x201d;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:OperatingExpenses
      contextRef="iebe6c97e0a004df6add4d077081e8986_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfNDk2_600521d4-211c-46d6-b2a0-391075466226"
      unitRef="usd">800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i25502e94a007481095a51420d5929626_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfNTAz_91b01162-32d1-419b-af30-a6b33fab70eb"
      unitRef="usd">700000</us-gaap:OperatingExpenses>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6233338a3de4492ac7fc3602d7b3429_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfODgz_1c41805c-49f3-46a0-aa47-5e41d4b75f25"
      unitRef="usd">21000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81e3ed0434cf4e1fb660521a3660854b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfNTQ5NzU1ODE3ODMy_ea81de63-3932-428f-8092-baa4f569dea9"
      unitRef="usd">19000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm
      contextRef="iea4329433de54b779062bdcbf483862a_D20210201-20210228"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfMTQ0Ng_df0b45f6-fee8-45f0-8ac9-41582806c228">P3Y</sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm>
    <sera:RelatedPartyTransactionCashReceivedFromRelatedParty
      contextRef="i5f467c43c88a4619bd1e2b17c7062c3b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF81OC9mcmFnOjliN2UwYTg5OGIxZDQ5OTI4NmZjNjhhOWE5YzlmNzU5L3RleHRyZWdpb246OWI3ZTBhODk4YjFkNDk5Mjg2ZmM2OGE5YTljOWY3NTlfMTY1OQ_ab04daa1-6cec-41b5-8e4d-84fe72528af5"
      unitRef="usd">6000000</sera:RelatedPartyTransactionCashReceivedFromRelatedParty>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfMTE0Mw_3b78ad98-274a-4004-9002-4d819751ca52">Capital Structure&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to one share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#x2019;s amended and restated certificate of incorporation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following shares of Class A common stock were reserved for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,875,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,428,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,312,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,926,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;894,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;598,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,206,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,729,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <sera:NumberOfCommonStockClassesAuthorized
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfNTIz_b73c8826-a655-4005-8e61-a2fe060e4796"
      unitRef="common_stock_class">2</sera:NumberOfCommonStockClassesAuthorized>
    <sera:NumberOfVotesPerShare
      contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfNzU2_18fb034d-63d7-4bff-a60a-6e1d33bba733"
      unitRef="vote">1</sera:NumberOfVotesPerShare>
    <sera:CommonStockConversionRatio
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfODgy_0c92ec8f-9370-4aea-8221-e1173bb37b6c"
      unitRef="number">1</sera:CommonStockConversionRatio>
    <sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RleHRyZWdpb246M2Y4MWY3MTA0ZTRkNDQwMzg5NWNhYzdkZWQ5MDBkMDhfMTE0NA_bd9eef8c-aa51-4141-9ddd-229f21914b7c">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following shares of Class A common stock were reserved for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,875,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,428,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,312,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,926,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;894,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;598,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,206,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,729,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ie51451f721f248449b164911776d14cf_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMS0xLTEtMS01MDUzMQ_c20cb0b5-7007-4cf0-9f8c-21a8d19b3dc1"
      unitRef="shares">2775978</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i8e8d27e73cfa42b68409d0498a6072d5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMS0zLTEtMS01MDUzMQ_2628eb09-dd1f-4a7d-9418-bf233ff312f8"
      unitRef="shares">2775978</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i1bac8f889d2845938fb80af53ea359b9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMi0xLTEtMS01MDUzMQ_a072ee66-1663-4f1d-8126-f8a8af5fbf56"
      unitRef="shares">8875249</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i64464d2a8cea488d9bf93bc83aac4914_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMi0zLTEtMS01MDUzMQ_e49de198-d18b-4199-840e-46b25ca8e066"
      unitRef="shares">8428441</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5056875ac3244f5dbc3045e076055486_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0xLTEtMS01MjQ1NA_f3f47fee-426b-41ba-be95-262a1355f8f4"
      unitRef="shares">347436</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i008a3034f9504be4bce1130bdf12035d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0zLTEtMS01MjQ1NA_1c525951-4523-435e-ab2a-c720eb9ec65f"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i721dc8e4c62a42abba54bc026dbfa057_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0xLTEtMS01MDUzMQ_443547db-b87b-4f2d-99d5-958ba5704bd7"
      unitRef="shares">2312525</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i6df48d3ee72046c1810e7e4afa6e12be_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfMy0zLTEtMS01MDUzMQ_4af0a1b6-12fc-44ec-b90a-8afaed242c54"
      unitRef="shares">1926356</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="id97654d11c5a4152b663b94b04260e41_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNC0xLTEtMS01MDUzMQ_aace4a43-d94d-4b23-aa86-10f113da8b37"
      unitRef="shares">894903</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i08ddab687a264ed4a1e0870d43ec1462_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNC0zLTEtMS01MDUzMQ_8d0701e1-7d1a-4b51-a0c8-aa6cc02ad979"
      unitRef="shares">598777</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5d7acae39b0445e2914b0355b32a99e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNS0xLTEtMS01MDUzMQ_7af74880-30ae-4deb-84b2-d0a9f4c955d0"
      unitRef="shares">15206091</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i44fb940986b84760a203d1102bc5f10c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82MS9mcmFnOjNmODFmNzEwNGU0ZDQ0MDM4OTVjYWM3ZGVkOTAwZDA4L3RhYmxlOmMwYjNlMTIzMjZiMjQxN2ZiZThlY2M3OWVjMzg3MDBhL3RhYmxlcmFuZ2U6YzBiM2UxMjMyNmIyNDE3ZmJlOGVjYzc5ZWMzODcwMGFfNS0zLTEtMS01MDUzMQ_31a777b1-d09d-4ee4-bc3e-a220dd432df4"
      unitRef="shares">13729552</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4Ng_265143dd-b760-4482-be87-d473133fce53">Stock-Based Compensation&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#x201c;2011 Plan&#x201d;) and reserved shares of the Company&#x2019;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a four-year period and generally expire ten years from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors, and consultants of the Company. Options generally vest over a four-year period, are exercisable only to the extent vested, and generally expire ten years from the date of grant. Restricted stock units (&#x201c;RSUs&#x201d;) generally vest over a four-year period. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of March&#160;31, 2023, there were 2,312,525 shares of the Company&#x2019;s Class A common stock that were available for future grants under the 2021 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Employee Stock Purchase Plan (the &#x201c;2021 ESPP&#x201d;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of March&#160;31, 2023, there were 894,903 shares of the Company&#x2019;s Class A common stock that were available for future grants under the 2021 ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise noted, references to &#x201c;options&#x201d; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. The following table summarizes information about these options granted and outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Subject to&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (In Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;br/&gt;(In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,428,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;612,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(161,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,875,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and expected to vest at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,497,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and exercisable at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,890,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding &#x2014; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding &#x2014; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total employee stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of March&#160;31, 2023 was as follows (in thousands, except years):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized Stock-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Period of Recognition (in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unrecognized stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iddd0a6e59f784d5e8a2a70335dc43e4b_D20111101-20111130"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4Nw_ef887e8d-262e-482b-9d83-fa03f23a1635">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="iddd0a6e59f784d5e8a2a70335dc43e4b_D20111101-20111130"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMzM2_63699541-357a-4452-9bfd-17a20b02301c">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4OA_61451510-57e8-4e6f-8107-3f150fb6f955">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfOTQ1_b3512352-d2a0-46d2-8ebd-e02b417d92eb">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie41c6353df034ac1bc696e260d7c181d_D20210701-20210731"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfNTQ5NzU1ODE3MzUw_57726f68-133b-4c88-acc0-c1b44e19de63">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="if2b38bbfb8c44e16b1a98f32cc4e64da_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMTM2OA_3c00fabf-f264-4ac4-83b7-d0438ff5fa8e"
      unitRef="shares">2312525</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i10f872c050a642a4bd7b0d7bf50b2c15_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMTc5MA_5e0c25c1-4589-42d1-b109-a169264716f0"
      unitRef="shares">894903</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU4OQ_a805d2d8-2d0e-45f2-97df-98b433e506ed">The following table summarizes information about these options granted and outstanding:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Subject to&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (In Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;br/&gt;(In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,428,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;612,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(161,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,875,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and expected to vest at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,497,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and exercisable at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,890,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS0xLTEtMS01MDUzMQ_e9f87654-b125-42f9-8a0c-3620619feee0"
      unitRef="shares">8428441</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS0zLTEtMS01MDUzMQ_a0970530-94d1-483b-9b30-42062ade533e"
      unitRef="usdPerShare">3.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i589f0422795f40b0be50fa589249a5ab_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS01LTEtMS01MDUzMQ_c843e4ff-e3af-4025-b484-595fc6e60b00">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMS03LTEtMS01MDUzMQ_44a1aa31-fffb-439f-adb8-6dc3aa719073"
      unitRef="usd">115000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMi0xLTEtMS01MDUzMQ_9c166a1a-11f6-48c4-99ce-bac2c381549b"
      unitRef="shares">612276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMi0zLTEtMS01MDUzMQ_c4ec1c20-b77c-4f31-8f6e-8371c90da8e8"
      unitRef="usdPerShare">3.79</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMy0xLTEtMS01MDUzMQ_c8690f68-97ca-4091-984f-0a33712dc321"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfMy0zLTEtMS01MDUzMQ_8e191330-8f5c-4d0f-91c6-7390ee28d8d7"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNC0xLTEtMS01MDUzMQ_5f6bfe9b-a662-4762-976c-992e35ffda92"
      unitRef="shares">161374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNC0zLTEtMS01MDUzMQ_d81b66e0-5f22-4c43-95ac-25e78c284b01"
      unitRef="usdPerShare">6.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNS0xLTEtMS01MDUzMQ_3f320192-487e-4fec-8f2f-bb60f8d9e73e"
      unitRef="shares">4094</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNS0zLTEtMS01MDUzMQ_04f0aa07-9ba2-47db-9eac-70c813d86deb"
      unitRef="usdPerShare">0.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi0xLTEtMS01MDUzMQ_30411d22-6d2a-4639-99ae-acabc103cc42"
      unitRef="shares">8875249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi0zLTEtMS01MDUzMQ_6d62b34f-68c0-45d6-8f6f-ef7fece35ba2"
      unitRef="usdPerShare">3.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi01LTEtMS01MDUzMQ_c4e11fb4-a8f1-437c-bc4c-2791490819fe">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNi03LTEtMS01MDUzMQ_939dbc60-5838-4a80-accf-fc322a05304f"
      unitRef="usd">9755000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy0xLTEtMS01MDUzMQ_4bbef8c1-c410-455f-8a94-1c6480d6510a"
      unitRef="shares">8497717</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy0zLTEtMS01MDUzMQ_f6150245-f625-4b9e-876d-453c7f800dfb"
      unitRef="usdPerShare">3.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy01LTEtMS01MDUzMQ_2b99beba-8d11-4a35-bf66-80652cd64e14">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfNy03LTEtMS01MDUzMQ_36093c01-a308-4f2c-9a12-f9b5089ed292"
      unitRef="usd">9630000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC0xLTEtMS01MDUzMQ_c0447ac5-5c5a-47d5-8c3e-e1a48bfe53bd"
      unitRef="shares">4890492</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC0zLTEtMS01MDUzMQ_66a51e75-46b4-4e0c-9853-b888bcde2dfd"
      unitRef="usdPerShare">3.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC01LTEtMS01MDUzMQ_2f33aab5-9e05-4f77-9763-c9ff3892f7b0">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmFhNWI1ZGU4NTU5ZjRjZmQ4MTgzM2Q2YjU5ODUyMGRlL3RhYmxlcmFuZ2U6YWE1YjVkZTg1NTlmNGNmZDgxODMzZDZiNTk4NTIwZGVfOC03LTEtMS01MDUzMQ_f2415f34-f8e2-456f-8457-9ce41f3aad4f"
      unitRef="usd">7562000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfNTQ5NzU1ODE3MzUx_d5b7b12e-e3f1-4ae3-b4e2-dbc77e80a062">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding &#x2014; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding &#x2014; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMS0xLTEtMS01MjcyNA_4d641278-3468-4725-9962-56bbe6dc18e6"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMS0zLTEtMS01MjcyNA_d6bbe88f-e686-4a16-b787-9ddba3eb37ea"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMi0xLTEtMS01MjcyNA_16eb1f6e-6bdb-4282-ab32-eaeb5a35866f"
      unitRef="shares">347824</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMi0zLTEtMS01MjcyNA_1b91e723-0f6e-457b-a2a2-d62508e5714a"
      unitRef="usdPerShare">3.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMy0xLTEtMS01MjcyNA_01e8a5f3-b1b7-4b3c-bb37-e6a519dafd4a"
      unitRef="shares">388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfMy0zLTEtMS01MjcyNA_07ac435a-4eb0-4519-a1e2-914eed443aba"
      unitRef="usdPerShare">3.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNC0xLTEtMS01MjcyNA_1fa894bb-0e2b-41f4-8b8e-82e7838d8885"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNC0zLTEtMS01MjcyNA_f065fd72-8f3f-43b9-8e11-a276f9356066"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i77a70c0650fb42628493971aa4f0049c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNS0xLTEtMS01MjcyNA_1f402349-1017-4303-85dc-3b25ce3b4b9d"
      unitRef="shares">347436</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i77a70c0650fb42628493971aa4f0049c_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjhjNjc3OWZlZDQ2MDRiNDY4OTRkODFmNzBlZWEzZDhhL3RhYmxlcmFuZ2U6OGM2Nzc5ZmVkNDYwNGI0Njg5NGQ4MWY3MGVlYTNkOGFfNS0zLTEtMS01MjcyNA_367cfe23-e61d-4630-a936-3a39e8c07b67"
      unitRef="usdPerShare">3.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfMjU5MA_d5456b8c-9d1f-4d36-8861-cc344fa01165">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total employee stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib678e71d507240f7846a08db78ba061b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMi0xLTEtMS01MDUzMQ_75426a10-6e21-4bea-a890-fe764dc48d29"
      unitRef="usd">349000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0e85b9ebdb094f55a3f434b347ee787f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMi0zLTEtMS01MDUzMQ_7fd2e7f4-6abb-4753-af4f-34bf35b6dc6e"
      unitRef="usd">383000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i93bd5d88af7d410491f05716f1ed0e5f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMy0xLTEtMS01MDUzMQ_4c08f3be-3ec6-4924-940c-49707a26f6b5"
      unitRef="usd">184000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i52391e73e9df469c9e683c465b16f7c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfMy0zLTEtMS01MDUzMQ_d19e2cb0-9c6e-4769-abe0-b1a4a880f408"
      unitRef="usd">313000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i91b41e5291034c509f187d546c338915_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNC0xLTEtMS01MDUzMQ_50258b4c-2a0d-4126-9ad8-04827e2304e0"
      unitRef="usd">771000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifd63d2c7f48d408eb0ef89901295964a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNC0zLTEtMS01MDUzMQ_78833888-8b2e-43e7-97c1-33e2ca8154cd"
      unitRef="usd">526000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNS0xLTEtMS01MDUzMQ_de421e19-1bea-45ef-9c6f-f17a649e0214"
      unitRef="usd">1304000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOmIwNDgyNDhmYjQ5MzQ0ZGY4NDIzMTk0YjMxN2I0OGJhL3RhYmxlcmFuZ2U6YjA0ODI0OGZiNDkzNDRkZjg0MjMxOTRiMzE3YjQ4YmFfNS0zLTEtMS01MDUzMQ_5ad26543-4b4f-461d-9e1e-f4e35443fae0"
      unitRef="usd">1222000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RleHRyZWdpb246YTBhZDZiZWVmZWQ2NDg3ZDk0NjBlYzA0MTc5MjU2MTVfNTQ5NzU1ODE3MzYx_f6acbf03-07f9-4c1d-9167-f30064efeea9">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of March&#160;31, 2023 was as follows (in thousands, except years):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized Stock-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Period of Recognition (in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unrecognized stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMS0xLTEtMS01MzczOQ_2660e9a7-3df6-4405-89f7-d02bdc53050a"
      unitRef="usd">10071000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMS0zLTEtMS01MzczOQ_fa2a9ac7-c170-4fd1-85b1-dbe155445f61">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i77a70c0650fb42628493971aa4f0049c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMi0xLTEtMS01MzczOQ_84950b94-2e6a-4550-9f26-9c4519e8efbb"
      unitRef="usd">1013000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5583b97a3fff44ff94049c6a9fbbc8c2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMi0zLTEtMS01MzczOQ_55f662c4-7260-48d1-adf3-155863372ecd">P3Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82NC9mcmFnOmEwYWQ2YmVlZmVkNjQ4N2Q5NDYwZWMwNDE3OTI1NjE1L3RhYmxlOjY2NWExM2M3YTlkNjQxNTU4MWVjY2U4MjQ0MWM5NGMwL3RhYmxlcmFuZ2U6NjY1YTEzYzdhOWQ2NDE1NTgxZWNjZTgyNDQxYzk0YzBfMy0xLTEtMS01MzczOQ_30078dc9-c8e0-497f-8ac6-8365ca62374c"
      unitRef="usd">11084000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <sera:WarrantsTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RleHRyZWdpb246ZDAzM2VlMzk2NmFlNDRiN2E3MmJjMzlkOWVhYTMyYzJfMzUy_2823bef6-4f51-4989-96bc-69a4360a2556">Warrants&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. The Company&#x2019;s common stock warrants outstanding were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Number of Warrants Outstanding as of:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sera:WarrantsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RleHRyZWdpb246ZDAzM2VlMzk2NmFlNDRiN2E3MmJjMzlkOWVhYTMyYzJfMzUz_d20f505f-08bf-4b0b-a869-bb22f4e0d4e4">The Company&#x2019;s common stock warrants outstanding were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Number of Warrants Outstanding as of:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ia80510f4b99d4483a37744999f4d0341_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMi0wLTEtMS01MDUzMQ_a52109cb-d42b-429c-be45-990f211989a1"
      unitRef="usdPerShare">5.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ia80510f4b99d4483a37744999f4d0341_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMi0yLTEtMS01MDUzMQ_3b0445bf-21cd-4a8b-9557-840709b35722"
      unitRef="shares">3473</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i97033eb4f8a64db2bc5f6fcfc26a6886_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMi00LTEtMS01MDUzMQ_7571d45c-52e8-4492-baa7-ec9d897c83bf"
      unitRef="shares">3473</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i4c737e7bf4884940ada07d1250bbf18e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMy0wLTEtMS01MDUzMQ_0ba26662-1e12-4878-ab4d-24e402e48571"
      unitRef="usdPerShare">9.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i4c737e7bf4884940ada07d1250bbf18e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMy0yLTEtMS01MDUzMQ_2b7dfcb7-cab3-403e-9781-1da9a0531a29"
      unitRef="shares">1032404</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i9359a27c7fc744aca0a2a0f6deb31bd8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfMy00LTEtMS01MDUzMQ_81d557b0-3630-48aa-9478-1deabe1ca4b6"
      unitRef="shares">1032404</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i78e203d056cc4c4ca4772af00ea4d039_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNC0wLTEtMS01MDUzMQ_4bba6775-e026-46a2-ac67-f778c32b5a4b"
      unitRef="usdPerShare">10.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i78e203d056cc4c4ca4772af00ea4d039_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNC0yLTEtMS01MDUzMQ_96a33247-9625-46db-b0a5-99d2dd971b35"
      unitRef="shares">1009795</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i204da10f0e0c49cc8fb8c1a4ead9508e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNC00LTEtMS01MDUzMQ_ddb42fda-5480-408a-a1c5-e15cba8110ee"
      unitRef="shares">1009795</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id725e1f4b6344f8c9931c7da191af02c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNS0wLTEtMS01MDUzMQ_b1bb6265-3ebf-4f34-9ab2-0317b830e344"
      unitRef="usdPerShare">12.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="id725e1f4b6344f8c9931c7da191af02c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNS0yLTEtMS01MDUzMQ_23dd617f-8947-4737-ab64-cd5bdf7466cd"
      unitRef="shares">8083</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i30dc8f5c5dd54233a474c8e03313302d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNS00LTEtMS01MDUzMQ_61506a2b-8b74-4793-b49f-68122e1e4282"
      unitRef="shares">8083</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i41ab44e1fd1540469f0224dbf57e43d2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNi0wLTEtMS01MDUzMQ_8231dd5c-fb18-40e4-940b-7a08de4b76db"
      unitRef="usdPerShare">20.77</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i41ab44e1fd1540469f0224dbf57e43d2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNi0yLTEtMS01MDUzMQ_1f3c29c8-9402-4261-8959-fe539d0dec4a"
      unitRef="shares">722223</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i81d9531da7ae47c68f3176caa531bcf5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNi00LTEtMS01MDUzMQ_c359086f-f8e9-4fbe-acae-2a55a918d530"
      unitRef="shares">722223</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNy0yLTEtMS01MDUzMQ_f485a8f9-08c8-4412-9cd5-3707f7bc0583"
      unitRef="shares">2775978</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF82Ny9mcmFnOmQwMzNlZTM5NjZhZTQ0YjdhNzJiYzM5ZDllYWEzMmMyL3RhYmxlOjdkZWFhMDRjODQ2ZjQzMzdiYTU5NjkwODJjMTg1MWE4L3RhYmxlcmFuZ2U6N2RlYWEwNGM4NDZmNDMzN2JhNTk2OTA4MmMxODUxYThfNy00LTEtMS01MDUzMQ_607b8600-a39b-42e2-a508-d153816d6362"
      unitRef="shares">2775978</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwNQ_3608fb44-e72d-4272-bb69-a9f025f081c6">Commitments and Contingencies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#x2019;s leases, the Company&#x2019;s incremental borrowing rate or the Company&#x2019;s intent to exercise or not exercise options available in lease contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease-Related Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Statement Line Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_6babe0e6-7d50-47d4-ae07-e3d8e9b39332"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_9f65a529-ecfc-438c-ac40-deeaa75b2ba3"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_25937204-c7d0-4da0-b8e8-5206df574dab"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_f6cc0dfd-5c42-43a4-b226-d068765cef24"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_0a2d43e5-22d4-456d-aeb7-ab2c07bd5c2e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_54e9da06-5917-4d9b-92d1-259e176f90a9"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligation, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs and other information consisted of the following (in thousands, except terms and rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for the Company&#x2019;s leases as of March&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases a total of approximately 24,300 square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2025 (as amended, the &#x201c;Office Lease&#x201d;). The Office Lease includes an early termination right which termination would occur under certain circumstances, as provided in the amended Office Lease, after July 1, 2024, if exercised. The Company is not currently reasonably certain it will exercise the termination right. The implicit rate provided in the Company&#x2019;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#x2019;s current finance leases include bargain purchase options that the Company is reasonably certain to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#x2019;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#x2019;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#x2019;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has no liabilities recorded for these agreements as of March&#160;31, 2023 and December&#160;31, 2022. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#x2019;s future results of operations, cash flows, or financial position.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwNg_1be961c2-2d8d-4536-8e95-1c53331f5219">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of March&#160;31, 2023 and December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease-Related Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Statement Line Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_6babe0e6-7d50-47d4-ae07-e3d8e9b39332"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi0yLTEtMS01MDUzMQ_9f65a529-ecfc-438c-ac40-deeaa75b2ba3"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_25937204-c7d0-4da0-b8e8-5206df574dab"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy0yLTEtMS01MDUzMQ_f6cc0dfd-5c42-43a4-b226-d068765cef24"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_0a2d43e5-22d4-456d-aeb7-ab2c07bd5c2e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy0yLTEtMS01MDUzMQ_54e9da06-5917-4d9b-92d1-259e176f90a9"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease obligation, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi00LTEtMS01MDUzMQ_8709c395-9fc6-4a81-bff6-2124a62181fc"
      unitRef="usd">1579000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMi02LTEtMS01MzAzNA_12a11fdf-9f4e-465e-ba29-3741c116408e"
      unitRef="usd">1707000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy00LTEtMS01MDUzMQ_dd69536a-1f14-4c47-8f22-4fda916d618b"
      unitRef="usd">1234000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMy02LTEtMS01MzAzNA_401ecb0b-a162-482b-83ae-aee9283bcf74"
      unitRef="usd">1317000</us-gaap:FinanceLeaseRightOfUseAsset>
    <sera:RightOfUseAssetTotal
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNC00LTEtMS01MDUzMQ_596858cb-d2f9-45af-80ee-3d6882f6ed8e"
      unitRef="usd">2813000</sera:RightOfUseAssetTotal>
    <sera:RightOfUseAssetTotal
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNC02LTEtMS01MzAzNA_554514af-caf7-454c-8aeb-ff6f2673e95c"
      unitRef="usd">3024000</sera:RightOfUseAssetTotal>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy00LTEtMS01MDUzMQ_b8da2025-7fcf-463f-a453-0643bb8e21b7"
      unitRef="usd">533000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfNy02LTEtMS01MzAzNA_19776d5e-e949-4fbd-a5b4-5f9c6d95525f"
      unitRef="usd">519000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOC00LTEtMS01MzA0Mg_80e7c401-d546-473f-b522-bc02fc552b83"
      unitRef="usd">1081000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOC02LTEtMS01MzAzNA_87045ec2-3882-4edd-8d65-977fe150023b"
      unitRef="usd">1222000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOC00LTEtMS01MDUzMQ_52807b4a-527c-4317-92a7-2f54f63b119a"
      unitRef="usd">451000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOS02LTEtMS01MzAzNA_2a011a30-d9fe-491d-a920-ca4602895ba9"
      unitRef="usd">464000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfOS00LTEtMS01MDUzMQ_f9298451-65f1-4102-97b7-2f3c150f5798"
      unitRef="usd">519000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMTAtNi0xLTEtNTMwMzQ_9064ed75-9f77-4bf5-ba6d-de4cc1655374"
      unitRef="usd">626000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sera:LeaseLiabilitiesTotal
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMTAtNC0xLTEtNTA1MzE_423491b5-2eb0-4869-860a-399c4a3a479b"
      unitRef="usd">2584000</sera:LeaseLiabilitiesTotal>
    <sera:LeaseLiabilitiesTotal
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOmEwNjhjZjdlY2E2YzQ5NWJiMjQ5ZTg4YmJmOWVjNWY3L3RhYmxlcmFuZ2U6YTA2OGNmN2VjYTZjNDk1YmIyNDllODhiYmY5ZWM1ZjdfMTEtNi0xLTEtNTMwMzQ_629477f7-8ac5-4d7b-a085-7699bcaa265c"
      unitRef="usd">2831000</sera:LeaseLiabilitiesTotal>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwNw_c5805e6d-daeb-487e-bc6f-b266a6ce48aa">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs and other information consisted of the following (in thousands, except terms and rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNC0yLTEtMS01MDUzMQ_076d9934-7b73-4b8e-ac9e-9cf817b3df7f"
      unitRef="usd">83000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNC00LTEtMS01MDUzMQ_adc43a65-6fac-42f5-bfe0-461b265a2ca2"
      unitRef="usd">16000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNS0yLTEtMS01MDUzMQ_e848cb9a-108d-4648-949d-5f6aa10f9ae6"
      unitRef="usd">16000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNS00LTEtMS01MDUzMQ_17480ad8-b06f-4564-8cfc-97d0988cfc09"
      unitRef="usd">4000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNi0yLTEtMS01MDUzMQ_fd02b113-95e2-4b2b-b861-d55e01a574cc"
      unitRef="usd">159000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNi00LTEtMS01MDUzMQ_e8a10154-7f58-4ebc-8d89-2a2ecce5647d"
      unitRef="usd">116000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCost
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNy0yLTEtMS01MDUzMQ_371f6951-4f4b-4ae1-b8bc-3864a21bb70f"
      unitRef="usd">258000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfNy00LTEtMS01MDUzMQ_2197745b-6ef3-4799-9255-165d095bf332"
      unitRef="usd">136000</us-gaap:LeaseCost>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTEtMi0xLTEtNTA1MzE_ee8b7e9d-910a-4588-817c-5a8078a2edba"
      unitRef="usd">16000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTEtNC0xLTEtNTA1MzE_78e6706d-83b4-4e60-839e-e2a3436bd9d1"
      unitRef="usd">2000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTItMi0xLTEtNTA1MzE_7ef9a7c3-49fe-4821-9cb7-154face48fcc"
      unitRef="usd">120000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTItNC0xLTEtNTA1MzE_9eff9d0f-6bc5-4ec8-9ff6-477750ce694c"
      unitRef="usd">18000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTMtMi0xLTEtNTA1MzE_f00de59b-6796-44dc-9359-21299b7b6327"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTMtNC0xLTEtNTA1MzE_891476bd-7799-4f31-b4f6-9bf99e2aff57"
      unitRef="usd">958000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTQtMi0xLTEtNTA1MzE_a9ecccb0-569f-41da-9b2e-7d437aa3752c">P2Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTQtNC0xLTEtNTA1MzE_421cabd3-3cc9-4259-b2e5-00eded1b6b42">P2Y10M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTUtMi0xLTEtNTA1MzEvdGV4dHJlZ2lvbjowZDliODY3MzE1MTk0MTlkYWIwMDQyMDM1NTAzN2NlN180_bf08ce52-3982-488c-9fdc-6cf898de3305"
      unitRef="number">0.064</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTUtNC0xLTEtNTA1MzE_a07d00ee-78e0-46ff-b592-b20ecd27e80d"
      unitRef="number">6.3</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTctMi0xLTEtNTA1MzE_9c26a88c-4ea4-40bc-bb73-7001d85b0e4e"
      unitRef="usd">157000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTctNC0xLTEtNTA1MzE_62c56140-5ccb-4050-a767-860a78420a46"
      unitRef="usd">151000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTgtMi0xLTEtNTA1MzE_51609c76-e934-4fea-9f81-8fc400ccca66"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTgtNC0xLTEtNTA1MzE_3c3c1cf2-1e93-4976-be35-2e2114d0e6ae"
      unitRef="usd">453000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTktMi0xLTEtNTA1MzE_4b829e9a-6a7d-4c98-a33e-75d1bc76db2c">P2Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMTktNC0xLTEtNTA1MzE_8dd1960b-fbb3-4c72-b2dd-b1c50ab2eb99">P0Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMjAtMi0xLTEtNTA1MzEvdGV4dHJlZ2lvbjplMzkzODAxZDdhMDA0NzI4YjEyYzJjZjBmM2IwZjBmOV80_dd7e9ae1-d003-4fad-b996-d6f3289c44f2"
      unitRef="number">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i1c4637a2a61f4b8590e6d478924a5417_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjE1YTEyMmVjMzRiNzQ4OGNiNGZmYWViNTgxYTVmZTA5L3RhYmxlcmFuZ2U6MTVhMTIyZWMzNGI3NDg4Y2I0ZmZhZWI1ODFhNWZlMDlfMjAtNC0xLTEtNTA1MzE_a73b7f2d-0147-496d-b8bd-8afe0c1aa85b"
      unitRef="number">4.5</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwOA_033ff345-f8cc-496a-96a4-1c1127b6c279">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for the Company&#x2019;s leases as of March&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfNDEwOA_ff5b00d7-63d8-441f-a7b8-fdc58396511b">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for the Company&#x2019;s leases as of March&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMS0yLTEtMS01MDUzMQ_ee1c80e9-3b38-4525-af6b-31841edf6cd2"
      unitRef="usd">471000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMS00LTEtMS01MDUzMQ_a374e871-6cfb-4c34-a7c9-f76187a68da3"
      unitRef="usd">382000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <sera:LeaseLiabilityToBePaidRemainderOfFiscalYear
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMS02LTEtMS01MDUzMQ_442f6144-a717-4a35-9358-4684634b8f4c"
      unitRef="usd">853000</sera:LeaseLiabilityToBePaidRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMi0yLTEtMS01MDUzMQ_56304b5e-fb95-4c32-8fa2-1f04ff3deb1b"
      unitRef="usd">646000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMi00LTEtMS01MDUzMQ_36fa00f8-56f2-46c6-9488-e9bca009b054"
      unitRef="usd">462000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <sera:LeaseLiabilityToBePaidYearOne
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMi02LTEtMS01MDUzMQ_e4ad9151-740b-4787-841c-e9ae9d7f31dd"
      unitRef="usd">1108000</sera:LeaseLiabilityToBePaidYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMy0yLTEtMS01MDUzMQ_331fdb29-5dbe-45aa-bcce-11a3b2c648d1"
      unitRef="usd">666000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMy00LTEtMS01MDUzMQ_729d6174-2c0c-4c3e-9993-170d0b2ae5bb"
      unitRef="usd">191000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <sera:LeaseLiabilityToBePaidYearTwo
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMy02LTEtMS01MDUzMQ_a92fad23-aa69-4f27-b8dc-c5abd9630c28"
      unitRef="usd">857000</sera:LeaseLiabilityToBePaidYearTwo>
    <sera:LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNS0yLTEtMS01MDUzMQ_aa6d3800-a674-46be-9798-1889693c7e44"
      unitRef="usd">0</sera:LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter>
    <sera:FinanceLeaseLiabilityToBePaidYearThreeAndThereafter
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNS00LTEtMS01MDUzMQ_4b7848bb-049c-414f-95bb-20b898fb46c9"
      unitRef="usd">0</sera:FinanceLeaseLiabilityToBePaidYearThreeAndThereafter>
    <sera:LeaseLiabilityToBePaidYearThreeAndThereafter
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNS02LTEtMS01MDUzMQ_1beab543-16ea-4d63-b4cd-9ea211b92921"
      unitRef="usd">0</sera:LeaseLiabilityToBePaidYearThreeAndThereafter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNi0yLTEtMS01MDUzMQ_4f3c7492-7c6b-44d0-b043-c1b371bed2b2"
      unitRef="usd">1783000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNi00LTEtMS01MDUzMQ_807f8ccd-4fa0-4dbb-8d98-79accd258135"
      unitRef="usd">1035000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <sera:LeaseLiabilityPaymentDue
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNi02LTEtMS01MDUzMQ_6bc5862e-cc02-4cf5-8646-632827a832f9"
      unitRef="usd">2818000</sera:LeaseLiabilityPaymentDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNy0yLTEtMS01MDUzMQ_8f7b1b0a-82c1-4535-a14d-b97cd2b61002"
      unitRef="usd">169000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNy00LTEtMS01MDUzMQ_6fc074d2-cb19-452b-b7c8-21b23236841c"
      unitRef="usd">65000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <sera:LeaseLiabilityUndiscountedExcessAmount
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfNy02LTEtMS01MDUzMQ_ee0a13b9-95d7-4dda-b2fc-15df2533ddba"
      unitRef="usd">234000</sera:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOC0yLTEtMS01MDUzMQ_577d13f4-b462-4a40-a4de-84de8034a41f"
      unitRef="usd">1614000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOC00LTEtMS01MDUzMQ_21f128d0-ad50-4ab9-8829-f02711577663"
      unitRef="usd">970000</us-gaap:FinanceLeaseLiability>
    <sera:LeaseLiabilitiesTotal
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOC02LTEtMS01MDUzMQ_4a88f725-e82e-41c0-8905-748d702804cf"
      unitRef="usd">2584000</sera:LeaseLiabilitiesTotal>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOS0yLTEtMS01MDUzMQ_98a1dab8-82ce-4fa0-90fc-bd02a9bd72e8"
      unitRef="usd">533000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOS00LTEtMS01MDUzMQ_a4024b2b-01bc-449e-a6d0-21a1c7c1853c"
      unitRef="usd">451000</us-gaap:FinanceLeaseLiabilityCurrent>
    <sera:LeaseLiabilityCurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfOS02LTEtMS01MDUzMQ_4782c8c2-1f79-48de-9b29-1fa903238aa6"
      unitRef="usd">984000</sera:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMTAtMi0xLTEtNTA1MzE_8abddaed-ccce-4af4-8782-bcae5db35a64"
      unitRef="usd">1081000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMTAtNC0xLTEtNTA1MzE_5a929844-55f9-4241-8905-2140e05dd7bd"
      unitRef="usd">519000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sera:LeaseLiabilityNoncurrent
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RhYmxlOjZhYjUwNDYyMzg1NTRkZTg4ZTU5MjA4NGUxNjZmODJmL3RhYmxlcmFuZ2U6NmFiNTA0NjIzODU1NGRlODhlNTkyMDg0ZTE2NmY4MmZfMTAtNi0xLTEtNTA1MzE_de54c987-1cab-410f-84c2-20a0bca5f7a1"
      unitRef="usd">1600000</sera:LeaseLiabilityNoncurrent>
    <sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory
      contextRef="i05a6fd71531c4266a8e69e0f3d9add84_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfMTA1MQ_f3d18913-8b77-44bf-83da-8cd311bb3bc1"
      unitRef="sqft">24300</sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory>
    <sera:IndemnificationLiability
      contextRef="if2f86cfb811b477c983db67e5f541347_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfMzA5Nw_45064c63-0cea-4e4c-bc4e-408f87457016"
      unitRef="usd">0</sera:IndemnificationLiability>
    <sera:IndemnificationLiability
      contextRef="i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83MC9mcmFnOmRkOWI1ZWMzMzkyMTRlOWE4Y2EwMjY1NTRlY2IyMTZmL3RleHRyZWdpb246ZGQ5YjVlYzMzOTIxNGU5YThjYTAyNjU1NGVjYjIxNmZfMzA5Nw_fd4b5488-5ec1-48ab-87c3-781af45637ca"
      unitRef="usd">0</sera:IndemnificationLiability>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RleHRyZWdpb246NWY4YjY3OGZhOTNmNDU5OTg1NzE1NTY3YjgyY2ZmOWNfMTUzMA_291a2447-829a-4a57-ba76-a740ab4e3081">Net loss per share&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the three months ended March&#160;31, 2023 and 2022, the Company reported net losses and as such, basic and diluted net loss per share are the same. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the liquidation and dividend rights are identical for Class A and Class B common stock, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the three months ended March&#160;31, 2023 and 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,875,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,016,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,998,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,805,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RleHRyZWdpb246NWY4YjY3OGZhOTNmNDU5OTg1NzE1NTY3YjgyY2ZmOWNfMTUzMg_fdf1892d-7fff-4ccc-bb4f-2d3cf9d5b645">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,875,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,016,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;347,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,998,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,805,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie0f674f4a02e45538fdadde638cf5023_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMi0xLTEtMS01MDUzMQ_062e6bf1-3695-438c-a820-70e04156a4cd"
      unitRef="shares">2775978</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5757bb4043fa4bfa81cdae4e0992837e_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMi0zLTEtMS01MDUzMQ_33e74547-6e3c-4918-b717-908086a2b3bb"
      unitRef="shares">2788484</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3457c2e17d7a435d9fb262c2803a96c4_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMy0xLTEtMS01MDUzMQ_b1af2a01-a501-471f-9b3a-976ab5ddf1b3"
      unitRef="shares">8875249</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic8b56fe25f1c4153929837bcc4db56ea_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfMy0zLTEtMS01MDUzMQ_e8efedf7-e905-4d75-8013-ab7dae7ab81e"
      unitRef="shares">8016915</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if70567ef2894436ab885809a5090432e_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0xLTEtMS01MzI1Mg_d3d12045-b186-4d89-bca1-80411df961a8"
      unitRef="shares">347436</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iaa36120b8dea4505af0c3a1b3720cbf0_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0zLTEtMS01MzI1Mg_ade20019-5fc6-4a90-9e70-08babce2ff3a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0xLTEtMS01MDUzMQ_2ae51c2d-ff9e-4d3c-9177-b210317b9355"
      unitRef="shares">11998663</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4352960b67cf4184a074b4e060c9d2ae_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzMDhjZjk3ODVhYzQwMTVhNmM0MzkzYmUwZDgyMGY0L3NlYzo0MzA4Y2Y5Nzg1YWM0MDE1YTZjNDM5M2JlMGQ4MjBmNF83My9mcmFnOjVmOGI2NzhmYTkzZjQ1OTk4NTcxNTU2N2I4MmNmZjljL3RhYmxlOjNmOWEyZjAzZTAyODRkZmZhOGQ4ZjU2ZmY0ZjI2NTIwL3RhYmxlcmFuZ2U6M2Y5YTJmMDNlMDI4NGRmZmE4ZDhmNTZmZjRmMjY1MjBfNC0zLTEtMS01MDUzMQ_058dc365-5051-4725-bac3-ba18ceb15c78"
      unitRef="shares">10805399</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>66
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( &^!JE8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !O@:I6SC\)].T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)VG10^CFLN))07!!\1:2V=U@DX9DI-VW-ZV[740?0,@E,W^^
M^0;2F2C-D/ Y#1$3.<PWD^]#EB9NV)$H2H!LCNAUKDLBE.9^2%Y3N:8#1&T^
M] &AX?P./)*VFC3,P"JN1*8Z:Z1)J&E(9[PU*SY^IGZ!60/8H\= &40M@*EY
M8CQ-?0=7P PC3#Y_%]"NQ*7Z)W;I #LGI^S6U#B.]=@NN;*#@+>GQY=EW<J%
M3#H8+*^RDW2*N&&7R:_M]G[WP%3#F[;BMY7@NX9+(<IYGUU_^%V%_6#=WOUC
MXXN@ZN#7OU!?4$L#!!0    ( &^!JE:97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MS5<TL3'3 9'1R.DZ V0>>=J )JBI"=IQYR$4D@;I D#TX?$C\(B?,O.8<7%
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MZ+G+U%$64VVW,L,1S"U=3A+$%JSPPSLW<#YU67PCLI;A86UX>-QPP^@-RK!
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ME%U:.5$\*QJ=)ZYTVU0,$]W9@C !^OZ:<_4Z,;U3W2N'?P%02P,$%     @
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M[9IF;'LUPJ/G"Q_3AY6H+DQFTS5YH'=4?%[?EO)LTJ(D:4X+GK("E71Y-?J
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M$M.KD4P$I^4C'<W>O,*N\5['_ [,J<&JM?1Q9AF>9V/3G4X>#TF%C!I"@D5
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M:%VN]@(!AE<(L*9@MXP>+Z :P4DQ0]"8$11:EYJ]3H#AA +<+[4=L\<(J%(
MBA:>TH$(*F27D+U8@+]?+<"Z MEP7$?E %0O $4+0=&BES/2?:VZEPQ,8,G
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M.'[LE8Z:=^J%A]?/VC\;X\&86R+IFF=_LU1MST>+$4KIAE29^L8??J5[@PS
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MDESH9SF )RKHNJT7DTH(V!P<%J85\Y#*H*4LHSYLF]@R=N%N22_TL]X5W5#
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M\P+\SV>V[H8=]&_&SO\!4$L#!!0    ( &^!JE;KQWZ^. <  )<5   9
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M[]AU+X=F\Q ^M&PJT%IHQR0T!$U/SR<1LT,;' PT76@]*X/4R,*RI3\'6!]
M^XTQN#/\ >._:/$74$L#!!0    ( &^!JE;L<&G>S@(  +$&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;)U546^;,!#^*Q:;IE:*"@&2M%D2*6DW
M;=*J1FVW/4Q[,.82K!J;V:9I__W.AE JI=&T%_#Y[OONOL,^9CNE'TP!8,E3
M*:29!X6UU30,#2N@I.9,52#1LU&ZI!9-O0U-I8'F'E2*,(ZB<5A2+H/%S.^M
M]6*F:BNXA+4FIBY+JI]7(-1N'@R#_<8MWQ;6;82+646W< ?V>[76:(4=2\Y+
MD(8K231LYL%R.%VE+MX'_."P,[TU<4HRI1Z<\36?!Y$K" 0PZQ@HOA[A$H1P
M1%C&GY8SZ%(Z8'^]9__LM:.6C!JX5.(GSVTQ#\X#DL.&UL+>JMT7:/6,'!]3
MPO@GV36Q8\S(:F-5V8+1+KELWO2I[4,/<!Z] 8A;0.SK;A+Y*J^HI8N95CNB
M732RN867ZM%8')?NH]Q9C5Z..+M8,J9KR F5.;FQ!6AR66L-TI)OG&9<<,O!
MS$*+J1P@9"WMJJ&-WZ!-R+62MC#DD\PA?XT/L<2NSGA?YRH^2GA-]1E)A@,2
M1W%RA"_I=">>+WE;MZJE-61-GVDFP#=@WXR>]$'7CU_+S%B-I^CWH78TV=+#
MV=S-FIJ*,I@'>'4,Z$<(%A_>#<?1QR-:TDY+>HS]_[_A4=K#1?]3+G)? -DH
M@3>>RRVQOL&>PW4<482ILE+2FVJ#5_.%5'E2UI**'BGUL7@06-&=! ^Y @9E
MAJAV-R8G7&(:51MTF]-I#_0J=B_&58-SAOHY\9Y,TA2?\2"^B+J01\H:]P@W
MT^3%D4;#DX=3O)*6%4XLPW.O>5:[8$.&DXB,QN?DI@*->/0+P!G2Z7H>=%(K
MI9L$24)&PXNVNX<:,1Z-R#B9D'MEJ?C'YCD]XXL8W^D@17V'CEW8&R,EZ*T?
MEH;XB]),E&ZWF\?+9@R]A#?#'!N^Y:A?P :AT=ED%!#=#,C&L*KR0RE3%D><
M7Q;X3P'M M"_4<KN#9>@^TLM_@)02P,$%     @ ;X&J5@66@-=R @  G04
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M@M;>7UJB"AHH28]H.L13%!D3+->A4+B^RV@8TLUO#N! <>I@#=L-.C!.BK
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M7R:HG0$]WRAJ[V[C IR^=>9_ U!+ P04    " !O@:I6!F6 1BX'   7%
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M[IW./YU>@U\%N]$5Y-IR#-?%P $ZV@SR!NG:(\7/("7LG59N9=FM*D2Q/WX
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M1I(I._(ZMF?V(YWVD'0G:9-#IP=:@BW.\L,EZ6CWWQ>D9%7I[#JYB""$]_
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M K:?<?W&FV.<*SOC:4I%LZ7? MH00._WAB[;L D)QA_-]E]02P,$%     @
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M^&IR6!Z^/0$]UH@'6#3'UO'H<CX(;6ASX\V6OZ&LC/>FY)\;M)7*T@*\SPV
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MOH"1P6>C?>7@DRZQ?!J?$)^!5'H@M4Y?!?PL[!EDXQC249J]@I<-(K. E[V
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M(],MM&,P020!#8_5Y7#IL"%TO3=OA$S?!<24:2#*P-"W)>5"+ZM)'4S\O]4
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ML*5?"5AO0/N-,;B;^ #CSVGQ'U!+ P04    " !O@:I6C H0;^$"  "N!@
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MI7N\[F;T<$+M#&A]HY0]#ER [BFV_!M02P,$%     @ ;X&J5ML(8@08 P
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M WJ_U=3#X\8'.'[25G\#4$L#!!0    ( &^!JE:ML6B9^ 0  ' -   9
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MPY12T366S35J,J1.1=3HYY?PW%$S8"4K#X7CX%()E(H\HSZTC.[W^9TM_NJ
M.TI>,Z-33>+6PMA:$9>T"U39NRY.\*Q=QT6A^-W0>N Y+LHKZ XKW?R[_=)W
MNN.B1D^)I[=7!><@5J;6EPBT*90MB)O>YG-B:JOHE^GV6P1W>,60?P9+-'6[
M,5XVPM;W]D7QTM34"ZZP0C?--7X2@= 3<'S)N:I?] +-1];D;U!+ P04
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M_<$ZT1'E1F0+DHX$19OWO4,;@KV8,Y+=< JNN^M7LT".#"<:VX\:<V_;9C<
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MP\*\QB!M@=E?":%W$]OPW?N>_@%02P,$%     @ ;X&J5N'OLUM@"0  (4L
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MZ<8A7NN;YZMR_Q<]-[+)!,UW996OF\7&@O5R\_H_^Z,)Q-$"S#P+2+. G+N
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MEXAO[/")5@%Y!=Z2);S\"PZ5K3,"RQT7+*V<)8,TSHZ?Y&>5B!,'Z%H<4.6
M7NJ *P=<!GID5H9U0P2937)V 'EA+=&*+V5N2F\939P5CW$A<OEK+/W$;$[X
MY@(4?\&?/W;QGB0T$QR0; 6^DOR1"G*?4+"@RUT>BYAR<&FY7WAH,'$&[C(Y
MNY+X/[H"7QCGX);QN'B '+R]D2AQPM])S+O%#7C[YAUX4[C\M6$[+O'X9"QD
MB 71\;(*Y\,Q'&0)1W*[ AA> .0@;'"?=[O?T&7MCIKN8YG8.KNHSBXJ\; 5
M[UZ<).D"O-_+B(O47<H5>+F0:;JP9@C\\T7"@<^"IOQ?4RJ.8[OFL8OU?\VW
M9$FG([G .<WW=#3[_3?H.W^8$C,06"--N$X3[D*??21Q#KZ39$=-81Y]_=*W
MJ$K[F><&GC<9[T_YZU:^ZWM.;=4@YM;$W$YBK4=#C3/R".&=C(P#W&*GVW@0
MFKEY-3>O1](\;4"$O"ALT=*ML.M";";FU\3\_DGSM9&AZ[?8Z39N8.$6U-R"
M'DD+M &# 'OM9ZE;19'C6XB%-;&P?])"PRR*6NQTFRATS=RBFEO4R6W.TI3F
MRY@D8$NV-#=1ZT0XMQ8-!-8(%CI*$9U7+-K5X -E:BBT9JI.-@^PQW*JG!OE
M!<$P:,U8@YGK6!<45-H+.S7K94NJPFAP;%=)@TW@6=@IR8-]-*]R/AW2:;/J
M,FF24G('!] [J(N9QJW+I,E-R1WLHW?0(&6FN::;=<TU)7EP ,V#NJ#I<TVW
ML<XU)7JP6_7F+-^RG @J&QQ9VWA=VXPL.['.+E #H34C5ZH*P]>LY9V:?G:J
M!D)KIDJ)/.Q6^6?6UZ "7Z$UMG_0\\WS'"GE1IUR][)5V(UQ=MODO+32(:6J
MJ(^J=CN?S5\77\]!E@A.VMX!I+<;X^Q =)&VU$VD-!KUT>ANY[/YZW(.?2^T
MA* 4'0V@Z-T89T=B:'8M82CQ1]WB?W>UN )KNJ*Y;$+( \V6OYZ1L6[ LV,:
M"*T9OMI>(/\USY$Z]S9GIVH@M&:JU%X']>GPD=Z\0QAJYR(F,Q3ZD64:J^T(
M&J#+1WH+#X-VFV\P0LA6+=0> /79 R"#:@>1=FQC,$,>=BVB@I6ZXP'4'>MZ
M'+4)&FPPMI0HK%0;]U%MK.LLBD+7;5,SM,PALAT58B7(> !!QKJ$HD [9S7H
MK*U_PB<'P-U*6];W![:G>9;2[+D6I1OLW((U%%HS=*70V'W%VHX'E?:AT)JI
M4KL W.<( .N]/73\H'TV833S?%MY4AJ-!S@"P(9S;T^K3[H1<BRU'2MAQ'V$
M$>N*Y_H>:C/3K4+/)HM8R2(>0!:QX?1;>[8&Z<2VXJ14$?=116Q010\C+74&
MLPAB2V5WE2JZ ZABA>$W9E1[VAF,L-OF-SYYU5R\Y_]*\H<XXR"A:^GE7 4R
MP/SXZOQX(=BV?/M\SX1@:?EU0XG<R!<&\O<U8^+IHGBA7?\#P^Q_4$L#!!0
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MP>G[,P]4.U':C9&U:\JE--3B;EG0$$9E$^A\):5YWM@^[\=Z^@=02P,$%
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M':#N;QB33Q-]WM.>[RW_ U!+ P04    " !O@:I6L6NZ9V8"  ##!0  &0
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MS"FM-^$U85+_WRLM<RYBW;:H3[YZH'A1'1X+KO115-UF^F,!A G0[U><J]W
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M1)?':<N(WI$-L1'&YGP/7N,])Q?FZRR/2EUASWUYL/'.5V1T!=M<4:F9Y^.
M>7Q72^YF4L5)I&;&"6#BHTQ@8<N=$.9+=(BY0: *'\>*;F-^OKB[8 ]ZH?/Z
MFOZHT_F/<^XDXHE=I$/0B0]XX@?.[B2%$BHU,T[ $A\E AMWRO/NQ(:8&P2F
M\'&H0-SYF#WI/*UOE<XY$UW".F-$:N8) 9CQ0V=GDO(*E9H9)Q"+C\*"C3,G
MYYV)#3$W"+CAX[S1[<SW6:I_L%6S>?:P.75OC4I;9XI(S;SS!K+AGO.]-RFQ
M4*F9<0*Q<)049C=1L63ZVR9^BI*Z/M,=L=_C+J=CT.G;''Y0 \%1P_U&!Q>V
MSM,051(.0,.%LQ])&85*S8P3&(7C-91^?@S.7AS1(>;>@"LXSA544(DO8YVP
M(<HC'%B&*V=CDB(*E9H9)R *QPLN_8P9GC?F$ 3"@4 X3B!;#_-S-4I<Q3IU
M0Y10.$ -GSI;E)19J-3,2CHPB\"K,>=JE;OIA^Z<3GT1'I?0V\-\SY,>[[Y^
M"F -@;-&A_=ZOI3CPK9IHE(S3P,0C7!NZPA29*%2,^,\Z.R0M79$VW&^-^7'
MQNP8)GTI3_@2F$/TZ=NT?6E1Q<17L$[<$/43 9PCG/LZ@A1=J-3,. %=!%Z&
ML3!HN\WC^Z$Z]F?'*"5/W $)( _1I]5S;$][[,27L<[=$!PC@&.$<_-'D+(+
ME9H9)["+H&H B79_)Q"^+XY-VAXF)MSWNUT: 'P$?5I!G2[M7=/$E[!NC0]1
M60F =@+G7E! BC-4:F:<@#,!52\H:#=Z_-#GQP[M&E9AZBF' H\$?7I"QP[M
M5]O$I:TS-LB[5 [>IN+<!PIHWYPR!,<$P#$!7J_I=<L>G&\!H4/,O0%[!'U:
M0"[W0KBP=8J&J*H$P#:!<^,G(,45*C4S3L"5 "^[]+-BNZ'#92B."^U=PY0(
MPA.6!-0(^O1^?ITS\66L$S=$344"UDCG/I DI14J-3-.H!5)T >2[1;/9"J/
M[(DOY!H(X(CLTR\2YPJ<N(IU\H:HM$@@&^G<')*DX$*E9L8)X"+Q0LVY J<\
MWQ="AYC;.G@;;)^^D'!X+<>%K;,S1#E% M)(YTZ0)&46*C4S3F 6B==C^M_P
MR//M('2(N4& #=FGQ]/VHT4]$U_!.F%#U% D@(UT[O](4E:A4C/?J0ZLHO 2
M3']CJG:+Y]B8Z!!S@P 9JD\#Z-B8]H2)+V.;-2HU\Z0 L"CG=I BA10J-3-.
M@!1%U0Y2[3Y/RYW8$'.#0!>J3QNHTYV]*YCX$M89&Z)^HH!KE',?2)&""Y6:
M&>?!1WRH^D"JW>%I.1,;8FX0B$/UZ0 =.[-?Y1*7ML[4$&44!62CG+L^BI18
MJ-3,.(%8%%Z*Z74WKLY_Y <=8G[N#"@C[-/H<;G;P86M/WHV1,$D!)8)G=L[
M(2F>4*F9<0*>A'@]I9<5P_.?\MD-43VL"$@1]NGH_#I/XLM8)VR((DD(&!,Z
M=W="4CJA4C/C!#H)";H[.XUNU^W"((6/\<$W)M1?5U&QQ6.<%BS1#Y6\=U&O
MEF^_ 6)[4&;KYDL4[K.RS%;-PZ6.*O/6 ZJ_/V19^?.@_EZ&_?=PS/X'4$L#
M!!0    ( &^!JE9/TI(2W0,  "L4   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0R+GAM;+5876_;-A3]*X16#"W015^.[62V@,1*T0(-%B3I]C#L@9:N+:$2
MZ9&TG0#]\2,I699BA:@&YL7ZNN>0Y\B7NKRS/67?>08@T%-9$#YW,B$VEZ[+
MDPQ*S,_H!HA\LJ*LQ$)>LK7+-PQPJD%EX0:>-W9+G!,GFNE[=RR:T:TH<@)W
M#/%M66+V? T%W<\=WSG<N,_7F5 WW&BVP6MX /%M<\?DE=NPI'D)A.>4( :K
MN7/E7\;^N0+HB#]SV//6.5)2EI1^5Q=?TKGCJ1E! 8E0%%@>=K" HE!,<A[_
MUJ1.,Z8"ML\/[)^T>"EFB3DL:/%7GHIL[DP=E,(*;PMQ3_>?H1:D)YC0@NM?
MM*]B)R,')5LN:%F#Y0S*G%1'_%0;T0)(GGY 4 ."GP6$-2!\"7AM2J,:,-+.
M5%*T#S$6.)HQND=,14LV=:+-U&@I/R?JO3\()I_F$B>B>RBP@!3=82:>T2/#
MA&/]1CAZ'X/ ><$_H-_0MX<8O7_W ;U#.4&/&=UR3%(^<X6<@B)RDWJXZVJX
MX)7A?'1+B<@XNB$II#WXA1D?&O"NE-[H#P[ZKP,CX2=8GJ%@^A$%7N#WS<<,
MO\7L#(6^AH<]\/CGX8%!3=B\S5#SA4/?)OK[JPQ%7P24_)^^UU;QCOIYU>)S
MR3<X@;DC5Q<.; =.].LO_MC[O<\SFV2Q);*.GZ/&SY&)/?IC PR+G*S1S9-<
M:3GT_N6-'$.]J\C&FDPMVKO(]T?!Q<S=M4WIB0K"<-I$==2>-VK/C6KO80=D
M"WT2C<"A$BNR\_;D/>^%P-.8U]2-&W5CH[I;S 7(+YZ<79X 1WC- .073* ?
MJ)LW/]!GP(7($LIDRI"DSQ#C6$,-L4D66R+K>#QI/)Z\T?HSL>FG3;+8$EG'
MSVGCY]3"^F/D&.K=]"3QIB?)>1HS:<5TE%XT2B^,2K_B)952*7M&#X<,O3)D
MZ$T!.TP2J%/UXVMY:AQUJ#<VR6)+9!VW?>]8]GEOE*DUL25+K;+%MMBZIK9J
M:?__?D#-R,&N^2<9J*K73I+6,9T:X:(_2?W@J# P*ES0L@26Y+A <J=55$FK
M_C4V<M4\]F"/;++%MMBZOA_K>O^M"GO?:F5OE2VVQ=8U]5C<^^;J_A%8B>CJ
M6 GV^F?F"-$S8-;W65Z8D8.]LL36]>JX-?#->X,%YAEBD$"^$?W[?JM;A)JM
MO7B-O9,ZQ-:8E2=NJXLB%[FU[D9QE- M$55#H;G;=+RN=)_GQ?V%ZH3I[LR1
MIFJCR?W^.B<<%;"2E-[91 I@56>JNA!THWLU2RH$+?5I!C@%I@+D\Q6EXG"A
M!FCZ@]%_4$L#!!0    ( &^!JE:5)>*8<0(  *$&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0S+GAM;+65;6O;,!#'O\KAP=B@JQ,[#R5S#&W*6&$KH67;
MBS&*XEQB$<GR)#GI1C_\3K)K4N:D8VQO$IVD^]_O3M(YV2F],3FBA7LI"C,-
M<FO+21B:+$?)S*DJL:"5E=*263+U.C2E1K;T3E*$4:\W"B7C19 F?FZNTT15
M5O "YQI,)273/RY0J-TTZ >/$S=\G5LW$:9)R=9XB_93.==DA:W*DDLL#%<%
M:%Q-@_/^Y&+L]OL-GSGNS-X87"8+I3;.N%I.@YX#0H&9=0J,_K8X0R&<$&%\
M;S2#-J1SW!\_JK_SN5,N"V9PIL07OK3Y-#@+8(DK5@E[HW;OL<EGZ/0R)8S_
MA5V]=Q0'D%7&*MDX$X'D1?W/[ILZ[#G$9P<<HL8A\MQU($]YR2Q+$ZUVH-UN
M4G,#GZKW)CA>N$.YM9I6.?G9=,9*;ID FJLR6VF$-W#-M&:N6/#J$BWCPKQ.
M0DO!G$N8-<(7M7!T0/@CTZ<0]T\@ZD4Q;)5%R)24JKBCG++-72:8,4]E0V)O
M$XC:!"(?)SZ4@-,!M:(,2!:^?J!UN+(HS;<NZ%ILT"WF7L#$E"S#:4!7W*#>
M8I"^?-$?]=X>08U;U/B8>GI=R05JQUI7 GPEP%<"#;#*YDKSG[B$AV=K56=3
MQQOZ>.[Y;=,H";<=B(,6<7 4<;8'=D(0Q19U_?[H0J@NA,%O"/UNA&&+,#R.
MX _T_$F-N@(?5?G+DQRUC*-_>>E&_P%UW**.__#2N3=HH"3#Y(P>^H.?Z>(=
M/WNFX5['<<V;7ON:%P8$KLBG=SHF9UTWQ-JPJO1-:*$LM30_S.D;@MIMH/65
M(I;&<'VM_2JEOP!02P,$%     @ ;X&J5E(15T?. P  81,  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#0N>&ULM5A=;]LV%/TKA 8,*;!&(O6=V0):9T,#
MK)@1(^O#L =&IBTBDJB2E-W\^Y&2(ENVK,T;^Q*+XKV']UP>TR><[1E_$1DA
M$GPK\E+,K4S*ZLZV19J1 HM;5I%2S6P8+[!40[ZU1<4)7C=)16XCQPGL M/2
M2F;-NR5/9JR6.2W)D@-1%P7FKQ])SO9S"UIO+Q[I-I/ZA9W,*KPE*R*?JB57
M([M'6=."E(*R$G"RF5L?X-T"1CJAB?B#DKTX>@::RC-C+WKPL)Y;CJZ(Y"25
M&@*KCQU9D#S72*J.KQVHU:^I$X^?W]!_;<@K,L]8D 7+O]"US.969($UV> Z
MEX]L_XETA'R-E[)<-'_!OHMU+)#60K*B2U85%+1L/_&WKA%'"="[D("Z!/1O
M$]PNP6V(MI4UM.ZQQ,F,LSW@.EJAZ8>F-TVV8D-+O8TKR=4L57DR6>"*2IP#
M]:Y.9<T)> \6K"A4AU>2I2_@YIY(3'/Q3D_D6 CP :1M@&@"W@.184[$S):J
M'HUJI]W:']NUT86U/V-^"USX$T .<D?2%]/I]R3MT]$PW59=Z%N!^E:@!L^]
MU(J&'=MTQ/_\3<V#!TD*\=<8MQ;,&P?3W[X[4>&4S"WU]1*$[XB5_/@##)R?
MQY@: AOP=GO>[A1ZLFJV#W3 :Z#.!K"I&RU0(6I<I@3<T++;YG=CO6@7\)L%
M],&Q2Z"/G,")X<S>'?,<"71#%/L^Z@,''+R>@S?)X9$(R6DJ5?GM[CV55 IP
M\[AZ&J]X$N[:W3,$-F#N]\Q]DZKU3?(V!#;@'?2\@^^MVN!,C*X7>FYPHMGS
M,&=<K&%?>CA9^A?,.2Z5/"4#5<W33/T,C9ZM8T5/0E^[@8; !EV(^BY$)H4;
MF>1M"&S .^YYQ]];N/&9(E$8^G$8G2CWG^,&#*!S, W.)(??*^W!_IN IZ&O
MW4E3:,-&'+DG:%+$'9HI[H;0AMP/=@E.NA(30NY6.%9H%(4^\N(3)8\%>BCR
M/'A!R@?S Z?=SZBGQ3ME>?%S3HY);=M#NR[7A .9$>T[(?CE:TWE*WA0;$O]
M'PE8YK@<Y3I9Q]5[;PAMV+6#W8*>4=T;M5NFT(;<#X8+3OH:([KWST]F%R(?
M^:>Z/P^$,0I</[B@^X-]@M/^Z7_KOJAR]DI(IX#EV\_ 1?E/EG.U! RA#9MW
M,' P-"I_HZ;-%-J0^\&VP4EW9$3^T?EI'GNQXYZJ_SS.CZ,P#$_$;Q_=?^C+
MI\^8;ZFR)SG9J$3G-E0(O+W/:0>25<V5R#.3DA7-8T:PTK<.4/,;QN3;0-^R
M]+=JR=]02P,$%     @ ;X&J5H /%)9N!   X1\  !D   !X;"]W;W)K<VAE
M971S+W-H965T-#4N>&ULQ9EO;ZLV%,:_BL6D:5=:"X:0/UT2*0E,N]-Z%=UJ
M=R^FO7# 25 !9[:3M-(^_&R@$#KB%NU(?=. X^=G^SSE. =/SXP_BCVE$CUE
M:2YFUE[*PYUMBVA/,R)NV8'FZILMXQF1ZI;O;''@E,2%*$MMUW&&=D:2W)I/
MB[8UGT_94:9)3M<<B6.6$?Z\I"D[SRQLO31\379[J1OL^?1 =O2!RM\/:Z[N
M[)H2)QG-1<)RQ.EV9BWP78@G6E#T^);0L[BX1GHI&\8>]<WG>&8Y>D8TI9'4
M"*(^3G1%TU23U#S^KJ!6/:867EZ_T'\N%J\6LR&"KECZ1Q++_<P:6RBF6W),
MY5=V_H56"_(U+V*I*/ZB<]EW-+%0=!229958S2!+\O*3/%6!N! H3K? K03N
M:\'@BL"K!-Y[!8-*,'BOP*\$Q=+M<NU%X (BR7S*V1EQW5O1]$41_4*MXI7D
M^A_E07+U;:)T<OX@6?1XLU2ACM&*9>K_3Y#"P1OTA7!.M(WHAX!*DJ3BDVH5
M>\*IF-I2#:X1=E0-M"P'<J\,A-$]R^5>H#"/:=S6VVK2]<S=EYDO72/PUV-Z
MBSS\(W(=%W?,9V66?V$G)7>T''?) [/\GO!Z=*]#'IKE 8UJN6L(AE?;Z!6\
MP17>*B5"H 6*6)8I\X1VM<LC(T4GI3MQ(!&=62KK",I/U)I__QT>.C]U!1@2
M%D#"0B!8RXI!;<6@H'O7GBC]@-QL_OM$+=3CE.^HRK(2;9[19;\U>2Z:%V?"
M8_3G;PJ)/DN:B;^Z3!Q F@@)"R!A(1"L9:)?F^@;GZ?"'('(2:4]LDDI4ELR
MVA[ED5.4"'$D>:328I)7Z?!3ETW&$?K:! D+2IA?P/0OB=,<^ZXS="8J$9XN
M+>CHZ(W<B>^[=<=6>(=U>(?&\.J<B]8IR;OB9I3VC1LD+("$A4"P5OQ'=?Q'
M'YRC1I F0L("2%@(!&N9.*Y-'!L?HF]4R"3?H0/E"8N[3##J^YI@GLP /5/"
MNWX7!I"S"(%@K8!/ZH!/C&L,GPX)+Y\327G6%7$CH&_$S;/!SO600TXC!(*U
M0HZ=ICYQWM@JW.M;A5G;-]Z@M "4%D+1VBY<5(GX@S>,:@)05D+2 E!:"$5K
M6^DV5KK_<]MX W ]U:_,RMYAAZ2%4+1VV)L"'9LK]'=L'F\0# E_99;V#CQH
M,0Y%:P>^*<>QL5!L-A#T#WKO:Q(SLG<R JVQ06DA%*UM3E-F8_^C]Q70,AR4
M%H#20BA:V\JFI,?FFA[BE8EYB-YF@1;_%>WR98CK8==W_5<O3:"&;?O0E/;8
M6'26^2Y\6*_[Y#O0<AV4%H#20BA:VYRF9,?CC\YWH$4_*"T I850M+:5S<L
M;*Z_0?(=Z/L"4%I0T2[SW7@RF#C>ZW0'^G[ OCC*S"C?%6?(0B6P8R[+L\&Z
MM3ZG7A2GLZ_:E_AN59XV-YCR\/N>\%V2"Y32K4(ZMR.U1%Z>)Y<WDAV* ],-
MDY)EQ>6>DIARW4%]OV5,OMSH >I3_?F_4$L#!!0    ( &^!JE8AQI<>\@4
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M5&O;'H RL5D-D-/\V5$W.1C0:Y3^L*S]H;KXKU:Y/0"U34"SVE6W-YC.:S@
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M,D-E%]#\7$JS[U@'5:T7?P-02P,$%     @ ;X&J5A/CA<;I P  P!8  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3 N>&ULM5A=CZ,V%/TK%JU676D;L($
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MB<"J[=+J1-!MN>/X2(6@>7FX(7A)F J0]U>4BL.)VL1L-JWC_P!02P,$%
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MUPW4[SO&Y.N)WJ"H-Z16_P%02P,$%     @ ;X&J5G*6,BR< @  ! @  !D
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MOUS@F ;M%/"\4LIN!#<)NL&?_P502P,$%     @ ;X&J5@K,!H*0 P  S@\
M !D   !X;"]W;W)K<VAE971S+W-H965T-34N>&ULS5==;]LV%/TKA 84*;!$
MG[:ES#:0.!U6H%V#&%D?BCTP\K5%1!(UDHJS?[]+2I8M1]&:0BC\8HL4[^$Y
MA[P4[W3+Q:-, !1YSM)<SJQ$J>+2MF6<0$;E!2\@QS=K+C*JL"DVMBP$T)4)
MRE+;<YRQG5&66_.IZ;L5\RDO5<IRN!5$EEE&Q;_7D/+MS'*M7<<=VR1*=]CS
M:4$WL 1U7]P*;-D-RHIED$O&<R)@/;.NW,N%Z^L ,^(O!EMY\$RTE ?.'W7C
MXVIF.9H1I! K#4'Q[PD6D*8:"7G\4X-:S9PZ\/!YA_Z[$8]B'JB$!4^_LI5*
M9E9HD16L:9FJ.[[] VI!(XT7\U2:7[*MQSH6B4NI>%8'(X.,Y=4_?:Z-. A
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M_.L7Z.TUK779'/)9]Y7"Y!-02P$"% ,4    " !O@:I6!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M &^!JE;./PGT[0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( &^!JE:97)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ;X&J5GM)
MQB-^!@  I24  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( &^!JE:R\0&1U04  &@8   8
M  " @< .  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !O
M@:I6W<"^K]T"   W"P  &               @('+%   >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ ;X&J5HPWV8OA!   Q!(  !@
M         ("!WA<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( &^!JE8DY=@=S@4  (PE   8              " @?4<  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !O@:I6*U@U'*@#  !.#0
M&               @('Y(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ ;X&J5KN^:Y:>!@  F!T  !@              ("!UR8  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( &^!JE;DN-3/- @
M -83   8              " @:LM  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " !O@:I6]J):=1T'   E$P  &               @($5
M-@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ ;X&J5NO'
M?KXX!P  EQ4  !D              ("!:#T  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " !O@:I6'^UN$N,"  "7!@  &0
M    @('71   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M &^!JE;L<&G>S@(  +$&   9              " @?%'  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ ;X&J5@66@-=R @  G04  !D
M             ("!]DH  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " !O@:I6- DJSVD&  #3$0  &0              @(&?30  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( &^!JE;00ETP4P<
M  (4   9              " @3]4  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ ;X&J5J<U'QW@ P  ]P@  !D              ("!
MR5L  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " !O@:I6
M!F6 1BX'   7%   &0              @('@7P  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( &^!JE8D+'I3TP(  '0&   9
M      " @45G  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ ;X&J5M\MQ8MI"@  8!L  !D              ("!3VH  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !O@:I6C)35!^8#  !O"0
M&0              @('O=   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( &^!JE:K=W6%] 8  +X2   9              " @0QY  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ ;X&J5F$2OE)R
M!@  6A0  !D              ("!-X   'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " !O@:I6XUTXR/D"  "H!@  &0
M@('@A@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( &^!
MJE:,"A!OX0(  *X&   9              " @1"*  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ ;X&J5JOBP6F) @  K@4  !D
M         ("!*(T  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " !O@:I6/.1MH',#  "6"0  &0              @('HCP  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( &^!JE;;"&($& ,  -X&
M   9              " @9*3  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ ;X&J5JVQ:)GX!   < T  !D              ("!X98
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !O@:I6-:TY
M&JT"  #?!0  &0              @($0G   >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( &^!JE;?;5JO7@4  *H0   9
M  " @?2>  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M;X&J5AE;NF4E P  T08  !D              ("!B:0  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " !O@:I6SNAV_GH"  #K!0  &0
M            @('EIP  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( &^!JE;A[[-;8 D  "%+   9              " @9:J  !X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ ;X&J5B8UEPYC!0
MS"   !D              ("!+;0  'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " !O@:I63=8RQFL"  #B!0  &0              @(''
MN0  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( &^!JE93
M 679J@(  ($'   9              " @6F\  !X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ ;X&J5H:;7'?: P  ZQ,  !D
M     ("!2K\  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &^!JE9/TI(2W0,  "L4   9              "
M@:'3  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ ;X&J
M5I4EXIAQ @  H08  !D              ("!M=<  'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " !O@:I64A%71\X#  !A$P  &0
M        @(%=V@  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( &^!JE: #Q26;@0  .$?   9              " @6+>  !X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ ;X&J5B'&EQ[R!0  ,R0
M !D              ("!!^,  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " !O@:I6!]UU_B8#  #*"@  &0              @($PZ0
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( &^!JE8NE=?P
M; ,  )$.   9              " @8WL  !X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ ;X&J5HBOC2<? P  ]PD  !D
M ("!,/   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " !O
M@:I6$^.%QND#  # %@  &0              @(&&\P  >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( &^!JE9/3/C#PP,  %4.   9
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M970U-2YX;6Q02P$"% ,4    " !O@:I6)<A2ARX#  #P$@  #0
M    @ %:"P$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &^!JE:7BKL<P
M !,"   +              "  ;,. 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M &^!JE9[&W_?C@0  ,PD   /              "  9P/ 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " !O@:I6O '6P> !  #L(   &@
M@ %7% $ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !O
M@:I6%-1QY- !  "M(   $P              @ %O%@$ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     /P _ # 1  !P& $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>171</ContextCount>
  <ElementCount>256</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>53</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Statements of Operations and Comprehensive Loss (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited</Role>
      <ShortName>Condensed Statements of Operations and Comprehensive Loss (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited</Role>
      <ShortName>Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical</Role>
      <ShortName>Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Description of Business and Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition</Role>
      <ShortName>Description of Business and Financial Condition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Cash, Cash Equivalents and Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Accrued and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities</Role>
      <ShortName>Accrued and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Other Income, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/OtherIncomenet</Role>
      <ShortName>Other Income, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Capital Structure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructure</Role>
      <ShortName>Capital Structure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Commitments and Contingences</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingences</Role>
      <ShortName>Commitments and Contingences</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Net loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/Netlosspershare</Role>
      <ShortName>Net loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/PropertyandEquipment</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Accrued and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Other Income, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/OtherIncomenetTables</Role>
      <ShortName>Other Income, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/OtherIncomenet</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Capital Structure (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructureTables</Role>
      <ShortName>Capital Structure (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/CapitalStructure</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/StockBasedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/Warrants</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Net loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/NetlosspershareTables</Role>
      <ShortName>Net loss per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/Netlosspershare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Description of Business and Financial Condition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails</Role>
      <ShortName>Description of Business and Financial Condition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Property and Equipment - Components of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment - Components of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Property and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails</Role>
      <ShortName>Property and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Accrued and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Other Income, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/OtherIncomenetDetails</Role>
      <ShortName>Other Income, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/OtherIncomenetTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/RelatedPartyTransactions</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Capital Structure - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails</Role>
      <ShortName>Capital Structure - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Capital Structure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails</Role>
      <ShortName>Capital Structure - Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Stock-Based Compensation - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Stock-Based Compensation - Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Stock-Based Compensation - Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Stock-Based Compensation - Unrecognized Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails</Role>
      <ShortName>Stock-Based Compensation - Unrecognized Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Warrants - Common Stock Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails</Role>
      <ShortName>Warrants - Common Stock Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Commitments and Contingences - Leases in Financial Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails</Role>
      <ShortName>Commitments and Contingences - Leases in Financial Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Commitments and Contingences - Lease Cost and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails</Role>
      <ShortName>Commitments and Contingences - Lease Cost and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingences - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Commitments and Contingences - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails</Role>
      <ShortName>Commitments and Contingences - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="sera-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails</Role>
      <ShortName>Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sera-20230331.htm">sera-20230331.htm</File>
    <File>sera-20230331.xsd</File>
    <File>sera-20230331_cal.xml</File>
    <File>sera-20230331_def.xml</File>
    <File>sera-20230331_lab.xml</File>
    <File>sera-20230331_pre.xml</File>
    <File>sera-20230331x10qxex311.htm</File>
    <File>sera-20230331x10qxex312.htm</File>
    <File>sera-20230331x10qxex321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="596">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>71
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sera-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 15,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 596,
    "http://xbrl.sec.gov/dei/2023": 32
   },
   "contextCount": 171,
   "dts": {
    "calculationLink": {
     "local": [
      "sera-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sera-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sera-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sera-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sera-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sera-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 411,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 6,
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 11
   },
   "keyCustom": 31,
   "keyStandard": 225,
   "memberCustom": 20,
   "memberStandard": 27,
   "nsprefix": "sera",
   "nsuri": "http://www.seraprognostics.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.seraprognostics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Cash, Cash Equivalents and Marketable Securities",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities",
     "shortName": "Cash, Cash Equivalents and Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Property and Equipment",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Accrued and Other Current Liabilities",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities",
     "shortName": "Accrued and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Other Income, net",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.seraprognostics.com/role/OtherIncomenet",
     "shortName": "Other Income, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.seraprognostics.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.seraprognostics.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Capital Structure",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.seraprognostics.com/role/CapitalStructure",
     "shortName": "Capital Structure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Warrants",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.seraprognostics.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Commitments and Contingences",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingences",
     "shortName": "Commitments and Contingences",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Balance Sheets (unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
     "shortName": "Condensed Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Net loss per share",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.seraprognostics.com/role/Netlosspershare",
     "shortName": "Net loss per share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "21",
     "role": "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables",
     "shortName": "Cash, Cash Equivalents and Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Accrued and Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Other Income, net (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.seraprognostics.com/role/OtherIncomenetTables",
     "shortName": "Other Income, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.seraprognostics.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Capital Structure (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.seraprognostics.com/role/CapitalStructureTables",
     "shortName": "Capital Structure (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Warrants (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.seraprognostics.com/role/WarrantsTables",
     "shortName": "Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "i5d7acae39b0445e2914b0355b32a99e9_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Balance Sheets (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
     "shortName": "Condensed Balance Sheets (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "i5d7acae39b0445e2914b0355b32a99e9_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Commitment and Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.seraprognostics.com/role/CommitmentandContingenciesTables",
     "shortName": "Commitment and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Net loss per share (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.seraprognostics.com/role/NetlosspershareTables",
     "shortName": "Net loss per share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Description of Business and Financial Condition (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails",
     "shortName": "Description of Business and Financial Condition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Narrative (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Property and Equipment - Components of Property and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails",
     "shortName": "Property and Equipment - Components of Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Property and Equipment - Narrative (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails",
     "shortName": "Property and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Accrued and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Statements of Operations and Comprehensive Loss (unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
     "shortName": "Condensed Statements of Operations and Comprehensive Loss (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Other Income, net (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.seraprognostics.com/role/OtherIncomenetDetails",
     "shortName": "Other Income, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ie9901b75d0bf4b4595246dc12220f857_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingExpenses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "iebe6c97e0a004df6add4d077081e8986_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sera:NumberOfCommonStockClassesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "common_stock_class",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Capital Structure - Narrative (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
     "shortName": "Capital Structure - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sera:NumberOfCommonStockClassesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "common_stock_class",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "i5d7acae39b0445e2914b0355b32a99e9_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Capital Structure - Common Stock (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
     "shortName": "Capital Structure - Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "i5056875ac3244f5dbc3045e076055486_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "i5d7acae39b0445e2914b0355b32a99e9_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "iddd0a6e59f784d5e8a2a70335dc43e4b_D20111101-20111130",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Stock-Based Compensation - Stock Options (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails",
     "shortName": "Stock-Based Compensation - Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "i81c7d1fbd1ef43c18dcf8b61c0abcb5b_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Stock-Based Compensation - Restricted Stock Units (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails",
     "shortName": "Stock-Based Compensation - Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "iccb57ade95d94b5ba12b4d4d2cb8aa20_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Stock-Based Compensation - Expense (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation - Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Stock-Based Compensation - Unrecognized Cost (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails",
     "shortName": "Stock-Based Compensation - Unrecognized Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ie6969513749542aeafcd5cabd8aff333_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
     "shortName": "Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ie6969513749542aeafcd5cabd8aff333_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Warrants - Common Stock Warrants Outstanding (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails",
     "shortName": "Warrants - Common Stock Warrants Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Commitments and Contingences - Leases in Financial Statement (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
     "shortName": "Commitments and Contingences - Leases in Financial Statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Commitments and Contingences - Lease Cost and Other Information (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails",
     "shortName": "Commitments and Contingences - Lease Cost and Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
     "shortName": "Commitments and Contingences - Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sera:IndemnificationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Commitments and Contingences - Narrative (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails",
     "shortName": "Commitments and Contingences - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "if2f86cfb811b477c983db67e5f541347_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sera:IndemnificationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails",
     "shortName": "Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical",
     "shortName": "Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Statements of Cash Flows (unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
     "shortName": "Condensed Statements of Cash Flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Description of Business and Financial Condition",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition",
     "shortName": "Description of Business and Financial Condition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.seraprognostics.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20230331.htm",
      "contextRef": "ibc9a3c9d26964f0aa14c9ade7dc747d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 53,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sera_CapitalSharesReservedForFutureIssuanceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table relating to information on capital stock reserved for future issuance.",
        "label": "Capital Shares Reserved for Future Issuance [Axis]",
        "terseLabel": "Capital Shares Reserved for Future Issuance [Axis]"
       }
      }
     },
     "localname": "CapitalSharesReservedForFutureIssuanceAxis",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_CapitalSharesReservedForFutureIssuanceDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information on capital stock reserved for future issuance.",
        "label": "Capital Shares Reserved For Future Issuance [Domain]",
        "terseLabel": "Capital Shares Reserved for Future Issuance [Domain]"
       }
      }
     },
     "localname": "CapitalSharesReservedForFutureIssuanceDomain",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CarelonResearchMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Carelon Research, a wholly-owned subsidiary of Elevance Health, Inc.",
        "label": "Carelon Research [Member]",
        "terseLabel": "Healthcore Inc"
       }
      }
     },
     "localname": "CarelonResearchMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 1.0,
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 3.0,
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Amortized Cost",
        "label": "Cash And Cash Equivalents, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAmortizedCost",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CommercialCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the Commercial Collaboration Agreement with Anthem and its affiliates (the \"Commercial Collaboration Agreement\").",
        "label": "Commercial Collaboration Agreement [Member]",
        "terseLabel": "Commercial Collaboration Agreement"
       }
      }
     },
     "localname": "CommercialCollaborationAgreementMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the table relating to information of commitments and contingencies.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Available For Future Issuance Under2021 Employee Stock [Member]",
        "label": "Common Stock Available For Future Issuance Under2021 Employee Stock [Member]",
        "terseLabel": "Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]",
        "label": "Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]",
        "terseLabel": "Class A common stock available for future grants under the 2021 Equity Incentive Plan"
       }
      }
     },
     "localname": "CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Conversion Ratio",
        "label": "Common Stock, Conversion Ratio",
        "terseLabel": "Common stock, conversion ratio"
       }
      }
     },
     "localname": "CommonStockConversionRatio",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "sera_CommonStockWarrantAt10.84SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $10.84 per share.",
        "label": "Common Stock Warrant At10.84 Share Price [Member]",
        "terseLabel": "10.84"
       }
      }
     },
     "localname": "CommonStockWarrantAt10.84SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt1238SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrant At 12.38 Share Price [Member]",
        "label": "Common Stock Warrant At 12.38 Share Price [Member]",
        "terseLabel": "12.38"
       }
      }
     },
     "localname": "CommonStockWarrantAt1238SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt2077SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $20.77 per share.",
        "label": "Common Stock Warrant At 20.77 Share Price [Member]",
        "verboseLabel": "20.77"
       }
      }
     },
     "localname": "CommonStockWarrantAt2077SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt520SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrant At 5.20 Share Price [Member]",
        "label": "Common Stock Warrant At 5.20 Share Price [Member]",
        "terseLabel": "5.20"
       }
      }
     },
     "localname": "CommonStockWarrantAt520SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt9.03SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $9.03 per share.",
        "label": "Common Stock Warrant At9.03 Share Price [Member]",
        "terseLabel": "9.03"
       }
      }
     },
     "localname": "CommonStockWarrantAt9.03SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense",
        "label": "Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CurrentMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Marketable Securities [Member]",
        "label": "Current Marketable Securities [Member]",
        "terseLabel": "Current marketable securities:"
       }
      }
     },
     "localname": "CurrentMarketableSecuritiesMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_ElevanceHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Elevance Health, Inc",
        "label": "Elevance Health, Inc [Member]",
        "terseLabel": "Elevance Health, Inc"
       }
      }
     },
     "localname": "ElevanceHealthIncMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, Year Three and Thereafter",
        "label": "Finance Lease, Liability, to be Paid, Year Three and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidYearThreeAndThereafter",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_FinanceLeasesOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Leases, Other Information",
        "label": "Finance Leases, Other Information [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "FinanceLeasesOtherInformationAbstract",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_IndemnificationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of indemnification liability.",
        "label": "Indemnification Liability",
        "terseLabel": "Indemnification liability"
       }
      }
     },
     "localname": "IndemnificationLiability",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_LaboratoryServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the laboratory services agreement.",
        "label": "Laboratory Services Agreement [Member]",
        "terseLabel": "Laboratory Services Agreement"
       }
      }
     },
     "localname": "LaboratoryServicesAgreementMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_LeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities",
        "label": "Lease Liabilities [Abstract]",
        "terseLabel": "Lease liabilities:"
       }
      }
     },
     "localname": "LeaseLiabilitiesAbstract",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_LeaseLiabilitiesTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities, Total",
        "label": "Lease Liabilities, Total",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilitiesTotal",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability, Current",
        "label": "Lease Liability, Current",
        "terseLabel": "Less: current portion"
       }
      }
     },
     "localname": "LeaseLiabilityCurrent",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability, Noncurrent",
        "label": "Lease Liability, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "localname": "LeaseLiabilityNoncurrent",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityPaymentDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payment, Due",
        "label": "Lease, Liability, Payment, Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentDue",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityPaymentDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payment, Due",
        "label": "Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentDueAbstract",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_LeaseLiabilityToBePaidRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "label": "Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidRemainderOfFiscalYear",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityToBePaidYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year One",
        "label": "Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidYearOne",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityToBePaidYearThreeAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year Three and Thereafter",
        "label": "Lease, Liability, to be Paid, Year Three and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidYearThreeAndThereafter",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityToBePaidYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year Two",
        "label": "Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidYearTwo",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Other Information",
        "label": "Lease Other Information [Abstract]",
        "terseLabel": "Other information"
       }
      }
     },
     "localname": "LeaseOtherInformationAbstract",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The area of leased office and laboratory space.",
        "label": "Lessee Operating Lease Area Of Leased Space Office And Laboratory",
        "terseLabel": "Number of square feet under lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_MasterServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the master services agreement.",
        "label": "Master Services Agreement [Member]",
        "terseLabel": "Master services agreement"
       }
      }
     },
     "localname": "MasterServicesAgreementMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_NonCurrentMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Current Marketable Securities [Member]",
        "label": "Non-Current Marketable Securities [Member]",
        "terseLabel": "Long-term marketable securities:"
       }
      }
     },
     "localname": "NonCurrentMarketableSecuritiesMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_NumberOfCommonStockClassesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Common Stock Classes Authorized",
        "label": "Number Of Common Stock Classes Authorized",
        "terseLabel": "Number of common stock classes authorized"
       }
      }
     },
     "localname": "NumberOfCommonStockClassesAuthorized",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sera_NumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Votes Per Share",
        "label": "Number Of Votes Per Share",
        "terseLabel": "Number of votes per share"
       }
      }
     },
     "localname": "NumberOfVotesPerShare",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sera_OfficeAndLaboratorySpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to office and laboratory space.",
        "label": "Office And Laboratory Space [Member]",
        "terseLabel": "Office and laboratory space"
       }
      }
     },
     "localname": "OfficeAndLaboratorySpaceMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_OperatingLeasesOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases, Other Information",
        "label": "Operating Leases, Other Information [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "OperatingLeasesOtherInformationAbstract",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_Plan2011Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2011 Employee, Director and Consultant Equity Incentive Plan.",
        "label": "Plan2011 [Member]",
        "terseLabel": "2011 Plan"
       }
      }
     },
     "localname": "Plan2011Member",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_Plan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2021 Equity Incentive Plan.",
        "label": "Plan2021 [Member]",
        "terseLabel": "2021 Plan"
       }
      }
     },
     "localname": "Plan2021Member",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_PlanEspp2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2021 Employee Stock Purchase Plan.",
        "label": "Plan Espp2021 [Member]",
        "terseLabel": "2021 ESPP"
       }
      }
     },
     "localname": "PlanEspp2021Member",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.",
        "label": "Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities",
        "verboseLabel": "Purchases of property and equipment in accounts payable and accruals"
       }
      }
     },
     "localname": "PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_RelatedPartyTransactionCashReceivedFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Cash Received From Related Party",
        "label": "Related Party Transaction, Cash Received From Related Party",
        "terseLabel": "Cash receipts"
       }
      }
     },
     "localname": "RelatedPartyTransactionCashReceivedFromRelatedParty",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Related Party Transaction, Commercial Collaboration Agreement Term",
        "terseLabel": "Term of agreement"
       }
      }
     },
     "localname": "RelatedPartyTransactionCommercialCollaborationAgreementTerm",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sera_RightOfUseAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset",
        "label": "Right-of-Use Asset [Abstract]",
        "terseLabel": "Right-of-use assets:"
       }
      }
     },
     "localname": "RightOfUseAssetAbstract",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_RightOfUseAssetTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset, Total",
        "label": "Right-of-Use Asset, Total",
        "totalLabel": "Total right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseAssetTotal",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of common stock reserved for future issuance.",
        "label": "Schedule of Common Stock Reserved For Future Issuance [Table Text Block]",
        "terseLabel": "Schedule of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leases In Statement Of Financial Position",
        "label": "Schedule Of Leases In Statement Of Financial Position [Table Text Block]",
        "terseLabel": "Schedule of Leases in Financial Statement"
       }
      }
     },
     "localname": "ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sera_WarrantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Warrants [Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsTextBlock",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sera_WarrantsToPurchaseCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrants To Purchase Common Stock [Member]",
        "terseLabel": "Warrants to purchase Class A common stock"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockMember",
     "nsuri": "http://www.seraprognostics.com/20230331",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r141",
      "r142",
      "r252",
      "r258",
      "r381",
      "r531",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r141",
      "r142",
      "r252",
      "r258",
      "r381",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r13",
      "r548"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r188",
      "r189"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Accrued 401(k) matching contributions"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities and Other Liabilities",
        "totalLabel": "Total accrued and other current liabilities",
        "verboseLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r15",
      "r530"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedVacationCurrent": {
     "auth_ref": [
      "r15",
      "r36"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Vacation, Current",
        "terseLabel": "Accrued vacation"
       }
      }
     },
     "localname": "AccruedVacationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r20",
      "r21",
      "r60",
      "r113",
      "r425",
      "r437",
      "r438"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r1",
      "r6",
      "r21",
      "r333",
      "r336",
      "r374",
      "r433",
      "r434",
      "r580",
      "r581",
      "r582",
      "r587",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r55",
      "r548",
      "r645"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r450",
      "r587",
      "r588",
      "r589",
      "r635",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r41",
      "r42",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r315",
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total employee stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r87",
      "r109",
      "r138",
      "r172",
      "r179",
      "r183",
      "r221",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r328",
      "r330",
      "r350",
      "r422",
      "r482",
      "r548",
      "r558",
      "r605",
      "r606",
      "r639"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r105",
      "r114",
      "r138",
      "r221",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r328",
      "r330",
      "r350",
      "r548",
      "r605",
      "r606",
      "r639"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r192",
      "r229",
      "r421"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [
      "r231",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "terseLabel": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r594"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r200",
      "r420"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r199",
      "r419"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r193",
      "r229",
      "r415",
      "r592"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Marketable securities:",
        "totalLabel": "Fair Value",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r43",
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r24",
      "r107",
      "r529"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 2.0,
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents:",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r24",
      "r68",
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r0",
      "r68"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r102",
      "r110",
      "r111",
      "r112",
      "r138",
      "r159",
      "r160",
      "r162",
      "r164",
      "r170",
      "r171",
      "r221",
      "r243",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r256",
      "r257",
      "r260",
      "r263",
      "r270",
      "r350",
      "r442",
      "r443",
      "r444",
      "r445",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r470",
      "r491",
      "r514",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r566",
      "r585",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r170",
      "r256",
      "r257",
      "r258",
      "r260",
      "r263",
      "r268",
      "r270",
      "r442",
      "r443",
      "r444",
      "r445",
      "r541",
      "r566",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in usd per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Number of warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r76",
      "r553",
      "r554",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r17",
      "r50",
      "r423",
      "r469"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r75",
      "r241",
      "r242",
      "r528",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingences"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingences"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Class A common stock"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Class B common stock"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)",
        "verboseLabel": "Shares available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r549",
      "r550",
      "r551",
      "r553",
      "r554",
      "r555",
      "r556",
      "r587",
      "r588",
      "r635",
      "r644",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock (Class A and B)"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in shares)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r54",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at the ending (in shares)",
        "periodStartLabel": "Balance at the beginning (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r54",
      "r470",
      "r488",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r54",
      "r424",
      "r548"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 150,000,000 Class A shares authorized; 29,616,781 and 29,612,687 Class A shares issued and outstanding as of March\u00a031, 2023 and December\u00a031, 2022, respectively; 1,500,000 Class B shares authorized; 1,405,259 Class B shares issued and outstanding as of March\u00a031, 2023 and December\u00a031, 2022."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r22",
      "r120",
      "r122",
      "r128",
      "r417",
      "r431"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r273",
      "r274",
      "r277"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r542",
      "r544",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r194",
      "r229",
      "r237",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "terseLabel": "Debt Securities, Available-for-Sale, Allowance for Credit Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r94",
      "r234",
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r94",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r94",
      "r234",
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r94",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r92",
      "r232",
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r93",
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable": {
     "auth_ref": [
      "r231",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "terseLabel": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r91",
      "r538",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities and Cash Equivalents in Unrealized Loss Positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r4",
      "r176"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r284",
      "r288",
      "r316",
      "r317",
      "r319",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r129",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r157",
      "r159",
      "r162",
      "r163",
      "r164",
      "r168",
      "r341",
      "r342",
      "r418",
      "r432",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r129",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r159",
      "r162",
      "r163",
      "r164",
      "r168",
      "r341",
      "r342",
      "r418",
      "r432",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r156",
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net loss per share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/Netlosspershare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized stock-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Options to purchase Class A common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r7",
      "r103",
      "r123",
      "r124",
      "r125",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r169",
      "r222",
      "r223",
      "r272",
      "r320",
      "r321",
      "r322",
      "r325",
      "r326",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r374",
      "r433",
      "r434",
      "r435",
      "r450",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [
      "r344",
      "r345",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r344",
      "r345",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r11",
      "r45",
      "r46",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r345",
      "r386",
      "r387",
      "r388",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r253",
      "r278",
      "r283",
      "r345",
      "r386",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r253",
      "r278",
      "r283",
      "r345",
      "r387",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r345",
      "r388",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r386",
      "r387",
      "r388",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r343",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r362",
      "r367",
      "r547"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r364",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash outflows"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r360",
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Present value of future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 4.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease obligation, current portion",
        "verboseLabel": "Less: current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligation, net of current portion",
        "verboseLabel": "Long-term portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r363",
      "r369"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Finance lease principal payments",
        "terseLabel": "Financing cash outflows"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails",
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 2.0,
       "parentTag": "sera_RightOfUseAssetTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r362",
      "r367",
      "r547"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r372",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r371",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r235",
      "r236",
      "r254",
      "r268",
      "r338",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r430",
      "r538",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r63",
      "r493"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r239",
      "r240",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r240",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r583"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r413",
      "r583"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedTerseLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r47",
      "r90",
      "r126",
      "r175",
      "r358",
      "r499",
      "r557",
      "r646"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest bearing assets classified as other.",
        "label": "Interest Income, Other",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r131",
      "r133",
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.",
        "label": "Investment Income, Net, Amortization of Discount and Premium",
        "terseLabel": "Investment income, net"
       }
      }
     },
     "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities Classified by Contractual Maturities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r366",
      "r547"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Cost and Other Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r14",
      "r138",
      "r221",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r329",
      "r330",
      "r331",
      "r350",
      "r468",
      "r536",
      "r558",
      "r605",
      "r639",
      "r640"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r59",
      "r88",
      "r427",
      "r548",
      "r586",
      "r599",
      "r636"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r16",
      "r106",
      "r138",
      "r221",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r329",
      "r330",
      "r331",
      "r350",
      "r548",
      "r605",
      "r639",
      "r640"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r578"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r578"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r68",
      "r69",
      "r70"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r61",
      "r70",
      "r89",
      "r104",
      "r118",
      "r121",
      "r125",
      "r138",
      "r146",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r155",
      "r161",
      "r172",
      "r178",
      "r182",
      "r184",
      "r221",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r342",
      "r350",
      "r428",
      "r490",
      "r512",
      "r513",
      "r537",
      "r557",
      "r605"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing information"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "totalLabel": "Other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r172",
      "r178",
      "r182",
      "r184",
      "r537"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r368",
      "r547"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of future lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 3.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "netLabel": "Operating lease liability, current portion",
        "terseLabel": "Operating leases",
        "verboseLabel": "Less: current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r365",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 1.0,
       "parentTag": "sera_RightOfUseAssetTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Amortization Expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r372",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r371",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r52",
      "r85",
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Description of Business and Financial Condition"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r115",
      "r116",
      "r117"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gain (loss) on available-for-sale debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r7",
      "r12",
      "r119",
      "r122",
      "r127",
      "r351",
      "r352",
      "r357",
      "r416",
      "r429",
      "r580",
      "r581"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive gain",
        "totalLabel": "Total other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive gain (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other Income, net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaidInKindInterest": {
     "auth_ref": [
      "r4"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "PaidInKindInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r23",
      "r130",
      "r190"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities and sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r2",
      "r10"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r568",
      "r569",
      "r603"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r569",
      "r601"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r567",
      "r577",
      "r602"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails",
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r73",
      "r97",
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Schedule of Components of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails",
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedAndNonrelatedPartyStatusAxis": {
     "auth_ref": [
      "r139",
      "r140",
      "r378",
      "r379",
      "r380",
      "r381",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r487",
      "r489",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by related and nonrelated party status.",
        "label": "Related and Nonrelated Party Status [Axis]",
        "terseLabel": "Related and Nonrelated Party Status [Axis]"
       }
      }
     },
     "localname": "RelatedAndNonrelatedPartyStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedAndNonrelatedPartyStatusDomain": {
     "auth_ref": [
      "r139",
      "r140",
      "r378",
      "r379",
      "r380",
      "r381",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r487",
      "r489",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated party status.",
        "label": "Related and Nonrelated Party Status [Domain]",
        "terseLabel": "Related and Nonrelated Party Status [Domain]"
       }
      }
     },
     "localname": "RelatedAndNonrelatedPartyStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r378",
      "r379",
      "r380",
      "r381",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r487",
      "r489",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family.",
        "label": "Related Party [Member]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [
      "r494",
      "r495",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r379",
      "r382",
      "r447",
      "r448",
      "r449",
      "r496",
      "r497",
      "r498",
      "r518",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r51",
      "r324",
      "r641"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r56",
      "r80",
      "r426",
      "r436",
      "r438",
      "r446",
      "r471",
      "r548"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
      "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r103",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r222",
      "r223",
      "r320",
      "r321",
      "r322",
      "r325",
      "r326",
      "r332",
      "r334",
      "r335",
      "r337",
      "r340",
      "r433",
      "r435",
      "r450",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r173",
      "r174",
      "r177",
      "r180",
      "r181",
      "r185",
      "r186",
      "r187",
      "r275",
      "r276",
      "r414"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r370",
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r370",
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components of Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Impact of Stock-based Compensation Expense in the Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Schedule of Components of Other Income, Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r48",
      "r49",
      "r494",
      "r495",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r285",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r8",
      "r9",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Options Granted and Outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r78",
      "r79",
      "r80",
      "r110",
      "r111",
      "r112",
      "r170",
      "r256",
      "r257",
      "r258",
      "r260",
      "r263",
      "r268",
      "r270",
      "r442",
      "r443",
      "r444",
      "r445",
      "r541",
      "r566",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Warrants or Rights"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing expense"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, ending balance (in usd per share)",
        "periodStartLabel": "Outstanding, beginning balance (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r285",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r292",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at the end (in shares)",
        "periodStartLabel": "Outstanding at the beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares Subject to Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r292",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at the end (in usd per share)",
        "periodStartLabel": "Outstanding at the beginning (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Number of shares subject to options outstanding, vested and exercisable at the end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price per share, vested and exercisable at the end (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and expected to vest at the end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationRestrictedStockUnitsDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationUnrecognizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Expired (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, vested and exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted average remaining contractual life, vested and expected to vest at the end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r71",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r102",
      "r110",
      "r111",
      "r112",
      "r138",
      "r159",
      "r160",
      "r162",
      "r164",
      "r170",
      "r171",
      "r221",
      "r243",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r256",
      "r257",
      "r260",
      "r263",
      "r270",
      "r350",
      "r442",
      "r443",
      "r444",
      "r445",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r470",
      "r491",
      "r514",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r566",
      "r585",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r7",
      "r19",
      "r103",
      "r123",
      "r124",
      "r125",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r169",
      "r222",
      "r223",
      "r272",
      "r320",
      "r321",
      "r322",
      "r325",
      "r326",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r374",
      "r433",
      "r434",
      "r435",
      "r450",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r169",
      "r414",
      "r441",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r492",
      "r493",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r514",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r169",
      "r414",
      "r441",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r492",
      "r493",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r514",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r53",
      "r54",
      "r80",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Issuance of common stock upon exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical",
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r19",
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r54",
      "r57",
      "r58",
      "r72",
      "r472",
      "r488",
      "r515",
      "r516",
      "r548",
      "r558",
      "r586",
      "r599",
      "r636",
      "r647"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Balance at the ending",
        "periodStartLabel": "Balance at the beginning",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r137",
      "r255",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r272",
      "r339",
      "r517",
      "r519",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity.",
        "label": "Equity [Text Block]",
        "terseLabel": "Capital Structure"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r254",
      "r268",
      "r338",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r430",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r534",
      "r542",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. federal agency securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r95",
      "r96",
      "r98",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]",
        "terseLabel": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r158",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares of common stock outstanding, diluted (In shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r157",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares of common stock outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org//260/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org//850/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(g)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(h)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r559": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r561": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r562": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r563": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r564": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r565": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r576": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org//320/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org//505/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "https://asc.fasb.org//610/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "https://asc.fasb.org//720/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org//810/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>72
<FILENAME>0001534969-23-000051-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001534969-23-000051-xbrl.zip
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MV!\HSOM>%TQ_,'K?,IW!6L=O_CUL'B>1P>?O2'8M#D#?'##$82L%'S?"<2^
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M03,9S'-,["SB2/C\@K9(."6\QB@&)CA6DC"@.MH9D*DS<O$$_?CCYQQ(5=!
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MCN4TP]PQ3E(99-K:J)AFR'B#I,>$(VMA@"S#.?0/EI->0;1\!D6Y-D2FO
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M^QL'H]K;/?2.UEM[9UVXOL;VR!ZOGQW@O<_PW,8FWFOL']4W:KQ&_MVJO?W
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M:!153EJ7\ER"6IO6('MGOH8L">OY(+"@@MN]]^!/ ^6KW.VY4ZB]+QY)(UU
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M\[0;B.>Q^ZK==HC+M.E5PY?&^]X@PC"^QS"[(EH _/:+[70MS!0"E$5#P%(
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M8RX.>2$KG.@*8>])7ZL[ONB,X/'^QQI,*R?@86Q9G]U_MG>:>S+U^B-XGAW
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MS5$X0V@*"A/$+#>("^^1"0K^P5@Z&A4G!"B<66+&8D&T@FA->O5;G8$!F*+
MUR(ABM/DK>? #:2*-$E,"%L*HA4FMSRXVYUC<M$P(&N*H!2 SG%M$G(^*)2,
M(48E2@6/:QL4F)P42VBI7B"O0%X#(>\6B*>)5X$D%TA,G'FB@T_:2>*Q==X)
M5TS61@#=Z7RX08)PF(\"$2L4XHPFI+' R IN1-)*8>LSKVL;ODK^N:?;A^]F
MFILC=56HM9]RE9J<=C;,FM4:G\"/\5L<^,ZPNEK_N7^2!7IUPL**-;6_C[!J
M=(%J*C!A-/)@A7%@H:HD-1 #ZJ*^YESS)?'5"NOJF.JK\0#F[A]XC?ZD8'1U
M<;<6R^N)O$KH=7E8>+H8>HTB6DFD1<;D@C8XZ?I@7C+!DTBTC)&L;? V-LNJ
M9K.B-6M63]6K8ROT]R*E1DOI%GS3D"")T"8H[3F.PI$0X"].!H%E%->A\17$
M<Q&,_V.[XW@%%A?J>2NXG8^6"!^8LDFBX'C*+D4 7H4=XMPIX2,)F&>X+5"[
M6DI<H+9(J4CIP3?$I9?/+!OB/6^("[X8IF1(8%DB)I-%W"6'M#)@B22NG#0Z
MXAQC:]*&N,P>$JOH9JGT #F;S\SG:B"Q-ZR*(K3BM_QSO$L/R-5#JY_;4YI7
M,K](J4CIL:7TF*;P>2'_X5[__#1N/HR[U9L<Q:V<E!7PO9S!O;?Q?\>=86<4
MW\7!EXZ/-65X&WW_H%?=I6(/):*S+!:13>H%LSK79TS*(VZ)0IRP@$RVLJ.6
M7O"0/(NY6&.;X2?8[>1I@T*![B*E(J75-ZW+!KM"&^RBF>ZH599C%(0)B,N
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MHJJW4=4%9X2@6 5*$$@H("X21D;2A&RBBGJ57+1I;:,X(AY%U:HN9L_+[_#
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M!(B,;AMVY_(X)7]F:7PEYN:C5S&5>S3HFC9)_WU/[_Y4$#S1I*5/3A, ;*5
MH5D BS;F(IZ$\1K!;Y!!5!"\(0CN%[B:PDQI*SV*)ME\/M@BFZ1!BCOJE4DJ
MX A<3;4IOG-X8)5<7 4%"PI.4)!X+IFRU$J2N,L==*($8JL-Y19PL$;!^_;@
M%11<*@K.YX '[2BS%HF0J[DZ8H#'VH 2!\F"N4*DR%6I>1OK.Y\I+AZYY9P?
M?#<^.>G&G-5HN[EVD^_VA^-!=<#,3X\6MCJ]6FU 3C]UEG QHLU (J$_SF6P
M+TCKIXX(WM25< ]#?"XVT(D%O8)% $MA% < KW?)PWR:^_F3W+67?@QB:[)^
M_H$%M1-+9:+;[;F+K0IY3$PJ*A$35"&N/4=:&8T\]S8&G:@F^>##8@KBRE<6
M*XCS)!%GZ2'_@CAW1)SY-,A@O?<\H)A4CDL1@JP5 5$"6!-PH&#,K6V4.NY-
MH?$@ U11^9F*:+TP<Y)C2>R^*13^N?+T&Y3RSZFOH+SPGJ-A/@-<M2'*GX _
M#L: GX75/XL]=FFL'D9J7YPMO/,*I+/%1[=Z.3\N'TK8G"R]?^J5!Q_:S.LN
MAK\[UG6ZY93";;?GG5>+O1^#YCY$C)'$0B >I$$Z2HY$TCI01[UD?FV#+R;9
M%H.@@%43P6II!L%]@%4IFKX<$)MOM,Z"ERH0%((@B NLD5;<(&)92A96!#&T
MB473*YKY6]5;#/X;.E\V_@?^F3[ZV X..KW*N3QW"MS';*0N6Q4)GNIB=<<7
M'3 ..O['VDDQ:.?>8:QXXC&,YC2;"+W^*#>R'&2V6+F #P95%9G!*)/-$7P<
M5#;$7CXR/C$LX/IP9$?Q8IV9^2F9/)8+&.E)?]C)\GLQB%VP1K[$W[]VPN@0
M7B./:?9;]:2_P.=?L6[8[XY'5W_E 2?[2N 3_T_5EF1V*F;_S:.MT((SK'TR
M2@OK.2;"2L^982[BH"E._!,@W/1+AX/I&YS8@XC<(-K/R"9XP1>V^]6>#M=^
MN[@&80'.3OK\?%TY*RG=VZS4F@"0W1]45N@+4,XXR)^",=G&C*5U.,@;TG]=
M+Q\%*E395J <+_->5JF W;A,]I?C Z$/"Q!7.1<J.'CW^NUFZY^WNV]V=M_M
M;;U\UVYM[;Q<OU*GFS+LG0JT1OTL@@DV_7F&3>^NQZ:FO,<O[WMV'#JC&'Y=
M'.L- 8.O7;_>'NGUR'IKP@9WQL=P"[\$6_6B!WAW<&![G>^5/L-:J)($JE^
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MQ+*OUVV_WCBJ+YPMX=EE DN^6LJCZBUA+]E[NUVMZAN+[A%LOLNWX;\[,&<
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MO!*)IJNUNN'DCA=T*E7&<!QUJMD[TQUW.KDS6*ZCZ ][0)H.:IY\;JQ-[&B
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MD6ML7,(1)\EDLBG().;5\S(3Z_+<\9GC)//+RIW"A2/@S)._G;9&IR?QZO.
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M!+D(_P0/E-';:$7N2/)D(YU/5\4K4^&7INOXG#N@Z/)M='G>[)<IL$A(0E&
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M>D$SK*QQNTKE8K1[?X002&6$>V6$ZINX'R:8"([$I*UVQA/*(Q#0AI;DA41
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M7 ./#??J&I@!UI.N 1>XS]384KP^(I@%$)<])Y(E:EUT03*# KR>-EH<++<
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M#I>7V&P8OLRB=GK>U2XK)U9.;,%3+SPG3BF%E2+G09%B@B*UR,EXD<LQ9TN
MA42,9ISX"-$&3U-FJE)DI<A*D?=/D5<38W4;SI'^Y 3]@0Y,96])",(1\,P0
M$ZPHYSVXAJ234;2Z#2O[/3WV:Y_;\&KZJ\[!V>(DDV5NM&,Q>N:)%"80T#H1
MB\M(E.>!&ESB5,K<M-\[.*?B\:UFIJ:G?4XXBV[0<9_2?CBM?>UOP%>"T:PE
M5U(9C2:-,)EFET$&S;+-,=7X[V+SVGGU@XNN/J%%"@Z(-\X0<,(2KZ%4[XHI
M1V4E+_4?&5LU=IK::A?L=D/_-KI*.[%?M9B9T#X9XJ11<M8XK"C%'SIK8JGU
M)!NGI4E2B6P0[7JZU&MMCMU:E"\<R'\>QJL"?B;(3\;R3/:&F2A(SBJC@/>4
M.)H%D0Z4L(QK&4MY3KUJ85X-82KTJX"_<[BJHOTV:)\,2X5LA,6E1=EN2N&=
MP(CCLJ!=FBPM#:ZT?[+32*_RO;4@;QW&:[SEWG$]&6]1'M5SGQB)$!0![R0I
MKQ A8V"*"8A4K*QQNVI@NE1AE>+M!GC[I'@-*=R'ZVTJI&"2R]I18JQ%B0U6
M$\^T(,I0;5A4V7"-H-;35?,?15HOPW&Y)G+PZ0"'M+^7]H]GC1HL14OL$#E8
M%H(-4J#:&8TT/&J?%40OC*Y1@T6GKOY4U,!HI6V,GMB4+9H97A*G?21*!TJ=
M$RZX7$H\KBI-6]0X>TY)'D\<^K=11]J)_:JHS(3VJ:B!XAH\C81)[0@H:P@J
M+$""X!#!!4B)(]KE+%Z%BO(JX&O4X-$@/QDUR#D)54Z$YV@I <H=*;UBB7-!
M<FFMR9RNK,&JDO/J.U.17^5[#1H\"-@G@P:>2T1YHD1K'@AXSHEE-)"4 $)F
M1G"-8)?3FGP5[ZT%>>LP7H,&]X[KR:!!CI)*H1C1IG1WUU$2KP7"G,=4W(N"
M\Q+ZEZOX2Y7B"P;P]DGQ&C2X#\_;9- @<R8!T4L8LT  DB6.)TUH%!"%B)+1
MM++&:4N,\3D=-VCNK5L>/)BNPWN#R$SMF7:_4]-N%K_-83*>C0HEFX]YT#I8
M(Z)7.LF,?("T7L,L"T[VT\7YN!**,B.)8#H24 F(83$2SX3VP@:1O$###%:U
MG+FS^APQ]\C9(I5Q*^/.Z?QN*RFW:M0SD>QD=,L)%KE!VQAX<75G1HGA-A)D
MSQPT;@$JS,J:T--]*F^=A5/)M9+KDR;7A>/6&E2\1Z:=*BO(-*?")6*$-022
MSL0X$"12G5ST ;+C*VN<K\JYG36NC%L9]TDS[N*ILS68.U>2G0SF C/6 '5$
MT)*:*8T@7O F!A0R-3I#\"MK[(K#GE6=K>1:R;75ZFP-HM\[GTX&T77FCBEO
M".?1$]!.$J<X)4:!MR[E*(5>6=-Z5<AI#T%56BNO5EY= *6UYB[<1SAK,G?!
M&S")@R=:6TE*\@G2*'*IRC:8'), H5;6))M#^:''Y- FY^&WX[*]\-_8_[+V
M#_QQ/N0]-_S4WQ_=FS>DV7QRHO,B/LW '1ZEY^>__![[1X<#=_J\O]\ JOG2
M[^.+C1]3'DZ-K!GYZ.W?S]NCTV=TI-Z,\S+&=_YU9W4NGQEE:W?Y.M@ZV$4;
MK+[9@&;N'#[50W;,38O<1G8]A;3GT[ CV&H'U0T^UV;K3ZX??0E8=XYW\+Z,
M=_8:9]_]]BU^<C/X?=XZ!\/.)U1-CZ<[]]8I_.D43B=CSDQM3VV*:EOQVK6^
M;J_V35S=7G5[/=KV6H8J3R\/]O;2,/3=H'/H#J=5JU\]ZW+ZIY]2%Y];.* ]
M!*TA@0C. 4W9YLQ3-D8I!2;:T#B@.>/UW,7<'=6?N^N?OW4_O/Z\M?OW;O?L
M'>MQ_-YZ..OB];9W__[</</[?-@ZG794O_NZL?GJV]:'/_N]#]VSWOI[L?WF
MU=?>6?<4GP^_@\_]9@NO\4?3[.=[S&\7Q_#I(X^2,BXY\0(X 9\,,=8!R3(P
M$W($P=C*&M!5JF:.^=7N9I47V_/4MXG,M9,8GVC,[J&H\&R""JFW6:?,B$H"
M"%#'B#<E;I<]L]1D7.&\LC93B=+*@)4!V_/4"T> /S_"\/0Z?C\4$[)))LS"
M!A\Y4;PP869 K'>1"*8@.25  =2.WY43*R>VCQ.GE,)*D?.@2#%I-TN?I96*
M)%T.>/ELB;6&D230CK9@07E6*;)29*7(^Z?()3XJ\%#T)R?H+T21 YA$C(\1
M-423B8<HB/ F1NDMIQJJV["RW]-CO_:Y#9<JH?_!XB0_$OK??NMN;GT$ZF-@
M0 D(I#T07!,?6"31*,YI ,8A+H)W<$Y5"EO-3"\/AH<'0]SZB"H_<V>CQ>VV
M=@NJBCX(9B53R0E@UEGG;:;4)LIR!@HU]+O8E-9[.17Z==QX5VHF!RLX@4 C
M<2%0$@P(G8 ;8]/*&EN]JMM)[;-8D?^PL<WJQIH'!TS&/(6+DAGOB4#+C4"D
MGIB8+7%6)VZDIC'SN;FQ*@M4%KAM@*_"^S;PG@SD9<.4BV"(Y-ZAB =);"F3
M Y31X)WF5OG2[F3FG@@5VBUV0[03V]5!,1/4IP)20FDE<R1>193DQ@7B9.#$
M4A8XQS7'M4>HMZ._<L7X0HKO&FBY=UA/!EJL5:"-]$0I61J6149<"E#*Y//(
M',IO%HJ1KN2\ZHA6?"^O#*^AA/OPNTV%$IA4U#J*IC9:WL"*5BZH(Y0:+;35
M.5C1&E&]#(?DWC_[ZUDGIYB&;M!QG])^.)TU:+"XW=9N04K:*.:DCER:"-18
MGU42 1)%F04\Y!HT6'#R^FLJ:""5LMZ62N8NZ7)>C!,?LB?!:N,Y*BK)ZU+4
M8]6HZ=)FM=%BNZ%_&X6DG=BOJLI,:)\Z$J6#"A8H02M#%.O#$)O1&!&X^-+8
M(*DSI8W!M.U1^R6W%N4+!_*E[%SR4)"?#!GP)(.&TB/**49 T$1<Y(JP1)VS
MC$9JT#CA<E5 [:2\:-!?/ %?HP9S1?MDU,"#-)[F1**4J,XSX8E#-9XPGZ)G
M0LG(4)T78@YIC17E2RO@:]S@WH$]&3>(S":KDB32,D= >D>L!D<<*O1<@9 \
M902V6>6,53&^8 !OGQBO@8/[\+U-!@Y,5(%*80BW)A  )8G/.A(E,N6!1L<8
M@EI><>3J4:3U,APU:$('GPYP2/M[:;^>-;@));EL:18*J#<>:.8&"4EK2TVT
M3,9<R\PM.G7UI\(&0?HD$V12XM;(7%H11[,A6DK.G%"E8=_*&J.K4M5<Q$6#
M_FW4D79BORHJ,Z%],FQ@$W,FZTQ21@L$O!%H?*A <CE30*/A3,B5-4YG"1M4
ME%<!7\,&CP;YR;"!#CYSSSEA2I5((:/$0(HDYZ@#BS$&$5;6#,KWF=,"*O*K
M?*]1@X<$^V340( $%.*2:.L,@10D<2Y$$I5%K*?@J<ZHS8M9_! 5Y<LNWVO4
MX-Z!/1DU<"X988,C&9I3@FBK.ZHU"5RH)+/*TA<SW:XR,7/4H )\Z<5XC1K<
MA^MM,FK =+!:@R94EQ8/3@1B/<O$&Z8"\&Q%,BMK J81O<@'#II[ZY9'#Z8[
M]]V\/E1M*']/4]-N%K\%B1L6=&391Y8RB,!,#-EXQ0)U/GCI:YQEP<E^NIV/
M$Z5ACTA$@"M<SP3QF1H2A3<N)AI42=A6L*HDG6]=SD=I/_^P53LKXRXEX]Y&
M;VXGY5:->B:2G0QO&<93]@Z(=\ZBE1PC<3$DXFT*G#'\FR/)RBL2Z^Y:"[22
M:R77ITFN"\>M-:IXCTP[&544FANJC2.HN$H"TII2F9 3(5WV/-@<@BJNBU5@
M<RXS7QFW,N[39-S%4V=K-'>N)#L9S;5*94.=(UIY1< [29S/FD2E0"/;*JV0
M9$'/(:N\DFLEUR=-KJWCUAI$OW<^G0RB2ZM5PG4E%!>0@%""6!D\<<%I<%2P
M%.S*FK7S[XU4>;7RZM/DU?8IK35WX3["69.Y"]$YQ7@$8K70! (+Q$6?2-+4
MTZ0R=1)U4VM@L773)N?AM^.RO?#?V/^R=OX\O9,]1$Q8^P>^>/X(>V[XJ;\_
M&@L_)[/^?DS["!?3L.H#8Y07C+XXZASD3M<-P\Y(B@FVVD&HB8[;CYWU%-*>
M3\-+;_'5SO%.ZKP\V,/QGG9V7.S< NB99Z-"]H8Q#UH':T3T2B>9)3 !N@&Z
MH.(RT-_V7M\.Z2\&@X.O;C^4OU\.4^P?WZ@C"5U,R _2__OS=/M#//0<5'?S
M/>_N=D7WS?O3K=W7>[TWK\ZV-@=[O=W!7G=]>[#UX>W7K<U7^'XO]S;?X;C>
MLXWU<K\M^9%E+K,PEF0I@4#RI1BYY"3S$ 5/5G!E'D!CKNO]0.L=($;4?0W)
M5E,"6BGB 4IJN(K<&B] \96U_8,IJIYZX;@S3*$0;NP46G#G"U*6H!.:)>D,
M<$V0NX:I$;:=XX-.__BHX\[7DN!'R1$NS(43V<\ZFQ?(QAT?#_O^Y!@O4C@(
M-TRAM*-.?[_Y.[O^L//%#4Y28;5?7KL,8+]LD$$'Z?ES.FY(KX^[=YB.\'E*
M,[H\. G')ZX\XG@L%V]ZX89NF/!BQS^&V#S?Q0^/)^$_)RA-CD\O/U@\P,^4
MKY>[[S=?/4J# ?[Y!8=23JD?=;[N]''X^)RGS<WPBJY [URE:6:W<SA6:II'
M^7Y5GP;]]*5\V>$M\+^CSMX!7F/0_YP&I^7E_>9SS?L7V?UK'P?A$R[9?T[Z
MP_1C8.5#%P?G4RX7+'L I>9IF7_\",Z.PQL=-^,+!SBIWAWUCU;+LX0=G/73
M<G%$:%F1TV??Q7\C32\)TXDFG<$Z$6SDRBI A<(QP%=BTC%HT-%^7&^D"*.,
M_! GE_GD[8_!OQRXHZ-^[J?XS]/BURQ;&A>I.Q[6.NZ#S;*'-O'^_QP<A,]+
MQAK=S:[8>/<Q)*IXI&@9NXPV<G*46)Q_%!7<:>ZMM9JO=!)2ZR'.\_'P)*TL
M@@IT 89-SRS]^]&8#LJ:7Z2+\'V?=/QILR''.^5\!Y</N6LUJJ](*^7M?%"X
M\:CSOPUK'9S@X./1_SV_O/FOGS><IO'(QLKQ2,O%Z1JXPZ/T_/R7WV/_Z'#@
M3I_W]YN';K[T^_AB8XU9'DXIN<VJC-[^_6L_'N\4:^X9'7G*QBF^XSN/WW[6
MO#6ALH_>4_!,27WMV_09N_:]GUV6R6>:F3M=]N?O 57W,UA[H\O^(HWZEV<@
MIC]ZA>\DI"+@'LE3H*_T%+SX+B->HHRXM@C+$LS$ZZ)0_%T4BDNSL P%_==1
MB?K:/]Y!5CS83YW3Y(;WU*S\27L4%]MG>.^>A&F7X:0I^</(+"9G][MD_]#L
MS8W]M(4[\SMC%<):@LC,;F^WN_L)NNO%'?CY='L=KWOV%C;*W[MXG3>O=WN;
M;T][9V_9I#NQR[NG&^N?OG;/NG1C\X_/O?5/9\VUSO"=-^^_XKA9=_>MZ.[^
MG;L7FQ>LOS_KOOL(U$F::2(<HD,+U:)QJJ%4*J#"".4]&%A9 [%JZ73!TYDB
M,T\B]E*YL'+A/7-AT5D:E:7RX!QY\&R*!YGS5@;"F4P$/$_$VAR(,S)G(9-P
MT30\*(U>"!Y<ADJ31:=U&8V,[RHM6OSX4)]V.KG_9?1*+3K9&EI[498*66US
MM$:O<8D*P1U5;>]^6*X_I>VQP$Q.(1.G>"#@G"3>LT2$]AZW>I;.EN8U=I7*
M6LRB(O_>D5]UF_M _:1NDR!R):,F"D3)9J:,&!TC45HK)X4+B2=$O5FU;&;=
MIE:]J%4OVF.A/N7\OQ;0_432R$4U[I\E$%U9?6ZL?CJERX7(C5(Z$!]%*4RF
M4:LS:+;*LK+)*&^C6%G3?-5*57.J*Z=63ET(3KVL0O_XJW+I'+ET4D/.*8FL
MLR<Y:TW F$R\I)$8ZY.6V0CK1UPJZ71:]>)QZ0URJ\O?870(U8TR$B^DS(PQ
M R6_Y3PC[GF3=HB&W8^TEO^YG* T?E3ZXRO.XX.='%__E:EL@H?G!29Q3*5N
MR<7TH8L_RW ;S(&@)F2KC70!*)-.!1!6^%3*^],,'T&LG']I9_@C@>)3(GZ8
MW&?2N#*?N\%7=WJT\MOE)*7^/KDXZY,3=NVTY'QOTS+:=+&DI39;Y#EN\C0L
MG\(QN=:,I;,S+(3]7[]>'XUV6)/Z=9 [)5&Q)"_^XS>W=M7:_S2![(%36YH\
M.WC6N>>4SG\/#PZ154[_/7#[QR_VXZO_G/0/2X;G>O\H# Z.3H;M2>$\/1=#
M$5]_)5&,G&[OO>7=S7>T]^'OG8WU]RB27ISU^)^?>V=_]+N;O:D4SAY'L;'Y
M&<7('WM;NUO?>NOOV/:'5]#;?+V'(DILOWDGBFCK\E[NGKWZ^C'EP$$*3VQ*
M@4 "37#.)3&*.Q RBQ3R2(E 4DWQ11'E.L6HI,^>9XO?"$Y9KQ7SU&C-P/C)
MA,_S-6CRC[\OP#1[3R3Z7F3RT<K\^L:7!\J$M%IZ&J70($(TCDN P**-F4K-
M5NX[H?C:W;?$>^[;1PB)2V<\8<9'5%R\:W068F.,3&2?F-<+FC0\RN-%5:<S
MRL<]'*:C)A>^Y,:'@[W#@_WF3R3KPXNH2.<;8[6SG_#']1G#UY_!6H;D8<V>
M67']VW?.Q^7/J+EK@O"#)P^7P8KE3!XVOU(K&.##-[CI("[^X8>_K178/,G\
MX9M-QCE97)P/ODR9Q,TL_,OYHF4?#$]_<.V2IA(W\[%TZ7/-4]_"54:5L<XZ
MSH%I_,\Y17F(:'1)(S(*BYNZRJY5 ?'WU_W]<ASR7\D=I3_+,#?R^Z/TXN@H
M'?^S.3MWH0S!>D)=(O0;;1B_.HY;N 6J G,W57/L9>NR[CJ.;[/[#:\_P.]\
MV_[P1W_[#7[N;*>_M3GH=QL/W79_RLMV]OXKCN=;]^PU/LM[5$]?#[;V_OB\
MM??V;./-'SL;']Z>EM-MVWM_7)5KG#D7SF=+E!" RBIUQ%.TDC0X@>HK4SJJ
ME36Y:NV<"W$_B9!$Y<IEX$KF*$C&%:5H(PMIO# N,)FHY\EH2#>MU%*Y<K&X
M<C(BH;7E+H @P<1 0(,E/GI#(#B;C4\RI!%7LCD')&HZ\IUA7HXYGY1LY&O5
MXJ>;@7A;GLLFVAR\I9%Q"&!\9E&SK, YX>.8YZI.^,1X;CHCF1J01IM &$1!
MH-0(-,AOQ'D+7D>>DV$K:VR5B]HD]PG3050Q.BNYD3J# H8Z#Q4J*I^=R6%L
M(E:UY\G1P:3:@]QOG<J22*X8 :")&*J <)>4=5Y):NF(#F8V$=N7J=QJY::!
MS<[!(';Z>X?#@R]I;Q0>OX."<\73/SU&R\I)'XV(U*!HT]EH1CEJ\,Q2\$!]
MJQ2<2EHW)ZWI3-SHD4B,MD2!1M+*.1!KN6FJ^C&N46R5#G.X_G.RU%KDNZIX
M_Y[BX$6(@1DN508FK4M, #ZVUY2C@FM:I<%4O-\&[Y-*B@I19>$\8=R7JHY6
M$RMH)(D9XZV,DB7?-KPO@__EKX-\_-4-4_6Z7%\N5@A#7>1&.' J&&-!&0$@
M:&(L5Z_+4V2PWLMIC06\LEDI(IP5!*1"!K-0:H@S&;@V7%-;S"QV10?TZG5Y
M,G20I*52"Z^5T*BK2-1A !DA2!IL4%2W2F>I=# W.I@J?I-0%C#MB.7*$1 0
MB&%&$2Z3Q#]LLH&UCPZ6P>OR^F2(\#TIE6WW8R?CWL??J]?E^E2CD+D2LMAA
M$5) *RQ$+QBJY]([:EVK%)Q*6C<GK>EL(L>90'5%DYQ3). \(R6CC* Y!E9'
ME%LIK*P)WB8KK'I=YHUW7NP9#MRR!&C &)\\E3QF+Y0 !ZW28"K>;X/WJ2HV
MS&K*M"3*FD# 0R3>!D^D=<(I:8(3LFUXGY/7I>TE;!K4-B5LKCF*,XM'9H;T
MQX6FMGD5&*C&V2+QWG2&C 'K- HT0I5#W@O:$^>8("CNN-86-!BZLF97<</-
MR3AK1];T'+TXRTHA\VK[6"EDL2AD*JM&)!^E#D1R2PE0[H@-B1,3I7093>5,
MH5"(8#/7>'\0"ED&S\^_TM%1Q_W #@+T!W@:[<I=@,^2>81NT_OVD?6H2G\/
M3'_3^3DY"@DY"4*1!0EDY$#C@R!,!&.HSR@@W<J:6@4[W7S\UCUSJYNHC23P
MR)I0)8$')X%)'0BE@$L\E*:*4,IEQH"_:2 Q<AD#4]P)7DB 7U$M\U%(8)E\
M1_^^OH#+'37/IUW \Y9G:><Y->V6"0ND%Y9B?U4N/*Q<V)A.A;)!H1Y %8E!
M, (A:>)=U@14\CI$[R&C7."KELZK-OXB5%'^A?.MDG EX:?@H:PD_#@D/*F<
MH]9,G6*1F%1B'/@7_J8HP1T0;1!*T*Q7UL0JE?,Z!;S(Y9=;6K3QZD*CORX<
MNOXSQV8G?3M,^T>I\]4==?[[%LP"0G*K*&IT(0,SX*@&#XDJ6NJ0NM24'.7G
M)4?YE)XG)RGFXC#Q]T&Z,TFHQ22)NU<JW=RB'[6604J=B%*E786UGG@M)0&7
M(W,R&1?D[0Y<W:6F;%W@>UO@$"2+:#D1*J@EP+DB%I>$\$0C+H+45(>5-?J,
M3S'X-92.%#4H>P!GO(-B8:>4<2VU7X]WABEU]G O[!QU$M)>O+:Z:T'VLVDR
M[4S7<[UA!7>ULM;6 N#RW@N HZ*$DO3XZ-_NM,@N_'-XDN*_^L[W!Z,.0/MQ
M U=H>.&E'[7!7YX,ARTJU]SKGV/D'?3.!H/>9E?T/O3V>KM_[F[M#E#;><>[
M>^6[K[YU=W=0\^D-IC"R_DEL?'C/NF>!X7UY[TVOO_'ACYW>^A;B#>^_^>IT
MXPUJ/OQOQ,A;^=%(8:U)D>00(YJ87A,3(R59*1^0(3.-=++R-EJ@(@LC$^<&
MN <;&4.IAK+,X/\3FRSO/%Z69O\WJ]$9SWSGPK+<H6+X+\=QWQ7 _PH[*9X,
MTD:>WGE-W?[EW5K=KQ^U ,]%$:BI'$J-(1%+(1'CA')&^\22?/J5P-V%S7_0
M;/XPWOR#'YNEE@2O)<%K2?!:$KR6!)^7Q^]<YRADC-;ZE2E)M<QM+7,[_^YY
MHXWWEQNX(4KVL:;;&G?L'37!L3OV5;G/Z?;NNV]=-,0W-M^QWOI[O/;.H+O^
M@F]OOCO=WNRB=MBE4^[8S?),?^R5ZVYL=B5^C_8V/Z'&^/YK<</VUG&<9W_O
M;IW]>56A;K10.$6#G0CC/ %00+R3EM#,@S<Y2L/<RIJ&Q2@]6\MT5_YJ:]SJ
M.OY:A%C3@I#;9*S)2I&C4))X2C4!ZSCQ(!6143H5C0Z,-@%_OB!="):ALM.Y
M?OG%A;NGNR]%29<Y*U9_CR>\*E9WX)[ILWS M/39)5*BD\@]7A$'S!%-C65<
M"V=*>5LY._/4JDOMA>B<=8<*T9D@.JD>R*2-SLP2I1DE8% S,%9XXI17P0D6
MF,PK:U#K3S^2"@"4_>_G_^N@=AQV2DB@0&O8]R=E"6IAI(?2"U[M'0X.3E/Z
M9]I/N7]<'2]W()\KZC)F3IEC-A,O#>H'K,3ON+3$ @<AHM/,ZI4UIMM4XZ0>
M5FNW?E"A.A>H3NH)D?NHF-?$Q]*@RUL@J!UPHB.7P>AD+>>HRBO3(J@N@ZM@
MXS -41]&S6!0$KZ_Q_U/5[^G AR6?+[J1+A_9>'[6C2Y]^?I.J>5@>[ 0--1
M&F:38(ZB?>)Y)+CH@5B1,REIMA(T$T)&9" Q?:B].A.>#%3GI2Q4J,X3JI/*
M A7@K+*>&)"9 ,\"]7HFB4D0,E#O7(DY2-:F'G?+X%38N"Y%L#H2[ETW*%,_
MG<A;"><.A#,=:."&:>HD(T8[00 $$&L-(YDG1J-54A7"47+F>E_5D=!>J,Y-
M-ZA0G2-4IQP)P@KCA28BBG(<CEEB*=-$"DLUZ@R)9890%3.7'VB?(V$A:M.,
MZAK?Z&!!K553RR2T6NFZT9&]FGTV-[:?KD7(*5*]4HYHFTJ1&7#$!*-(IHQS
M*720*9;L,V6GS\DN7J6#6FZF\FB;>'3.H;7*HP_&H],>-0_"Y4 B+UISC(EX
M&X$XBB+2HJ3,!GD45F'V0PHMX-$[5XRY85D#V]ZR!NK>RQHTN'V['P[VTCF*
M7XV*SOPH7M"6H^4;?XW1NO<*NNM;9QOK+Z"W_H)MK__YN;?Y2G9W2Y6.WJ"[
M.]@K%3MZ_-VWR:/E6YN?OO9VN_C]3WBOOS_WWKQCB-[3WOK?@RW^_G3CPQ9%
M-(KM]=>E:@%\E))'G&!%M-*<0!">>$$#82PD \DJK<1DU0)'17*" C*L!"^8
M239Y36V0++ <T^11])$G=K0*X[J?MZY0\,M[/ER%@N9Q>@?[!^=AE=&3C?=5
MJZH5/,*6DA\#Y52E7"I?((<#]Y$8;BT))G.O(#(#_NE7*Q@Y$OH_-OUJ4^SF
M#D5N:G6"6IU@SM4)[&(>R-]L@-,= >=5 4YS+/]'T8);G,V_1=&""_H??:;E
M)17P"BVPW7-XPYH.-WWF)9R^Y2L!\;:L0CHZ'HNS&<Y(_G(#+*BKYC:!R5OA
MX9G0M[<K6^ZIF;6ZXY3+YGQ_CA3Q1C]OC0_FCBKXR >SM\6[_-59[^P5W_ZP
M!;W==W3[PUO87@]\ZZQ4]-W"^_TYZ.Z]_S;I@]G>W3K;VNR*[N;V8'OW$^^M
M_SG8VMWYW#O;WFTJ^NY^/MM^\_YT>_/U5:<9HZ69,0%$RXAV8=9 /-.&@.=)
M,<YX\ [94$Y'+F\B7.ZQ/D-EF,HP,Q<(K@PS?X:9]/*"\"QXG8DSO!0U3+YT
M[I)$22^Y-BKI[%?6]/09B]G4KP4\]O!V_PMNO5+Q_J(_X4X\>]73_R" IY0@
M=0]*QODJC$B@EXXO5H_>R,6C7&KHOMB/_QZFO?[)7J6(VU#$=$ =/$N*@D$E
M)*=2=AHI(A8EA*>LG'8RE;Y>DD^?@I@'.&YBVBXQP.Y!QE: W3/ IGIS.!VU
M4P@KP1AJ^=(1KP4CSG(6@ >0C*ZLL7G+X)]D*T(#EE:+XXU)S_X=_2%71YLG
M L[5G)GS?#U)>V?NRLZUX<W*N+=@W"MR!"E7CANT>C3G@%8/0_L'*!#' E/E
M+>\:JV>Z"L0C^E4J4U6F:JO66)EJ3DPUJ1N*<LHL&B ,2A:>@$0\!4]LTE3@
M-H64S<J:G>ZH/*T;WE]VFY3MS6[3]Y[=]MKUAW^[P<F%9+:CEJ0>L=Y?W_M4
M];??;.$]/N%.C/VRVWOK.SO=L[B#UX#M-Z_WNIMOSWJ[[Z=2CWK\C\_;NP$V
MUL.W'G][6O)(-]X@&OAK'._.YZT/6]^ZNUW>*];-YB?9??&1AD 5IY%(&P(!
M9DW)P0\$"3IJ+8SF=JH+CX"80//,RI$+_(B71H:R#A!%4,).)BN5:>\T\][I
M)E=FO1BMO^B[T_X$IZL3[WX].9<GTV8?P2*3JW+Z'?<U3]0&6YPW"GD#\?KB
M#AU:5D<95FXX/"W95VZO:59UWC7LY<$>SM?I__=?AC/]^U%GB-?H?RF<<[1:
M<K0.7?^JTUVNM G%3[AQ[ZO.X:CYU>JH4^'-VLT<'@X/OJ%T.BYY70DW1BZ[
MXTO9'<W-T4[L'[K!X+03<;\<'S0#/MHY&!Z3XS3<0T0?XP8Z?Y+1D)I[7KC+
MLTY)/L.G*MI#'%_\_"MYU )U5!+G\H!^#*6TQ2D?[I]'\E%@3GP8=^7G=#SQ
MB2L:K%V[K<>;"4JNV.'!4;]\^ODP#?!K7]*/%+'_N9SM-]:5Z(^O.(\ZT<GQ
M]5^92A!Y!+5'XI@8OSP7%W_N#'\D&GU"R3E,[C-QI27M<S?XZDZ/5GZ[S E(
M"!<G</+9KWW"G._M"4?$%,NV:Y;^.2J\:5@^A6-RK1E+9V=8!.I__5I;T"MK
M37IN@<[+(HL;UG9K5RWCE63X2W*;)$.7HF/:>Y0]D)0W3@HN>$I"6>E57HC$
MU^[!?CH]IX>,\XZ\@8RU@Q]!5AOT_W."[-K_[KP=L5?Y1-$'OR3\S/$0]9HX
M8C%DQ% HO+\_.D%3YA;_VYN^2;\0N8OX0!WWQ?4'S<J5:P>< U^X+*;#U$P/
M?@1IKA]+G^=Q![#"=GL_I'.GO%=&T!^S7FDZB3QW,L !-_FU*%X&2+_]W _C
M4347.4*V3LC\W[N+_2OA,W78=_K]P;$[?;1#4*J=/ELTT?_^V5_/.I\.T*;<
M;R8+*6L_G';\ :[#:F?RW?'+:&NAHA/Z;H""$TVPD=A$@!X6C":TVOSQI;D;
M?E\17*3CBS-W<E2VQ&AF.2['X<GQ6.B-13LNU9=^^GK4;*5& RA[JW]\VMSS
M?$^-$ZR/TN7MV.R'ILOH](98M)6Z.">C;'1\P"LW(<X$3C).S4&9_[-TK@"4
MN2UZ2/GX:*,?I["SCS#&CYP<X=K@F^.)NG#A9YW7/VZ"((H)%8\1VESIY-QO
M[A50>1JF<5I\DR=?E)I&6QN-Y^O!R2 6](YTM-'=CM)@4*[2:#\=7,1&82NZ
MTA"G*J/JY7[4^BMHQ<\VCI01M^P?C?T./AU_36G_G$8.77&1H/:U7W83JIU'
M)V%G]>)D%3(8?YIX5Y[]X@YI!HRJVGC$,16%K7GHT6</FA&?[!TV]8E''[_B
MUN-G/FFVY?>]>O%QOS_;:,^/S@<,"AJ.?D8S(Y(].M\'-SX8T):]?,ZDXSU9
MGN; X[6^C)3P_YP<%#IO=M51YW]/]EW</3G"E_ZOV0*-<!G/]U$#_7YYH.(3
M.U>C+TQM/XT7Z(*]T @25//3T5%G_,X402SFG/*KY_3\U9$Y@].Q/S'):*P,
M3HJ)@1-\OCK-K$U<)_6;*\0^HK@(WS+Y^Q?_FKSL]W7Z?K7]@^/Q&OY>OG!^
M7&;$3E?<$C\SEOLH888'OI$QB,33BQ\:HP]7SC4[XNC$'QTC!ON- =;@Z 2I
MIC&\+EM<E[?*@BZ[N+CL)_O3"X\+\76GCX*PS'9#?_B\QZ/9W3^X.'VKXP\.
M$ZIWPW0)-DC,L=SOX+#3+U/W]1(//ILZS?<0'K 7S3*^V+]X;GOLG(D;^W\6
M+01-\4_X@=[!_O#\SW^ZHWZK^@L_CMOLW<<RS3P%3Z@5I7%2<L1IQ8G.F6<)
M1BG#)XV;J'R.-C,?I ,FI..6132.P.L<2ACK:9SQ0P7@Z]&5;J8Q=5RCTQ;M
MH/-]IQ65 >&&=-7(]<Y79-"QV7&E:+]\YN_ZKL9/\C2@-,\8\'H:<+$&"[6Q
M\O7GQL;:U!)W4QYKIDL_ V+IC@^.=+/GLR2P_+H$RYVR=6]:;G091[A,=2!?
MNJ.=3K%T4 TK/L.[[=5[R!]_LM>89\XP$^W=7O3J",HLA5T7-(_N5H_X9/+=
MR@D6+Y-VS$30#'SQ;H@0 7A,S/";5O<L#/5B/Y9_7OW@J2L2@-J2]G973\:X
M^-R6W'[S"K8V=P:]S9+N]F<?QRE['[;[O?4MWOVP)7J;[[]N[6U-I;WU=@>?
M\7L[&V_>LVY)=WOSQ][&YF>VO?>6]G:WOFWO!M;;_"=>[\HS1U3H'(5)Q"IJ
M"&1&B;<N$>49*"J4">5(A&A5[Z<'R@:N)-2F9[L%"=FLE(HB)89?S<8ZJD**
M)E(=6'"!W0,)72R/F?O?4B1G:7A0R>EVY#29D\N<TUPJ1;((C(#5EKA2MT^
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M*Z;/,>T4\]YP[ZU20+UR5M$(B&?PE$6AJY!N)YPGC0B;//,A4\)RH 2\E,2
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M^<T0APF1%#$:<JJ)<<@FAI&5CK%DG<+1Y46_J83K:-%']*-_ J)?:\'ZGO2
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M_3,P^OI7)OY==,5S=21<N;F;>&CNX8<:/]%)(X#E]F;=C.#RV*0%!NUI'EN
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M=Q@):1+B)%@ ,QJ1"IPI:YD2-%?NW\*S)>XKR5F(Y!#/)4PUM9(D[K0P.,K
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M%8[ZQ40_^ILG&SJG(M9@)R>(%@<_N*YG;4[UX+!D:MC;L4KQ<Y3@\B9UR1N
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MG!5": BO$R4INI#PG:>L*-+:(D:BG=1@64N<@H9<@-G%<*)9, A9O[H%X8%
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M;?63-]K"X/'F($_"JCS*8*L5>HA'P(C4$X,#K8&CB2G@JC=2=P2KM,A6!,T
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MW>N+9H%4 IAFH2X-D39HH!'#?XSIV5^-3HXON(.#-FG%S[\:C8_'VK8U5IX
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MS]R/L <JI6(69C/(4'F#)1=3L<KA-\4Q);XD8;HW4K9H@[7.S7XHI'&_P(R
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M<5]5$-<%:+/(L(&DC1PX;Y7#-V39H?7NXI5]XMAL"...R''"MY(R"86*(6@
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MS[/JF81>L"I[(@V\/L5E3 [QC.241QJA/KD"L5DH_R'%JQ9\FH8T1;WX!&%
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MT4SIV#=3;U1O@0W5J9 \F$3"P-\TS=Z(4!30WMD% XUB3F],7)Z3,V>O.R6
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M@][*LH3DXCHT6]PU!K:P9J C^[$LNT3+$QT\G.E9IK@JRO.AR6OM3D%^E,-
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M;M/@RO,RU;3G7?'A@Y8- *:HLLF0M3-<)]]?#4^*@E>-YE_FLR3UMLB1% E
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MU4Q<F!R/@P.MU1_,2]NA,<*[PCD9+W2P-<6'"D.)H379FII$1WX7-!7*=4E
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M^',ZTT;<L5)_IVMXI@*XTPD/X5W^VFBSYB6)RPG_HWY1EUW7<^6-M[6U'8>
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M3/OBL<78Z;G-<L11)2KR5&D%N$@N\BP_<J.9R2QF,3MD^AB48X/656:2@L\
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M_#1RCO3MU5736S8VA,&>#JD/:5^F/RV#50"3!Y,YCSL?-7FE3*SIHE=7DE6
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MKC?KG+Q-FQ7, $*LF^R]I,,$.727EK1Z<6AD<'")WT6K+6D9-BI%R!1Q;H
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MKV3/YJU'@,U[Z_>1,)_5&<"IS,17BCSTY)=: .D256D1P=,E5V7FQYFA+7B
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M]08RG\)-:/51W]!#W=$L+047E.M6^!8,TT5V3:,?G8(PF;43,5PBO3 ^EYC
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M%C3+J%H*6;UN[4&;VR&A]J3FQ.3>-5_G;?,-G*Y#347N7+KM-28"6F61M'"
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MRKM$U=1]"974DR+:0"VU SJQ0!/>3_G#KEWR_\O9,R(:;:(BMS'K8\;W!R(
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M^PZ&^:95$(=G4&P1:/^I 1XMIR"F.HNQ5,':#<)#F'#[C_0.P0+"4LVAOJ>
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M46#T*L)F@#4&U!H3/*S]C)ZCUPS:4?;OCJ+RW)54PY*'(9=9B1.()8:;7%Q
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MH\/;C4^T6@"Z*+>1()3E=DT)53&']"WX,]8!K&+'(QW<>>^7=M-&A^.#0P;
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M?IDG1;,P^7 X&D4OF>TLCEYPX2)=(8[Y+'I)P[W"DF(P3][A6%[QQQ'W?>"
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M57>8)!!ZT)O+#E#S:,,E)3!/R&X(W'MB/0*KIE:4B6/)U2!:&M<9* KI(21
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ML+1EF4.8$C[&+@S/MU-"I/ 9]ATJ82I7L\W+T8QLC!0%MZHM24Q'"(A"1!1
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MIIKLC_5B_=2JL*=DAC^]^3]02P,$%     @ <(&J5I6FF,LD'@  6BX! !4
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MCA1 5W=KNF[1=F.20YHU*WN.SIGIB1;6>ND#$#;^JM;L"C@%OK!ZKRYEC&(
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ME(S!B/41]%XWC^PEAT$F]MXE*,B*114#2@;3BHPCA"@]D- 5VTW/TO6>EO8
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MHA+%27;"" =<GP@>ATABY&7CDSN%HX,7CO,#QU$Z?I?S3L7CCQ[DDRHB5UM
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M!8HJ4@5&^ A61,L N&/*"!DU\N1+MV3]ZK&/C?'M%;N$[T[9LSK9/)\@S(&
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M#FH\N#J9A6'5I68\JH[.?%O8!_)%HB.5"%&/GRC'(EC'DB!'18-6NH=DS@.
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M_4V(Z2%/\&(\^3R>P R7NHOD5 @C%#!3(J\7DS@6$34304FIO!"BM+Z"X$%
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MS??,'L;4=5)[2[X@S.@5??GU,X5 .!UP30NXQT1OA.)52,X"MVE^TEY:%X.
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MQSPFRZQ$FYUS,:]9/KE_2UE5!GV0AK*)WGN]FW ^H_Y!^I^^__#'Q0K(I:/
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MU'JV76O,G1OLXVS>BU W4=[*>6Z%=W'QX_I/I!?@/_[M_P%02P,$%     @
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M##D7J>UYR%G$8Y5ES,]?OCSH^'S<S^)>R?6LC-2U-N)B7CH_YJ>]PD];56[
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M6*8:D@1%,,LIC1)-,.%.YQRG'CZVC[64#Y0"U@E>[E_J$7"7/]-KX.CY&_5
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M5&+(;+%6$:M<DY3%7!AV7*S8S,')=!C0BPZWP_;W%6Z% U8ZG[Q=!W =W,[
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M#&/.,$Y(1K#VZN=^/,38".-Z<C@!HQLK7 =.SW10AQ%OX G_U9_7/FCP\-X
MSQ W?$K!TR'#)Z^\TC"HJDJ>#O5ZOYA_*R.URJBNHCP?;/Z[3<Q\OUC]2ZV,
MR[;X.K=;@55(UYO%LOY5F=8S$5QP%FL.,Q0IB#'GT+Q>QOB04A/":9IJ+U]J
M6/''QDC50LS/+\1;S3>!I595\]L5>#).PT[;FSJ M*SCVM"XH^TSS+OD:5"-
M[@UY;BNMMY>CNUDWZ!R%MA6'$?YY#-!!)^:L53NL%)U-Y4,_?KMQE2.N9(XS
M*"*90&,E&YN9FB4PH22/4X;-/U&?B**6L<864_3RRCW"-EB=;>@08/5O3+OL
M]-V V]5J.>7KE3V'M7L8'UGHP..+<(6SOL^.-+09?DGE$_;XQ5M&9IA/&)8)
MIBF%*";(1B=%D*,H@UH+PB*5\90X-?WJ7=)QFMM!+*K;LO/,2,SKY[:D1T2_
MPTWQ>(SD'\4>_K_$]!W<RNVX$-EX^U=U#,>=N762$,1SG$<PHS&#F&4"4D$2
MJ)(XRN(4$42<>BP=/GAL-+^1#5CAW)-8]K!J9]1K$.B9 -V4]\I5.:5IIQR5
MO0<-EIMR2OQF3LK)?^_:G?562C.;1?W'N^E<Q1.1,(13K2%A20ZQH,9K%)+!
MU%:8XYKG"7/^[LZ.,K:/L!(4U"+>;/X"K+#@P]SCNSP/[.6/- A</7^QG9'J
MT-&U!8DK&KN>>NK _5U;%#MN\]IV<3=G[S>V_$.5KOPNRMHL]:+.ILX2IJFD
M$G+!# ,@VV/"N&HPPBB-293$N?3RV-J'&QL5V!)PT ST !ZV<H-B*[B?$W4!
M:3=/*!Q^/7/#3M"]I(^=K.'<$S=, OD8%P8;U%%P4_S0VG>\*YP=@28)U5H(
MDL.8R1AB*A"D+$T@DT)J)2G7"%]K1Z"QD4?KZMA6 MX#V.YVA!=<SVE'!"F6
M[X1$4#L"/;\=@7SL"'2E'7$KQ'*MY*:^A<W5FE?AI8U?36(M2)P9(D@HBB!6
M.($T4L:OSSGE61:3/$63;VK)%QXA[9?']7G7FZ/W]\K78I<=<^I0]HI_M_V_
MO>T+MQF@228RDE&8$Y5"C,U_:*XIU DBF5!I@B+I55H@-/X#EAEXKCEP,_6"
M(]LSBV]>Z89T);15'L$[!TB[Y JX0Q0N0\!AS*'S MQA.)$-X'%SQ\7!+#IR
M.ENOIM^:1N>NSR>)J%8Z2F"NJ'$S51Y#DBD%(Y4@I;.4BMBKF\&E <=F*S;E
MW?>7_#NL.H/N2$,!H>R;@:Y#T9]^'*$)Q3R7AAN6=!R5/^(;U_LZ%E'95F/Y
MH)O'4W46ISVE*HY*1A9WZOOJA='NCPG55&1:)#!);*MY)3CDF#)C'R64,L5E
M% FO BK7R3,VHBK3.TY4F/6LH7+E)+DQUX#0]TQL%V(#P!<K-"BE#DAO@? +
M513E2FF&+8@2!KJC8BB!'OL,+:NK@->W<[&T_;1>J>K/U]_%;&U;)6S*ZGTR
M>KS66HG5A&&11[&@T/S%,#&-;.7<B$*5RQC1A! 6(Z^0U4'%'YO+:P,X?Y*U
MW#^#::V)K> MSK58'K"CLO_KX;8&C'?2>UXR0O5LWJ9@;&  /VV ^/D&;+'8
M51JU:( *CI'T>^X\C6-H$.TO_(_34;KSQ 1M0=U=BF[+J%F;I\4'?2N$C=(T
M(WQ<S*;BJ?KOSL;%4LA<RQ3B%.<0,]OC),\3B#3F22J-,Y*D/HZ(V[!C\S=*
MJ6WFP4?SU$U))[]UR1%OM_4D/(H]KP-; '<B&THOQ05?ZC][\1[\D I$M8Z#
M#DJ1?D <4IOGW1U[3MOM7AL#8)BQ2B5Y_=TZ%VJB,\$SB2DT)K=EH2R&)&8:
MXBB7.$-(:(DVG9;<>.CL6$X?S7Y7I)[)IQ35L^WT623=^.4Z= 9J0ET>Z-1"
M;A/%:CG/]XSR[T9]"8M03:G/CC-L;^I+ZAZUJ+YX0S<VV.X;+&Z%,9.6ZK#J
MZF[;UE9GG41IGG">$ICA7!IS!2E(19S#E&(JA)":9+)#-S9/,3K0QQ!-U3[6
M!9[*-3A %*'OY+C13A]8#T-&&\EM(FHM.W H-1V.I3I"%XB[?$<?E-$Z0G/(
M<UT?TXW]WDSGMI/K.^L$;KOU;$1XM5;OC<UU]Z>:?5-5H^B)X&E"$TX@32@U
MAA%'MAR5@!RK),L%BU'DU=?+5X"QN6SF'<5^G.8-N1NI]0EDSZQ6BPY*V??:
M?!F:XPI\9%-Y _ZEV#),GL6UD 5B,^_A!Z6SKN <\EGGYPS<E;<N4_EAO2I6
MK&QH_4\U_7IO4T"_J27[:LQ-M1330GU<3H7ZM)C-S.IJ;YP8LR_-&<M@Q%0&
ML8X)9)'$D.4TBI14B$?*AQ*'5V%LI+H1&X):<+"1')2BVUWZJJWK0#U[N[\<
M;N0][BD?\+R_8Q_?;:?>!A W8 /%N;?HRRTORIZ% 3<"GV\FG[NU;W<%?HPF
MOU=/4+!VO]=+TJ$WC*V(.5V5J_;M7-INGV9<-1?&#WDWG:NW*_503%*B518I
M!O-4FZ60"6:60J6@S%'.DT@@)IV*U3J/.+:5JR$S,$*#/:G!%RLW* 5W#&]U
MA[Y]H>D%T+X/]9\-2X_F+J$Q':B;2P!L_9JW^.#4VJW%Z4'#M6?QT6NO'XO7
MC=U#V.KRUS$6(E-9 I,X$Q#GN8(DBB.8I&DD&<WB1'K5 ]X]>G0,;"3S#^7R
MJQ+>2?F^V=(>3_50$_Q(UX!Q0L]2 _Q(H5/Q-4%J?E?'5)\-EY?FW,;;F&0T
MS<S_<1C;A$2<,0$YR1DDC,L\3FQM;J^/\<PX8_LRZ[/3K9PN_I<7KFY?;P"T
M>OZ4NP#E_6%?@"'05WYNE$$_^0NJ'G[_ERY_GHW)-XNE5M/5VKQH;^=5%-\D
M)YA%+,UA&L4$XDAQR!7-8)HIQ%BN>2ZD7[Q*#U*.+]+EI=V0GLV4!#]-YZ"P
M^A3G(SD&F\UAM@J[SM"/MQ?8T-0&_E>ZCF>GKV4B1K*5=TK"'VJOK@7BT)MQ
M;4/Y%Q>JS_B?8L3OIJN9FDB1(,Z(<8BI5A 3;IB>4PD3)@76F2:2.J6,GWKX
MV.S$4B@;0!2CG_C/F] 6QX:^)]%K9]9K,>F9$GWA\"H3=$[O3M6!CAXV6%&@
M<VHT:P&=O:;#9OA',T,HBN-ZVT!P%B412F%&;4Q@E-C#7R1ABA-;4U2I)(Z=
MM[WWGSVVC]-*!JR('GNN!V@Y[%1WQZ#GCW$CV.6=EHLP>&PR=X=CL.;@CU7&
MBK6T]&+Y4!EMCVJY8M.YS9A;+4")VZ;Z]@UX-5TJ89BIS,E[:9;0]6S%C!EG
MDY563S;2VCS/UK:PVO\2:!OZ-)*M&\X'MPRWM7Q:UKU-Y#.7=/-0_\FLM5-N
M1W^RQXG%^\5*[9*PM]LL6F.1I\86P4IHB!/S'\82 G5&LBA6B4R%4WU#SW''
MQH0;L:N<TE)PVY] @9WHG7>X7*?"S67L >">:380MMX^G2=2@?PTUU$'];T\
MH3CTIWQO[W["94_/]G-<W[#I\A]LMFZ,-Y%12B4QOE/.L7&@<I5 HHB &<X(
MY4KDN8S\:C$ZC^WS70U3C]$*"4HI_4_*W.#F1J,<,PE%DJ75>2.-!(.I(#F7
M+)<\<[*(>P5[J./(9I6)O_6%N/O197 <ASC9+(W$HVH-NQ>YL3*$/?ST0BO@
MV:C;N(,?G7K!<>IDU>\! Y^U5+['V[E9G$JWJ2BS#N_NV;S>YMOV!3J(N/N[
M7>Q>L97:*C.A.%,8$PDSE")HTX<AT8F"/,=)+ P!9I1/'LN=PL\KMESU?$ 3
M4#4?;CA4L#^:V O]Y>KK=%XZGIS-RN02>]2S+J3U2:LCGZ%.?$*^4URB),]$
M!!7.,[.L"@&-YY5#E1-,"492D,T[]7K>]Y'?L[Y1&_4&>I]4^>?_72]3S^>-
MS_1ZC/^ <KO!M46FKAJ],MCLCB^W\)Q(9"@A A8CX&#+#W>TV<.</_=9:$B5
M?HS#TQXF,=AI:Q^R==QZF+&B^*#+$K'OMI'CL51,2A1#G,8)Q'%J(W(PA0IE
M).92">P7VG=RE-'YN%9(>T)9BMDA,K\=4T?/]EJD^O9B.X#D[["V@1#*.3TY
MQK".:)N:1TYGZ\4=#G_-U[18VHEXJEO(%K=?EZJDK<UY,(DHQ7D"J<BPH8(D
MAD00 ;% "1?('I XL8#;<&.C@YW 8",QV(KL<5YZ&6>'D^2@Z/5,$:W =3EQ
MOHR@QR%T4"0'.I>^NY\6X*&4#I3.7 'TPAK:"LQV8!<;L-E&H5#'S<Z8M9Y
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M(WZ[UMJ@A&7H^B$#F=[64<?B@-%V7*>9[P^R;IA/JB_X?B&^/ZZ6FX?'#\H
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MKMAYJ9=MT/P-"VF;@W.YPK;%<SKN?)0RH'79MBF/(*1()" CA&H-XU1Q74)
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MX+/Z.DGQV(B1^*;609AP#,1EQS,]:4&?G7U<_._90OVG^O)$L9Y2&-(LIA%
M-(8 0J;FLFI1 U*9(BY1'&)N10G'38R-#M2;#,I7>58;&(@K[[0IEF9<T \A
MSSR@C0.S!=#F!8U]#O.VS_KN*DW[N(%AL[+/.GB4A'W^RNX:_G4*4IT=G$ )
MLS21(&<ZBB-,$2 \IT P$8<ICN,DM-KT/FIA;)]V.[LM^*72ZKLK#[7>6"X9
MC\$T^[A[0>3YV]Y#QX]V_TG7'>KV[S]_<,W^D^Z=TNL_?:%]P.;;V?KU;B7(
MVR474Q9F(6:< ,EX B A'!!*<I 0&I,H"F-"C%/^V@\>W5>LPYFU<8&VSCP0
M<P^LRY]K'PA\?Z5FWEL%6)YRM5-,Y=Z#!@NC/&5^.W+RY-^[IMO><:ZZ4PLR
MK<G\_YT]EV\3YF&4\0P!!!%2(VF. ,Z9!"ED"8](A+@PBO.YW,S8/L0Z@;0V
M=1)4Q@;*6LLO\P*RU[]3-WAY_FJ[0M4AV?82$CUR;4\^=N!4VTNN'6?:7KRZ
MVQSZ\.ARISR+8HE3$:IU<H;+8.@84)DF  LA9"RR1++$9BY]MJ6QD<!GL0[F
M6NEP>_IB-Y,^#ZG9C-H)4+Z__MI&G1M1G6)X4NB]"H:CN?;Y=@:=<U]U]W#N
M??V&SH'"RR>Q+9K]27?4;+EXMWPBL\4TXSI]BD$04B@!Q)(!$N(,Q$2F49J%
M49(9E;4V:FUL_%#+5>^JP#?F!G]5!MOG@%Z VHPSG 'HF3=Z8-<EXO8Z)N["
M:2^T-72L['6W3P3"&MS44QJQ5,;4\;2M"-H_!-%"X/Q^\56'2:T4EZD+/B\7
MJ^:?;T@QJTH>[ ;26,@L%WD&6!0G "9Q!C"47,U-9!0+*FDHHDZ*BLY,'!MI
MM6M[5/5I=%7+RMU@_4C6@1[#&U=U+,I.KB)0GR<)MLX'5+O;4=+1W3M@1HRW
M[5G/;-KJHMJ5,FUHTNHKO17<=JBNY!)XF:SY ]NU,J4[ V\C:.D<X+,ZF.Y;
MZIO%KS,AJW3S3.:)X)B -$49@#&! (<" P8A3F26H2R"W7+XMVV,C<</<]/+
MM-!>^?L[.*_O3#D R3,E=L"G1^;^$0(.\O9WS[Q1UOZ14^=S]H\O[9@(565=
M_8-4T\ZW5<KD-.4P1VDF@<P2!J!()$ L%$#/\3A,TE3$1M_WY6;&]HDW:8HO
MM9F6"4>GH32;+?4'R//GW6#36#@):AL=9OA<Q,!5<L[I1H;-J[GHZ%%*S.6K
M.VAB?U$OQ:.N(GLO&WW^MC2_6I*6V39E3N9RH^:U7\BKGE&HBXZS-*<H4V,^
MY#'((LH!)"@&& D$.)$X(;%ZLS(\?1$KNC02TG9JG,T'U#;1WW>T=4^O!Y]K
M!\O%@FA<U!G3I'8N>*Z\*Z\@VC\R-YQP>.CJRUQVV^[SS'^[?KN70>-9H*P.
MMKX%C7/JAZ!Q+ZC]*R\]D0=_L[ZTD!V_69\.I%3^_5%]7T_:<OU1FGVA=4^?
M^E27J^I+57^NPSWKC9X?8B7TK9K!>< WU3Y!L*CCG=5]SV2UUMM#S:_6*[(H
M"-/N_^9(,=U+9UX467?;XG"Z[%Z0VI-R]]-"AQG!O@K.]^4;H6-&]2+C?B&F
M(N<L2P0%492G .9A!&B"$*!AGB!*24A#(V7GZTV-;45@KK]E */!Z.D,',^C
M84_%+%OD+,8J9P@.-/8,I3UF#LY%+K_\A.&XV<B3/:XUNZ-C#MRN6OC)7)HR
M0K?.RKM3H_F+MF#_4$6D/"<D3@&%D &8(JC#_C(0"DQ%'*4BAU:EROJ;-#8N
M_K9Y>B*K5STKJ^T.?E?3HW6M^=7*=K3,MNO?>69[/,-VB><1X&H67^7()&@\
M\7K^Y0Y:5UF _0T:-F/0&8!'V87NGMR-G$L-,=WB2CRJ1F<OHHJYT+5P/XOU
MO?Q.?DXEY@Q%20QH3', 8YX#C'(!1"I2!D/.4L&GZ^6:S,WHUZ11*X+=-NUQ
M&:S;:+03VZ8'#T2M<W_1H9F6N4U&V(<)YC"*.6!J! 0P8@F@E'* <A@F>1+'
M";82_W6._0"#V_T9U#W ;398N0;1\W!4X;=G;U"'O/VB3?YU$NCH8C5W4':[
M&W=L4'(TLA@U.>C880/"X>A@=6_OR?E1K8//R[7X)]'3EG5QO_JJ13**W;2.
MA2'-1$X!RS(,( QCK4H>@2S'L1H7\HR;%;[K;<G8V*H=T]88K;<O*[,[3[\M
MN\=ZUNT/=-^3[1;>)RNR:$<F)[IBJ$EW-V3=S[4M[;C5%+L;7!=FUAT?V)%0
MFV#E>_F6%(\?YLL?Q;;T7!HS@4A( 8EX!*!@$""FYG:2XCA.*0T9S*TX\T)C
MHZ/%;7"]^DZUM4%IKDEY.7N@#=G/$7R^":X[<O:T90")*V:ZU-2PY&/@]!&_
MF-S3X;"IX:7=2(X%$CG"'&18JM5W$JK5=Q1*(&!.LS!5<RUBM/EY^O%CHXG&
M0(OCD6/(# Z3>@'A^8/?3E6,DA=- +$X(^H%S( Q":J5V4H$?%:P^5+'?6MV
M_-&:Y*VJ2=ZL*#:"_[:;_^G]\/IOR[;.J7Z86,U>2"G67>S$NLOPA ?]2RV$
M6LTDRA_+I^@CJ>?ZJ+I]UR^;8D/F\]<R,&+]^FN@>:>\K;1HI9-92% \"S:3
M,Q8\:[7!X,=L_:BC)@(F5FN]K[2>J46Z7"DLVAZ4SJ[%8C_4(EB('\H%NJY:
MT(9ID)@.JW@1A2+^0JM[DN!1V:T,6(GU9K4(GM5L:*$#*WX+-*XZM4JA*J58
M"<6> 17K'T(U]:.-'U.>!<OZH&'61'"T[:M@+R]^V)#R*$+]4S6O$6!5->9)
M\$/9(4BQ?92^4_Q46"X>M-6*3LO7J6I4_W&Q7#>/WG_6;\'=O%A.RE_-9U*4
MP*DW@C1F:3,KT)Z:="+EZ*L@JT+;,9N+$_>J5W>FX[4K^_0CVC<_E;5O?@O>
M5>]@]8#U;%VM1:I.4#^T7@J-F[I7JM=3F?_C\BM9.4,>'E;B00TVK2B<?D_D
M^F'EVZC<9H_E[TY\.%5?E%J8>IDT*9^IKZU>5=WAA[=O[]9(M>YU%9YSEILN
M'LL>WS7<4>Q9B_>.7\]?U3%PO<J.:6;#%$HJ=.U<EL5$+3L$ C2E F1<"Z8P
M];_(:JMF__%CFT%4UEF&I^\#9K9\Z Z#Y_E#G3_II7#W29]=A9_O/WS8L/.3
MCAV%FY^^JN/9VUZ9M7(;XE[^652Y;:WUQ38Q]LNRF.EQZ/W/M=X.5L3Z:5:L
MIS&-((Q) D@6:TF4G &<0@18&$48)AG$Q"H?Q9%=8^.%HY*&I6=@*8'RK<HY
MG@1[:^U=1G+C8?#7SL?@_4)-3E;E5-=R[\)5SQN>5@W?G[X/M&[2E?8'8&Z!
M=W5&YLBJ88_1W$)Y=-+F^/'=!H3/8JWWDKZLEB\SM:A[\ZHLX!\7=:.+ASH"
M1"<H8$*1C(@ :1YQ+2D; I2Q%(1"QEF..0E);!.28=[TV (S],EUF0Z@%MSE
MLNQ7G9=0>J%71++Q("!;%^S(VJ)7S/C8#]:>*5?#7.X]?VF!^\N?#>1;XX.[
MZS!;$ZD]8HZXTJ+A0>G0'I!#QNOPA.YRV+-UN8MSM^!OEPM-LT*U(8IWV[V[
MW4YE2@0,([56C4(1 YA1II.K$Y D$$4II!(FS%8KV[SYL<U96]:7VR\[^VU9
MS+(;S)C,'[B>V>P\KGI/;6>[)_G ;K@YU.^V:'QP<6][8$XI?W=X2C=^^RKT
M1KW@C>1AH_F/LA01@8!DD5J41RD#E*J?0D2HY+F$/+;2(CS=S-CXZHZQS=-F
M3G3>P3LA9VQV7@+!!DTS.NJ/D6?::0P,MD*E[N7_+X/@B$/.-#(H5UQV]) 3
MKESM-"WT^X_E%$LHB)0""*E6:5#-9@!%(0<L2^,TEA%&W&A3[GI38^, ];*D
M3I(;-8P&)_G.P/'\\1LD,RJ#G2'G)"W4$L'QI(5>0M)56F@+G(YIH?H)8T@+
M;7EBF!;:OJ-OY/G[I^?Y\E6(;V+U,F/B3&7'^;Q6?[V77P5;/BQF_RWXE[(@
M[MMET0YVD2BG,0W5K"M,(( DH@#'600RH>9>+"1Y*NRJ*_JR=&S,W8ZD_OBD
M+EIO8ZKKLHU[56/K$H0Z$D+' &RW28LJ"[7>3^\<\>[ZM3";0XZBLSV/1%?3
M4^N>K<)WWI+GV9K,M5^3X*Z*01DF<MY3#SB/K'=MYXTB[SW!?3XRWU>#W0:D
MEEK,W8(?9PU,PS@F*,8AR%)" 8PI!8A@"!(NXP13DL;(ZLSE6H-C.VFI4F#G
M.ZM+>BCV4FZJ8$<[RK\*O!ESNX33]U+@ ,/WEU&SIE!3*!PQX=7F!B4T4^</
M><GXOHXQ>2]D-M>CYH?EZAN9BW>"KK]MXSC5N+I::V+3E%;*5$\374 @CQ!@
M*<IU6 \'.$<QH%$H4TF3*(+0AFYL#1@;_6PM#+2)EO%]MN";48Y/2#U3D#8U
MV-FJ9G:-+T N5T![4\[V3""WCR+LB)NK.$/;YH>-1.P(SE&L8M?G]% 2J>(C
M=8WZ6N"90,(1#W,0BE0 B*  *&0$2,%"F"6,I(18RU<<MC*V=72EMT ZQ"&?
M!M&,C'I#XYEQ*E0J R?!SD3'@A/G$'"I,''4QO"2$N?</*DA<?9B#X'+4PA1
M FF6 Y0G!$"HJ[5&1!=%(J$D$-)86"4Y7VQM=)_^-C)UKJVU_?PO FM( Z[@
M\DT'UV-X!XK$=<T0%]L:3]3L6<8PNLE-75<]\6#3*,$Y$RD!&<1JDL!C#"B!
M&(1IFJ<BE9(E1A*Z%UL9&U,<UW.=E"7,6/#+;!%L"K[[@Z6NV&F0S=BC-W2>
M6>.XPNLD*&WT5]MU#P)/=5VK-FY:TW7/S6OU7/<O[L@%)KN_:LZB4Y<%O_M!
M5KPHMR#;?]>KE\_+];^+]6YON"V:.$4II5+]CR(372\ZS4- 910!F60\3L(X
M(\1*/V\0J\?&57^J/S8[ 47K.)"UCP.9]:[,,&^ (?&-K5]O?0:X]34HG=UI
MUFHGM:96\*I&L)V?S=F@0R(>LDM<$?L@-@\[4 S9#4<#SZ"-=RX3IU]\-3Y^
M6<YG.LIXFTB>0)DCEE- 1:JS&00"6$829&FF_R(HSNTR[\\V-;8A8V=IT)C:
M6>KK L"&^_1.8//,R!T1ZU))[@H8[JK)G6MHZ(IR5QP^457NVAV]J.)BJ9JZ
MAMWV%<\Q93 B,4A$+@$,,0681QF01&1)'G'!I%4F00<;1DHNN_IAY'3]L&T=
MQK[48]5A5ISDJQN&(2NW/="5RKI@Z);CK"RX!?EU@>@,*W9Z5,>0+%$40NQO
M2&[#D>M52_%5:,DR]5"=GM^4_YVF4(@\A@E(PQ@#B D%2/ ,L#2C:M7/4Q9R
M&];L;LK8R%._PY8!6MV[P8P+AP'7,R563DR"HX.-,WD*6W\J?9)M77"'86"]
M8745(-;=D&%#QWH#=A14UO^)W:CS(-KC(!;DS\5*5"'=NI9 (V;R@<Q6_R#S
MC3BHX!1!QB"2 L"4ZADH00!!#$$:)4B&F"40)C9<ZM"VL9%K.X7B#[+Z3[$N
M9T<[;^N0^N*Q#/I\4?[J6=1L$>S<#K3?6YTBRR-DE_UN1MXWZDW/;&X4'W>N
MSR:!=C H/?2:*^$!>T>4[]*R0<< #Y >#@H^FK ;);B83=\OUFH,NN-<?3;%
M6_7C_>K[\L=BBB6/.1(4,,@Y@)Q$ *>*[9E@<<@BAI"9G."%-L;&VI6906VG
M6K/J?RU7@;;5C'XO 7J91AW!Y/O<O0M"QG1F@,$)6BH$^^UA^?*_U-T5(ZD?
M=D1TZ9F#$(J!4PTQF%S:0:&@$G,2%[)X%:IZ'?^]E.&6ZE.;4H+2!.<$I$PF
M .9Q!F@F,X!B%$(8QV$4&IV7=S5@;-2@WJ>L4;ZN3;1(T>_2 Y?I8@A</7-)
M;?V5Y7&5QJ_]*.'_/A3\%KH)GKMA(#4%7]UA)[/0 \N+X@M=GCN<)$,/K_>$
M&OH\IZOL5:GR](6LUJ^U2%/&\Y ('@,>$J8+U62 0(E!1G,8BD3]@EGI4!\W
M,;;!H;8P*$VT%;HZPL]LN=T/%<_4O@>(%W&K<\X[$[8Z:F!@4:MS#AX+6IV]
MLK>857V*,\5YE!"FHR5YFFHE%0)('$J029*P4#*!D9&2RODFQO9%Z_W:?PWJ
M-)G@60<]+@V7@!=P-)C2]4;'^^F&KF_4FAR\O9*]98I-9YVJ#A@-J4]E@U4?
M1:JWI]+<C)2HW@Z9O';=\@O*4X=7=E2<TL&#]$A?9!?T^N9U=TE]-E-&%-9A
M@O^H8@P77,OC,/7C]Z7^U?VNOM(_A<Z64=>\*!\>1'6NHWZO)4CU<?B&S+^+
MU5,T19%(!8H)H%A01:PL!C3G" B1Y0D.D:+7=*H>0I?&(E6C<<[F@VR[Z.][
M;"P/2&5ZL&IL#]C.^++TUR2H@Y[U(D?44.B%D/ZUKGFU+DO/<4M1J]%TCJD*
MUF@,'M$0V Z9WQ-":^&B5?%/AM:W8^B+2?"/W5OVOO66Z5^KJ]H5V[8O;XU4
ML(4J:&$5:+ <:G"-KO]=B7:-Q[%A5;[&X_>9]<P(+>PQS3B6,3MRY(V=(^]W
MY10_;\K] @BC/)4D!X1G>JM>9  C1$'"XPC'L<Q98E08>&C#Q[;FJZPJZVIJ
M]XJ@V-#_4 YH0FX*D^X5T=R;(FR=ZS<[&.*%L1C[1_8:_)\RLK]OUU.M8' \
M: _8<2Z'Y"','G[ '; S3@ZG0[;O0DKF<,%O40HQ#TDF&84 )3I&,:$,D"RE
M@ A!LR23<<RL1)]=&3:VP>Y2='+MW&VJ8/;H>[-Q[18]ZGG<NDUG]E3?Z8^\
M%Z&>'F;=4-.G/YB7Y7\</-]9:973&29$AHS2' $B,020<PPPA!F@/)%1%F=I
M&,J>A5;^#TOKL8;8^OC*&7!#'&JY2]#IAW+O@BV]T1Y%^19_:5%=H>M0W.6&
MN4Q=O30H_.(R3TF'O+ZKW[?O:E%2#2%?A3YRG\82,T%C!G 2*4Y7_P*Z;!X@
M.!$D3C'#H9%J[*5&QL;?C9W!SM"@LM0\ OTLH)<9W!5,GMFZ T)6$>C7(.@4
M@G[VH8/%H%]SJQV$?O7:;JO\+ZLE$X(7'Y1A.L7E;L'_(&N=__)Z+W=I<KN<
MF*G@>4R2A( <ADS-ZG3YO(B$(,YSF<8L11&W2M^VMF!L]- X$.C.#9XJV[<U
M.)1'9=6EIUW*8;%UQ6Y5;M]79LMOKSW@F7GVP=?6E[ W]I]-]G2WA.Z,GJ.U
MLGW[@RZ*.\-SN/KM_J!NS/AQP59ZKO5.5/_]<7&@LC%-(IZ&).% 45ZBQ7$C
M0#.1 HFC2(19(IC=QN;5%L?&?%NIF>?*/CLZNPZP&7TYA<TS736V!K\TUOZJ
M,\P/-7O<L9,Q.([8Z'I[@[*/L?N';&-^8S=VT870EXM2ZK \["GN-NO'Y4KG
M%D]SDK,XP1'@&=$%RC,,2)810$/.(YIG:9XA&UZYT-;8&*4RM5*RG32'_F1K
M;BG 7?W64GG[$MYF-.,(1<\$4P/XK0*P,C386>J.6 S@<$0IEUH:E$P,7#ZD
M$9-;W!0MV\U[]C4,IDQ*&DJ&09Y$D6(3HB5/80Y8FF.8X)R*F-@%-)LV/;YP
MXYWV1[\B96?!CN.$)(PA$(E(30D)80!'/%38LX@(GG&4T#Z5X5Q /41%..]
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MP]4F]M+OMZY<[-:IOT==8R\=Z:SJL1_KG*B^?=I*^I T9&&JTPE%J$;FG(2
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M1S&]KZL:0!D8I1[_>;E85?_X0E;KUV]KM>XKWBWUY&>*$809SB3@21G.)#*
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MAF$>0R% &D,"8!Y)0+,P!!)CCJ5$,D5628!'+8R-*ZI=5;:T79@=0V?&![T
M\<P!]<)*6^=E1^>L[R[#K?>>/WR0]2GW3H96G[RPX^&Y/HQ_HY[)WRZ?]%Y0
M64'\;K72F\?E;.3-Z^Z:>H9R]X.L^/VSOK)X__-YMBIO*CXNOHC5;,D/CO_?
M_Q0K-BO4;&;&Q#0/,[WZB4$>LAS -&* B!BJ'N$B8TCD:1Y-U8UT:7PJ/[ +
M-E]=VQ%_'U_I@ Y14B/OIN"!FC16H4J6D4J#OPR&<04C[F#?X0K:+5#Z%;2=
M#]K>!_0U:%]8(Q"4$&A]E])S+02SA4&?%%9 G$C=:\ (2C0<!D7<J!]=Q5H,
M;?ZP(1PWZIRCR)!;V=%M_'Q#YGK[\=NC$.M/^@O0QFI!>9%!A/,<@YRD&$ I
M4T!1G(,40ICG'$<TM%I%GVMH;)/BVLZ@-#1H+.TDUW\66[-APP5BGNF]&UC6
MQ'L-"4<$>;:908GLFK.'A'/U^CXZ76I1C$@D: H03A0-)(@!%(="L0+.)9,L
MH9!/UTNU*C?<3"L?:_71;Q_N[SW^KMNH@\.ZR&Y9:6N-Z/N]N^QQ1WDLU[M8
MU4-O('1U=E]J_Z]V'UBAQO#IVS)=XYO.UFC+M7S8K#<K\;$H-OJ3_G.AGJ;@
MB-X_/<^7KT*4U]=;L'$B$-0!GC A%, H0^K#S 20*,;J4^510HV4!=R8,[91
M_.V<Z'/P_;08TKA6QA;*TKG@04W,U!)DHYT+UH\BT!X&C8M!Z6/0G/^59U)F
M!.&HFR\3R_"=YYF0*E]JU+?>!!]T+&C57XU#P=:CP\ZZNF?OHY_XDFWT3+X<
M?D?47WMV_<W[S7@X<@MS-8SI9Y9C4Y@D43D^.6IED''-+2+->.CXJ?:%7M\N
MU8IX>PJ1TXC%82:!S)DN,Y=+@$,) 8$PY!&2D,C4M-#KWI-'-[IIXTR.*:X
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M.-"86?;"5>M*KGPJ"4*TDOYARAE%:T>6X6#RTQXP$<\/)H<(>428;-F5*4K
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MUFY);$*QA4Z,9=!!2]JAI01?:B:'CJ9@D D?S, \!$H[D#5.3Z;A,-5:$QV
MZS;Q"046ZRQHH8AXSC0$9018[IUV%IV4#]T^'!VRC=.O:<"-[&#I'@Z-^2J<
M-+([\R^X6'U_=Q)('+-< X0O]1"$OCX_!<%?,"SQ?1U5\[;\E59$9?=%(732
M#GYV>G92I]V\0F(@3<^U.,LO3FL*_#_6WTY\D;EVWP:;7#U?E0DBK19@];*7
M.<N4:7VL-#Q7/3CU3<X;.@- !]9R4WSSVWR6+K/SA?)D$@J4A/&\VTV(I9X
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M0V-3O(I9.T"Y;NN6+/@2/"3G X_:&V$>*LLXYD#]-B7=@.DH/6\Y3S]"Z'U
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MEUYUFC@X$KWSA"&ZM0P8;>[:RH,)C<85!HQ9!BI:#5%[!3$[GFN+_-2\Q<+
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M EZ?S?*E,+((JNA ZTXZV@*$$>"3SC6M,"5C4-+/&H-H,R7C[I:C :J!6CH
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MX@CA?=;E:9O8/4!LUV<?3^$\'Z>^#FWJ3H[4C98E@5N1/8/D:D52"9EV$%Y
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M"@H[! ?'Z*53J"VO5NR%/>=<,A%<!,;KS*$DR!-=)]YH)4U +MI/R]Z%KD[
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M5/==&#61?0<@NDG_Q6D@-UEFHS,(Z2TM+V+#)T5?15T+S;B.MO65[WTJQC9
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M\$^IUQ'2Q^OI++P263"@N-*!\LQ J!ZF*Z0,7HN@;.NKCEY>3[\F(,V_(W[
MQ;=IPF?4^VSUD?35V_(>$TE^^B_:U$I!5CN]?!H1;0Z!F0">-!"44PI"\0@L
MYJ(TUUS$YG-NAB#DJ%]5;X/EYU]5CP6+#ORT-S.R9_B!!+XZSWZ[(G'U#%-&
MIY4)'G UQ,-F 5&7#%F;4(*5)30?&KQF.[V\OAX-+/-A)-<O"*\>4THMF/:6
MF&1L'2:<$%R,''0IM9-PRJ5YK>G:#8T+Q&9BWPQ..\B@ T"])YG0!CZ_FN5?
M\!N>S;]6FJY<LZN7M'1"H,?,@'EG0)'>@</H@,("U,XKDVWK!-$&V^H27+N
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M7F9K*3K>K&?%VF6.J;9G%P>X,:/'OJ*Z>U8NGZ6(,\XEK^,QBR0E0.XA>!U
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MR;D8/22C:ET=LQ#KW#GTHK8%T;5.Y)!X?&ZC&X'3G#8XFPAQ>Z3Z2Z3.\,]
M"W\<NA7&1.=H!>;:X8V3&^*SA\"J!EK)E'%61#5LR_+MKB7MT8.NA2 Z,( O
M]#55A9O"/ /,M2]S+87S7"8@CU?8;&O/YF%K+W9JV^A.%5V[B*6+:6P;M#HU
M4D;!/6!U8$E3-$07)11R73TYMIK9UJF:-@UG_:F";4?A=!!8/%5A_@S?A&+2
M1:)'V5PO7$4$3]$2:,-,0J^1N2$;2S2X=.GD%><^ERX#R:M3)+Z0FS<!29,3
M*3&K4X2Y8."D8Z1PACS3'&)2AT!DSU<L0^%EDR:X[837.SR?RL*K6B_B-()
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MQZ\$5P\7N)%2^6*A]C4F?J,$7SNY(U<B:E2D_IUIP!:/37H-8';$7%O@[P"
MX>\>KGY0_XKD2?_7?_P_4$L#!!0    ( '"!JE; ]$/+W@<  *4A   ;
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M7^RX7N3.JJ4*VXTG\H\+3+1RF7[/NKZJ^9@"_Z$TUP/F6P"^+2>P/FSBE:E
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M-J=\XZN!ZAH^8/"?4IS]!U!+ P04    " !P@:I6N+10%<,'  !C(0  &P
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M[UJG8NT%_A("7-O47B[A 7"@L.M+OO'.O_KT/S]P/X0X^Q]02P,$%     @
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M82TR,#(S,#,S,2YH=&U02P$"% ,4    " !O@:I6.$@4T#P/  #8JP  $0
M            @ &890( <V5R82TR,#(S,#,S,2YX<V102P$"% ,4    " !P
M@:I6E::8RR0>  !:+@$ %0              @ $#=0( <V5R82TR,#(S,#,S
M,5]C86PN>&UL4$L! A0#%     @ <(&J5LI=R!Y*/0  1;L" !4
M     ( !6I," '-E<F$M,C R,S S,S%?9&5F+GAM;%!+ 0(4 Q0    ( '"!
MJE:N5=ZJ"\,  !90"  5              "  =?0 @!S97)A+3(P,C,P,S,Q
M7VQA8BYX;6Q02P$"% ,4    " !P@:I6\\1; A9S  #(:04 %0
M    @ $5E , <V5R82TR,#(S,#,S,5]P<F4N>&UL4$L! A0#%     @ <(&J
M5L#T0\O>!P  I2$  !L              ( !7@<$ '-E<F$M,C R,S S,S%X
M,3!Q>&5X,S$Q+FAT;5!+ 0(4 Q0    ( '"!JE:XM% 5PP<  &,A   ;
M          "  74/! !S97)A+3(P,C,P,S,Q>#$P<7AE>#,Q,BYH=&U02P$"
M% ,4    " !P@:I60GR_E>8$  #P%P  &P              @ %Q%P0 <V5R
M82TR,#(S,#,S,7@Q,'%X97@S,C$N:'1M4$L%!@     )  D 90(  ) <!
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
